"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,ES,T3,ES 2739197 T3,058-619-529-435-244,2020-01-29,2020,ES 13749229 T,2013-02-19,US 201261599988 P;;US 2013/0026665 W,2012-02-17,Dispositivo multifuncional híbrido de artrodesis interespinosa posterior,"Un dispositivo de estabilización interespinosa (10) que comprende: una parte de cuerpo definida por una pared inferior (11), una primera y una segunda paredes laterales opuestas (12, 13) y una pared trasera (14) que cooperan para definir un espacio parcialmente cerrado; un par de soportes de montaje (16, 17) fijados a, y que se extienden hacia arriba, desde la pared trasera (14) por encima de las paredes laterales (12, 13), un par de placas de montaje (18, 19) que se extienden desde los extremos superiores del par de soportes de montaje (16, 17), en el que el par de placas de montaje (18, 19) están adaptadas para acoplarse a una primera vértebra; un par de placas de conexión (20, 21) apoyadas en la parte de cuerpo y adaptadas para acoplar una segunda vértebra; y una ranura (14a) formada entre partes de las paredes laterales (12, 13) y la pared trasera (14) para definir una bisagra similar a un resorte entre la pared inferior (11) y la pared trasera (14), en el que la bisagra similar a un resorte permite el movimiento pivotante de la pared trasera (14) con respecto a la pared inferior (11).",UNIV TOLEDO,AGARWAL ANAND;;GOEL VIJAY;;AGARWAL AAKASH,,https://lens.org/058-619-529-435-244,Granted Patent,no,0,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,0,0,,,,ACTIVE
2,WO,A1,WO 2022/187029 A1,165-907-079-380-594,2022-09-09,2022,US 2022/0017328 W,2022-02-22,US 202163155964 P;;US 202217672520 A,2021-03-03,ELECTROSTATIC CHUCK WITH METAL SHAFT,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic bottom plate, a ceramic top plate, and a bond layer between the ceramic top plate and the ceramic bottom plate, the ceramic top plate in direct contact with the bond layer, and the bond layer in direct contact with the ceramic bottom plate. A metal shaft is coupled to the ceramic bottom plate at a side of the ceramic bottom plate opposite the bond layer.",APPLIED MATERIALS INC,PARKHE VIJAY;;AGARWAL ASHUTOSH,,https://lens.org/165-907-079-380-594,Patent Application,yes,5,0,4,4,0,H01J37/32724;;C23C16/4586;;H01L21/6833;;H01L21/68792;;H01L21/68792;;H01L21/6833;;H01L21/67103;;H01L21/67109;;H01L21/68785;;H01L21/68757;;C23C16/4586;;H01J37/32724;;C23C16/4586;;H01J37/32724;;H01L21/6833,H01L21/683;;C23C16/458;;H01J37/32;;H01L21/67;;H01L21/687,,0,0,,,,PENDING
3,US,B2,US 9582358 B2,016-324-727-458-795,2017-02-28,2017,US 201514700543 A,2015-04-30,IN 4928CH2014 A,2014-09-30,Initialization scheme during dual programming of a memory system,"A memory system or flash memory device may include mechanism for handling power loss with a dual programming architecture. The state of primary and secondary blocks may be reconstructed to a state immediately preceding a power loss. The reconstruction may include comparing error correction code (ECC) headers of blocks to recreate a block exchange with fewer control updates. The comparison can be used to identify a primary and secondary block. The header may identify a particular stream, identify a free block, identify a release block, and other information.",SANDISK TECHNOLOGIES INC;;SANDISK TECHNOLOGIES LLC,AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-13),https://lens.org/016-324-727-458-795,Granted Patent,yes,5,4,2,2,0,G06F11/1068;;G06F11/1068;;G06F3/0616;;G06F3/0616;;G06F3/0619;;G06F3/064;;G06F3/064;;G06F3/0679;;G06F3/0679;;G11C7/20;;G11C7/20;;G11C29/52;;G11C29/52,G11C29/00;;G06F3/06;;G06F11/10;;G11C7/20;;G11C29/52,,0,0,,,,ACTIVE
4,US,B2,US 8050350 B2,199-013-232-992-302,2011-11-01,2011,US 34607508 A,2008-12-30,US 34607508 A,2008-12-30,Receiver I-Q balance calibration,"In an I-Q receiver, I-Q baseband mixer receives a real signal, and outputs an in-phase baseband information signal and a quadrature baseband information signal, a decoupling compensator multiplies in-phase baseband information signal and the quadrature baseband information signal by a trained decoupling matrix that, based on adaptive training in response to purely in-phase and purely quadrature phase training signals, decouples the in-phase baseband information signal from a quadrature component of the I-Q signal, and decouples quadrature-phase baseband information signal from an in-phase component of the I-Q signal. Optionally, a trained I-arm-Q-arm imbalance compensator performs a filter compensation on one or both of the decoupled in-phase baseband signal and the quadrature-phase baseband signal output by the trained decoupling matrix. Optionally, the filter is trained based on training signals generated by inputting equal in-phase and quadrature phase training signals to the I-Q baseband mixer, and multiplying the result by the trained decoupling matrix.",NXP BV,AHIRWAR VIJAY;;AGARWAL MOHIT,NXP B.V (2008-12-26),https://lens.org/199-013-232-992-302,Granted Patent,yes,2,4,4,4,0,H04B1/28;;H04L27/0014;;H04L27/3863;;H04B1/28;;H04L27/0014;;H04L27/3863,H04L27/10,375/281,1,0,,,"Xing et al., ""Frequency Offset and I/Q Imbalance Compensation for Direct-Conversion Receivers"", IEEE Tranactions on Wireless Comm., vol. 4, No. 2, Mar. 2005.",INACTIVE
5,WO,A3,WO 2010/076746 A3,025-185-371-810-776,2011-02-24,2011,IB 2009055917 W,2009-12-23,US 34607508 A,2008-12-30,I-Q BALANCE COMPENSATION,"In an I-Q receiver, I-Q baseband mixer receives a real signal, and outputs an in-phase baseband information signal and a quadrature baseband information signal, a decoupling compensator multiplies in-phase baseband information signal and the quadrature baseband information signal by a trained decoupling matrix that, based on adaptive training in response to purely in-phase and purely quadrature phase training signals, decouples the in-phase baseband information signal from a quadrature component of the I-Q signal, and decouples quadrature -phase baseband information signal from an in-phase component of the I-Q signal. Optionally, a trained I-arm-Q-arm imbalance compensator performs a filter compensation on one or both of the decoupled in-phase baseband signal and the quadrature -phase baseband signal output by the trained decoupling matrix. Optionally, the filter is trained based on training signals generated by inputting equal in-phase and quadrature phase training signals to the I-Q baseband mixer, and multiplying the result by the trained decoupling matrix.",NXP BV;;AHIRWAR VIJAY;;AGARWAL MOHIT,AHIRWAR VIJAY;;AGARWAL MOHIT,,https://lens.org/025-185-371-810-776,Search Report,yes,3,0,4,4,0,H04B1/28;;H04L27/0014;;H04L27/3863;;H04B1/28;;H04L27/0014;;H04L27/3863,H04L27/38;;H04L27/00,,1,1,016-437-275-477-653,10.1093/ietcom/e89-b.8.2257,"BAE J ET AL: ""I/Q IMBALANCE COMPENSATION USING NULL-CARRIERS IN OFDM DIECT-CONVERSION RECEIVER"", IEICE TRANSACTIONS ON COMMUNICATIONS, COMMUNICATIONS SOCIETY, TOKYO, JP, vol. E89-B, no. 8, 1 August 2006 (2006-08-01), pages 2257 - 2260, XP001246289, ISSN: 0916-8516, DOI: DOI:10.1093/IETCOM/E89-B.8.2257",PENDING
6,US,A1,US 2016/0092302 A1,031-887-678-638-564,2016-03-31,2016,US 201514700543 A,2015-04-30,IN 4928CH2014 A,2014-09-30,INITIALIZATION SCHEME DURING DUAL PROGRAMMING OF A MEMORY SYSTEM,"A memory system or flash memory device may include mechanism for handling power loss with a dual programming architecture. The state of primary and secondary blocks may be reconstructed to a state immediately preceding a power loss. The reconstruction may include comparing error correction code (ECC) headers of blocks to recreate a block exchange with fewer control updates. The comparison can be used to identify a primary and secondary block. The header may identify a particular stream, identify a free block, identify a release block, and other information.",SANDISK TECHNOLOGIES INC,AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-13),https://lens.org/031-887-678-638-564,Patent Application,yes,5,13,2,2,0,G06F11/1068;;G06F11/1068;;G06F3/0616;;G06F3/0616;;G06F3/0619;;G06F3/064;;G06F3/064;;G06F3/0679;;G06F3/0679;;G11C7/20;;G11C7/20;;G11C29/52;;G11C29/52,G06F11/10;;G06F3/06;;G11C29/52,,0,0,,,,ACTIVE
7,WO,A2,WO 2010/076746 A2,123-626-457-037-183,2010-07-08,2010,IB 2009055917 W,2009-12-23,US 34607508 A,2008-12-30,RECEIVER I-Q BALANCE CALIBRATION,"In an I-Q receiver, I-Q baseband mixer receives a real signal, and outputs an in-phase baseband information signal and a quadrature baseband information signal, a decoupling compensator multiplies in-phase baseband information signal and the quadrature baseband information signal by a trained decoupling matrix that, based on adaptive training in response to purely in-phase and purely quadrature phase training signals, decouples the in-phase baseband information signal from a quadrature component of the I-Q signal, and decouples quadrature -phase baseband information signal from an in-phase component of the I-Q signal. Optionally, a trained I-arm-Q-arm imbalance compensator performs a filter compensation on one or both of the decoupled in-phase baseband signal and the quadrature -phase baseband signal output by the trained decoupling matrix. Optionally, the filter is trained based on training signals generated by inputting equal in-phase and quadrature phase training signals to the I-Q baseband mixer, and multiplying the result by the trained decoupling matrix.",NXP BV;;AHIRWAR VIJAY;;AGARWAL MOHIT,AHIRWAR VIJAY;;AGARWAL MOHIT,,https://lens.org/123-626-457-037-183,Patent Application,yes,0,0,4,4,0,H04B1/28;;H04L27/0014;;H04L27/3863;;H04B1/28;;H04L27/0014;;H04L27/3863,H04L27/00,,0,0,,,,PENDING
8,US,A1,US 2010/0166049 A1,145-701-454-751-555,2010-07-01,2010,US 34607508 A,2008-12-30,US 34607508 A,2008-12-30,RECEIVER I-Q BALANCE CALIBRATION,"In an I-Q receiver, I-Q baseband mixer receives a real signal, and outputs an in-phase baseband information signal and a quadrature baseband information signal, a decoupling compensator multiplies in-phase baseband information signal and the quadrature baseband information signal by a trained decoupling matrix that, based on adaptive training in response to purely in-phase and purely quadrature phase training signals, decouples the in-phase baseband information signal from a quadrature component of the I-Q signal, and decouples quadrature-phase baseband information signal from an in-phase component of the I-Q signal. Optionally, a trained I-arm-Q-arm imbalance compensator performs a filter compensation on one or both of the decoupled in-phase baseband signal and the quadrature-phase baseband signal output by the trained decoupling matrix. Optionally, the filter is trained based on training signals generated by inputting equal in-phase and quadrature phase training signals to the I-Q baseband mixer, and multiplying the result by the trained decoupling matrix.",NXP BV,AHIRWAR VIJAY;;AGARWAL MOHIT,NXP B.V (2008-12-26),https://lens.org/145-701-454-751-555,Patent Application,yes,2,12,4,4,0,H04B1/28;;H04L27/0014;;H04L27/3863;;H04B1/28;;H04L27/0014;;H04L27/3863,H04B1/38,375/221,0,0,,,,INACTIVE
9,WO,A1,WO 2022/221103 A1,032-281-327-420-424,2022-10-20,2022,US 2022/0023552 W,2022-04-05,US 202217686324 A;;US 202163175218 P,2021-04-15,ELECTROSTATIC CHUCK WITH MESAS,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic top plate having a top surface with a processing region. One or more electrodes is within the ceramic top plate. A plurality of mesas is within the processing region and on the top surface of the ceramic plate or vertically over an edge of one of the one or more electrodes.",APPLIED MATERIALS INC,PARKHE VIJAY;;AGARWAL ASHUTOSH,,https://lens.org/032-281-327-420-424,Patent Application,yes,5,0,5,5,0,H01J37/32715;;H01L21/6833;;H01L21/68757;;H01L21/6833;;H01L21/68757;;H01J37/32715;;H01L21/6833;;H01L21/68757;;H01J37/32715,H01L21/683;;H01J37/32;;H01L21/687,,0,0,,,,PENDING
10,WO,A1,WO 2013/123497 A1,055-682-762-714-074,2013-08-22,2013,US 2013/0026665 W,2013-02-19,US 201261599988 P,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,"This invention relates to an improved structure for an interspinous stabilization device that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further readily compensates for graft settling so as to maintain continued axial loading of the graft. More specifically, this invention relates to a medical device that helps in performing a spinal fusion procedure by holding the bone graft in place and stabilizing the facet screw by a plate that is attached to it. The invention also performs a dynamic function that compensates for settling of the bone graft over time. This dynamic function may, if desired, be enhanced by a movement-limiting mechanism that allows extension but not flexion such that the bone graft fusion remains in contact and fusion takes place.",UNVERSITY OF TOLEDO;;AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,,https://lens.org/055-682-762-714-074,Patent Application,yes,11,6,9,9,0,A61B17/7062;;A61B17/7068;;A61B17/7062;;A61B17/7068,A61B17/70,,0,0,,,,PENDING
11,TW,A,TW 202249190 A,110-055-132-948-183,2022-12-16,2022,TW 111113186 A,2022-04-07,US 202163175218 P;;US 202217686324 A,2021-04-15,Electrostatic chuck with mesas,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic top plate having a top surface with a processing region. One or more electrodes is within the ceramic top plate. A plurality of mesas is within the processing region and on the top surface of the ceramic plate or vertically over an edge of one of the one or more electrodes.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,,https://lens.org/110-055-132-948-183,Patent of Addition,no,0,0,5,5,0,H01J37/32715;;H01L21/6833;;H01L21/68757;;H01L21/6833;;H01L21/68757;;H01J37/32715;;H01L21/6833;;H01L21/68757;;H01J37/32715,H01L23/15;;H01L23/32,,0,0,,,,PENDING
12,EP,B1,EP 2814410 B1,101-519-495-978-150,2019-05-01,2019,EP 13749229 A,2013-02-19,US 201261599988 P;;US 2013/0026665 W,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,,https://lens.org/101-519-495-978-150,Granted Patent,yes,13,0,9,9,0,A61B17/7062;;A61B17/7068;;A61B17/7062;;A61B17/7068,A61B17/70,,0,0,,,,ACTIVE
13,EP,A1,EP 3527155 A1,003-954-931-571-562,2019-08-21,2019,EP 19162722 A,2013-02-19,US 201261599988 P;;EP 13749229 A;;US 2013/0026665 W,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,"This invention relates to an improved structure for an interspinous stabilization device that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further readily compensates for graft settling so as to maintain continued axial loading of the graft. More specifically, this invention relates to a medical device that helps in performing a spinal fusion procedure by holding the bone graft in place and stabilizing the facet screw by a plate that is attached to it. The invention also performs a dynamic function that compensates for settling of the bone graft over time. This dynamic function may, if desired, be enhanced by a movement-limiting mechanism that allows extension but not flexion such that the bone graft fusion remains in contact and fusion takes place.
",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,,https://lens.org/003-954-931-571-562,Patent Application,yes,11,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,0,0,,,,DISCONTINUED
14,US,B2,US 10188434 B2,175-453-618-662-320,2019-01-29,2019,US 201314379139 A,2013-02-19,US 201314379139 A;;US 201261599988 P;;US 2013/0026665 W,2012-02-17,Hybrid multifunctional posterior interspinous fusion device,"This invention relates to an improved structure for an interspinous stabilization device that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further readily compensates for graft settling so as to maintain continued axial loading of the graft. More specifically, this invention relates to a medical device that helps in performing a spinal fusion procedure by holding the bone graft in place and stabilizing the facet screw by a plate that is attached to it. The invention also performs a dynamic function that compensates for settling of the bone graft over time. This dynamic function may, if desired, be enhanced by a movement-limiting mechanism that allows extension but not flexion such that the bone graft fusion remains in contact and fusion takes place.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,THE UNIVERSITY OF TOLEDO (2014-09-17),https://lens.org/175-453-618-662-320,Granted Patent,yes,44,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,3,0,,,"PCT International Search Report, Application No. PCT/US2013/026665, dated Apr. 19, 2013.;;PCT Written Opinion, Application No. PCT/US2013/026665, dated Apr. 19, 2013.;;European Supplementary Search Report, Application No. EP 13749229.4, dated Dec. 4, 2015.",ACTIVE
15,EP,A4,EP 2814410 A4,095-715-589-441-816,2015-12-16,2015,EP 13749229 A,2013-02-19,US 201261599988 P;;US 2013/0026665 W,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,,https://lens.org/095-715-589-441-816,Search Report,no,8,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,1,0,,,See also references of WO 2013123497A1,ACTIVE
16,US,A1,US 2019/0150992 A1,160-778-705-510-617,2019-05-23,2019,US 201916258967 A,2019-01-28,US 201916258967 A;;US 201414379139 A;;US 2013/0026665 W;;US 201261599988 P,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,"An interspinous stabilization device is provided that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further can readily compensate for graft settling so as to maintain continued axial loading of the graft material.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,THE UNIVERSITY OF TOLEDO (2014-09-17),https://lens.org/160-778-705-510-617,Patent Application,yes,0,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,0,0,,,,DISCONTINUED
17,KR,A,KR 20230170065 A,199-916-422-391-759,2023-12-18,2023,KR 20237039118 A,2022-04-05,US 202217686324 A;;US 202163175218 P;;US 2022/0023552 W,2021-04-15,메사들을 갖는 정전 척,"플라즈마 프로세싱 챔버들을 위한 정전 척(ESC)들 및 ESC들을 제조하는 방법들이 설명된다. 한 예에서, 기판 지지체 어셈블리는 프로세싱 영역을 갖는 최상부 표면을 구비하는 세라믹 최상부 플레이트를 포함한다. 하나 이상의 전극들이 세라믹 최상부 플레이트 내에 있다. 복수의 메사들이 프로세싱 영역 내에 그리고 세라믹 플레이트의 최상부 표면 상에 있거나 또는 하나 이상의 전극들 중 하나의 전극의 가장자리 위에 수직으로 있다.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,,https://lens.org/199-916-422-391-759,Patent Application,no,0,0,5,5,0,H01J37/32715;;H01L21/6833;;H01L21/68757;;H01L21/6833;;H01L21/68757;;H01J37/32715;;H01L21/6833;;H01L21/68757;;H01J37/32715,H01L21/683;;H01J37/32;;H01L21/687,,0,0,,,,PENDING
18,EP,A1,EP 2814410 A1,134-074-751-912-272,2014-12-24,2014,EP 13749229 A,2013-02-19,US 201261599988 P;;US 2013/0026665 W,2012-02-17,HYBRID MULTIFUNCTIONAL POSTERIOR INTERSPINOUS FUSION DEVICE,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,,https://lens.org/134-074-751-912-272,Patent Application,yes,0,0,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,,0,0,,,,ACTIVE
19,US,A1,US 2015/0012040 A1,161-921-455-184-067,2015-01-08,2015,US 201314379139 A,2013-02-19,US 201314379139 A;;US 201261599988 P;;US 2013/0026665 W,2012-02-17,Hybrid Multifunctional Posterior Interspinous Fusion Device,"This invention relates to an improved structure for an interspinous stabilization device that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further readily compensates for graft settling so as to maintain continued axial loading of the graft. More specifically, this invention relates to a medical device that helps in performing a spinal fusion procedure by holding the bone graft in place and stabilizing the facet screw by a plate that is attached to it. The invention also performs a dynamic function that compensates for settling of the bone graft over time. This dynamic function may, if desired, be enhanced by a movement-limiting mechanism that allows extension but not flexion such that the bone graft fusion remains in contact and fusion takes place.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH,THE UNIVERSITY OF TOLEDO (2014-09-17),https://lens.org/161-921-455-184-067,Patent Application,yes,64,21,9,9,0,A61B17/7068;;A61B17/7068;;A61B17/7062;;A61B17/7062,A61B17/70,606/248,0,0,,,,ACTIVE
20,WO,A1,WO 2013/142443 A1,043-127-538-236-372,2013-09-26,2013,US 2013/0032864 W,2013-03-18,US 201261612766 P,2012-03-19,ZERO ARTIFACT VASCULAR CLIP METHOD AND APPARATUS,"The present invention relates to vascular clip made of biocompatible, non-metallic material that minimizes artifacts and obscuration of a diagnostic image developed using modalities such as CATSCAN, and MRI. The vascular clip is dimensionally comparable to metal clips, while maintaining sufficient clamping force to stop the flow of blood from an aneurysm, a subarachnoid hemorrhage or bleeding on the brain.",LITHERLAND CRAIG MICHAEL;;AGARWAL VIJAY,LITHERLAND CRAIG MICHAEL;;AGARWAL VIJAY,,https://lens.org/043-127-538-236-372,Patent Application,yes,5,0,2,2,0,A61B17/122;;A61B17/122;;A61B17/128;;A61B17/128,A61B17/122;;A61B17/08,,0,0,,,,PENDING
21,US,A1,US 2022/0336249 A1,050-208-643-938-825,2022-10-20,2022,US 202217686324 A,2022-03-03,US 202217686324 A;;US 202163175218 P,2021-04-15,ELECTROSTATIC CHUCK WITH MESAS,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic top plate having a top surface with a processing region. One or more electrodes is within the ceramic top plate. A plurality of mesas is within the processing region and on the top surface of the ceramic plate or vertically over an edge of one of the one or more electrodes.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,APPLIED MATERIALS INC (2022-03-08),https://lens.org/050-208-643-938-825,Patent Application,yes,5,0,5,5,0,H01J37/32715;;H01L21/6833;;H01L21/68757;;H01L21/6833;;H01L21/68757;;H01J37/32715;;H01L21/6833;;H01L21/68757;;H01J37/32715,H01L21/683;;H01J37/32;;H01L21/687,,2,0,,,"Machine Translation of Fujisawa et al. Chinese Patent Document CN 102237292 A November 9, 2011 (Year: 2011);;Machine Translation of Fukazawa et al. Japanese Patent Document JP 2017-212332 A November 30, 2017 (Year: 2017)",PENDING
22,US,A1,US 2022/0282371 A1,156-878-601-431-870,2022-09-08,2022,US 202217672520 A,2022-02-15,US 202217672520 A;;US 202163155964 P,2021-03-03,ELECTROSTATIC CHUCK WITH METAL SHAFT,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic bottom plate, a ceramic top plate, and a bond layer between the ceramic top plate and the ceramic bottom plate, the ceramic top plate in direct contact with the bond layer, and the bond layer in direct contact with the ceramic bottom plate. A metal shaft is coupled to the ceramic bottom plate at a side of the ceramic bottom plate opposite the bond layer.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,APPLIED MATERIALS INC (2022-02-15),https://lens.org/156-878-601-431-870,Patent Application,yes,0,0,4,4,0,H01J37/32724;;C23C16/4586;;H01L21/6833;;H01L21/68792;;H01L21/68792;;H01L21/6833;;H01L21/67103;;H01L21/67109;;H01L21/68785;;H01L21/68757;;C23C16/4586;;H01J37/32724;;C23C16/4586;;H01J37/32724;;H01L21/6833,C23C16/458;;H01J37/32;;H01L21/683,,0,0,,,,PENDING
23,TW,A,TW 202249167 A,017-117-401-942-135,2022-12-16,2022,TW 111107250 A,2022-03-01,US 202163155964 P;;US 202217672520 A,2021-03-03,Electrostatic chuck with metal shaft,"Electrostatic chucks (ESCs) for plasma processing chambers, and methods of fabricating ESCs, are described. In an example, a substrate support assembly includes a ceramic bottom plate, a ceramic top plate, and a bond layer between the ceramic top plate and the ceramic bottom plate, the ceramic top plate in direct contact with the bond layer, and the bond layer in direct contact with the ceramic bottom plate. A metal shaft is coupled to the ceramic bottom plate at a side of the ceramic bottom plate opposite the bond layer.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,,https://lens.org/017-117-401-942-135,Patent of Addition,no,0,0,4,4,0,H01J37/32724;;C23C16/4586;;H01L21/6833;;H01L21/68792;;H01L21/68792;;H01L21/6833;;H01L21/67103;;H01L21/67109;;H01L21/68785;;H01L21/68757;;C23C16/4586;;H01J37/32724;;C23C16/4586;;H01J37/32724;;H01L21/6833,H01L21/683;;C23C16/458;;H01J37/32;;H02N13/00,,0,0,,,,PENDING
24,CN,A,CN 117121180 A,114-751-995-014-700,2023-11-24,2023,CN 202280027165 A,2022-04-05,US 202217686324 A;;US 2022/0023552 W;;US 202163175218 P,2021-04-15,Electrostatic chuck with mesa,"An electrostatic chuck (ESC) for a plasma processing chamber and a method of manufacturing the ESC are described. In one example, a substrate support assembly includes a ceramic top plate having a top surface with a process region. One or more electrodes are located within the ceramic top plate. A plurality of mesas is within the processing region and on a top surface of the ceramic plate or vertically above an edge of one of the one or more electrodes.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,,https://lens.org/114-751-995-014-700,Patent Application,no,0,0,5,5,0,H01J37/32715;;H01L21/6833;;H01L21/68757;;H01L21/6833;;H01L21/68757;;H01J37/32715;;H01L21/6833;;H01L21/68757;;H01J37/32715,H01L21/683,,0,0,,,,PENDING
25,KR,A,KR 20230150371 A,062-293-640-302-957,2023-10-30,2023,KR 20237033227 A,2022-02-22,US 202163155964 P;;US 202217672520 A;;US 2022/0017328 W,2021-03-03,금속 샤프트를 갖는 정전 척,"플라즈마 프로세싱 챔버들을 위한 정전 척(ESC)들 및 ESC들을 제조하는 방법들이 설명된다. 예에서, 기판 지지 조립체는 세라믹 최하부 플레이트, 세라믹 최상부 플레이트, 및 세라믹 최상부 플레이트와 세라믹 최하부 플레이트 사이의 본드 층을 포함하고, 세라믹 최상부 플레이트는 본드 층과 직접 접촉하고, 본드 층은 세라믹 최하부 플레이트와 직접 접촉한다. 본드 층의 반대편에 있는 세라믹 최하부 플레이트의 측면에서 금속 샤프트가 세라믹 최하부 플레이트에 결합된다.",APPLIED MATERIALS INC,PARKHE VIJAY D;;AGARWAL ASHUTOSH,,https://lens.org/062-293-640-302-957,Patent Application,no,0,0,4,4,0,H01J37/32724;;C23C16/4586;;H01L21/6833;;H01L21/68792;;H01L21/68792;;H01L21/6833;;H01L21/67103;;H01L21/67109;;H01L21/68785;;H01L21/68757;;C23C16/4586;;H01J37/32724;;C23C16/4586;;H01J37/32724;;H01L21/6833,H01L21/687;;C23C16/458;;H01J37/32;;H01L21/67;;H01L21/683,,0,0,,,,PENDING
26,US,A1,US 2023/0037342 A1,009-193-235-409-566,2023-02-09,2023,US 202217960443 A,2022-10-05,US 202217960443 A;;US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,ZERO VERGENCE ULTRASOUND WAVES FOR SONODYNAMIC THERAPY,"Disclosed are methods of obtaining zero vergence ultrasound waves for providing sonodynamic therapy with ultrasound waves. The method includes coupling a sonodynamic therapy device with an array of flat piezoelectric transducers to a skin surface. A controller is configured to generate an electrical drive signal at a frequency, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a zero vergence ultrasound wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/009-193-235-409-566,Patent Application,yes,1,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,ACTIVE
27,US,A1,US 2023/0338752 A1,045-079-326-028-693,2023-10-26,2023,US 202318214372 A,2023-06-26,US 202318214372 A;;US 202217960443 A;;US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF USING ULTRASOUND WAVES FOR SONODYNAMIC THERAPY,Disclosed are methods of producing ultrasound waves for providing sonodynamic therapy. The method includes coupling a sonodynamic therapy device with an array of piezoelectric transducer elements to a skin surface. A controller is configured to generate an electrical drive signal to produce ultrasound waves to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/045-079-326-028-693,Patent Application,yes,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,ACTIVE
28,WO,A3,WO 2013/116452 A3,089-002-111-235-274,2013-09-26,2013,US 2013/0024033 W,2013-01-31,US 201261593270 P,2012-01-31,BIOACTIVE FUSION DEVICE,"In a first broad aspect, there is provided herein a bioactive device and system for fusion between two bones, two parts of a bony joint, or a bony defect, such as of the spine. The fusion device includes a screw having a head and a threaded shaft. The fusion device also includes a bone dowel having an internal bore of which at least a distal portion is threaded to engage the threads of the screw shaft. The bone dowel is made of a bone-like, biocompatible, or allograft material to provide a layer of bone-like, biocompatible, or allograft material between the screw and the spinal bone. The device is generally coaxial and is further described in the drawings and description herein.",UNIV TOLEDO;;GOEL VIJAY K;;AGARWAL ANAND K,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/089-002-111-235-274,Search Report,yes,5,0,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/86,,0,0,,,,PENDING
29,BR,A2,BR 112014018704 A2,189-415-081-186-061,2017-07-11,2017,BR 112014018704 A,2013-01-31,US 2013/0024033 W;;US 201261593270 P,2012-01-31,"dispositivo de fusão, método de fixação e/ou fusão de uma junta de faceta de vértebras adjacentes, método de estabilização de uma coluna, método de tratamento de estenose espinhal e dispositivo hibrído",,UNIV TOLEDO,ANAND K AGARWAL;;VIJAY K GOEL,,https://lens.org/189-415-081-186-061,Patent Application,no,0,0,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61F2/44,,0,0,,,,DISCONTINUED
30,US,B2,US 10675482 B2,056-618-035-318-331,2020-06-09,2020,US 201515109506 A,2015-01-02,US 201515109506 A;;US 201461923639 P;;US 2015/0010053 W,2014-01-04,Device and method for use of photodynamic therapy,An intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,ALPHEUS MEDICAL INC (2018-05-23),https://lens.org/056-618-035-318-331,Granted Patent,yes,53,7,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61N5/06;;A61B18/00;;A61B18/22;;A61B90/00;;A61B90/10;;A61K41/00,,4,0,,,"Agarwal, V., International Patent Application No. PCT/US2015/010053, International Search Report and Written Opinion, dated May 4, 2015.;;USPTO; Office Action for U.S. Appl. No. 15/447,185 dated Jun. 15, 2017, 26 pages.;;USPTO; Final Office Action for U.S. Appl. No. 15/447,185 dated Nov. 29, 2017, 28 pages.;;European Patent Application No. 18191185.0, Extended European Search Report dated Oct. 17, 2018, 8 pages.",ACTIVE
31,US,B2,US 10635326 B2,100-462-936-376-067,2020-04-28,2020,US 201715848774 A,2017-12-20,US 201715848774 A;;IN 4925CH2014 A;;US 201514700747 A,2014-09-30,Method and apparatus for wear-levelling non-volatile memory,Apparatus and method for performing wear leveling are disclosed. An ordered list of references to each of a set of memory blocks is stored. A set of memory blocks in the ordered list is sequentially allocating. The allocated set of memory blocks in the ordered list are erased in the sequence in which they were allocated.,SANDISK TECHNOLOGIES LLC,AGRAWAL CHETAN;;AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-30),https://lens.org/100-462-936-376-067,Granted Patent,yes,31,0,4,4,0,G06F3/0616;;G06F3/0616;;G06F3/0628;;G06F3/064;;G06F3/064;;G06F3/0652;;G06F3/0679;;G06F3/0683;;G06F3/0688;;G06F3/0688;;G06F12/0246;;G06F12/0253;;G06F12/0623;;G11C16/3495;;G11C16/3495,G06F3/06;;G06F12/02;;G06F12/06;;G11C16/34,,1,0,,,"Yongkun et al., “Stochastic modeling and optimization of garbage collection algorithms in solid-state drive systems”, Apr. 5, 2014, Springer Science + Business Media New York, pp. 115-148.",ACTIVE
32,US,A1,US 2023/0277877 A1,160-072-009-569-039,2023-09-07,2023,US 202318125959 A,2023-03-24,US 202318125959 A;;US 202217733868 A;;US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF TREATING TUMORS WITH DRUGS,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as drugs, may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/160-072-009-569-039,Patent Application,yes,1,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,ACTIVE
33,US,A1,US 2023/0330441 A1,187-915-542-737-101,2023-10-19,2023,US 202318214386 A,2023-06-26,US 202318214386 A;;US 202217960443 A;;US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF PRODUCING RANDOMIZED ULTRASOUND WAVES FOR SONODYNAMIC THERAPY,Disclosed are methods of producing randomized ultrasound waves for providing sonodynamic therapy. The method includes coupling a sonodynamic therapy device with an array of piezoelectric transducer elements to a skin surface. A controller is configured to generate an electrical drive signal to produce ultrasound waves to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/187-915-542-737-101,Patent Application,yes,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,PENDING
34,US,B2,US 11550577 B2,012-670-900-221-385,2023-01-10,2023,US 201916412968 A,2019-05-15,US 201916412968 A,2019-05-15,Memory circuit for halting a program counter while fetching an instruction sequence from memory,"A memory circuit included in a computer system includes a memory array that stores multiple program instructions included in compressed program code. In response to receiving a fetch instruction from a processor circuit, the memory circuit may retrieve a particular instruction from the memory array. The memory circuit may, in response to a determination that the particular instruction is a particular type of instruction, retrieve additional program instructions from the memory array using an address included in the particular instruction, and send the particular program instruction and the additional program instructions to the processor circuit.",WESTERN DIGITAL TECH INC,CHINCHOLE VIJAY;;RASTOGI NAMAN;;AGARWAL SONAM,WESTERN DIGITAL TECHNOLOGIES INC (2019-05-13),https://lens.org/012-670-900-221-385,Granted Patent,yes,17,0,2,3,0,G06F13/1668;;G06F16/901;;G06F7/08;;G06F9/44521;;G06F9/3017;;G06F9/3005;;G06F9/30145;;G06F9/30178;;G06F9/44521;;G06F16/9024;;G06F7/08;;G06F9/321;;G06F13/1668;;G06F9/30054,G06F9/32;;G06F7/08;;G06F9/30;;G06F9/445;;G06F13/16;;G06F16/901,,2,1,129-189-971-111-636,10.1109/date.2005.46,"O. Ozturk et al., “Access Pattern-Based Code Compression for Memory-Constrained Embedded Systems,” IEEE Computer Society, DATE05: Design, Automation and Test in Europe, Mar. 2005.;;Stan Y. Liao, et al., “Code Density Optimization for Embedded DSP Processors Using Data Compression Techniques,” Revised Version for Paper in ARVLSI 1995, 14 pages.",ACTIVE
35,US,A1,US 2020/0364050 A1,008-785-459-151-093,2020-11-19,2020,US 201916412968 A,2019-05-15,US 201916412968 A,2019-05-15,PROGRAM CODE COMPRESSION AND DECOMPRESSION USING MEMORY CIRCUIT,"A memory circuit included in a computer system includes a memory array that stores multiple program instructions included in compressed program code. In response to receiving a fetch instruction from a processor circuit, the memory circuit may retrieve a particular instruction from the memory array. The memory circuit may, in response to a determination that the particular instruction is a particular type of instruction, retrieve additional program instructions from the memory array using an address included in the particular instruction, and send the particular program instruction and the additional program instructions to the processor circuit.",WESTERN DIGITAL TECH INC,CHINCHOLE VIJAY;;RASTOGI NAMAN;;AGARWAL SONAM,WESTERN DIGITAL TECHNOLOGIES INC (2019-05-13),https://lens.org/008-785-459-151-093,Patent Application,yes,0,0,2,3,0,G06F13/1668;;G06F16/901;;G06F7/08;;G06F9/44521;;G06F9/3017;;G06F9/3005;;G06F9/30145;;G06F9/30178;;G06F9/44521;;G06F16/9024;;G06F7/08;;G06F9/321;;G06F13/1668;;G06F9/30054,G06F9/30;;G06F7/08;;G06F9/32;;G06F9/445;;G06F16/2458;;G06F16/901,,0,0,,,,ACTIVE
36,MX,A,MX 2016008818 A,100-425-885-011-056,2017-04-13,2017,MX 2016008818 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY.,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,VIJAY AGARWAL,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE,"CRANIOVATION, INC. (2019-04-23)",https://lens.org/100-425-885-011-056,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61B90/00;;A61B90/10;;A61N5/06,,0,0,,,,ACTIVE
37,CN,A,CN 113677397 A,160-155-336-590-066,2021-11-19,2021,CN 202080027197 A,2020-02-12,US 201962805186 P;;US 2020/0017983 W,2019-02-13,NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed is a system for providing sonodynamic therapy. The system includes a transducer a patient interface, and a controller coupled to the transducer. The patient interface is configured to acoustically couple the transducer to a patient. The controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELLIASON BRADEN;;LING JIAN,,https://lens.org/160-155-336-590-066,Patent Application,no,8,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,0,0,,,,PENDING
38,US,A1,US 2012/0272137 A1,094-295-857-033-292,2012-10-25,2012,US 201213533722 A,2012-06-26,US 201213533722 A;;US 68919610 A,2010-01-18,EFFICIENT VALIDATION OF BINARY XML DATA,"Data used and generated by the process of validating XML documents is divided into two categories: compile-time static data and runtime data. Runtime data may be specific to a particular XML document and changes when validating the XML document, while compile-time data does not change in this way. For example, compile-time data may be data that defines, according to a schema, the descendant elements and ordering between them. Runtime data is information generated to track which descendants occurred in a particular XML document being validated. Compile-time static data, once generated to validate a particular XML document, is cached within a shared volatile memory. Once the compile-time data is cached, the compile-time static data may be used to validate other XML documents without the need to regenerate the compile-time static data.",MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN;;ORACLE INT CORP,MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN,,https://lens.org/094-295-857-033-292,Patent Application,yes,0,2,4,4,0,G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143;;G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143,G06F17/00;;G06F40/143,715/234,0,0,,,,ACTIVE
39,US,A1,US 2016/0092122 A1,116-931-160-833-557,2016-03-31,2016,US 201514700747 A,2015-04-30,IN 4925CH2014 A,2014-09-30,METHOD AND APPARATUS FOR WEAR-LEVELLING NON-VOLATILE MEMORY,Apparatus and method for performing wear leveling are disclosed. An ordered list of references to each of a set of memory blocks is stored. A set of memory blocks in the ordered list is sequentially allocating. The allocated set of memory blocks in the ordered list are erased in the sequence in which they were allocated.,SANDISK TECHNOLOGIES INC,AGRAWAL CHETAN;;AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-30),https://lens.org/116-931-160-833-557,Patent Application,yes,15,20,4,4,0,G06F3/0616;;G06F3/0616;;G06F3/0628;;G06F3/064;;G06F3/064;;G06F3/0652;;G06F3/0679;;G06F3/0683;;G06F3/0688;;G06F3/0688;;G06F12/0246;;G06F12/0253;;G06F12/0623;;G11C16/3495;;G11C16/3495,G06F3/06,,1,0,,,"Yongkun et al., 'Stochastic modeling and optimization of garbage collection algorithms in solid-state drive systems', April 5, 2014, Springer Science + Business Media New York, pages 115-148.",ACTIVE
40,US,A1,US 2023/0226379 A1,136-051-487-339-948,2023-07-20,2023,US 202318125971 A,2023-03-24,US 202318125971 A;;US 202217733868 A;;US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF TREATING TUMORS WITH PRO DRUGS,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/136-051-487-339-948,Patent Application,yes,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,PENDING
41,US,B2,US 11491353 B2,148-971-540-655-534,2022-11-08,2022,US 202117400011 A,2021-08-11,US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Zero vergence ultrasound waves for sonodynamic therapy,"Disclosed are methods of obtaining zero vergence ultrasound waves for providing sonodynamic therapy with ultrasound waves that do not converge and do not diverge. The method includes coupling a sonodynamic therapy device with an array of flat piezoelectric transducers to a skin surface. A controller is configured to generate an electrical drive signal at a frequency, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a zero vergence ultrasound wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/148-971-540-655-534,Granted Patent,yes,134,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,21,11,032-029-745-353-127;;054-725-159-197-552;;064-980-553-392-71X;;065-394-564-594-215;;024-860-166-646-700;;064-842-608-180-947;;051-039-627-241-261;;051-574-595-812-959;;050-636-574-781-211;;039-694-157-560-781;;107-189-280-953-430,29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;16716552;;10.1016/j.ejrad.2006.04.007;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;18068747;;10.1016/j.ultras.2007.11.001;;28759636;;pmc5536352;;10.1371/journal.pone.0181654;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;24752138;;10.1159/000358687;;10.1016/s1350-4177(96)00024-7,"Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020 (6WO).;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.;;U.S. Appl. No. 17/399,996, Methods Of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017 ;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;U.S. Appl. No. 15/109,506 now Granted U.S. Pat. No. 10,675,482, Device and Method for Use of Photodynamic Therapy, filed Jul. 1, 2016.;;U.S. Appl. No. 15/447,185, Device and Method for Use of Photodynamic Therapy, filed Mar. 2, 2017.;;U.S. Appl. No. 16/861,622, Device and Method for Use of Photodynamic Therapy, filed Apr. 29, 2020.;;U.S. Appl. No. 17/266,157, Tissue Treatment With Sensitizer and Light and/or Sound, filed Feb. 5, 2021.;;U.S. Appl. No. 17/399,964, Methods Of Using Planar Acoustic Waves For Non-Invasive Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/399,996 now Granted U.S. Pat. No. 11,318,322, Methods Of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, Zero Vergence Ultrasound Waves For Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/733,868, Methods Of Treating Tumors With Pro Drugs, filed Apr. 29, 2022.;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy” 1996, Ultrasonics Sonochemistry, pp. S187-S191.",ACTIVE
42,US,A1,US 2016/0094339 A1,182-558-262-043-266,2016-03-31,2016,US 201514700776 A,2015-04-30,IN 4911CH2014 A,2014-09-30,SCRAMBLING SCHEMES FOR SCRAMBLING AND DESCRAMBLING DATA,"A storage module may be configured to scramble data before the data is stored in memory. The storage module may scramble the data in accordance with a scrambling scheme that identifies a plurality of scrambling keys to use to scramble the data and a pattern in which to use the scrambling keys. The scrambling scheme may be applied to a plurality of sets of pages of the data, and may be repeated for each of the sets. The scrambling scheme may also be used when descrambling the scrambled data, or a copy of the scrambled data.",SANDISK TECHNOLOGIES INC,AGARWAL DINESH;;SIVASANKARAN VIJAY;;MANOHAR ABHIJEET,SANDISK TECHNOLOGIES LLC (2015-03-09),https://lens.org/182-558-262-043-266,Patent Application,yes,2,13,1,1,0,G06F12/0246;;G06F12/0246;;G06F12/1408;;G06F12/1408;;G06F2212/1032;;G06F2212/1032;;G06F2212/7202;;G06F2212/7202;;G09C1/00;;G09C1/00;;H04L9/065;;H04L9/065;;H04K1/00;;H04K1/00;;H04L9/085;;H04L9/085;;H04L2209/12;;H04L2209/12,H04L9/06;;G06F12/14;;H04L9/08,,0,0,,,,DISCONTINUED
43,US,B2,US 9875039 B2,041-016-491-446-019,2018-01-23,2018,US 201514700747 A,2015-04-30,IN 4925CH2014 A,2014-09-30,Method and apparatus for wear-leveling non-volatile memory,Apparatus and method for performing wear leveling are disclosed. An ordered list of references to each of a set of memory blocks is stored. A set of memory blocks in the ordered list is sequentially allocating. The allocated set of memory blocks in the ordered list are erased in the sequence in which they were allocated.,SANDISK TECHNOLOGIES INC;;SANDISK TECHNOLOGIES LLC,AGRAWAL CHETAN;;AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-30),https://lens.org/041-016-491-446-019,Granted Patent,yes,31,0,4,4,0,G06F3/0616;;G06F3/0616;;G06F3/0628;;G06F3/064;;G06F3/064;;G06F3/0652;;G06F3/0679;;G06F3/0683;;G06F3/0688;;G06F3/0688;;G06F12/0246;;G06F12/0253;;G06F12/0623;;G11C16/3495;;G11C16/3495,G06F3/00;;G06F3/06;;G06F12/02;;G06F12/06,,1,0,,,"Yongkun et al., ‘Stochastic modeling and optimization of garbage collection algorithms in solid-state drive systems’, Apr. 5, 2014, Springer Science + Business Media New York, pp. 115-148.",ACTIVE
44,EP,A2,EP 2809252 A2,053-101-640-052-657,2014-12-10,2014,EP 13743220 A,2013-01-31,US 201261593270 P;;US 2013/0024033 W,2012-01-31,BIOACTIVE FUSION DEVICE,,UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/053-101-640-052-657,Patent Application,yes,0,0,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/86,,0,0,,,,DISCONTINUED
45,CA,A1,CA 3128067 A1,069-223-815-143-056,2020-08-20,2020,CA 3128067 A,2020-02-12,US 201962805186 P;;US 2020/0017983 W,2019-02-13,NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed is a system for providing sonodynamic therapy. The system includes a transducer a patient interface, and a controller coupled to the transducer. The patient interface is configured to acoustically couple the transducer to a patient. The controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/069-223-815-143-056,Patent Application,no,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,0,0,,,,PENDING
46,EP,B1,EP 3924046 B1,085-534-308-317-806,2023-11-22,2023,EP 20710018 A,2020-02-12,US 201962805186 P;;US 2020/0017983 W,2019-02-13,NON-INVASIVE SONODYNAMIC THERAPY,,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,"ALPHEUS MEDICAL, INC. (2023-03-08)",https://lens.org/085-534-308-317-806,Granted Patent,yes,4,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,1,1,032-000-168-605-558,10.1016/j.pdpdt.2014.04.004;;24905843,"TETARD MARIE-CHARLOTTE ET AL: ""Experimental use of photodynamic therapy in high grade gliomas: A review focused on 5-aminolevulinic acid"", PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, vol. 11, no. 3, 1 September 2014 (2014-09-01), AMSTERDAM, NL, pages 319 - 330, XP055938592, ISSN: 1572-1000, Retrieved from the Internet <URL:http://dx.doi.org/10.1016/j.pdpdt.2014.04.004> [retrieved on 20220706], DOI: 10.1016/j.pdpdt.2014.04.004",ACTIVE
47,US,A1,US 2023/0338753 A1,083-357-941-610-322,2023-10-26,2023,US 202318214421 A,2023-06-26,US 202318214421 A;;US 202117399964 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF USING FOCUSED ACOUSTIC WAVES FOR NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed are methods of using focused acoustic waves for providing non-invasive sonodynamic therapy. The method includes acoustically coupling an array of piezoelectric transducers to a patient. A controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce modulated acoustic waves to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/083-357-941-610-322,Patent Application,yes,8,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,1,1,034-117-466-818-529,10.17116/neiro2016802108-118;;27331236,"Galkin, ""The Use of Transcranial Focused Ultrasound in CNS Diseases"", January 2016, Problems of Neurosurgery, pages 1-108 (Year: 2016)",PENDING
48,EP,A4,EP 2809252 A4,122-578-344-330-009,2016-02-17,2016,EP 13743220 A,2013-01-31,US 201261593270 P;;US 2013/0024033 W,2012-01-31,BIOACTIVE FUSION DEVICE,,UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/122-578-344-330-009,Search Report,no,6,0,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/86,,1,0,,,See also references of WO 2013116452A2,DISCONTINUED
49,US,B2,US 11724132 B2,149-026-393-728-43X,2023-08-15,2023,US 202217960443 A,2022-10-05,US 202217960443 A;;US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Zero vergence ultrasound waves for sonodynamic therapy,"Disclosed are methods of obtaining zero vergence ultrasound waves for providing sonodynamic therapy with ultrasound waves. The method includes coupling a sonodynamic therapy device with an array of flat piezoelectric transducers to a skin surface. A controller is configured to generate an electrical drive signal at a frequency, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a zero vergence ultrasound wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/149-026-393-728-43X,Granted Patent,yes,142,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B18/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00,,23,14,032-029-745-353-127;;054-725-159-197-552;;064-980-553-392-71X;;051-039-627-241-261;;051-574-595-812-959;;050-636-574-781-211;;065-394-564-594-215;;024-860-166-646-700;;064-842-608-180-947;;039-694-157-560-781;;107-189-280-953-430;;127-445-262-134-314;;032-000-168-605-558;;067-424-605-912-927,29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;28759636;;pmc5536352;;10.1371/journal.pone.0181654;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;16716552;;10.1016/j.ejrad.2006.04.007;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;18068747;;10.1016/j.ultras.2007.11.001;;24752138;;10.1159/000358687;;10.1016/s1350-4177(96)00024-7;;19414331;;10.1016/j.pdpdt.2014.04.004;;24905843;;10.1007/pl00008471;;11043398,"U.S. Appl. No. 15/109,506, now Granted U.S. Pat. No. 10,675,482, Device and Method for Use of Photodynamic Therapy, filed Jul. 1, 2016.;;U.S. Appl. No. 15/447,185, Device and Method for Use of Photodynamic Therapy, filed Mar. 2, 2017.;;U.S. Appl. No. 16/861,622, Device and Method for Use of Photodynamic Therapy, filed Apr. 29, 2020.;;U.S. Appl. No. 17/266,157, Tissue Treatment With Sensitizer and Light and/or Sound, filed Feb. 5, 2021.;;U.S. Appl. No. 17/399,964, Methods of Using Planar Acoustic Waves for Non-Invasive Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/399,996, now Granted U.S. Pat. No. 11,318,322, Methods of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, Zero Vergence Ultrasound Waves for Sonodynamic Theragpy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/733,868, Methods of Treating Tumors With Pro Drugs, filed Apr. 29, 2022.;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020 (6WO).;;Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017 ;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011.;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain-A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy” 1996, Ultrasonics Sonochemistry, pp. S187-S191.;;Nonaka et al. “Sonodynamic therapy consisting of focused ultrasound and photosensitizer causes a selective antitumor effect in a rat intracranial glioma model”, Anticancer Res 29: 943-950, 2009 (Year: 2009).;;Tetard et al., “Experimental use of photodynamic therapy in high grade gliomas: A revie focused on 5-aminolevulinic acid”, Photodiagnosis and Photodynamic Therapy, vol. 11, No. 3, Sep. 1, 2014, pp. 319-330.;;Yumita et al. “Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma.” J Cancer Res Clin Oneal 126: 601-606, 2000 (Year: 2000).",ACTIVE
50,US,A1,US 2014/0350608 A1,033-458-374-992-465,2014-11-27,2014,US 201314375942 A,2013-01-31,US 201314375942 A;;US 201261593270 P;;US 2013/0024033 W,2012-01-31,Bioactive Fusion Device,"In a first broad aspect, there is provided herein a bioactive device and system for fusion between two bones, two parts of a bony joint, or a bony defect, such as of the spine. The fusion device includes a screw having a head and a threaded shaft. The fusion device also includes a bone dowel having an internal bore of which at least a distal portion is threaded to engage the threads of the screw shaft. The bone dowel is made of a bone-like, biocompatible, or allograft material to provide a layer of bone-like, biocompatible, or allograft material between the screw and the spinal bone. The device is generally coaxial and is further described in the drawings and description herein.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,THE UNIVERSITY OF TOLEDO (2014-08-18),https://lens.org/033-458-374-992-465,Patent Application,yes,3,5,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61F2/44;;A61B17/86,606/279;;606/309;;623/17.16,0,0,,,,ACTIVE
51,US,A1,US 2022/0257984 A1,172-264-613-245-227,2022-08-18,2022,US 202217733868 A,2022-04-29,US 202217733868 A;;US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF TREATING TUMORS WITH PRO DRUGS,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/172-264-613-245-227,Patent Application,yes,1,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,1,1,015-977-286-269-092,10.3171/jns.2004.100.2.0272;;15086235,"Wang et al., “Rapid and selective cerebral hypothermia achieved using a cooling helmet,” J. Neurosurg. 2004;100(2):272-77. PMID: 15086235. (Year: 2004)",ACTIVE
52,EP,A1,EP 3431031 A1,064-178-875-495-596,2019-01-23,2019,EP 18191185 A,2015-01-02,US 201461923639 P;;EP 15700918 A;;US 2015/0010053 W,2014-01-04,DEVICE FOR USE OF PHOTODYNAMIC THERAPY,"An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.
",CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/064-178-875-495-596,Patent Application,yes,6,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,DISCONTINUED
53,US,B2,US 9684639 B2,134-559-103-338-917,2017-06-20,2017,US 201213533722 A,2012-06-26,US 201213533722 A;;US 68919610 A,2010-01-18,Efficient validation of binary XML data,"Data used and generated by the process of validating XML documents is divided into two categories: compile-time static data and runtime data. Runtime data may be specific to a particular XML document and changes when validating the XML document, while compile-time data does not change in this way. For example, compile-time data may be data that defines, according to a schema, the descendant elements and ordering between them. Runtime data is information generated to track which descendants occurred in a particular XML document being validated. Compile-time static data, once generated to validate a particular XML document, is cached within a shared volatile memory. Once the compile-time data is cached, the compile-time static data may be used to validate other XML documents without the need to regenerate the compile-time static data.",MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN;;ORACLE INT CORP,MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN,,https://lens.org/134-559-103-338-917,Granted Patent,yes,124,0,4,4,0,G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143;;G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143,G06F17/00;;G06F17/30;;G06F40/143,,55,15,106-809-566-107-553;;086-033-760-705-419;;123-188-971-656-051;;172-989-677-470-421;;001-760-995-735-142;;153-560-851-435-04X;;191-038-550-261-206;;035-655-789-713-910;;045-445-731-521-438;;093-965-920-960-413;;103-480-371-023-923;;012-124-850-800-371;;089-513-628-343-627;;153-560-851-435-04X;;065-000-606-310-504,10.14778/1687553.1687561;;10.1145/1042046.1042050;;10.1145/988672.988719;;10.1007/978-3-540-24607-7_14;;10.1145/1066157.1066216;;10.1109/icde.2000.839412;;10.1145/342009.335405;;10.1145/1008992.1009010;;10.1145/872757.872775;;10.1145/502200.502202;;10.1023/b:wwwj.0000047377.03543.64;;10.1145/1031453.1031462;;10.1145/1185448.1185606;;10.1109/icde.2000.839412;;10.1007/11581062_44,"U.S. Appl. No. 11/437,512, filed May 18, 2006, Advisory Action, May 10, 2013.;;Oracle Corporation, “What is Reduced XML?,” Publicly presented as early as Jul. 8, 2003, 4 pages.;;Jinyu Wang and Mark Scardina, “XML Data Streaming for Enterprise Applications Using PL/SQL and SAX,” Apr. 3, 2002, 11 pages.;;Deepak Vohra, “Validating XML Documents Against XML Schema,” Feb. 4, 2004, http://otn.oracle.com/pub/articles/vohra—xmlschema.html?—template+/otn/content/.;;W3C, “XQuery 1.0 and XPath 2.0 Data Model,” Nov. 12, 2003, http://www.w3.org/TR/2003/WD-expath-datamodel-20031112/, retrieved Jun. 22, 2004, pp. 1-72.;;W3C, “XML Schema Part 1: Structures,” May 2, 2001, http://www.w3org./TR/2001/REC-xmlschema-1-20010502/, retrieved Jun. 22, 2004, pp. 1-186.;;Zhang et al., “Binary XML Storage and Query Processing in Oracle 11g”, Proc. VLDB Endow. 2,2, dated Aug. 2009, pp. 1354-1365.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Final Office Action, Mar. 1, 2013.;;U.S. Appl. No. 13/224,327, filed Sep. 2, 2011, Office Action, Mar. 14, 2013.;;Ozden, Mustafa, “A Binary Encoding for Efficient XML Processing”, Dec. 17, 2002, pp. 81-102.;;Ozden, Mustafa, “A Binary Encoding for Efficient XML Processing”, Dec. 17, 2002, 114 pages.;;“WD97: How Word for Windows Uses Temporary Files” dated Nov. 16, 2006, downloaded from the Internet on Jan. 28, 2011, <http://support.microsoft.com/kb/89247> 6 pages.;;Balmin et al., “Incremental Validation of XML Documents”, ACM Trans. Database System, Dec. 24, 2004, 42 pages.;;Bayardo et al., “Optimizing encoding: An evaluation of binary XML encoding optimizations for fast stream based XML processing”, May 2004, Proceedings of the 13th International Conference on World Wide Web WWW 04, Publisher ACM press, pp. 345-354.;;Bouchou et al., “Updates and Incremental Validation of XML Documents”, LNCS 2921, 2004, pp. 216-232.;;Catania et al., Lazy XML Updates: Laziness as a Virtue of Update and Structural Join Efficiency, SIGMOD 2005 Jun. 14-16, 2005, pp. 515-526.;;Kanne et al., “Efficient Storage of XML data”, Dec. 13, 1999, pp. 1-22.;;Kim et al., “An Efficient XML Index Technique with Relative Position Coordinates”, Dept. of Computer Science, Seoul, South Korea, WSEAS Transaction on Information Science and Applicaltions, vol. 2, No. 4, Apr. 2005, pp. 373-379.;;La Fontaine et al., “A delta Format for XML: Identifying Changes in XML Files and Representing the Changes in XML”, 2001, 26 pages.;;Liefke et al., “Xmill: An efficient compressor for XML data”, May 2000, ACM SIGMOD Record, Proceedings of the 2000 ACM SIGMOD international conference on Management of data SIGMOD 00', vol. 29, Issue 2, Publisher: ACM Press, pp. 153-164.;;Liu et al., “Configurable indexing and ranking for XML information retrieval”, Jul. 2004, Proceedings of the 27th annual international ACM SIGIR conference on Research and Development in information retrieval SIGIR 04, Published by ACM Press. pp. 88-95.;;Min et al., “XML Indexing and compression: XPRESS: a queriable compression for XML data”, Jun. 2003, Proceedings of the 2003 ACM SIGMOD international conference on Management of data SIGMOD 03, Published by ACM Press, pp. 122-133.;;PCT/US2007/010163, Notification of Transmittal of the International Search Report and Written Opinion of the International Searching Authority, Oct. 12, 2007, 12 pages.;;“WAP Binary XML Content Format” downloaded from the Internet Nov. 9, 2007 <http://www.w3.org/TR/wbxm/> 15 pages.;;“What's New in the XDK?” downloaded from the Internet Nov. 9, 2007 <http://download.oracle.com/docs/cd/B28359—01/appdev.111/b28394/whatsnew.htm > 3 pages.;;Wong, “The Extended XQL for Querying and Updating Large XML Databases”, DocEng '07, Nov. 9-10, 2001, pp. 95-104.;;Yu et al., “Dynamically updating XML Data: Numbering Scheme Revisited”, Internet and Web Information Systems, 8, 2005, pp. 5-26.;;Zou et al., “XML Processing: Ctree:a compact tree for indexing XML data”, Nov. 2004, Proceedings of the 6th annual international workshop on Web information and data management WIDM '04, Published by ACM Press, pp. 39-46.;;“3 Using Oracle XML DB” downloaded from the Internet Nov. 9, 2007 <http://download.oracle.com/docs/cd/B28359—01/appdev.111/b28369/xdb03usg.htm> 63 pages.;;“4 XML Parsing for Java” downloaded from the Internet Nov. 9, 2007 <http://download.oracle.com/docs/cd/B28359—01/appdev.111/b28394/adx—j—parser.htm> 42 pages.;;“4 XMLType Operations” downloaded from the Internet Nov. 9, 2007 <http://download.oracle.com/docs/cd/B28359—01/appdev.111/b28369/xdb04cre.htm> 29 pages.;;“20 Using the XML Schema Processor for C” downloaded from the Internet Nov. 9, 2007 <http://download.oracle.com/docs/cd/B28359—01/appdev.111/b28394/adx—c—sproc.htm> 10 pages.;;Zhang et al., “TDX: A High Perfomrance Table-driven XML Parser”, In proceedings of the 44th annual (ACM) Southeast Regional Conference, Mar. 2006, ACM, pp. 726-731.;;U.S. Appl. No. 11/437,512, filed May 18, 2006.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Aug. 5, 2009.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Mar. 16, 2010.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Oct. 4, 2010.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Mar. 28, 2011.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Nov. 1, 2012.;;Kanne et al., “Efficient Storage of XML Data”, dated Jun. 16, 1999, 20 pages.;;U.S. Appl. No. 13/224,327, filed Sep. 2, 2011, Final Office Action, Nov. 4, 2015.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, Oct. 14, 2015.;;Myer, “A Really, Really Good Introduciton to XML”, Sitepoint, dated Aug. 24, 2005, 107 pages.;;Kangasharju et al., “Xebu: A Binary Format with Schema-Based Optimzations for XML Data”, dated Nov. 20-22, dated 2005, pp. 528-535.;;Ewald, Arnold, “1.9. Using the WAP Binary XML Parser”, dated Dec. 27, 2005, the Ulxmlrpcpp Handbook, p. 1 through table of content, 3 pages.;;U.S. Appl. No. 11/427,512, filed May 18, 2006, Notice of Allowance, May 17, 2016.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Interview Summary, Feb. 25, 2016.;;U.S. Appl. No. 13/224,327, filed Sep. 2, 2011, Office Action, Nov. 1, 2016.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Office Action, May 22, 2014.;;U.S. Appl. No. 13/224,327, Filed Sep. 2, 2011, Office Action, Mar. 3, 2015.;;U.S. Appl. No. 11/437,512, Filed May 18, 2006, Advisory Action, Jan. 28, 2015.;;U.S. Appl. No. 13/224,327, filed Sep. 2, 2011, Final Office Action, Nov. 6, 2013.;;U.S. Appl. No. 13/631,434, filed Sep. 28, 2012, Notice of Allowance, Nov. 20, 2013.;;U.S. Appl. No. 13/631,434, filed Sep. 28, 2012, Notice of Allowance, Mar. 20, 2014.;;U.S. Appl. No. 11/437,512, filed May 18, 2006, Final Office Action, Oct. 3, 2014.",ACTIVE
54,AU,A1,AU 2020/221841 A1,006-649-985-639-348,2021-09-09,2021,AU 2020/221841 A,2020-02-12,US 201962805186 P;;US 2020/0017983 W,2019-02-13,Non-invasive sonodynamic therapy,"Disclosed is a system for providing sonodynamic therapy. The system includes a transducer a patient interface, and a controller coupled to the transducer. The patient interface is configured to acoustically couple the transducer to a patient. The controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/006-649-985-639-348,Patent Application,no,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,0,0,,,,PENDING
55,KR,A,KR 20140133532 A,069-098-604-767-133,2014-11-19,2014,KR 20147024418 A,2013-01-31,US 201261593270 P;;US 2013/0024033 W,2012-01-31,BIOACTIVE FUSION DEVICE,,UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/069-098-604-767-133,Patent Application,no,2,4,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/70;;A61B17/86;;A61L27/06;;A61L27/14,,0,0,,,,ACTIVE
56,US,A1,US 2023/0338751 A1,069-344-458-775-194,2023-10-26,2023,US 202318214371 A,2023-06-26,US 202318214371 A;;US 202117399964 A;;US 2020/0017963 W;;US 201762605186 P;;US 201962805097 P,2017-08-04,METHODS OF USING PLANAR OR DEFOCUSED ACOUSTIC WAVES FOR NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed are methods of using planar or defocused acoustic waves for providing non-invasive sonodynamic therapy. The method includes acoustically coupling an array of piezoelectric transducers to a patient. A controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce modulated acoustic waves to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/069-344-458-775-194,Patent Application,yes,0,1,3,3,0,A61B5/024;;A61B5/021;;A61B5/02;;A61B5/02405;;A61B5/0816;;A61B5/486;;A61M21/02;;A61M2021/0027;;A61M2021/005;;A61B2017/320069;;A61P35/00;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/003;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N2007/0082;;A61N2007/0095;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61F7/00;;A61N7/00;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,0,0,,,,PENDING
57,ES,T3,ES 2694723 T3,117-556-039-267-148,2018-12-26,2018,ES 15700918 T,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,Dispositivo para su uso en terapia fotodinámica,"Un aparato (20, 60) que incluye una fuente de luz (24, 64) para tratamiento endoscópico o intracraneal de una región tisular del cuerpo o el cerebro de un paciente, comprendiendo además del aparato de tratamiento: un eje exterior (38, 72), que tiene un extremo proximal (39, 73) y un extremo distal (42, 74) para colocar dentro de la región tisular del cuerpo o del cerebro el eje exterior (38, 72), que define un diámetro interior que se extiende entre el extremo proximal (39, 73) y el extremo distal (42, 74) del eje exterior y que tiene al menos una abertura (45) adyacente al extremo distal del eje exterior; un elemento de suministro de luz interior (40, 76) que tiene un extremo distal y un extremo proximal adaptado para conectarse operativamente a la fuente de luz (24, 64), estando el elemento de suministro de luz configurado para ser recibido dentro del diámetro interior y extendiéndose desde el extremo proximal del eje hasta estar adyacente al extremo distal del eje; y un elemento cerámico piezoeléctrico (52) dispuesto en el extremo distal (42) del eje (38) y que permite la aplicación de una intensidad variable de una frecuencia deseada en donde el elemento de suministro de luz (40, 76) está adaptado para suministrar luz desde la fuente de luz (24, 64) a través de al menos una abertura (45) del eje exterior a la región tisular del cuerpo o del cerebro en la proximidad con el eje distal (42, 74) del eje exterior (38, 72).",CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/117-556-039-267-148,Granted Patent,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
58,US,A1,US 2021/0008385 A1,014-673-838-721-034,2021-01-14,2021,US 202016861622 A,2020-04-29,US 202016861622 A;;US 201615109506 A;;US 2015/0010053 W;;US 201461923639 P,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,ALPHEUS MEDICAL INC (2018-05-23),https://lens.org/014-673-838-721-034,Patent Application,yes,0,7,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61N5/06;;A61B90/00;;A61B90/10;;A61K41/00,,0,0,,,,DISCONTINUED
59,EP,A1,EP 3924046 A1,078-787-489-207-201,2021-12-22,2021,EP 20710018 A,2020-02-12,US 201962805186 P;;US 2020/0017983 W,2019-02-13,NON-INVASIVE SONODYNAMIC THERAPY,,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,"ALPHEUS MEDICAL, INC. (2023-03-08)",https://lens.org/078-787-489-207-201,Patent Application,yes,0,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,0,0,,,,ACTIVE
60,CA,A1,CA 2935743 A1,091-281-322-525-374,2015-07-09,2015,CA 2935743 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/091-281-322-525-374,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,DISCONTINUED
61,US,A1,US 2018/0129428 A1,180-444-483-774-291,2018-05-10,2018,US 201715848774 A,2017-12-20,US 201715848774 A;;IN 4925CH2014 A;;US 201514700747 A,2014-09-30,METHOD AND APPARATUS FOR WEAR-LEVELLING NON-VOLATILE MEMORY,Apparatus and method for performing wear leveling are disclosed. An ordered list of references to each of a set of memory blocks is stored. A set of memory blocks in the ordered list is sequentially allocating. The allocated set of memory blocks in the ordered list are erased in the sequence in which they were allocated.,SANDISK TECHNOLOGIES LLC,AGRAWAL CHETAN;;AGARWAL DINESH;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-30),https://lens.org/180-444-483-774-291,Patent Application,yes,0,0,4,4,0,G06F3/0616;;G06F3/0616;;G06F3/0628;;G06F3/064;;G06F3/064;;G06F3/0652;;G06F3/0679;;G06F3/0683;;G06F3/0688;;G06F3/0688;;G06F12/0246;;G06F12/0253;;G06F12/0623;;G11C16/3495;;G11C16/3495,G06F3/06,,0,0,,,,ACTIVE
62,BR,A2,BR 112016015490 A2,159-769-141-558-470,2022-07-19,2022,BR 112016015490 A,2015-01-02,US 2015/0010053 W;;US 201461923639 P,2014-01-04,"APARELHO, QUE INCLUI UMA FONTE DE LUZ, PARA TRATAMENTO ENDOSCÓPICO OU INTRACRANIANO",DISPOSITIVO E MÉTODO PARA USO DE TERAPIA FOTODINÂMICA. A presente invenção se refere a um aparelho que inclui uma fonte de luz que possibilita o tratamento intra craniano de uma região de tecido de um cérebro de um paciente. O aparelho de tratamento intracraniano compreende uma haste externa que tem uma extremidade proximal e uma extremidade distal para posicionamento na região de tecido do cérebro. A haste externa define um lúmen que se estende entre a extremidade proximal e a extremidade distal da haste externa e que tem pelo menos uma abertura adjacente à extremidade distal da haste externa. Um elemento de distribuição de luz interno que tem uma extremidade distal e uma extremidade proximal é adaptado para ser conectado de modo operacional à fonte de luz. O elemento de distribuição de luz é configurado para ser recebido no lúmen e se estender da extremidade proximal da haste até as adjacências da extremidade distal da haste. O elemento de distribuição de luz é adaptado para distribuir luz da fonte de luz através da pelo menos uma abertura da haste externa para a região de tecido do cérebro próxima à extremidade distal da haste externa.,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE;;CRANIOVATION INC,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE,"JACK RATCLIFFE (US) ; CRANIOVATION, INC. (US) (2019-04-09);;CRANIOVATION, INC. (US) (2019-04-24);;ALPHEUS MEDICAL, INC. (US) (2022-12-20);;RANJITH BABU (US) ; JACK RATCLIFFE (US) ; CRANIOVATION, INC. (US) (2019-03-26);;RANJITH BABU (US) ; JACK RATCLIFFE (US) ; CRANIOVA (2019-03-26)",https://lens.org/159-769-141-558-470,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,PENDING
63,WO,A1,WO 2015/103484 A1,189-501-013-862-516,2015-07-09,2015,US 2015/0010053 W,2015-01-02,US 201461923639 P,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/189-501-013-862-516,Patent Application,yes,6,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,PENDING
64,US,A1,US 2017/0173351 A1,065-989-720-400-754,2017-06-22,2017,US 201715447185 A,2017-03-02,US 201715447185 A;;US 201615109506 A;;US 2015/0010053 W;;US 201461923639 P,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,ALPHEUS MEDICAL INC (2018-05-23),https://lens.org/065-989-720-400-754,Patent Application,yes,3,9,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61N5/06;;A61B18/22;;A61B90/00;;A61K41/00,,0,0,,,,DISCONTINUED
65,US,A1,US 2009/0112890 A1,138-539-798-339-920,2009-04-30,2009,US 92455607 A,2007-10-25,US 92455607 A,2007-10-25,EFFICIENT UPDATE OF BINARY XML CONTENT IN A DATABASE SYSTEM,"Various techniques are described hereafter for improving the efficiency of updating XML documents in a content repository, such as a database system. Specifically, techniques are described for updating an XML document by dynamically merging a stream of XML data from the document with update information. Techniques are also described for efficient validation of XML documents. Because of the manner of the updates, specifically because the XML data being updated is in the form of a stream, the database system validates only those portions of the stream of XML data that have been updated. In the alternative, the database system validates that portion of the XML data that is associated with the parent node of the portion of XML data that has been updated.",ORACLE INT CORP,MEDI VIJAY;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2007-10-25),https://lens.org/138-539-798-339-920,Patent Application,yes,34,34,2,2,0,G06F16/83;;G06F16/83;;G06F16/80;;G06F16/80,G06F17/30,707/100;;X707E17005,0,0,,,,ACTIVE
66,US,A1,US 2021/0370102 A1,069-786-507-687-448,2021-12-02,2021,US 202117399964 A,2021-08-11,US 202117399964 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF USING PLANAR ACOUSTIC WAVES FOR NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed are methods of using planar acoustic waves for providing non-invasive sonodynamic therapy. The method includes acoustically coupling an array of flat piezoelectric transducers to a patient. A controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated planar acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/069-786-507-687-448,Patent Application,yes,4,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61F7/02;;A61K41/00,,3,2,181-889-014-496-418;;004-551-214-113-411,10.1002/0471221155;;10.1159/000366383;;25502879,"Hendee et al., ""Medical Imaging Physics, Fourth Edition"", 2002, pages 303-353 (Year: 2002);;Olympus Corporation, ""Ultrasonic Transducers"", 2010 (Year: 2010);;Xu et al., ""Protoporphyrin IX Induces a Necrotic Cell Death in Human THP-1 Macrophages through Activation of Reactive Oxygen ""Species/c-Jun N-Terminal Protein Kinase"", 2014, Cellular Physiology and Biochemistry (Year: 2014)",ACTIVE
67,US,B2,US 11617904 B2,110-689-816-996-930,2023-04-04,2023,US 202217733868 A,2022-04-29,US 202217733868 A;;US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Methods of treating tumors with pro drugs,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/110-689-816-996-930,Granted Patent,yes,136,2,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,21,12,015-977-286-269-092;;051-039-627-241-261;;065-394-564-594-215;;032-029-745-353-127;;054-725-159-197-552;;024-860-166-646-700;;051-574-595-812-959;;050-636-574-781-211;;064-842-608-180-947;;064-980-553-392-71X;;107-189-280-953-430;;039-694-157-560-781,10.3171/jns.2004.100.2.0272;;15086235;;28759636;;pmc5536352;;10.1371/journal.pone.0181654;;16716552;;10.1016/j.ejrad.2006.04.007;;29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;18068747;;10.1016/j.ultras.2007.11.001;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;10.1016/s1350-4177(96)00024-7;;24752138;;10.1159/000358687,"Wang et al., “Rapid and selective cerebral hypothermia achieved using a cooling helmet,” J. Neurosurg. 2004;100(2):272-77. PMID: 15086235. (Year: 2004).;;Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017 ;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;McDannold et al., “Transcranial Magnetic Resonance Imaging—Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020 (6WO).;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy” 1996, Ultrasonics Sonochemistry, pp. S187-S191.;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;U.S. Appl. No. 15/109,506 now Granted U.S. Pat. No. 10,675,482, Device and Method for Use of Photodynamic Therapy, filed Jul. 1, 2016.;;U.S. Appl. No. 15/447,185, Device and Method for Use of Photodynamic Therapy, filed Mar. 2, 2017.;;U.S. Appl. No. 16/861,622, Device and Method for Use of Photodynamic Therapy, filed Apr. 29, 2020.;;U.S. Appl. No. 17/266,157, Tissue Treatment With Sensitizer and Light and/or Sound, filed Feb. 5, 2021.;;U.S. Appl. No. 17/399,964, Methods Of Using Planar Acoustic Waves For Non-Invasive Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/399,996 now Granted U.S. Pat. No. 11,318,322, Methods Of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, Zero Vergence Ultrasound Waves For Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/733,868, Methods Of Treating Tumors With Pro Drugs, filed Apr. 29, 2022.",ACTIVE
68,WO,A2,WO 2013/116452 A2,135-890-461-324-79X,2013-08-08,2013,US 2013/0024033 W,2013-01-31,US 201261593270 P,2012-01-31,BIOACTIVE FUSION DEVICE,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO;;GOEL VIJAY K;;AGARWAL ANAND K,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/135-890-461-324-79X,Patent Application,yes,3,4,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61F2/44,,1,0,,,See also references of EP 2809252A4,PENDING
69,WO,A1,WO 2020/167992 A1,139-079-431-948-561,2020-08-20,2020,US 2020/0017983 W,2020-02-12,US 201962805186 P,2019-02-13,NON-INVASIVE SONODYNAMIC THERAPY,"Disclosed is a system for providing sonodynamic therapy. The system includes a transducer a patient interface, and a controller coupled to the transducer. The patient interface is configured to acoustically couple the transducer to a patient. The controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",CRANIOVATION INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/139-079-431-948-561,Patent Application,yes,6,11,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/02;;A61B18/00;;A61F7/00;;A61N7/00,,3,2,032-029-745-353-127;;032-420-283-438-450,29204925;;10.1007/s13346-017-0448-6;;12140544;;10.1038/418381b,"JAIN ANKIT ET AL: ""Ultrasound-based triggered drug delivery to tumors"", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, GERMANY, vol. 8, no. 1, 4 December 2017 (2017-12-04), pages 150 - 164, XP036414704, ISSN: 2190-393X, [retrieved on 20171204], DOI: 10.1007/S13346-017-0448-6;;DETLEF LOHSE: ""Sonoluminescence, Inside a micro-reactor"", NATURE, vol. 418, 2002, pages 381 - 383;;DAVID COSTLEY ET AL., TREATING CANCER WITH SONODYNAMIC THERAPY: A REVIEW, 17 October 2014 (2014-10-17), pages 107 - 117",PENDING
70,EP,A1,EP 3089690 A1,152-142-122-099-869,2016-11-09,2016,EP 15700918 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE FOR USE OF PHOTODYNAMIC THERAPY,,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,"ALPHEUS MEDICAL, INC. (2021-09-20);;ALPHEUS MEDICAL, INC., CHANHASSEN, US (2023-02-17);;ALPHEUS MEDICAL, US (2023-02-06);;ALPHEUS MEDICAL, INC., OAKDALE, US (2021-06-09);;ALPHEUS MEDICAL, INC.; US (2021-06-15);;CRANIOVATION, INC. (2018-08-08)",https://lens.org/152-142-122-099-869,Patent Application,yes,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
71,US,B2,US 9808299 B2,012-322-363-885-512,2017-11-07,2017,US 201314375942 A,2013-01-31,US 201314375942 A;;US 201261593270 P;;US 2013/0024033 W,2012-01-31,Bioactive fusion device,"In a first broad aspect, there is provided herein a bioactive device and system for fusion between two bones, two parts of a bony joint, or a bony defect, such as of the spine. The fusion device includes a screw having a head and a threaded shaft. The fusion device also includes a bone dowel having an internal bore of which at least a distal portion is threaded to engage the threads of the screw shaft. The bone dowel is made of a bone-like, biocompatible, or allograft material to provide a layer of bone-like, biocompatible, or allograft material between the screw and the spinal bone. The device is generally coaxial and is further described in the drawings and description herein.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,THE UNIVERSITY OF TOLEDO (2014-08-18),https://lens.org/012-322-363-885-512,Granted Patent,yes,22,5,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/86;;A61B17/56;;A61B17/70;;A61F2/44,,5,0,,,"PCT International Search Report and the Written Opinion, Application No. PCT/US2014/043830 filed Jun. 24. 2014, dated Nov. 14, 2014.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024033 filed Jan. 31, 2013, dated May 13, 2013.;;Chinese Notification of First Office Action, Application No. CN 201380013369.X, dated Feb. 1, 2016.;;European Search Report, Application No. 13743220.9, dated Jan. 12, 2016.;;Extended European Search Report, Application No. EP14817934.4, dated Jan. 25, 2017.",ACTIVE
72,JP,A,JP 2020028738 A,047-031-026-631-431,2020-02-27,2020,JP 2019211153 A,2019-11-22,US 201461923639 P,2014-01-04,DEVICE AND METHOD FOR USING PHOTODYNAMIC THERAPY,"To provide an intracranial therapy of a tissue region in a patient's brain.SOLUTION: A device including a light source provides an intracranial therapy of a tissue region in a patient's brain. An intracranial therapeutic device includes an outer shaft having a proximal end and a distal end for positioning in a tissue region of the brain. The outer shaft defines a lumen that extends between the proximal end and the distal end so as to be adjacent to the distal end, and includes at least one opening. An internal light supply element having a distal end and a proximal end are operably connected to the light source. The light supply element is configured so as to be received in the lumen and extend from the proximal end of the outer shaft to a position adjacent to the distal end of the outer shaft. The light supply element supplies a light from the light source to the tissue region in the brain close to the distal end of the outer shaft through the at least one opening of the outer shaft.SELECTED DRAWING: Figure 1",CRANIOVATION INC,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE,,https://lens.org/047-031-026-631-431,Patent Application,no,5,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61N5/06,,0,0,,,,ACTIVE
73,US,A1,US 2021/0370103 A1,043-533-390-875-090,2021-12-02,2021,US 202117400011 A,2021-08-11,US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,ZERO VERGENCE ULTRASOUND WAVES FOR SONODYNAMIC THERAPY,"Disclosed are methods of obtaining zero vergence ultrasound waves for providing sonodynamic therapy with ultrasound waves that do not converge and do not diverge. The method includes coupling a sonodynamic therapy device with an array of flat piezoelectric transducers to a skin surface. A controller is configured to generate an electrical drive signal at a frequency, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a zero vergence ultrasound wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/043-533-390-875-090,Patent Application,yes,0,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;B06B1/02;;B06B1/06,,0,0,,,,ACTIVE
74,AU,B2,AU 2015/204075 B2,074-021-277-406-992,2019-02-07,2019,AU 2015/204075 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,Device and method for use of photodynamic therapy,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,"ALPHEUS MEDICAL, INC. (2021-06-03);;CRANIOVATION, INC. (2018-07-12)",https://lens.org/074-021-277-406-992,Granted Patent,no,1,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
75,BR,A8,BR 112016015490 A8,121-612-052-730-289,2022-12-06,2022,BR 112016015490 A,2015-01-02,US 2015/0010053 W;;US 201461923639 P,2014-01-04,"APARELHO, QUE INCLUI UMA FONTE DE LUZ, PARA TRATAMENTO ENDOSCÓPICO OU INTRACRANIANO",DISPOSITIVO E MÉTODO PARA USO DE TERAPIA FOTODINÂMICA. A presente invenção se refere a um aparelho que inclui uma fonte de luz que possibilita o tratamento intra craniano de uma região de tecido de um cérebro de um paciente. O aparelho de tratamento intracraniano compreende uma haste externa que tem uma extremidade proximal e uma extremidade distal para posicionamento na região de tecido do cérebro. A haste externa define um lúmen que se estende entre a extremidade proximal e a extremidade distal da haste externa e que tem pelo menos uma abertura adjacente à extremidade distal da haste externa. Um elemento de distribuição de luz interno que tem uma extremidade distal e uma extremidade proximal é adaptado para ser conectado de modo operacional à fonte de luz. O elemento de distribuição de luz é configurado para ser recebido no lúmen e se estender da extremidade proximal da haste até as adjacências da extremidade distal da haste. O elemento de distribuição de luz é adaptado para distribuir luz da fonte de luz através da pelo menos uma abertura da haste externa para a região de tecido do cérebro próxima à extremidade distal da haste externa.,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE;;CRANIOVATION INC;;ALPHEUS MEDICAL INC,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE,"JACK RATCLIFFE (US) ; CRANIOVATION, INC. (US) (2019-04-09);;CRANIOVATION, INC. (US) (2019-04-24);;ALPHEUS MEDICAL, INC. (US) (2022-12-20);;RANJITH BABU (US) ; JACK RATCLIFFE (US) ; CRANIOVATION, INC. (US) (2019-03-26);;RANJITH BABU (US) ; JACK RATCLIFFE (US) ; CRANIOVA (2019-03-26)",https://lens.org/121-612-052-730-289,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,PENDING
76,US,A1,US 2021/0369843 A1,014-253-874-790-490,2021-12-02,2021,US 202117399996 A,2021-08-11,US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,METHODS OF TREATING TUMORS WITH PRO DRUGS,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/014-253-874-790-490,Patent Application,yes,0,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61K41/00;;A61F7/00;;A61K9/00;;A61N7/00,,0,0,,,,ACTIVE
77,CN,A,CN 106232045 A,051-490-639-709-542,2016-12-14,2016,CN 201580007024 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,Device and method for use of photodynamic therapy,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/051-490-639-709-542,Patent Application,no,16,1,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
78,US,A1,US 2016/0325110 A1,089-464-135-144-55X,2016-11-10,2016,US 201515109506 A,2015-01-02,US 201515109506 A;;US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,ALPHEUS MEDICAL INC (2018-05-23),https://lens.org/089-464-135-144-55X,Patent Application,yes,4,7,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61N5/06;;A61B18/22;;A61B90/00;;A61B90/10,,0,0,,,,ACTIVE
79,US,B2,US 8255372 B2,162-102-178-960-415,2012-08-28,2012,US 68919610 A,2010-01-18,US 68919610 A,2010-01-18,Efficient validation of binary XML data,"Data used and generated by the process of validating XML documents is divided into two categories: compile-time static data and runtime data. Runtime data may be specific to a particular XML document and changes when validating the XML document, while compile-time data does not change in this way. For example, compile-time data may be data that defines, according to a schema, the descendant elements and ordering between them. Runtime data is information generated to track which descendants occurred in a particular XML document being validated. Compile-time static data, once generated to validate a particular XML document, is cached within a shared volatile memory. Once the compile-time data is cached, the compile-time static data may be used to validate other XML documents without the need to regenerate the compile-time static data.",MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN;;ORACLE INT CORP,MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2010-01-13),https://lens.org/162-102-178-960-415,Granted Patent,yes,28,1,4,4,0,G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143;;G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143,G06F17/30;;G06F40/143,707/701,7,2,106-809-566-107-553;;106-809-566-107-553,10.14778/1687553.1687561;;10.14778/1687553.1687561,"Ning Zhang, Nipun Agarwal, Sivasankaran Chandrasekar, Sam Idicula, Vijay Medi, Sabina Petride, and Balasubramanyam Sthanikam. 2009. Binary XML storage and query processing in Oracle 11g. Proc. VLDB Endow. 2, 2 (Aug. 2009), 1354-1365.;;Oracle Corporation, ""What is Reduced XML?,"" Publicly presented as early as Jul. 8, 2003, 4 pages.;;Jinyu Wang and Mark Scardina, ""XML Data Streaming for Enterprise Applications Using PL/SQL and SAX,"" Apr. 3, 2002, 11 pages.;;Deepak Vohra, ""Validating XML Documents Against XML Schema,"" Feb. 4, 2004, http:otn.oracle.com/pub/articles/vohra-xmlschema.html?-template+/otn/content/print, retrieved Jun. 18, 2004, pp. 1-4.;;W3C, ""XQuery 1.0 and XPath 2.0 Data Model,"" Nov. 12, 2003, http://www.w3.org/TR/2003/WD-expath-datamodel-20031112/, retrieved Jun. 22, 2004, pp. 1-72.;;W3C, ""XML Schema Part 1: Structures,"" May 2, 2001, http://www.w3org./TR/2001/REC-xmlschema-1-20010502/, retrieved Jun. 22, 2004, pp. 1-186.;;Zhang et al., ""Binary XML Storage and Query Processing in Oracle 11g"", Proc. VLDB Endow. 2,2, dated Aug. 2009, pp. 1354-1365.",ACTIVE
80,US,B2,US 11318332 B2,013-606-670-262-762,2022-05-03,2022,US 202117399996 A,2021-08-11,US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Methods of treating tumors with pro drugs,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/013-606-670-262-762,Granted Patent,yes,120,4,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,10,9,051-039-627-241-261;;051-574-595-812-959;;050-636-574-781-211;;032-029-745-353-127;;054-725-159-197-552;;064-980-553-392-71X;;065-394-564-594-215;;024-860-166-646-700;;064-842-608-180-947,28759636;;pmc5536352;;10.1371/journal.pone.0181654;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;16716552;;10.1016/j.ejrad.2006.04.007;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;18068747;;10.1016/j.ultras.2007.11.001,"Fisher et al., “ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neurol. Dec. 2012;14(6):541-8. PMID: 23007950. (Year: 2012).;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020.;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.",ACTIVE
81,US,B2,US 11865372 B2,092-735-774-617-35X,2024-01-09,2024,US 202318125959 A,2023-03-24,US 202318125959 A;;US 202217733868 A;;US 202117399996 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Methods of treating tumors with drugs,"Methods of treating tumors by administering compounds to a patient are provided. Compounds such as drugs, may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/092-735-774-617-35X,Granted Patent,yes,154,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,16,15,051-039-627-241-261;;065-394-564-594-215;;032-029-745-353-127;;054-725-159-197-552;;024-860-166-646-700;;051-574-595-812-959;;050-636-574-781-211;;064-842-608-180-947;;064-980-553-392-71X;;107-189-280-953-430;;039-694-157-560-781;;015-977-286-269-092;;127-445-262-134-314;;032-000-168-605-558;;067-424-605-912-927,28759636;;pmc5536352;;10.1371/journal.pone.0181654;;16716552;;10.1016/j.ejrad.2006.04.007;;29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;18068747;;10.1016/j.ultras.2007.11.001;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;10.1016/s1350-4177(96)00024-7;;24752138;;10.1159/000358687;;10.3171/jns.2004.100.2.0272;;15086235;;19414331;;10.1016/j.pdpdt.2014.04.004;;24905843;;10.1007/pl00008471;;11043398,"Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 2017. 31 ;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020.;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy” 1996, Ultrasonics Sonochemistry, pp. S187-S191.;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;Wang et al., “Rapid and selective cerebral hypothermia achieved using a cooling helmet,” J. Neurosurg. 2004; 100(2):272-77. PMID:15086235. (Year: 2004).;;Nonaka et al. “Sonodynamic therapy consisting of focused ultrasound and photosensitizer causes a selective antitumor effect in a rat intracranial glioma model”, Anticancer Res 29: 943-950, 2009 (Year: 2009).;;Tetard et al., “Experimental use of photodynamic therapy in high grade gliomas: A revie focused on 5-aminolevulinic acid”, Photodiagnosis and Photodynamic Therapy, vol. 11, No. 3, Sep. 1, 2014, pp. 319-330.;;Yumita et al. “Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma.” J Cancer Res Clin Oneal 126: 601-606, 2000 (Year: 2000).",ACTIVE
82,EP,B1,EP 3089690 B1,097-225-153-257-111,2018-08-29,2018,EP 15700918 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE FOR USE OF PHOTODYNAMIC THERAPY,,CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,"ALPHEUS MEDICAL, INC. (2021-09-20);;ALPHEUS MEDICAL, INC., CHANHASSEN, US (2023-02-17);;ALPHEUS MEDICAL, US (2023-02-06);;ALPHEUS MEDICAL, INC., OAKDALE, US (2021-06-09);;ALPHEUS MEDICAL, INC.; US (2021-06-15);;CRANIOVATION, INC. (2018-08-08)",https://lens.org/097-225-153-257-111,Granted Patent,yes,6,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
83,DK,T3,DK 3089690 T3,139-336-173-556-200,2018-12-03,2018,DK 15700918 T,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,APPARAT TIL ANVENDELSE AF FOTODYNAMISK TERAPI,,CRANIOVATION INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,,https://lens.org/139-336-173-556-200,Granted Patent,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
84,US,A1,US 2011/0179088 A1,162-300-101-870-646,2011-07-21,2011,US 68919610 A,2010-01-18,US 68919610 A,2010-01-18,Efficient Validation Of Binary XML Data,"Data used and generated by the process of validating XML documents is divided into two categories: compile-time static data and runtime data. Runtime data may be specific to a particular XML document and changes when validating the XML document, while compile-time data does not change in this way. For example, compile-time data may be data that defines, according to a schema, the descendant elements and ordering between them. Runtime data is information generated to track which descendants occurred in a particular XML document being validated. Compile-time static data, once generated to validate a particular XML document, is cached within a shared volatile memory. Once the compile-time data is cached, the compile-time static data may be used to validate other XML documents without the need to regenerate the compile-time static data.",MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN,MEDI VIJAY;;IDICULA SAM;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2010-01-13),https://lens.org/162-300-101-870-646,Patent Application,yes,28,10,4,4,0,G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143;;G06F16/86;;G06F40/146;;G06F40/226;;G06F40/143,G06F17/30;;G06F40/143,707/803;;X707E17127,1,1,106-809-566-107-553,10.14778/1687553.1687561,"Ning Zhang, Nipun Agarwal, Sivasankaran Chandrasekar, Sam Idicula, Vijay Medi, Sabina Petride, and Balasubramanyam Sthanikam. 2009. Binary XML storage and query processing in Oracle 11g. Proc. VLDB Endow. 2, 2 (August 2009), 1354-1365.",ACTIVE
85,MX,B,MX 363909 B,160-125-940-856-994,2019-04-08,2019,MX 2016008818 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,DEVICE AND METHOD FOR USE OF PHOTODYNAMIC THERAPY.,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,CRANIOVATION INC,VIJAY AGARWAL;;RANJITH BABU;;JACK RATCLIFFE,"CRANIOVATION, INC. (2019-04-23)",https://lens.org/160-125-940-856-994,Granted Patent,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61B90/00;;A61B90/10;;A61N5/06,,0,0,,,,ACTIVE
86,US,B2,US 11872414 B2,179-004-971-259-77X,2024-01-16,2024,US 202318214372 A,2023-06-26,US 202318214372 A;;US 202217960443 A;;US 202117400011 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Methods of using ultrasound waves for sonodynamic therapy,Disclosed are methods of producing ultrasound waves for providing sonodynamic therapy. The method includes coupling a sonodynamic therapy device with an array of piezoelectric transducer elements to a skin surface. A controller is configured to generate an electrical drive signal to produce ultrasound waves to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,,https://lens.org/179-004-971-259-77X,Granted Patent,yes,142,0,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B17/32;;A61B18/00;;A61F7/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00;;B06B1/02;;B06B1/06,,27,14,051-039-627-241-261;;065-394-564-594-215;;032-029-745-353-127;;054-725-159-197-552;;039-694-157-560-781;;024-860-166-646-700;;127-445-262-134-314;;051-574-595-812-959;;050-636-574-781-211;;032-000-168-605-558;;107-189-280-953-430;;064-842-608-180-947;;064-980-553-392-71X;;067-424-605-912-927,28759636;;pmc5536352;;10.1371/journal.pone.0181654;;16716552;;10.1016/j.ejrad.2006.04.007;;29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;24752138;;10.1159/000358687;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;19414331;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;10.1016/j.pdpdt.2014.04.004;;24905843;;10.1016/s1350-4177(96)00024-7;;18068747;;10.1016/j.ultras.2007.11.001;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459;;10.1007/pl00008471;;11043398,"U.S. Appl. No. 15/109,506, now Granted U.S. Pat. No. 10,675,482, Device and Method for Use of Photodynamic Therapy, filed Jul. 1, 2016.;;U.S. Appl. No. 15/447,185, Device and Method for Use of Photodynamic Therapy, filed Mar. 2, 2017.;;U.S. Appl. No. 16/861,622, Device and Method for Use of Photodynamic Therapy, filed Apr. 29, 2020.;;U.S. Appl. No. 17/266,157, Tissue Treatment With Sensitizer and Light and/or Sound, filed Feb. 5, 2021.;;U.S. Appl. No. 17/399,964, Methods of Using Planar Acoustic Waves for Non-Invasive Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/399,996, now Granted U.S. Pat. No. 11,318,322, Methods of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, now Granted U.S. Pat. No. 11,491,353, Zero Vergence Ultrasound Waves for Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/733,868, now Granted U.S. Pat. No. 11,617,904, Methods of Treating Tumors With Pro Drugs, filed Apr. 29, 2022.;;U.S. Appl. No. 17/960,443, Zero Vergence Ultrasound Waves for Sonodynamic Therapy, filed Oct. 5, 2022.;;U.S. Appl. No. 18/125,959, Methods of Treating Tumors With Drugs, filed Mar. 24, 2023.;;U.S. Appl. No. 18/125,971, Methods of Treating Tumors With Pro Drugs, filed Mar. 24, 2023.;;U.S. Appl. No. 18/040,610, Ultrasound Arrays for Enhanced Sonodynamic Therapy for Treating Cancer, filed Feb. 3, 2023.;;Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Hynynen et al. “Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020 (6WO).;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332.;;Nonaka et al. “Sonodynamic therapy consisting of focused ultrasound and photosensitizer causes a selective antitumor effect in a rat intracranial glioma model”, Anticancer Res 29: 943-950, 2009 (Year: 2009).;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011; 31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;Tetard et al., “Experimental use of photodynamic therapy in high grade gliomas: A revie focused on 5-aminolevulinic acid”, Photodiagnosis and Photodynamic Therapy, vol. 11, No. 3, Sep. 1, 2014, pp. 319-330.;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy” 1996, Ultrasonics Sonochemistry, pp. S187-S191.;;Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics, pp. 135-140.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;Yumita et al. “Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma.” J Cancer Res Clin Oneal 126: 601-606, 2000 (Year: 2000).",ACTIVE
87,US,B2,US 7831540 B2,199-493-015-518-087,2010-11-09,2010,US 92455607 A,2007-10-25,US 92455607 A,2007-10-25,Efficient update of binary XML content in a database system,"Various techniques are described hereafter for improving the efficiency of updating XML documents in a content repository, such as a database system. Specifically, techniques are described for updating an XML document by dynamically merging a stream of XML data from the document with update information. Techniques are also described for efficient validation of XML documents. Because of the manner of the updates, specifically because the XML data being updated is in the form of a stream, the database system validates only those portions of the stream of XML data that have been updated. In the alternative, the database system validates that portion of the XML data that is associated with the parent node of the portion of XML data that has been updated.",ORACLE INT CORP,MEDI VIJAY;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2007-10-25),https://lens.org/199-493-015-518-087,Granted Patent,yes,37,19,2,2,0,G06F16/83;;G06F16/83;;G06F16/80;;G06F16/80,G06F7/00;;G06F17/00,707/601;;707/605;;715/239,21,12,001-760-995-735-142;;153-560-851-435-04X;;103-480-371-023-923;;093-965-920-960-413;;172-989-677-470-421;;123-188-971-656-051;;035-655-789-713-910;;191-038-550-261-206;;045-445-731-521-438;;012-124-850-800-371;;089-513-628-343-627;;086-033-760-705-419,10.1145/1066157.1066216;;10.1109/icde.2000.839412;;10.1023/b:wwwj.0000047377.03543.64;;10.1145/502200.502202;;10.1007/978-3-540-24607-7_14;;10.1145/988672.988719;;10.1145/1008992.1009010;;10.1145/342009.335405;;10.1145/872757.872775;;10.1145/1031453.1031462;;10.1145/1185448.1185606;;10.1145/1042046.1042050,"Lazy XML Updates: Laziness as a Virtue of Update and Structural Join Efficiency, Catania et al, SIGMOD 2005 Jun. 14-16, 2005.;;Efficient Storage of XML data, Kanne et al, Dec. 13, 1999.;;An Efficient XML Index Technique with Relative Position Coordinate, Kim et al, Dept. of Computer Science, Seoul, South Korea, WSEAS Transactions on Information Science and Applications. vol. 2, No. 4, pp. 373-379. Apr. 2005.;;Dynamically updating XML Data; Numbering Scheme Revisited, Yu et al, Internet and Web Information Systems, vol. 8, pp. 5-26, 2005.;;The Extended XQL for Querying and Updating Large XML Databases, Wong et al, DocEng'Ol, Nov. 9-10, 2001.;;Updates and Incremental Validation of XMI Documents, Bouchou et al, LNCS 2921, pp. 216-232, 2004.;;A delta Format for XML: Identifying Changes in XML Files and Representing the Changes in XML, La Fontaine et al, 2001.;;PCT/US2007/010163, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, Oct. 12, 2007, 12 pages.;;Bayardo et al., ""Optimizing encoding: An evaluation of binary xml encoding optimizations for fast stream based xml processing"", May 2004, Proceedings of the 13th international conference on World Wide Web WWW 04', Publisher ACM press, 7 pages.;;Liu et al., ""XML retrieval: Configurable indexing and ranking for XML information retrieval"", Jul. 2004, Proceedings of the 27th annual international ACM SIGIR conference on Research and development in information retrieval SIGIR 04', Pulished by ACM press, 12 pages.;;Liefke et al., ""Xmill: an efficient compressor for XML data"", May 2000, ACM SIGMOD Record, Proceedings of the 2000 ACM SIGMOD international conference on Management of data SIGMOD 00', vol. 29 Issue 2, Publisher: ACM Press, 12 pages.;;Min et al., ""XML Indexing and compression: XPRESS: a queriable compression for XML data"", Jun. 2003, Proceedings of the 2003 ACM SIGMOD international conference on Management of data SIGMOD 03', Published by ACM Press, 8 pages.;;Zou et al., ""XML Processing: Ctree: a compact tree for indexing XML data"" Nov. 2004, Proceedings of the 6th annual international workshop on Web information and data management WIDM 04', Published by ACM Press, 10 pages.;;""WAP Binary XML Content Format"" downloaded from the Internet Nov. 9, 2007 15 pages.;;""3 Using Oracle XML DB"" downloaded from the Internet Nov. 9, 2007 63 pages.;;""What's New in the XDK?"" downloaded from the Internet Nov. 9, 2007 3 pages.;;""20 Using the XML Schema Processor for C"" downloaded from the Internet Nov. 9, 2007 10 pages.;;""4 XML Parsing for Java"" downloaded from the Internet Nov. 9, 2007 < http://download.oracle.com/docs/cd/B28359-01/appdev.111/b28394/adx-j-parser.htm > 42 pages.;;""4 XMLType Operations"" downloaded from the Internet Nov. 9, 2007 29 pages.;;Zhang, et al., ""TDX: A High Performance Table-driven XML Parser"", In proceedings of the 44th annual (ACM) Southeast Regional Conference, Mar. 2006, ACM, 6 pp.;;Balmin et al., ""Incremental Validation of XML Documents"", ACM Trans. Database System, Dec. 24, 2004, 42 pp.",ACTIVE
88,NZ,A,NZ 722168 A,198-866-290-304-393,2021-03-26,2021,NZ 72216815 A,2015-01-02,US 2015/0010053 W;;US 201461923639 P,2014-01-04,Device for use of photodynamic therapy,"Photodynamic therapy (PDT) is a form of treatment that relies on exposing an area of tissue to a selective wavelength of activating radiation. PDT has been used effectively in oncology for the destruction of malignant cell masses in the body. However, use in the brain has been limited by the lack of proven devices familiar to neurosurgeons to deliver PDT for the treatment of brain tissue. There is a need for a new device for PDT that is useful and effective for other parts of the body in addition to the brain. The present invention provides a non-implantable surgical apparatus that uses a light source and a power supply for minimally invasive surgical treatment of a tissue region of a brain of a patient. The apparatus comprises a housing having a proximal and distal end, and the housing comprises a handle configured to be grasped and manipulated by a surgeon during a surgical procedure and to remain outside of the patient throughout the surgical procedure. The apparatus also comprises a wand extending from the distal end of the housing. The wand comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain during the surgical procedure. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft. The wand also comprises an end cap having a closed distal end and being coupled to the distal end of the outer shaft. The end cap comprising one or more apertures disposed along a longitudinal surface of the end cap and parallel to a longitudinal axis of the end cap. The wand also comprises an inner fiber optic cable having a distal end and a proximal end adapted to be operatively connected to the light source. The fiber optic cable is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The wand also comprises a diffuser element disposed within the end cap and configured to receive light emitted at the distal end of the inner fiber optic cable, and a ball bearing having a reflective outer surface disposed at a distal end of the diffuser element and within the end cap, and configured to reflect light received from the diffuser element laterally and proximally through the one or more apertures. The wand also comprises a piezoelectric ceramic member disposed within the end cap and located distally from the ball bearing, the piezoelectric ceramic member being coupled to wire connectors that extend to the proximal end of the outer shaft where they are adapted to be operatively connected to the power supply. The piezoelectric ceramic member is adapted to deliver sound waves to the tissue region of the brain during the surgical procedure. The piezoelectric ceramic member has a cylindrical shape having a cylindrical axis co-axial with a longitudinal axis of the outer shaft lumen. The fiber optic cable is adapted to deliver light from the light source via the diffuser element and the ball bearing through the at least one aperture of the end cap to the tissue region of the brain in proximity to the distal end of the outer shaft during the surgical procedure.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,"CRANIOVATION, INC., US (2018-07-25)",https://lens.org/198-866-290-304-393,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,PENDING
89,US,B2,US 11730980 B2,035-154-729-481-323,2023-08-22,2023,US 202117399964 A,2021-08-11,US 202117399964 A;;US 2020/0017983 W;;US 201962805186 P,2019-02-13,Methods of using planar acoustic waves for non-invasive sonodynamic therapy,"Disclosed are methods of using planar acoustic waves for providing non-invasive sonodynamic therapy. The method includes acoustically coupling an array of flat piezoelectric transducers to a patient. A controller is configured to generate an electrical drive signal at a frequency selected from a range of frequencies, modulate the drive signal, and drive the transducer with the modulated drive signal at the frequency to produce a modulated planar acoustic wave to produce an average acoustic intensity sufficient to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY,ALPHEUS MEDICAL INC (2020-10-26),https://lens.org/035-154-729-481-323,Granted Patent,yes,144,1,26,26,0,A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61B2018/00446;;A61B2018/00577;;A61B2018/00791;;A61F2007/0056;;A61N7/02;;A61N2007/006;;A61N2007/0073;;A61N2007/0078;;A61N7/02;;A61F7/00;;A61N2007/0078;;A61N2007/0073;;A61N2007/006;;A61N2007/0021;;A61N2007/027;;A61B2018/00791;;A61B2018/00714;;A61B2018/00005;;A61B2018/00446;;A61B2018/00577;;A61F2007/0056;;A61B2017/00084;;A61B2018/00023;;A61B2018/00446;;A61F2007/0288;;A61K9/0053;;A61K31/197;;A61K41/0033;;A61K41/0061;;A61N7/00;;A61N2007/0073;;A61N2007/0095;;A61N2007/0078;;A61P35/00;;A61B2017/320069;;A61F7/0085;;A61F2007/0056;;A61F2007/0096;;A61N2007/003;;A61N2007/006;;A61N2007/0082;;B06B1/0207;;B06B1/0622;;B06B2201/76,A61N7/00;;A61B17/00;;A61B18/00;;A61F7/02;;A61K9/00;;A61K31/197;;A61K41/00;;A61P35/00,,26,15,065-394-564-594-215;;024-860-166-646-700;;064-842-608-180-947;;039-694-157-560-781;;107-189-280-953-430;;181-889-014-496-418;;004-551-214-113-411;;051-039-627-241-261;;051-574-595-812-959;;050-636-574-781-211;;127-445-262-134-314;;032-000-168-605-558;;032-029-745-353-127;;054-725-159-197-552;;064-980-553-392-71X,16716552;;10.1016/j.ejrad.2006.04.007;;20087132;;pmc2939497;;10.1227/01.neu.0000360379.95800.2f;;18068747;;10.1016/j.ultras.2007.11.001;;24752138;;10.1159/000358687;;10.1016/s1350-4177(96)00024-7;;10.1002/0471221155;;10.1159/000366383;;25502879;;28759636;;pmc5536352;;10.1371/journal.pone.0181654;;21873170;;10.1007/s11940-012-0201-x;;23007950;;pmc3519955;;19414331;;10.1016/j.pdpdt.2014.04.004;;24905843;;29204925;;10.1007/s13346-017-0448-6;;10.1667/rr3510.1;;16494518;;10.1016/j.ultrasmedbio.2014.11.019;;pmc4362523;;25728459,"Kullervo Hynynen et al., “Pre-clinical testing ofa phased array ultrasound system for MRI-guided noninvasive surgery of the brain—A primate study”, Apr. 7, 2006, European Journal of Radiology, pp. 149-156 (Year: 2006).;;Nathan McDannold et al., “Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients”, Feb. 2010, Neurosurgery, vol. 66 No. 2, pp. 323-332 (Year: 2010).;;Xiao Bing Wang et al., “Study of cell killing effect on S180 by ultrasound activating protoporphyrin IX”, Nov. 7, 2007 Ultrasonics , pp. 135-140 (Year: 2007).;;Li et al., “Cytotoxic Effect of Protoporphyrin IX to Human Leukemia U937 Cells under Ultrasonic Irradiation”, Apr. 15, 2014, pp. 1186-1196 (Year: 2014).;;Umemura et al., “Recent advances in sonodynamic approach to cancer therapy”, 1996, Ultrasonics Sonochemistry, pp. S187-S191 (Year: 1996).;;Hendee et al., “Medical Imaging Physics, Fourth Edition”, 2002, pp. 303-353 (Year: 2002).;;Olympus Corporation, “Ultrasonic Transducers”, 2010 (Year: 2010).;;Xu et al., “Protoporphyrin IX Induces a Necrotic Cell Death in Human THP-1 Macrophages through Activation of Reactive Oxygen” Species/c-Jun N-Terminal Protein Kinase, 2014, Cellular Physiology and Biochemistry (Year: 2014).;;Fisher et al., “ALA-Pp IX mediated photodynamic therapy of malignant gliomas augmented by hypothermia,” PLoS One Jul. 31, 2017;12(7):e0181654. PMID: 28759636. (Year: 2017).;;Ohmura et al., “Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat,” Anticancer Res. Jul. 2011;31(7):2527-33. PMID: 21873170. (Year: 2011).;;Song et al., “Overview of therapeutic hypothermia,” Curr. Treat. Options. Neural. Dec. 2012; 14(6):541-8. PMID: 23007950. (Year: 2012).;;U.S. Appl. No. 17/399,996, Methods of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, Zero Vergence Ultrasound Waves For Sonodynamix Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 15/109,506 now Granted U.S. Pat. No. 10,675,482, Device and Method for Use of Photodynamic Therapy, filed Jul. 1, 2016.;;U.S. Appl. No. 15/447,185, Device and Method for Use of Photodynamic Therapy, filed Mar. 2, 2017.;;U.S. Appl. No. 16/861,622, Device and Method for Use of Photodynamic Therapy, filed Apr. 29, 2020.;;U.S. Appl. No. 17/266,157, Tissue Treatment With Sensitizer and Light and/or Sound, filed Feb. 5, 2021.;;U.S. Appl. No. 17/399,996 now Granted U.S. Pat. No. 11,318,322, Methods of Treating Tumors With Pro Drugs, filed Aug. 11, 2021.;;U.S. Appl. No. 17/400,011, Zero Vergence Ultrasound Waves For Sonodynamic Therapy, filed Aug. 11, 2021.;;U.S. Appl. No. 17/733,868, Methods of Treating Tumors With Pro Drugs, filed Apr. 29, 2022.;;Nonaka et al. “Sonodynamic therapy consisting of focused ultrasound and photosensitizer causes a selective antitumor effect in a rat intracranial glioma model”, Anticancer Res 29: 943-950, 2009 (Year: 2009).;;Tetard et al., “Experimental use of photodynamic therapy in high grade gliomas: A revie focused on 5-aminolevulinic acid”, Photodiagnosis and Photodynamic Therapy, vol. 11, No. 3, Sep. 1, 2014, pp. 319-330.;;Jain et al., “Ultrasound-based triggered drug delivery to tumors”, Drug Delivery and Translational Search, Springer, Germany, vol. 8, No. 1, Dec. 4, 2017.;;Kinoshita et al., Mechanism of Porphyrin-Induced Sonodynamic Effect: Possible Role of Hyperthermia, Radiation Research 165, pp. 229-306, 2006.;;Wood et al. “A Review of Low-Intensity Ultrasound for Cancer Therapy” Ultrasound in Med. & Biol., vol. 41, No. 4, pp. 905-928, 2015.;;International Search Report and Written Opinion for International PCT Application No. PCT/US2020/017983, dated Jun. 15, 2020.",ACTIVE
90,CN,A,CN 104271058 A,116-373-442-776-382,2015-01-07,2015,CN 201380013369 A,2013-01-31,US 2013/0024033 W;;US 201261593270 P,2012-01-31,Bioactive fusion device,"In a first broad aspect, there is provided herein a bioactive device and system for fusion between two bones, two parts of a bony joint, or a bony defect, such as of the spine. The fusion device includes a screw having a head and a threaded shaft. The fusion device also includes a bone dowel having an internal bore of which at least a distal portion is threaded to engage the threads of the screw shaft. The bone dowel is made of a bone-like, biocompatible, or allograft material to provide a layer of bone-like, biocompatible, or allograft material between the screw and the spinal bone. The device is generally coaxial and is further described in the drawings and description herein.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K,,https://lens.org/116-373-442-776-382,Patent Application,no,6,2,11,11,0,A61B17/7064;;A61B17/8685;;A61F2/446;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61F2/446;;A61B17/7064;;A61B17/8685;;A61B17/8625;;A61B17/866;;A61B2017/564;;A61F2/442;;A61F2/4455,A61B17/86,,0,0,,,,INACTIVE
91,AU,A1,AU 2015/204075 A1,143-021-635-395-682,2016-08-04,2016,AU 2015/204075 A,2015-01-02,US 201461923639 P;;US 2015/0010053 W,2014-01-04,Device and method for use of photodynamic therapy,An apparatus including a light source provides for intracranial treatment of a tissue region of a brain of a patient. The intracranial treatment apparatus comprises an outer shaft having a proximal end and a distal end for positioning within the tissue region of the brain. The outer shaft defines a lumen extending between the proximal end and the distal end of the outer shaft and having at least one aperture adjacent the distal end of the outer shaft. An inner light-delivery element having a distal end and a proximal end is adapted to be operatively connected to the light source. The light-delivery element is configured to be received within the lumen and extend from the proximal end of the shaft to adjacent the distal end of the shaft. The light-delivery element is adapted to deliver light from the light source through the at least one aperture of the outer shaft to the tissue region of the brain in proximity to the distal end of the outer shaft.,AGARWAL VIJAY;;RATCLIFFE JACK;;BABU RANJITH,AGARWAL VIJAY;;BABU RANJITH;;RATCLIFFE JACK,"ALPHEUS MEDICAL, INC. (2021-06-03);;CRANIOVATION, INC. (2018-07-12)",https://lens.org/143-021-635-395-682,Patent Application,no,0,0,23,23,0,A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61B2018/2266;;A61N2005/0612;;A61N2005/063;;A61N5/062;;A61N2005/0651;;A61N2005/0665;;A61B2018/2272;;A61N5/0601;;A61B2018/00321;;A61B2018/2261;;A61N2005/0612;;A61N2005/063;;A61B2018/2266;;A61N5/062;;A61B90/10;;A61B90/39;;A61B2090/3954;;A61B2090/3966;;A61N2005/0651;;A61N2005/0665;;A61K41/0057,A61B18/22;;A61N5/06,,0,0,,,,ACTIVE
92,EP,A1,EP 3021795 A1,180-024-721-808-450,2016-05-25,2016,EP 14826731 A,2014-07-18,US 201361847841 P;;US 2014/0047156 W,2013-07-18,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,,https://lens.org/180-024-721-808-450,Patent Application,yes,0,0,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44,,0,0,,,,DISCONTINUED
93,EP,A4,EP 3021795 A4,136-749-911-643-055,2017-05-03,2017,EP 14826731 A,2014-07-18,US 201361847841 P;;US 2014/0047156 W,2013-07-18,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,,https://lens.org/136-749-911-643-055,Search Report,no,4,0,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44,,1,0,,,See also references of WO 2015009998A1,DISCONTINUED
94,WO,A9,WO 2015/009998 A9,181-154-578-403-830,2015-04-30,2015,US 2014/0047156 W,2014-07-18,US 201361847841 P,2013-07-18,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,"An intervertebral cage includes a plurality of segments that are connected together by one or more members formed from a shape memory alloy material such that the segments are automatically moved from an initial orientation before implantation/insertion in an intervertebral space to an expanded orientation after implantation/insertion in the intervertebral space. Each of the plurality of segments may have a plurality of passageways or recesses formed therethrough, and wherein a wire formed from a shape memory alloy material extends through each of the plurality of passageways or recesses. The member may be formed from a shape memory alloy material that demonstrates shape memory effects and superelasticity properties, such as nitinol.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,,https://lens.org/181-154-578-403-830,Search Report,yes,0,0,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44,,0,0,,,,PENDING
95,US,A1,US 2016/0143747 A1,139-205-001-912-213,2016-05-26,2016,US 201414904224 A,2014-07-18,US 201414904224 A;;US 201361847841 P;;US 2014/0047156 W,2013-07-18,Expandable Inter-Vertebral Cage and Method of Installing Same,"An intervertebral cage includes a plurality of segments that are connected together by one or more members formed from a shape memory alloy material such that the segments are automatically moved from an initial orientation before implantation/insertion in an intervertebral space to an expanded orientation after implantation/insertion in the intervertebral space. Each of the plurality of segments may have a plurality of passageways or recesses formed therethrough, and wherein a wire formed from a shape memory alloy material extends through each of the plurality of passageways or recesses. The member may be formed from a shape memory alloy material that demonstrates shape memory effects and superelasticity properties, such as nitinol.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,THE UNIVERSITY OF TOLEDO (2016-01-15),https://lens.org/139-205-001-912-213,Patent Application,yes,18,17,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44,,0,0,,,,ACTIVE
96,US,B2,US 10828171 B2,177-264-098-231-85X,2020-11-10,2020,US 201414904224 A,2014-07-18,US 201414904224 A;;US 201361847841 P;;US 2014/0047156 W,2013-07-18,Expandable inter-vertebral cage and method of installing same,"An intervertebral cage includes a plurality of segments that are connected together by one or more members formed from a shape memory alloy material such that the segments are automatically moved from an initial orientation before implantation/insertion in an intervertebral space to an expanded orientation after implantation/insertion in the intervertebral space. Each of the plurality of segments may have a plurality of passageways or recesses formed therethrough, and wherein a wire formed from a shape memory alloy material extends through each of the plurality of passageways or recesses. The member may be formed from a shape memory alloy material that demonstrates shape memory effects and superelasticity properties, such as nitinol.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,THE UNIVERSITY OF TOLEDO (2016-01-15),https://lens.org/177-264-098-231-85X,Granted Patent,yes,20,0,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44;;A61F2/30,,2,0,,,"PCT Written Opinion and International Search Report, Application No. PCT/US14/47156, dated Dec. 1, 2014.;;The Extended European Search Report, Application No. 14826731.3 dated Mar. 30, 2017.",ACTIVE
97,WO,A1,WO 2015/009998 A1,109-599-585-620-332,2015-01-22,2015,US 2014/0047156 W,2014-07-18,US 201361847841 P,2013-07-18,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,"An intervertebral cage includes a plurality of segments that are connected together by one or more members formed from a shape memory alloy material such that the segments are automatically moved from an initial orientation before implantation/insertion in an intervertebral space to an expanded orientation after implantation/insertion in the intervertebral space. Each of the plurality of segments may have a plurality of passageways or recesses formed therethrough, and wherein a wire formed from a shape memory alloy material extends through each of the plurality of passageways or recesses. The member may be formed from a shape memory alloy material that demonstrates shape memory effects and superelasticity properties, such as nitinol.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;AGARWAL AAKASH;;DICK DAVID,,https://lens.org/109-599-585-620-332,Patent Application,yes,7,6,6,6,0,A61F2/4455;;A61F2/4455;;A61F2002/30092;;A61F2002/30092;;A61F2002/30115;;A61F2002/30115;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/4415;;A61F2002/4415,A61F2/44,,1,0,,,See also references of EP 3021795A4,PENDING
98,WO,A1,WO 2021/101584 A1,102-455-874-565-117,2021-05-27,2021,US 2020/0025875 W,2020-03-31,US 201916687086 A,2019-11-18,CORE CONTROLLER ARCHITECTURE,A data storage system includes a storage controller and a storage medium in communication with the storage controller. The storage medium includes a memory core comprising an array of memory cells and core control logic configured to perform operations on memory cells in the array in accordance with instructions received from the storage controller. The core control logic comprises a firmware-implemented condition evaluation machine configured to determine whether a plurality of memory core conditions are met. The core control logic also comprises a firmware-implemented signal setting machine configured to set or reset a plurality of respective memory operation signals to implement the operations on the memory cells based on respective condition evaluation machine determinations.,SANDISK TECHNOLOGIES LLC,CHINCHOLE VIJAY;;AGARWAL SONAM;;AGARWAL AKASH;;PADATTIL NISHA;;DEVARAJ PAVITHRA,,https://lens.org/102-455-874-565-117,Patent Application,yes,5,0,2,2,0,G06F3/0607;;G06F3/0659;;G06F3/0626;;G06F3/0626;;G06F3/0632;;G06F3/0653;;G06F3/0658;;G06F3/0679;;G06F3/0688,G06F3/06,,0,0,,,,PENDING
99,US,B1,US 11080059 B1,009-335-430-972-953,2021-08-03,2021,US 202016834437 A,2020-03-30,US 202016834437 A,2020-03-30,Reducing firmware size and increasing firmware performance,"A method for reducing firmware size and increasing firmware performance. Core timing control conditions used by a die controller are converted into production ready core timing control conditions, from which firmware instructions are then generated. The production ready core timing control conditions comprise a plurality of fixed core timing control conditions. The firmware instructions are modified to determine core timing control condition values for fixed core timing control conditions before implementing storage operations, to store the core timing control condition values in global condition registers, and to modify references to fixed core timing control conditions to access the values in those global condition registers. Finally, the modified firmware instructions are stored on the die controller, which comprises a microcontroller configured to execute them.",SANDISK TECHNOLOGIES LLC,AGARWAL SONAM;;CHINCHOLE VIJAY SUKHLAL;;DEVARAJ PAVITHRA,SANDISK TECHNOLOGIES LLC (2020-04-01),https://lens.org/009-335-430-972-953,Granted Patent,yes,10,0,1,1,0,G06F8/4434;;G06F9/30189;;G06F8/65;;G06F9/30101,G06F9/30;;G06F8/65,,4,4,063-126-467-675-407;;084-432-882-086-666;;030-732-881-655-383;;120-982-555-755-586,10.1109/mm.2013.29;;10.1145/3316781.3317756;;10.1145/2597809.2597811;;10.1109/54.748806,"Bojnordi and Ipek; “Programmable DDRx Controllers”; IEEE Micro, vol. 33, No. 3 (pp. 106-115); May-Jun. 2013 (Year: 2013).;;Schwarz et al.; “Access: HW/SW Co-Equivalence Checking for Firmware Optimization”; 2019 56th ACM/IEEE Design Automation Conference (DAC) (pp. 1-6); 2019 (Year: 2019).;;Edler Von Koch, Tobias J.K.et. al., Exploiting Function Similarity for Code Size Reduction, LCTES '14, Jun. 12-13, 2014, pp. 85-94.;;Huang, Chih-Tsun et. al., A Programmable BIST Core for Embedded DRAM, IEEE Design & Test of Computers, Jan.-Mar. 1999, pp. 59-70.",ACTIVE
100,US,B2,US 10055267 B2,095-300-754-975-754,2018-08-21,2018,US 201514638860 A,2015-03-04,US 201514638860 A,2015-03-04,Block management scheme to handle cluster failures in non-volatile memory,"In a non-volatile memory system, such as flash memory, when selecting a block for write operation, the system selects blocks from a free block list (FBL). The memory circuits of non-volatile systems often experience cluster failures, where multiple blocks of a physical region are bad. If the free block list is loaded with blocks from a region having a cluster failure, this can result in multiple back to back write errors. To help avoid this situation, the blocks of a memory array are divided into physical zones and, when selecting blocks to replenish the free block list, blocks are chosen cyclically from the zones.",SANDISK TECHNOLOGIES LLC,AGARWAL DINESH KUMAR;;RAMAMURTHY RAMKUMAR;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-02),https://lens.org/095-300-754-975-754,Granted Patent,yes,75,3,2,2,0,G11C8/12;;G11C16/08;;G11C29/08;;G11C29/4401;;G11C29/76;;G11C2029/0409;;G11C8/12;;G11C16/08;;G11C29/08;;G11C29/4401;;G11C29/76;;G11C2029/0409;;G06F11/00,G06F3/06;;G06F11/00;;G11C8/12;;G11C16/08;;G11C29/00;;G11C29/04;;G11C29/08;;G11C29/44,,5,2,081-791-670-931-667;;118-571-555-290-872,10.1145/2463209.2488938;;10.1109/55.877205,"Che-Wei Tsao, Yuan-Hao Chang, and Ming-Chang Yang. 2013. Performance enhancement of garbage collection for flash storage devices: an efficient victim block selection design. In Proceedings of the 50th Annual Design Automation Conference (DAC '13). ACM, New York, NY, USA, Article 165 , 6 pages. DOI=http://dx.doi.org/10.1145/2463209.2488938.;;Eitan et al., “NROM: A Novel Localized Trapping, 2-Bit Nonvolatile Memory Cell,” IEEE Electron Device Letters, vol. 21, No. 11, Nov. 2000, pp. 543-545.;;Final Office Action in U.S. Appl. No. 13/754,644 dated Nov. 21, 2014, 13 pages.;;Office Action in U.S. Appl. No. 13/754,627 dated Aug. 7, 2014, 14 pages.;;Office Action in U.S. Appl. No. 13/754,644 dated Jun. 13, 2014, 8 pages.",ACTIVE
101,WO,A2,WO 2015/200543 A2,189-365-948-891-159,2015-12-30,2015,US 2015/0037527 W,2015-06-24,US 201462016498 P,2014-06-24,APPARATUS AND METHOD FOR INJECTING BONE GRAFT SUBSTITUTE AND OTHER MATERIALS,"A metering delivery apparatus for injecting bone graft cement includes a body portion, a material containment vessel, an actuator, and a control unit. The body portion includes a drive housing that supports an actuator drivetrain and receiver end that supports the material containment vessel. The actuator has a first end connected to the actuator drivetrain and a second end that supports a moveable portion of the vessel to dispense material in the vessel and a retracting movement that relieves pressure applied to the material. The control unit receives actuator parameter inputs and includes a sensor to detect a signal of at least one of a pressure level and a time period. The sensor provides the detected signal to the control unit such that the control unit operates the actuator between the dispensing and retracting movements based on the detected signal and the actuator parameter inputs.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,,https://lens.org/189-365-948-891-159,Patent Application,yes,0,0,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,G06F19/00;;A61M5/172,,0,0,,,,PENDING
102,US,A1,US 2016/0259570 A1,021-538-549-398-674,2016-09-08,2016,US 201514638860 A,2015-03-04,US 201514638860 A,2015-03-04,Block Management Scheme to Handle Cluster Failures in Non-Volatile Memory,"In a non-volatile memory system, such as flash memory, when selecting a block for write operation, the system selects blocks from a free block list (FBL). The memory circuits of non-volatile systems often experience cluster failures, where multiple blocks of a physical region are bad. If the free block list is loaded with blocks from a region having a cluster failure, this can result in multiple back to back write errors. To help avoid this situation, the blocks of a memory array are divided into physical zones and, when selecting blocks to replenish the free block list, blocks are chosen cyclically from the zones.",SANDISK TECHNOLOGIES INC,AGARWAL DINESH KUMAR;;RAMAMURTHY RAMKUMAR;;SIVASANKARAN VIJAY,SANDISK TECHNOLOGIES LLC (2015-03-02),https://lens.org/021-538-549-398-674,Patent Application,yes,12,9,2,2,0,G11C8/12;;G11C16/08;;G11C29/08;;G11C29/4401;;G11C29/76;;G11C2029/0409;;G11C8/12;;G11C16/08;;G11C29/08;;G11C29/4401;;G11C29/76;;G11C2029/0409;;G06F11/00,G06F3/06,,1,1,081-791-670-931-667,10.1145/2463209.2488938,"Che-Wei Tsao, Yuan-Hao Chang, and Ming-Chang Yang. 2013. Performance enhancement of garbage collection for flash storage devices: an efficient victim block selection design. In Proceedings of the 50th Annual Design Automation Conference (DAC '13). ACM, New York, NY, USA, , Article 165 , 6 pages. DOI=http://dx.doi.org/10.1145/2463209.2488938",ACTIVE
103,US,A1,US 2023/0384974 A1,100-166-941-704-559,2023-11-30,2023,US 202217825824 A,2022-05-26,US 202217825824 A,2022-05-26,DATA STORAGE DEVICE WITH MULTI-COMMANDS,"Providing constant fixed commands to memory dies within a data storage device may result in hardware and firmware overheads impacting the performance at a flash interface module (FIM) because the FIM has to handle both the constant fixed commands and the overheads associated with the constant fixed commands. To avoid the impact on performance at the FIM, multiple fixed commands may be combined into individual multi-commands that may be provided to the memory dies. The use of multi-commands reduces hardware and firmware overheads at the FIM relative to the constant fixed commands, which improves performance of the data storage device because the saturation of the FIM is decreased.",WESTERN DIGITAL TECH INC,AGARWAL DINESH KUMAR;;SIVASANKARAN VIJAY;;PALITYKA MIKHAIL,WESTERN DIGITAL TECHNOLOGIES INC (2022-05-26),https://lens.org/100-166-941-704-559,Patent Application,yes,0,0,1,1,0,G06F3/061;;G06F3/0679;;G06F3/0659;;G06F3/0658;;G06F3/0659;;G06F3/0679;;G06F3/0604;;G06F3/0658,G06F3/06,,0,0,,,,PENDING
104,US,B2,US 10478315 B2,197-582-545-071-261,2019-11-19,2019,US 201515320803 A,2015-06-24,US 201515320803 A;;US 201462016498 P;;US 2015/0037527 W,2014-06-24,Apparatus and method for injecting bone graft substitute and other materials,"A metering delivery apparatus for injecting bone graft cement includes a body portion, a material containment vessel, an actuator, and a control unit. The body portion includes a drive housing that supports an actuator drivetrain and receiver end that supports the material containment vessel. The actuator has a first end connected to the actuator drivetrain and a second end that supports a moveable portion of the vessel to dispense material in the vessel and a retracting movement that relieves pressure applied to the material. The control unit receives actuator parameter inputs and includes a sensor to detect a signal of at least one of a pressure level and a time period. The sensor provides the detected signal to the control unit such that the control unit operates the actuator between the dispensing and retracting movements based on the detected signal and the actuator parameter inputs.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,THE UNIVERSITY OF TOLEDO (2017-04-05),https://lens.org/197-582-545-071-261,Granted Patent,yes,7,0,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61B17/88;;A61F2/46;;A61M5/145;;A61M5/172,,1,0,,,"First Chinese Office Action, Application No. 201580042549.X, dated Mar. 22, 2019.",INACTIVE
105,US,A1,US 2017/0196702 A1,061-682-407-705-242,2017-07-13,2017,US 201515320803 A,2015-06-24,US 201515320803 A;;US 201462016498 P;;US 2015/0037527 W,2014-06-24,Apparatus and Method for Injecting Bone Graft Substitute and Other Materials,"A metering delivery apparatus for injecting bone graft cement includes a body portion, a material containment vessel, an actuator, and a control unit. The body portion includes a drive housing that supports an actuator drivetrain and receiver end that supports the material containment vessel. The actuator has a first end connected to the actuator drivetrain and a second end that supports a moveable portion of the vessel to dispense material in the vessel and a retracting movement that relieves pressure applied to the material. The control unit receives actuator parameter inputs and includes a sensor to detect a signal of at least one of a pressure level and a time period. The sensor provides the detected signal to the control unit such that the control unit operates the actuator between the dispensing and retracting movements based on the detected signal and the actuator parameter inputs.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,THE UNIVERSITY OF TOLEDO (2017-04-05),https://lens.org/061-682-407-705-242,Patent Application,yes,4,14,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61B17/88;;A61F2/46;;A61M5/145;;A61M5/172,,0,0,,,,INACTIVE
106,WO,A3,WO 2015/200543 A3,090-093-928-003-955,2016-04-07,2016,US 2015/0037527 W,2015-06-24,US 201462016498 P,2014-06-24,APPARATUS AND METHOD FOR INJECTING BONE GRAFT SUBSTITUTE AND OTHER MATERIALS,"A metering delivery apparatus for injecting bone graft cement includes a body portion, a material containment vessel, an actuator, and a control unit. The body portion includes a drive housing that supports an actuator drivetrain and receiver end that supports the material containment vessel. The actuator has a first end connected to the actuator drivetrain and a second end that supports a moveable portion of the vessel to dispense material in the vessel and a retracting movement that relieves pressure applied to the material. The control unit receives actuator parameter inputs and includes a sensor to detect a signal of at least one of a pressure level and a time period. The sensor provides the detected signal to the control unit such that the control unit operates the actuator between the dispensing and retracting movements based on the detected signal and the actuator parameter inputs.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,,https://lens.org/090-093-928-003-955,Search Report,yes,7,0,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61M5/20,,0,0,,,,PENDING
107,EP,A4,EP 3160548 A4,047-132-038-458-130,2018-03-21,2018,EP 15811190 A,2015-06-24,US 201462016498 P;;US 2015/0037527 W,2014-06-24,APPARATUS AND METHOD FOR INJECTING BONE GRAFT SUBSTITUTE AND OTHER MATERIALS,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,,https://lens.org/047-132-038-458-130,Search Report,no,4,0,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61M5/20;;A61B17/88,,0,0,,,,DISCONTINUED
108,CN,A,CN 106573107 A,080-020-318-190-132,2017-04-19,2017,CN 201580042549 A,2015-06-24,US 201462016498 P;;US 2015/0037527 W,2014-06-24,Apparatus and method for injecting bone graft substitute and other materials,"A metering delivery apparatus for injecting bone graft cement includes a body portion, a material containment vessel, an actuator, and a control unit. The body portion includes a drive housing that supports an actuator drivetrain and receiver end that supports the material containment vessel. The actuator has a first end connected to the actuator drivetrain and a second end that supports a moveable portion of the vessel to dispense material in the vessel and a retracting movement that relieves pressure applied to the material. The control unit receives actuator parameter inputs and includes a sensor to detect a signal of at least one of a pressure level and a time period. The sensor provides the detected signal to the control unit such that the control unit operates the actuator between the dispensing and retracting movements based on the detected signal and the actuator parameter inputs.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,,https://lens.org/080-020-318-190-132,Patent Application,no,7,1,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61M5/20,,0,0,,,,INACTIVE
109,US,A1,US 2023/0042508 A1,103-438-076-213-071,2023-02-09,2023,US 202117395123 A,2021-08-05,RO 202110042 A,2021-08-03,SECURELY COMMUNICATING SERVICE STATUS IN A DISTRIBUTED NETWORK ENVIRONMENT,"A monitoring service monitors performance of an authentication application that authenticates a user or service and securely communicates a status of the authentication application to a service application providing a software service. The monitoring service generates a token using a private key. The token is stored in a secure datastore writable only by the monitoring service and is also provided to the service application. The service application validates a signature of the token using a public key and determines an authenticity of the token by comparing the received token to the stored token in the secure datastore. In doing so, there is a high degree of confidence that the token, or an associated encrypted message, originated from the monitoring service and properly identifies the status of the authentication application.",ADOBE INC,AGARWAL PRAFULL;;SAHU VIJAY KUMAR;;SANDA CATALIN,ADOBE INC (2021-08-03),https://lens.org/103-438-076-213-071,Patent Application,yes,18,6,1,1,0,H04L9/3213;;H04L9/3213;;H04L9/3247;;H04L2209/60;;H04L67/1097;;H04L9/0825,H04L9/32;;H04L9/08,,0,0,,,,PENDING
110,EP,A2,EP 3160548 A2,024-667-258-213-924,2017-05-03,2017,EP 15811190 A,2015-06-24,US 201462016498 P;;US 2015/0037527 W,2014-06-24,APPARATUS AND METHOD FOR INJECTING BONE GRAFT SUBSTITUTE AND OTHER MATERIALS,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;GERBER JOEL M;;AGARWAL AAKASH,,https://lens.org/024-667-258-213-924,Patent Application,yes,0,0,8,8,0,A61M5/14526;;A61M2005/14513;;A61M5/20;;A61M5/2053;;A61M5/486;;A61B17/8827;;A61F2/4601;;A61B17/8822;;A61B17/8825;;A61M5/14526;;A61M2005/14513;;A61M5/2053;;A61M5/486;;A61M5/20;;A61B17/8827;;A61M5/172;;A61F2/4601;;A61B17/8822;;A61B17/8825,A61M5/20,,0,0,,,,DISCONTINUED
111,EP,A4,EP 3013267 A4,077-601-930-071-495,2017-02-22,2017,EP 14817934 A,2014-06-24,US 201361838375 P;;US 2014/0043830 W,2013-06-24,BIOACTIVE FUSION DEVICE,,UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,,https://lens.org/077-601-930-071-495,Search Report,no,1,0,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/86;;A61B17/68;;A61B17/70;;A61F2/28;;A61F2/44,,0,0,,,,DISCONTINUED
112,AT,T1,AT E326104 T1,108-342-567-188-734,2006-06-15,2006,AT 02000449 T,2002-01-08,US 75984601 A,2001-01-12,VERFAHREN ZUR PAKETABLAUFFOLGEPLANUNG UND FUNKRESSOURCENZUWEISUNG IN EINEM DRAHTLOSEN KOMMUNIKATIONSSYSTEM,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames rho that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the rho values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. <IMAGE>",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,,https://lens.org/108-342-567-188-734,Granted Patent,no,0,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56,,0,0,,,,EXPIRED
113,CN,A,CN 102791807 A,147-209-782-863-482,2012-11-21,2012,CN 201180008009 A,2011-01-31,IN 2011000063 W;;IN 273MU2010 A,2010-02-03,A process for the preparation of carbon black pellets,"The present invention envisages a process for pelletizing carbon black by mixing carbon black powder and water in a proportion in the range of 0.1:2 to 2:1 with a binding agent and a dispersing agent. The dispersing agent is an amine-based surfactant and is added in a proportion in the range of 0.005-0.1% of the total mixture. The mixture is pelletized in a pelletizer and subsequently the raw pellets are dried for 20-60 minutes at a temperature between 150-250 DEG C, to obtain the carbon black pellets. The process of the present invention provides uniform distribution of water on the surface of the pellets giving a uniform pellet quality, reduced water consumption, energy savings and an increased production rate.",ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,MAYUR PRABHU;;VIJAY AGARWAL;;RANJAN GHOSAL;;RAJAMOHAMED S,,https://lens.org/147-209-782-863-482,Patent Application,no,5,4,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
114,US,A1,US 2008/0092037 A1,088-196-001-505-706,2008-04-17,2008,US 72994307 A,2007-03-28,US 72994307 A;;US 82965206 P,2006-10-16,Validation of XML content in a streaming fashion,A method and apparatus for validating XML documents in a streaming fashion is provided. A streaming validator validates an XML document by comparing the contents of the XML document to an XML schema. Tokens are generated for each element or attribute of the XML schema and for each element or attribute of the XML document using the same generator token function. The elements and attributes of the XML document and XML schema are compared using tokens rather than string comparisons to perform the validation more efficiently.,ORACLE INT CORP,MEDI VIJAY;;IDICULA SAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2007-03-27),https://lens.org/088-196-001-505-706,Patent Application,yes,100,8,1,15,0,G06F40/226;;G06F40/143;;G06F40/226;;G06F40/143,G06F17/00;;G06F7/00;;G06F40/143,715/237;;707/102;;715/234;;707/100,1,0,,,"W3C, XML Schema Part 0: Primer, W3C Recommendation, 2 May 2001, Editor: David C. Fallside, Copyright 2001, 54 pages.",DISCONTINUED
115,US,B2,US 9156992 B2,044-542-514-247-661,2015-10-13,2015,US 201113576251 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,Process for the preparation of carbon black pellets,"The present disclosure envisages a process for pelletizing carbon black by mixing carbon black powder and water in a proportion in the range of 0.1:2 to 2:1 with a binding agent and a dispersing agent. The dispersing agent is an amine-based surfactant and is added in a proportion in the range of 0.005-0.1% of the total mixture. The mixture is pelletized in a pelletizer and subsequently the raw pellets are dried for 20-60 minutes at a temperature between 150-250° C., to obtain the carbon black pellets. The process of the present disclosure provides uniform distribution of water on the surface of the pellets giving a uniform pellet quality, reduced water consumption, energy savings and an increased production rate.",PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S;;ADITYA BIRLA SCIENCE & TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,BIRLA CARBON INDIA PRIVATE LIMITED (2015-04-09);;ADITYA BIRLA NUVO LIMITED (2012-10-25);;ADITYA BIRLA SCIENCE & TECHNOLOGY COMPANY LIMITED (2012-10-01);;ADITYA BIRLA SCIENCE & TECHNOLOGY COMPANY PRIVATE LIMITED (2015-03-30),https://lens.org/044-542-514-247-661,Granted Patent,yes,19,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58,,1,0,,,"International Search Report (ISR) mailed on Aug. 11, 2011 by the International Searching Authority of the State Intellectual Property Office, the P.R. China, in the counterpart International Application No. PCT/IN2011/000063.",ACTIVE
116,WO,A3,WO 2011/095986 A3,141-463-150-135-87X,2011-10-06,2011,IN 2011000063 W,2011-01-31,IN 273MU2010 A,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,"The present invention envisages a process for pelletizing carbon black by mixing carbon black powder and water in a proportion in the range of 0.1 : 2 to 2 : 1 with a binding agent and a dispersing agent. The dispersing agent is an amine-based surfactant and is added in a proportion in the range of 0.005 - 0.1 % of the total mixture. The mixture is pelletized in a pelletizer and subsequently the raw pellets are dried for 20 - 60 minutes at a temperature between 150 - 250 °C, to obtain the carbon black pellets. The process of the present invention provides uniform distribution of water on the surface of the pellets giving a uniform pellet quality, reduced water consumption, energy savings and an increased production rate.",ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD;;PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/141-463-150-135-87X,Search Report,yes,9,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,1,0,,,See also references of EP 2531564A4,PENDING
117,ES,T3,ES 2262710 T3,144-863-776-190-805,2006-12-01,2006,ES 02000449 T,2002-01-08,US 75984601 A,2001-01-12,METODO PARA LA PLANIFICACION DEL DESARROLLO DE PAQUETES Y LA ASIGNACION DE RECURSOS DE RADIO EN UN SISTEMA DE COMUNICACIONES INALAMBRICAS.,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames rho that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the rho values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. <IMAGE>",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,,https://lens.org/144-863-776-190-805,Granted Patent,no,0,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56,,0,0,,,,EXPIRED
118,EP,A1,EP 4054590 A1,161-318-168-478-672,2022-09-14,2022,EP 20817111 A,2020-11-03,US 201962930433 P;;US 202063024407 P;;US 2020/0058720 W,2019-11-04,METHODS FOR TREATING LEUKEMIA,,AMGEN INC,AGARWAL SURESH;;KHALDOYANIDI SOPHIA;;NAGORSEN DIRK;;UPRETI VIJAY,,https://lens.org/161-318-168-478-672,Patent Application,yes,0,0,4,4,0,C07K2317/31;;C07K2317/73;;C07K16/2803;;C07K16/2809;;A61P35/02;;A61K2039/545;;C07K2317/60;;C07K2317/622;;A61K39/3955;;A61K31/573;;A61P35/02;;A61K31/573;;A61K39/3955;;A61K2039/505;;A61K2039/545;;C07K16/2803;;C07K16/2809;;C07K2317/31;;C07K2317/622,A61K31/573;;A61K39/00;;A61P35/02;;C07K16/28;;C07K16/46,,0,0,,,,PENDING
119,US,A1,US 2022/0389099 A1,034-209-172-469-210,2022-12-08,2022,US 202017774125 A,2020-11-03,US 202017774125 A;;US 202063024407 P;;US 201962930433 P;;US 2020/0058720 W,2019-11-04,METHODS FOR TREATING LEUKEMIA,"The present invention relates to treatment methods for leukemia using bispecific antibody constructs that specifically bind to human CD33 and human CD3. In particular, the present invention relates to methods for treating myeloid leukemia, including relapsed/refractory myeloid leukemia, in a patient in need thereof comprising administering to the patient at least one initiation cycle and at least one maintenance cycle of an anti-CD33×anti-CD3 bispecific antibody construct, wherein each initiation cycle and maintenance cycle comprises administering the bispecific antibody construct according to specific dosage regimens. Pharmaceutical compositions comprising the bispecific antibody constructs for use in the methods are also disclosed.",AMGEN INC,AGARWAL SURESH;;KHALDOYANIDI SOPHIA;;NAGORSEN DIRK;;UPRETI VIJAY,AMGEN INC (2020-08-21),https://lens.org/034-209-172-469-210,Patent Application,yes,0,0,4,4,139,C07K2317/31;;C07K2317/73;;C07K16/2803;;C07K16/2809;;A61P35/02;;A61K2039/545;;C07K2317/60;;C07K2317/622;;A61K39/3955;;A61K31/573;;A61P35/02;;A61K31/573;;A61K39/3955;;A61K2039/505;;A61K2039/545;;C07K16/2803;;C07K16/2809;;C07K2317/31;;C07K2317/622,C07K16/28;;A61K31/573;;A61K39/395;;A61P35/02,,0,0,,,,PENDING
120,ES,T3,ES 2563804 T3,082-863-026-096-484,2016-03-16,2016,ES 11739500 T,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,Procedimiento para la preparación de gránulos de negro de carbón,"Un procedimiento de peletización de negro de carbón, comprendiendo dicho procedimiento las etapas siguientes: * obtención de una mezcla homogénea de polvo de negro de carbón, agua, un agente aglutinante y un agente dispersante; en la que, la proporción entre negro de carbón y agua está comprendida en el intervalo de 0,1:2,0 a 2:1 y dicho agente dispersante es un tensioactivo a base de amina que comprende una amina y un poliéter, estando dicho agente dispersante en el intervalo del 0,005 al 0,1% de dicha mezcla; * peletización de dicha mezcla homogénea en una peletizadora para obtener gránulos en bruto de negro de carbón; y * secado de dichos gránulos en bruto de negro de carbón durante un periodo de tiempo de 20-60 minutos a una temperatura de entre 150-250°C, para obtener gránulos de negro de carbón",ADITYA BIRLA SCIENCE AND TECH COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/082-863-026-096-484,Granted Patent,no,0,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
121,WO,A1,WO 2021/091906 A1,103-332-462-348-286,2021-05-14,2021,US 2020/0058720 W,2020-11-03,US 201962930433 P;;US 202063024407 P,2019-11-04,METHODS FOR TREATING LEUKEMIA,"The present invention relates to treatment methods for leukemia using bispecific antibody constructs that specifically bind to human CD33 and human CD3. In particular, the present invention relates to methods for treating myeloid leukemia, including relapsed/refractory myeloid leukemia, in a patient in need thereof comprising administering to the patient at least one initiation cycle and at least one maintenance cycle of an anti-CD33 x anti-CD3 bispecific antibody construct, wherein each initiation cycle and maintenance cycle comprises administering the bispecific antibody construct according to specific dosage regimens. Pharmaceutical compositions comprising the bispecific antibody constructs for use in the methods are also disclosed.",AMGEN INC,AGARWAL SURESH;;KHALDOYANIDI SOPHIA;;NAGORSEN DIRK;;UPRETI VIJAY,,https://lens.org/103-332-462-348-286,Patent Application,yes,31,1,4,4,139,C07K2317/31;;C07K2317/73;;C07K16/2803;;C07K16/2809;;A61P35/02;;A61K2039/545;;C07K2317/60;;C07K2317/622;;A61K39/3955;;A61K31/573;;A61P35/02;;A61K31/573;;A61K39/3955;;A61K2039/505;;A61K2039/545;;C07K16/2803;;C07K16/2809;;C07K2317/31;;C07K2317/622,A61K31/573;;A61K39/00;;A61P35/02;;C07K16/28;;C07K16/46,,51,41,030-721-734-138-26X;;050-904-861-474-351;;021-381-283-641-709;;034-126-590-804-364;;003-196-607-630-006;;121-994-099-301-744;;009-503-861-843-790;;076-281-989-097-52X;;080-859-361-982-913;;120-607-089-427-555;;080-946-545-954-103;;016-438-116-944-730;;112-266-667-870-856;;048-232-759-809-185;;092-901-269-723-937;;046-372-055-843-205;;032-074-100-404-380;;004-929-427-889-75X;;049-134-753-209-354;;024-995-475-936-443;;027-903-185-617-733;;019-982-436-313-59X;;078-566-213-668-235;;019-473-156-155-27X;;024-047-516-650-274;;017-150-654-990-340;;002-264-966-090-625;;107-893-263-643-528;;043-307-781-066-949;;023-907-179-348-058;;048-819-440-392-261;;032-728-154-591-070;;005-018-877-991-494;;051-940-176-386-905;;011-724-225-446-939;;008-587-496-850-953;;065-430-968-783-392;;021-430-782-622-770;;015-447-991-049-708;;032-074-100-404-380;;067-335-002-036-302,10.1182/blood-2018-99-109762;;10.1182/blood-2019-127977;;31268236;;10.1111/cts.12662;;pmc6853151;;10.1016/j.yonc.2011.08.040;;pmc4090680;;10.1016/j.beha.2013.10.005;;24309527;;8695828;;10.1182/blood.v88.2.756.bloodjournal882756;;pmc4081278;;20923968;;10.1182/blood-2010-07-296392;;10720145;;10.1038/sj.leu.2401568;;10.1200/jco.2005.06.027;;15632409;;2725060;;pmc1895250;;16131573;;10.1182/blood-2005-03-1072;;16397415;;10.4161/cc.5.3.2393;;10.1002/1097-0142(19940201)73:3+<1049::aid-cncr2820731344>3.0.co;2-1;;8306247;;10.1182/blood.v93.11.3678.411k24_3678_3684;;10339474;;10.1182/blood.v93.11.3678;;22482940;;10.1016/s0140-6736(12)60485-1;;10.3410/f.717952822.793458289;;22987091;;pmc4874205;;10.1200/jco.2012.43.0132;;10.1182/blood-2016-03-643544;;27069254;;10.1097/ppo.0000000000000035;;24667956;;pmc4119809;;10.1016/0022-2836(87)90412-8;;3681981;;10.1038/342877a0;;2687698;;15572068;;10.1016/j.dci.2004.07.003;;11397087;;10.1006/jmbi.2001.4662;;17910940;;10.1016/j.ab.2007.08.014;;25859949;;10.1007/978-1-4939-2425-7_10;;10.1158/0008-5472.can-03-3935;;15087403;;3140379;;10.1126/science.3140379;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;10.1074/jbc.m102107200;;11342547;;10.1021/bi011239a;;11888279;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;10.1038/312768a0;;6096720;;10.1016/0022-2836(70)90057-4;;5420325;;10.1073/pnas.63.1.78;;5257969;;pmc534037;;10.1073/pnas.77.7.4216;;pmc349802;;6933469;;10.1002/bit.10790;;14574701;;886304;;10.1099/0022-1317-36-1-59;;10.1095/biolreprod23.1.243;;6774781;;10.1111/j.1749-6632.1982.tb23161.x;;7046561;;6999941;;10.1016/0003-2697(80)90151-7;;10.1182/blood-2016-03-643544;;27069254;;10.1182/blood-2014-05-552729;;24876563;;pmc4093680,"RAVANDI FARHAD ET AL: ""A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE (R)) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)"", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 132, no. Suppl. 1, 29 November 2018 (2018-11-29), pages 25, XP009516802, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2018-99-109762;;MARION SUBKLEWE ET AL: ""Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)"", BLOOD, 13 November 2019 (2019-11-13), pages 833 - 833, XP055769660, Retrieved from the Internet <URL:https://ashpublications.org/blood/article/134/Supplement_1/833/427048/Preliminary-Results-from-a-Phase-1-FirstinHuman> [retrieved on 20210128], DOI: 10.1182/blood-2019-127977;;XIAOYING CHEN ET AL: ""A Modeling Framework to Characterize Cytokine Release upon T-Cell-Engaging Bispecific Antibody Treatment: Methodology and Opportunities"", CLINICAL AND TRANSLATIONAL SCIENCE - CTS, vol. 12, no. 6, 26 July 2019 (2019-07-26), US, pages 600 - 608, XP055769696, ISSN: 1752-8054, DOI: 10.1111/cts.12662;;BURNETT ET AL., J. CLIN. ONCOL., vol. 29, 2011, pages 369 - 377;;RAVANDI, BEST PRACT. RES. CLIN. HAEMATOL., vol. 26, 2013, pages 253 - 259;;ESTEY ET AL., BLOOD, vol. 88, 1996, pages 756;;RAVANDI ET AL., BLOOD, vol. 116, 2010, pages 5818 - 5823;;ESTEY, LEUKEMIA, vol. 14, 2000, pages 476 - 479;;BREEMS ET AL., J. CLIN. ONCOL., vol. 23, 2005, pages 1969 - 1978;;SCHEINBERG ET AL., LEUKEMIA, vol. 3, 1989, pages 440 - 445;;TAUSSIG ET AL., BLOOD, vol. 106, 2005, pages 4086 - 4092;;PEARCE ET AL., CELL CYCLE, vol. 5, 2006, pages 271 - 273;;CARON ET AL., CANCER, vol. 73, 1994, pages 1049 - 1056;;SIEVERS ET AL., BLOOD, vol. 93, 1999, pages 3678 - 3684;;CASTAIGNE ET AL., LANCET, vol. 379, 2012, pages 1508 - 1516;;RAVANDI ET AL., J. CLIN. ONCOL., vol. 30, 2012, pages 3921 - 3923;;ARBER ET AL., BLOOD, vol. 127, 2016, pages 2391 - 2405;;MAUDE ET AL., CANCER J., vol. 20, 2014, pages 119 - 122;;KABAT, SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST, 1987;;CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 878 - 883;;LEFRANC ET AL., DEV. COMP. IMMUNOL., vol. 29, 2005, pages 185 - 203;;HONEGGERPLUCKTHUN, J. MOL. BIOL., vol. 309, no. 3, 2001, pages 657 - 670;;RATHANASWAMI ET AL., ANALYTICAL BIOCHEMISTRY, vol. 373, 2008, pages 52 - 60;;KUMARASWAMY ET AL., METHODS MOL. BIOL., vol. 1278, 2015, pages 165 - 82;;CORTEZ-RETAMOZO ET AL., CANCER RESEARCH, vol. 64, 2004, pages 2853 - 57;;BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426;;HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883;;DESMYTER ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 26285 - 90;;EWERT ET AL., BIOCHEMISTRY, vol. 41, 2002, pages 3628 - 36;;CARILLO ET AL., SIAM J. APPLIED MATH., vol. 48, 1988, pages 1073;;""Biocomputing Informatics and Genome Projects"", 1993, ACADEMIC PRESS;;""Computer Analysis of Sequence Data, Part I"", 1994, HUMANA PRESS;;VON HEINJE, G.: ""Sequence Analysis in Molecular Biology"", 1987, ACADEMIC PRESS;;KABAT ET AL.: ""Sequence Analysis Primer"", 1991, NATIONAL INSTITUTES OF HEALTH, article ""Sequences of Proteins of Immunological Interest"";;DAYHOFF ET AL., ATLAS OF PROTEIN SEQUENCE AND STRUCTURE, vol. 5, 1978, pages 345 - 352;;HENIKOFF ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 10915 - 10919;;COSMAN ET AL., NATURE, vol. 312, 1984, pages 768;;NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;EDELMAN ET AL., PROC. NATL. ACAD. USA, vol. 63, 1969, pages 78 - 85;;URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216;;""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR LABORATORY PRESS;;BIANCHIMCGREW, BIOTECH. BIOTECHNOL. BIOENG., vol. 84, 2003, pages 439 - 44;;""REMINGTON'S PHARMACEUTICAL SCIENCES"", vol. 185, 1990, MACK PUBLISHING COMPANY;;GRAHAM ET AL., J. GEN VIROL., vol. 36, 1977, pages 59;;MATHER, BIOL. REPROD., vol. 23, 1980, pages 243 - 251;;MATHER ET AL., ANNALS N.Y ACAD. SCI., vol. 383, 1982, pages 44 - 68;;HAM ET AL., METH. ENZ., vol. 58, 1979, pages 44;;BARNES ET AL., ANAL. BIOCHEM., vol. 102, 1980, pages 255;;ARBER ET AL.: ""Blood"", vol. 127, 2016, WORLD HEALTH ORGANIZATION CLASSIFICATION, pages: 2391 - 2405;;LEE ET AL., BLOOD, vol. 124, 2014, pages 188 - 195",PENDING
122,US,B1,US 11284162 B1,196-716-093-238-175,2022-03-22,2022,US 201916523640 A,2019-07-26,US 201916523640 A,2019-07-26,"Consolidation of channel identifiers in electronic program guide (EPG) data for one or more EPG data providers, and use of consolidated channel identifiers for processing audience measurement data","Channel identifiers in electronic program guide (EPG) data are consolidated for one or more EPG providers, and the consolidated channel identifiers are used to automatically process audience measurement data.",ALPHONSO INC,GUPTA MANISH;;AGARWAL VIJAY;;JAIN MEHUL;;SINGH SUSHMITA,ALPHONSO INC (2019-07-23),https://lens.org/196-716-093-238-175,Granted Patent,yes,8,0,1,1,0,H04N21/4821;;H04N21/254;;H04N21/44222;;H04N21/6582;;H04N21/25866;;H04N21/4823;;H04H60/66;;H04H60/31;;H04H60/72;;G06Q30/0241;;H04N21/4821;;H04N21/258;;H04N21/235;;H04N21/26283,H04N21/482;;H04N21/235;;H04N21/258;;H04N21/262,,4,0,,,"“Metadata for Broadcast Television (Video Data Sources and Applications)” downloaded from webpage: http://what-when-how.com/video-search-engines/metadata-for-broadcast-television-video-data-sources-and-applications/, download date: Jul. 22, 2019, original posting date: unkown.;;Channel Lineup for DirectTV, Effective Mar. 1, 2017, 1 page.;;List of television stations in the United States by call signal (initial letter W), Wikipedia, printout date: Feb. 19, 2019, 6 pages.;;Electronic Program Guide, User Guide for Cisco Digital media Manager 5.2.x, Chapter 26, pp. 26-1 to 26-8, document No. OL-15762-03, revised May 13, 2015, 8 pages.",ACTIVE
123,EP,A3,EP 1227626 A3,127-127-298-090-401,2003-09-17,2003,EP 02000449 A,2002-01-08,US 75984601 A,2001-01-12,Method for packet scheduling and radio resource allocation in a wireless communication system,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames ρ that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the ρ values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell.",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,"GOOGLE TECHNOLOGY HOLDINGS LLC, US (2017-12-14);;GOOGLE TECHNOLOGY HOLDINGS LLC, MOUNTAIN VIEW, US (2018-04-26);;MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-03-24);;MOTOROLA MOBILITY, INC., US (2011-09-12)",https://lens.org/127-127-298-090-401,Search Report,yes,2,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56,,5,4,060-446-011-978-462;;111-986-372-679-201;;035-827-519-565-223;;096-036-301-070-094,10.1109/infcom.2000.832195;;10.1109/90.793003;;10.1109/infcom.2000.832465;;10.1109/infcom.1996.493057,"LU Y ET AL: ""Unified power control, error correction coding and scheduling for a CDMA downlink system"", WIRELESS NETWORKS, ACM, US, vol. 3, no. 1, 1 March 1997 (1997-03-01), pages 83 - 90, XP000688203, ISSN: 1022-0038;;GARG R ET AL: ""Fair bandwidth sharing among virtual networks: a capacity resizing approach"", INFOCOM 2000. NINETEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER AND COMMUNICATIONS SOCIETIES. PROCEEDINGS. IEEE TEL AVIV, ISRAEL 26-30 MARCH 2000, PISCATAWAY, NJ, USA,IEEE, US, 26 March 2000 (2000-03-26), pages 255 - 264, XP010376027, ISBN: 0-7803-5880-5;;LU S ET AL: ""FAIR SCHEDULING IN WIRELESS PACKET NETWORKS"", IEEE / ACM TRANSACTIONS ON NETWORKING, IEEE INC. NEW YORK, US, vol. 7, no. 4, August 1999 (1999-08-01), pages 473 - 489, XP000848693, ISSN: 1063-6692;;ECKHARDT D A ET AL: ""Effort-limited fair (ELF) scheduling for wireless networks"", PROCEEDINGS IEEE INFOCOM 2000. CONFERENCE ON COMPUTER COMMUNICATIONS. NINETEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER AND COMMUNICATIONS SOCIETIES (CAT. NO.00CH37064), PROCEEDINGS IEEE INFOCOM 2000. CONFERENCE ON COMPUTER COMMUNICATIONS. NINE, 2000, Piscataway, NJ, USA, IEEE, USA, pages 1097 - 1106 vol.3, XP010376045, ISBN: 0-7803-5880-5;;BHAGWAT P ET AL: ""Enhancing throughput over wireless LANs using channel state dependent packet scheduling"", PROCEEDINGS IEEE INFOCOM '96. THE CONFERENCE ON COMPUTER COMMUNICATIONS. FIFTEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER SOCIETIES. NETWORKING THE NEXT GENERATION (CAT. NO.96CB35887), PROCEEDINGS OF IEEE INFOCOM '96. CONFERENCE ON COMPUTER COM, 1996, Los Alamitos, CA, USA, IEEE Comput. Soc. Press, USA, pages 1133 - 1140 vol.3, XP010158183, ISBN: 0-8186-7293-5",EXPIRED
124,US,B2,US 6987738 B2,126-082-618-224-34X,2006-01-17,2006,US 75984601 A,2001-01-12,US 75984601 A,2001-01-12,Method for packet scheduling and radio resource allocation in a wireless communication system,"A method of performing packet level transmission scheduling in a communications systems including a plurality of cells, each cell including a base station and plurarity of mobile stations. The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fractions of frames ρ that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the ρ values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell.",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,MOTOROLA MOBILITY LLC (2012-06-22);;GOOGLE TECHNOLOGY HOLDINGS LLC (2014-10-28);;MOTOROLA INC (2001-01-12),https://lens.org/126-082-618-224-34X,Granted Patent,yes,7,87,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/26;;H04L12/56,370/252;;370/328;;370/468,10,6,013-645-555-036-403;;048-789-678-255-924;;060-446-011-978-462;;111-986-372-679-201;;035-827-519-565-223;;096-036-301-070-094,10.1109/vetecs.2000.851593;;10.1109/vetecs.2000.851554;;10.1109/infcom.2000.832195;;10.1109/90.793003;;10.1109/infcom.2000.832465;;10.1109/infcom.1996.493057,"""A Network-Assisted Dynamic Packet Assignment Algorithm for Wireless Data Networks"" by Xiaoxin Qiu, Kapil Chawls, Justin Chuang and Nelson Sollenberger, AT&T Labs.;;""Data Throughput of CDMA-HDR a High Efficiency-High Data Rate Personal Communication Wireless System"" by A. Jalali, R. Padovani, and R. Panjak; Qualcomm Inc. IEEE 2000, pp. 1854-1858.;;""CDMA Forward Link Waterfilling Power Control"" by Jack M. Holtzman; Qualcomm Inc. IEEE 2000 pp. 1663-1667.;;""Multiple Queue Scheduling over a Shared Time-Varying Channel"" by Alexander Stolyar and Rajiv Vijayaykumar; Bell Labs and University of Michigan.;;""Multiuser Diversity in Wireless Networks: Form Information Theory to Architecture"" by David Tse. MIT EECS Colloquium, Nov. 2000.;;Lu, Y. et al. ""Unified Power Control, Error Correction Coding and Scheduling for a CDMA Downlink System."" Wireless Networks, ACM; vol. 3, No. 1, Mar. 1997, pp. 83-90.;;Garg, R. et al. ""Fair Bandwidth Sharing Among Virtual Networks: a Capacity Resizing Approach."" INFOCOM 2000 Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies; Mar. 2000, pp. 255-264.;;Lu, S. et al. ""Fair Scheduling in Wireless Packet Networks."" IEEE/ACM Transactions on Networking; vol. 7, No. 4, Aug. 1999, pp. 473-489.;;Eckerhardt, D. et al. ""Effort-limited Fair (ELF) Scheduling for Wireless Networks."" INFOCOM 2000 Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies; Mar. 2000, pp. 1097-1106.;;Bhagwat, P. et al. ""Enhancing Throughput over Wireless LANs Using Channel State Dependent Packet Scheduling."" INFOCOM 1996 Fifteenth Annual Joint Conference of the IEEE Computer Societies; 1996, pp. 1133-1140.",EXPIRED
125,DE,D1,DE 60211230 D1,166-645-595-996-538,2006-06-14,2006,DE 60211230 T,2002-01-08,US 75984601 A,2001-01-12,Verfahren zur Paketablauffolgeplanung und Funkressourcenzuweisung in einem drahtlosen Kommunikationssystem,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames rho that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the rho values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. <IMAGE>",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,"MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-05-26)",https://lens.org/166-645-595-996-538,Granted Patent,no,0,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56;;H04L29/06,,0,0,,,,EXPIRED
126,WO,A1,WO 2019/121548 A1,173-311-470-295-766,2019-06-27,2019,EP 2018085269 W,2018-12-17,EP 17208131 A,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE,The present invention relates to a topical composition comprising a compound of formula (I) wherein R is a cycloalkyl group with the total number of carbon atoms in the cycloalkyl group in the range 4 to 6.,UNILEVER NV;;UNILEVER PLC;;CONOPCO INC DBA UNILEVER,AGARWAL KHUSHBU;;GADGIL VIJAY;;KUNJUPILLAI BALU;;MAJUMDAR AMITABHA,,https://lens.org/173-311-470-295-766,Patent Application,yes,3,1,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K8/49;;A61Q17/00,,6,2,130-200-651-336-713;;013-752-268-543-836,8450418;;10.1002/jps.2600820308;;24446666;;10.1021/ja4126609,"SIKDER A K ET AL: ""QUATERNARY SALTS OF 3,3'-BIS-PYRIDINIUM MONOOXIMES: SYNTHESIS AND BIOLOGICAL ACTIVITY"", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 82, no. 3, 1 January 1993 (1993-01-01), pages 258 - 261, XP000909817, ISSN: 0022-3549, DOI: 10.1002/JPS.2600820308;;HIEN-QUANG DO ET AL: ""Photoinduced, Copper-Catalyzed Alkylation of Amides with Unactivated Secondary Alkyl Halides at Room Temperature"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 136, no. 5, 21 January 2014 (2014-01-21), US, pages 2162 - 2167, XP055477549, ISSN: 0002-7863, DOI: 10.1021/ja4126609;;COTE L ET AL: ""Studies on nicotinamide derivatives"", JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 61, no. 4, 1 April 1951 (1951-04-01), pages 463 - 467, XP002560848, ISSN: 0021-9193;;DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 11 February 2016 (2016-02-11), XP002781273, Database accession no. 1864682-46-1;;DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 30 April 2001 (2001-04-30), XP002781274, Database accession no. 333430-06-1;;""The CTFA Personal care Ingredient Handbook"", 1992",PENDING
127,EP,A2,EP 3013267 A2,003-545-445-862-084,2016-05-04,2016,EP 14817934 A,2014-06-24,US 201361838375 P;;US 2014/0043830 W,2013-06-24,BIOACTIVE FUSION DEVICE,,UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,,https://lens.org/003-545-445-862-084,Patent Application,yes,0,0,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/86;;A61B17/68;;A61B17/70;;A61F2/28;;A61F2/44,,0,0,,,,DISCONTINUED
128,HU,T2,HU E031235 T2,039-010-128-691-037,2017-07-28,2017,HU E11739500 A,2011-01-31,IN 273MU2010 A,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,,ADITYA BIRLA SCIENCE AND TECH COMPANY PRIVATE LTD;;SKI CARBON BLACK (INDIA) PRIVATE LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/039-010-128-691-037,Amended Patent,no,0,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,PENDING
129,US,B1,US 10949498 B1,041-435-509-735-086,2021-03-16,2021,US 201916352764 A,2019-03-13,US 201916352764 A,2019-03-13,Softmax circuit,"Disclosed approaches for circuitry that implements a softmax function include difference calculation circuitry configured to calculate differences between combinations of elements, z k −z j , of a vector. First lookup circuitry is configured to lookup and output representations of exponential values, e z k −z j associated with the differences in response to input of the differences. Each adder circuit of N adder circuits sums a subset of the exponential values output from the first lookup circuitry and a value of 1. The sum output by each adder circuit denotes a denominator of a plurality of denominators of the softmax function. Second lookup circuitry is configured with quotients and looks-up and outputs quotients associated with the plurality of denominators as results of the softmax function.",XILINX INC;;XLNX INC,ENUMULA VIJAY KUMAR REDDY;;AGARWAL SUNDEEP RAM GOPAL,XILINX INC (2019-03-11),https://lens.org/041-435-509-735-086,Granted Patent,yes,0,1,1,1,0,G06F7/556;;G06F17/16;;G06F7/556;;G06F17/10;;G06F2207/4824;;G06N3/04;;G06N3/063,G06F17/16;;G06F7/556;;G06N3/04,,9,4,025-579-333-365-167;;029-433-753-264-411;;012-883-941-418-255;;039-477-082-472-160,10.1109/icasid.2018.8693206;;10.1109/mocast.2019.8741677;;10.1145/3060403.3060467;;10.1109/socc.2016.7905501,"Z. Li, H. Li, X. Jiang, B. Chen, Y. Zhang and G. Du, “Efficient FPGA Implementation of Softmax Function for DNN Applications,” 2018 12th IEEE International Conference on Anti-counterfeiting, Security, and Identification (ASID), Xiamen, China, 2018, pp. 212-216, doi: 10.1109/ICASID.2018.8693206. (Year: 2018).;;Geng, Xue, et al. “Hardware-Aware Softmax Approximation for Deep Neural Networks.” SpringerLink, Springer, Cham, Dec. 2, 2018, link.springer.com/chapter/10.1007/978-3-030-20870-7_7. (Year: 2018).;;Muthuramalingam, A., et al. “Neural Network Implementation Using FPGA: Issues and Application.” International Journal of Electrical and Computer Engineering, Dec. 22, 2008, publications.waset.org/15106/neural-network-implementation-using-fpga-issues-and-application. (Year: 2008).;;I. Kouretas and V. Paliouras, “Simplified Hardware Implementation of the Softmax Activation Function,” 2019 8th International Conference on Modern Circuits and Systems Technologies (MOCAST), Thessaloniki, Greece, 2019, pp. 1-4, doi: 10.1109/MOCAST.2019.8741677. (Year: 2019).;;Zihao Yuan University of Southern California, et al. “Softmax Regression Design for Stochastic Computing Based Deep Convolutional Neural Networks.” Softmax Regression Design for Stochastic Computing Based Deep Convolutional Neural Networks | Proceedings of the on Great Lakes Symposium on VLSI 2017 (Year: 2017).;;Machmach 1, et al. “Softmax vs Sigmoid Function in Logistic Classifier?” Cross Validated, Oct. 1, 1965, stats.stackexchange.com/questions/233658/softmax-vs-sigmoid-function-in-logistic-classifier. (Year: 2017).;;Oshana, Robert. “Floating Point Number.” Floating Point Number—an Overview | ScienceDirect Topics, 2006, www.sciencedirect.com/topics/engineering/floating-point-number. (Year: 2006).;;Yuan, Efficient Hardware Architecture of Softmax Layer in Deep Neural Network, IEEE, 2016, http://ieeexplore.ieee.org/stamp/stampjsp?arnumber=7905501.;;Igbinedion, Fast Softmax Sampling for Deep Neural Networks, Stanford reports, 2017, http://cs231n.stanford.edu/reports/2017/pdfs/130.pdf.",ACTIVE
130,EP,B1,EP 1227626 B1,197-524-893-574-564,2006-05-10,2006,EP 02000449 A,2002-01-08,US 75984601 A,2001-01-12,Method for packet scheduling and radio resource allocation in a wireless communication system,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames rho that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the rho values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. <IMAGE>",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,"GOOGLE TECHNOLOGY HOLDINGS LLC, US (2017-12-14);;GOOGLE TECHNOLOGY HOLDINGS LLC, MOUNTAIN VIEW, US (2018-04-26);;MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-03-24);;MOTOROLA MOBILITY, INC., US (2011-09-12)",https://lens.org/197-524-893-574-564,Granted Patent,yes,2,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56;;H04L29/06,,5,0,,,"LU Y ET AL: ""Unified power control, error correction coding and scheduling for a CDMA downlink system"" WIRELESS NETWORKS, ACM, US, vol. 3, no. 1, 1 March 1997 (1997-03-01), pages 83-90, XP000688203 ISSN: 1022-0038;;GARG R ET AL: ""Fair bandwidth sharing among virtual networks: a capacity resizing approach"" INFOCOM 2000. NINETEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER AND COMMUNICATIONS SOCIETIES. PROCEEDINGS. IEEE TEL AVIV, ISRAEL 26-30 MARCH 2000, PISCATAWAY, NJ, USA,IEEE, US, 26 March 2000 (2000-03-26), pages 255-264, XP010376027 ISBN: 0-7803-5880-5;;LU S ET AL: ""FAIR SCHEDULING IN WIRELESS PACKET NETWORKS"" IEEE / ACM TRANSACTIONS ON NETWORKING, IEEE INC. NEW YORK, US, vol. 7, no. 4, August 1999 (1999-08), pages 473-489, XP000848693 ISSN: 1063-6692;;ECKHARDT D A ET AL: ""Effort-limited fair (ELF) scheduling for wireless networks"" PROCEEDINGS IEEE INFOCOM 2000. CONFERENCE ON COMPUTER COMMUNICATIONS. NINETEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER AND COMMUNICATIONS SOCIETIES (CAT. NO.00CH37064), PROCEEDINGS IEEE INFOCOM 2000. CONFERENCE ON COMPUTER COMMUNICATIONS. NINE, pages 1097-1106 vol.3, XP010376045 2000, Piscataway, NJ, USA, IEEE, USA ISBN: 0-7803-5880-5;;BHAGWAT P ET AL: ""Enhancing throughput over wireless LANs using channel state dependent packet scheduling"" PROCEEDINGS IEEE INFOCOM '96. THE CONFERENCE ON COMPUTER COMMUNICATIONS. FIFTEENTH ANNUAL JOINT CONFERENCE OF THE IEEE COMPUTER SOCIETIES. NETWORKING THE NEXT GENERATION (CAT. NO.96CB35887), PROCEEDINGS OF IEEE INFOCOM '96. CONFERENCE ON COMPUTER COM, pages 1133-1140 vol.3, XP010158183 1996, Los Alamitos, CA, USA, IEEE Comput. Soc. Press, USA ISBN: 0-8186-7293-5",EXPIRED
131,US,A1,US 2012/0292794 A1,021-363-768-877-884,2012-11-22,2012,US 201113576251 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,"The present disclosure envisages a process for pelletizing carbon black by mixing carbon black powder and water in a proportion in the range of 0.1:2 to 2:1 with a binding agent and a dispersing agent. The dispersing agent is an amine-based surfactant and is added in a proportion in the range of 0.005-0.1% of the total mixture. The mixture is pelletized in a pelletizer and subsequently the raw pellets are dried for 20-60 minutes at a temperature between 150-250° C., to obtain the carbon black pellets. The process of the present disclosure provides uniform distribution of water on the surface of the pellets giving a uniform pellet quality, reduced water consumption, energy savings and an increased production rate.",PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,BIRLA CARBON INDIA PRIVATE LIMITED (2015-04-09);;ADITYA BIRLA NUVO LIMITED (2012-10-25);;ADITYA BIRLA SCIENCE & TECHNOLOGY COMPANY LIMITED (2012-10-01);;ADITYA BIRLA SCIENCE & TECHNOLOGY COMPANY PRIVATE LIMITED (2015-03-30),https://lens.org/021-363-768-877-884,Patent Application,yes,8,26,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,B29B9/10,264/6,0,0,,,,ACTIVE
132,CN,B,CN 102791807 B,023-691-178-558-635,2015-06-10,2015,CN 201180008009 A,2011-01-31,IN 2011000063 W;;IN 273MU2010 A,2010-02-03,A process for the preparation of carbon black pellets,,ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/023-691-178-558-635,Granted Patent,no,0,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
133,EP,A2,EP 2531564 A2,042-002-460-846-81X,2012-12-12,2012,EP 11739500 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,,ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,"ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LIMITE (2016-07-27);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PR, IN (2020-03-30);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED, IN (2017-04-28);;BIRLA CARBON INDIA PRIVATE LIMITED, IN (2020-03-30);;BIRLA CARBON INDIA PRIVATE LIMITED (2020-05-20);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PRIVAT (2016-08-10);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED (2016-08-10)",https://lens.org/042-002-460-846-81X,Patent Application,yes,0,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
134,EP,A2,EP 1227626 A2,176-998-594-587-800,2002-07-31,2002,EP 02000449 A,2002-01-08,US 75984601 A,2001-01-12,Method for packet scheduling and radio resource allocation in a wireless communication system,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames ρ that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the ρ values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell.",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,"GOOGLE TECHNOLOGY HOLDINGS LLC, US (2017-12-14);;GOOGLE TECHNOLOGY HOLDINGS LLC, MOUNTAIN VIEW, US (2018-04-26);;MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-03-24);;MOTOROLA MOBILITY, INC., US (2011-09-12)",https://lens.org/176-998-594-587-800,Patent Application,yes,0,35,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56,,0,0,,,,EXPIRED
135,EP,A4,EP 2531564 A4,003-679-337-698-188,2013-10-09,2013,EP 11739500 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,,ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,"ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LIMITE (2016-07-27);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PR, IN (2020-03-30);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED, IN (2017-04-28);;BIRLA CARBON INDIA PRIVATE LIMITED, IN (2020-03-30);;BIRLA CARBON INDIA PRIVATE LIMITED (2020-05-20);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PRIVAT (2016-08-10);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED (2016-08-10)",https://lens.org/003-679-337-698-188,Search Report,no,1,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
136,WO,A3,WO 2014/209976 A3,112-175-584-280-97X,2015-10-29,2015,US 2014/0043830 W,2014-06-24,US 201361838375 P,2013-06-24,BIOACTIVE FUSION DEVICE,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,,https://lens.org/112-175-584-280-97X,Search Report,yes,15,0,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/70;;A61B17/86;;A61F2/44,,0,0,,,,PENDING
137,US,A1,US 2016/0166291 A1,161-496-352-693-809,2016-06-16,2016,US 201414392209 A,2014-06-24,US 201414392209 A;;US 201361838375 P;;US 2014/0043830 W,2013-06-24,Bioactive Fusion Device,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,THE UNIVERSITY OF TOLEDO (2016-01-08),https://lens.org/161-496-352-693-809,Patent Application,yes,57,7,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/70;;A61B17/86,,0,0,,,,ACTIVE
138,KR,A,KR 20130006605 A,003-934-122-934-732,2013-01-17,2013,KR 20127022708 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,,ADITYA BIRLA NUVO LTD;;ADITYA BIRLA SCI & TECH CO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/003-934-122-934-732,Patent Application,no,0,1,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
139,US,B2,US 9743961 B2,060-445-372-030-365,2017-08-29,2017,US 201414392209 A,2014-06-24,US 201414392209 A;;US 201361838375 P;;US 2014/0043830 W,2013-06-24,Bioactive fusion device,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,THE UNIVERSITY OF TOLEDO (2016-01-08),https://lens.org/060-445-372-030-365,Granted Patent,yes,65,3,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/70;;A61B17/68;;A61B17/86,,5,0,,,"Chinese Notification of First Office Action, Application No. CN 201380013369.X, dated Feb. 1, 2016.;;European Search Report, Application No. 13743220.9, dated Jan. 12, 2016.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2014/043830 filed Jun. 24, 2014, dated Nov. 14, 2014.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024033 filed Jan. 31, 2013, dated May 13, 2013.;;European Search Report, Application No. 14817934.4, dated Jan. 25, 2017.",ACTIVE
140,US,B1,US 11663490 B1,067-142-391-886-165,2023-05-30,2023,US 201916600254 A,2019-10-11,US 201916600254 A,2019-10-11,Partial sum pre-computation to implement quantized neural networks on programmable devices,"An example method of implementing a quantized neural network (QNN) for a programmable device includes: identifying multiply-accumulate operations of neurons in the QNN; converting the multiply-accumulate operations to memory lookup operations; and implementing the memory lookup operations using a pre-compute circuit for the programmable device, the pre-compute circuit storing a pre-computed output of a neuron in the QNN for each of the memory lookup operations.",XILINX INC,ENUMULA VIJAY KUMAR REDDY;;AGARWAL SUNDEEP RAM GOPAL,XILINX INC (2019-09-18),https://lens.org/067-142-391-886-165,Granted Patent,yes,5,1,1,1,0,G06F7/5443;;G06N3/063;;G06N3/0464;;G06N3/0495;;G06N3/10;;G06N3/08;;G06F7/5443,G06N3/10;;G06F7/544;;G06N3/08,,3,2,017-722-056-656-431;;139-861-812-403-952,10.1145/3020078.3021744;;10.1109/fpl.2018.00014,"Umuroglu, Y. et al., “FINN: A Framework for Fast, Scalable Binarized Neural Network Inference,” International Symposium on Field Progammable Gate Arrays, Feb. 2017.;;Boutros, A. et al., “Embracing Diversity: Enhanced DSP Blocks for Low-Precision Deep Learning on FPGAs,” 28th International Conference on FPGAs, 2018.;;Fu, Y. et al., “Deep Learning with INT8 Optimizations on Xilinx Devices,” White Paper, Apr. 2017.",ACTIVE
141,RU,C2,RU 2569091 C2,071-181-329-191-211,2015-11-20,2015,RU 2012136825 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,METHOD OF PRODUCING GRANULAR CARBON BLACK,"FIELD: chemistry.SUBSTANCE: invention relates to chemical industry. The method includes first preparing a homogeneous mixture of carbon black powder, water, a binding substance and a dispersant, wherein the ratio of carbon black to water is in the range of 0.1:2.0 to 2:1. The dispersant is a surfactant which includes an amine and a polyether in ratio of 0.1:10 to 10:0.1. The polyether is selected from a group which includes ethylene oxide and/or propylene oxide in ratio of less than 1. Content of said dispersant is in the range of 0.005-0.1% of said liquid. The obtained homogeneous mixture is granulated in a granulator and the moist granules are dried for 20-60 minutes at 150-250°C.EFFECT: low water and power consumption, high efficiency of the process, improved quality of carbon black granules owing to uniform distribution of water, binding substance and soot in said granules.5 cl, 1 tbl, 2 ex",ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/071-181-329-191-211,Granted Patent,no,0,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
142,DE,T2,DE 60211230 T2,131-910-356-283-412,2006-09-21,2006,DE 60211230 T,2002-01-08,US 75984601 A,2001-01-12,Verfahren zur Paketablauffolgeplanung und Funkressourcenzuweisung in einem drahtlosen Kommunikationssystem,"A method of performing packet level transmission scheduling in a communications system including a plurality of cells, each cell including a base station (104) and a plurality of mobile stations (108, 110, 112). The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fraction of frames rho that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the rho values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. <IMAGE>",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,"MOTOROLA MOBILITY, INC. ( N.D. GES. D. STAATES, US (2011-05-26)",https://lens.org/131-910-356-283-412,Granted Patent,no,0,0,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56;;H04L29/06,,0,0,,,,EXPIRED
143,CN,A,CN 105916458 A,156-118-592-492-038,2016-08-31,2016,CN 201480042354 A,2014-06-24,US 201361838375 P;;US 2014/0043830 W,2013-06-24,Bioactive fusion device,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,,https://lens.org/156-118-592-492-038,Patent Application,no,6,1,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/86;;A61B17/70;;A61F2/44,,0,0,,,,INACTIVE
144,US,A1,US 2002/0147022 A1,128-707-948-692-744,2002-10-10,2002,US 75984601 A,2001-01-12,US 75984601 A,2001-01-12,Method for packet scheduling and radio resource allocation in a wireless communication system,"
   A method of performing packet level transmission scheduling in a communications systems including a plurality of cells,each cell including a base station and plurarity of mobile stations. The method performs scheduling while considering radio resource allocation at the wireless access node. In a schedule plan phase of the method, average power and average effective data rate are determined for all mobile stations in the system. In addition, the planned fractions of frames that each mobile in the system will transmit is determined so that resources are allocated fairly. In the actual schedule phase of the method, current power and effective data rate values are compared to the average power values. This information along with the values is used to determine the actual schedule of packet transmissions for all mobiles in a particular cell. 
",MOTOROLA INC,SUBRAMANIAN VIJAY G;;AGARWAL RAJEEV;;LA RICHARD J,MOTOROLA MOBILITY LLC (2012-06-22);;GOOGLE TECHNOLOGY HOLDINGS LLC (2014-10-28);;MOTOROLA INC (2001-01-12),https://lens.org/128-707-948-692-744,Patent Application,yes,5,59,9,9,0,H04L47/56;;H04L47/626;;H04W24/00;;H04W28/22;;H04W72/04;;H04L47/50;;Y02D30/70;;H04W28/0236;;H04W72/54;;H04L47/10;;H04L47/626;;H04W28/22;;H04L47/56;;H04W72/04;;H04W24/00;;H04L47/50;;Y02D30/70;;H04W8/04;;H04W72/54,H04L12/56,455/453;;455/67.1;;370/437,0,0,,,,EXPIRED
145,WO,A2,WO 2014/209976 A2,166-336-938-748-079,2014-12-31,2014,US 2014/0043830 W,2014-06-24,US 201361838375 P,2013-06-24,BIOACTIVE FUSION DEVICE,"A fusion device includes a screw having a head and a shaft. A hollow bone dowel is disposed about the shaft of the screw. The bone dowel is formed from a bone-like, biocompatible, or allograft material.",UNIV TOLEDO,GOEL VIJAY K;;AGARWAL ANAND K;;DICK DAVID,,https://lens.org/166-336-938-748-079,Patent Application,yes,0,3,8,8,0,A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/68;;A61B17/7035;;A61B17/7064;;A61B17/8685;;A61B2017/681;;A61B2017/8655;;A61B17/686;;A61B17/7071,A61B17/16,,0,0,,,,PENDING
146,WO,A2,WO 2011/095986 A2,117-735-952-136-053,2011-08-11,2011,IN 2011000063 W,2011-01-31,IN 273MU2010 A,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,"The present invention envisages a process for pelletizing carbon black by mixing carbon black powder and water in a proportion in the range of 0.1 : 2 to 2 : 1 with a binding agent and a dispersing agent. The dispersing agent is an amine-based surfactant and is added in a proportion in the range of 0.005 - 0.1 % of the total mixture. The mixture is pelletized in a pelletizer and subsequently the raw pellets are dried for 20 - 60 minutes at a temperature between 150 - 250 °C, to obtain the carbon black pellets. The process of the present invention provides uniform distribution of water on the surface of the pellets giving a uniform pellet quality, reduced water consumption, energy savings and an increased production rate.",ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD;;PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,,https://lens.org/117-735-952-136-053,Patent Application,yes,0,5,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58,,1,0,,,See references of EP 2531564A4,PENDING
147,EP,B1,EP 2531564 B1,039-347-029-196-552,2015-12-16,2015,EP 11739500 A,2011-01-31,IN 273MU2010 A;;IN 2011000063 W,2010-02-03,A PROCESS FOR THE PREPARATION OF CARBON BLACK PELLETS,,ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LTD;;ADITYA BIRLA NUVO LTD,PRABHU MAYUR;;AGARWAL VIJAY;;GHOSAL RANJAN;;RAJAMOHAMED S,"ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY LIMITE (2016-07-27);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED, IN (2017-04-28);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PR, IN (2020-03-30);;BIRLA CARBON INDIA PRIVATE LIMITED, IN (2020-03-30);;BIRLA CARBON INDIA PRIVATE LIMITED (2020-05-20);;ADITYA BIRLA SCIENCE AND TECHNOLOGY COMPANY PRIVAT (2016-08-10);;SKI CARBON BLACK (INDIA) PRIVATE LIMITED (2016-08-10)",https://lens.org/039-347-029-196-552,Granted Patent,yes,10,0,19,19,0,B01J2/00;;C09C1/58;;C09C1/58;;C09C1/58,C09C1/58;;B01J2/00,,0,0,,,,ACTIVE
148,US,A1,US 2021/0157607 A1,158-914-050-607-304,2021-05-27,2021,US 201916695759 A,2019-11-26,US 201916695759 A,2019-11-26,DYNAMIC RE-EVALUATION OF PARAMETERS FOR NON-VOLATILE MEMORY USING MICROCONTROLLER,"A non-volatile memory apparatus and corresponding method of operation are provided. The apparatus includes non-volatile memory cells in an integrated circuit device along with a microcontroller in communication with the non-volatile memory cells. The microcontroller is configured to receive a memory operation command and in response, determine a condition value of one of a plurality of conditions associated with the memory operation command and whether the one of the plurality of conditions is dynamic. In parallel, the microcontroller determines and outputs an output value using the condition value. The microcontroller then determines whether the one the plurality of conditions has changed. If the one of the plurality of conditions is dynamic and has changed, the microcontroller determines an updated condition value and in parallel, compares the condition value and the updated condition value and determines and outputs an updated output value using the updated condition value and the comparison.",SANDISK TECHNOLOGIES LLC,CHINCHOLE VIJAY;;PADATTIL KULIYAMPATTIL NISHA;;AGARWAL SONAM;;AGARWAL AKASH;;DEVARAJ PAVITHRA;;LI YAN,SANDISK TECHNOLOGIES LLC (2019-11-18),https://lens.org/158-914-050-607-304,Patent Application,yes,0,1,2,2,0,G06F11/3037;;G06F12/0246;;G06F3/0679;;G06F3/0607;;G06F3/0659;;G06F9/3895;;G06F9/3802;;G06F9/34;;G06F12/0246;;G06F9/544;;G06F11/3037;;G06F9/226;;G06F3/0607;;G06F3/0659;;G06F3/0679,G06F9/38;;G06F9/22;;G06F9/34;;G06F9/54;;G06F11/30;;G06F12/02,,0,0,,,,ACTIVE
149,US,B2,US 11487548 B2,143-121-022-834-468,2022-11-01,2022,US 201916695759 A,2019-11-26,US 201916695759 A,2019-11-26,Dynamic re-evaluation of parameters for non-volatile memory using microcontroller,"A non-volatile memory apparatus and corresponding method of operation are provided. The apparatus includes non-volatile memory cells in an integrated circuit device along with a microcontroller in communication with the non-volatile memory cells. The microcontroller is configured to receive a memory operation command and in response, determine a condition value of one of a plurality of conditions associated with the memory operation command and whether the one of the plurality of conditions is dynamic. In parallel, the microcontroller determines and outputs an output value using the condition value. The microcontroller then determines whether the one the plurality of conditions has changed. If the one of the plurality of conditions is dynamic and has changed, the microcontroller determines an updated condition value and in parallel, compares the condition value and the updated condition value and determines and outputs an updated output value using the updated condition value and the comparison.",SANDISK TECHNOLOGIES LLC,CHINCHOLE VIJAY;;PADATTIL KULIYAMPATTIL NISHA;;AGARWAL SONAM;;AGARWAL AKASH;;DEVARAJ PAVITHRA;;LI YAN,SANDISK TECHNOLOGIES LLC (2019-11-18),https://lens.org/143-121-022-834-468,Granted Patent,yes,8,0,2,2,0,G06F11/3037;;G06F12/0246;;G06F3/0679;;G06F3/0607;;G06F3/0659;;G06F9/3895;;G06F9/3802;;G06F9/34;;G06F12/0246;;G06F9/544;;G06F11/3037;;G06F9/226;;G06F3/0607;;G06F3/0659;;G06F3/0679,G11C7/00;;G06F3/06;;G06F9/22;;G06F9/34;;G06F9/38;;G06F9/54;;G06F11/30;;G06F12/02,,0,0,,,,ACTIVE
150,US,B2,US 9841910 B2,154-235-450-159-096,2017-12-12,2017,US 201514700814 A,2015-04-30,IN 4929CH2014 A,2014-09-30,Moving and committing valid data on a set-by-set basis,"A storage module may be configured to organize data to be moved from an initial storage location to a destination storage location into sets, and to determine whether to commit the data to the destination storage location on a set-by-set basis. Error correction and/or a post write and read process may be performed on the sets that are copied to the destination storage location to determine whether to commit each of the copied sets.",SANDISK TECHNOLOGIES INC;;SANDISK TECHNOLOGIES LLC,JAIN VIMAL KUMAR;;AGARWAL DINESH;;SIVASANKARAN VIJAY;;AMARJIT KUMAR,SANDISK TECHNOLOGIES LLC (2015-03-06),https://lens.org/154-235-450-159-096,Granted Patent,yes,11,8,2,2,0,G06F11/10;;G06F11/1048;;G06F3/0619;;G06F3/0647;;G06F3/0688;;G06F3/0619;;G06F3/0647;;G06F3/0688;;G06F11/10;;G06F11/1048,G06F3/06;;G06F12/00;;G06F11/10,,0,0,,,,ACTIVE
151,US,A1,US 2016/0092129 A1,035-259-060-966-599,2016-03-31,2016,US 201514701158 A,2015-04-30,IN 4920CH2014 A,2014-09-30,SYSTEM AND METHOD FOR FOLDING PARTIAL BLOCKS INTO MULTI-LEVEL CELL MEMORY BLOCKS,"A method and system for folding only a portion of data from an SLC block to an MLC block is described. The method includes identifying word lines with only valid data and word lines with non-valid data in a selected SLC block, copying data only from word lines with valid data to a destination MLC block and copying data from word lines in the selected SLC block with non-valid data to a separate SLC compaction block. The system includes a first controller module configured to scan for word lines with only valid data and pass only a bitmap regarding valid and invalid word lines to a second controller module. The second controller module is configured to perform on-chip folding of data from valid word lines, and to copy data from invalid data word lines to an SLC compaction block.",SANDISK TECHNOLOGIES INC,AGARWAL DINESH;;SIVASANKARAN VIJAY;;SANKULE SOURABH;;JAIN VIMAL KUMAR,SANDISK TECHNOLOGIES LLC (2015-04-29),https://lens.org/035-259-060-966-599,Patent Application,yes,9,40,2,2,0,G11C29/4401;;G11C2029/0409;;G06F11/1072;;G11C11/5621;;G11C29/52;;G06F3/0619;;G11C11/5621;;G06F3/065;;G06F3/0688;;G11C29/52;;G06F11/1072;;G11C29/4401;;G11C2029/0409,G06F3/06;;G06F11/10;;G11C11/56;;G11C29/52,,0,0,,,,ACTIVE
152,US,A1,US 2011/0245943 A1,127-268-661-203-562,2011-10-06,2011,US 200913127496 A,2009-11-04,US 200913127496 A;;US 11149608 P;;US 2009/0063321 W,2008-11-05,CONTROLLING AND CONFIGURING RESPONSIBLE GAMING DATA,"A wagering game system and its operations are described herein. In embodiments, the operations can include determining a player account that is logged in to a wagering game session and presenting a wagering game during the wagering game session. The operations can further include determining accounting transaction data that relates to an amount of money that the player account has spent on gambling during a time period. The operations can further include presenting the accounting transaction data during the wagering game session so that the accounting transaction data and the wagering game are both perceptible to the player account. The operations can also include indicating the amount of money that the player account has spent on gambling in the time period.",WMS GAMING INC,AGARWAL VIJAY K;;BURKE MARY M;;MASAKALERIS ELIAS R,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-11-10),https://lens.org/127-268-661-203-562,Patent Application,yes,3,14,5,5,0,G06Q30/00;;G07F17/32;;G07F17/3227;;G07F17/3237;;G06Q30/00;;G07F17/3237;;G07F17/3227;;G07F17/32,G06F19/00,700/91,0,0,,,,ACTIVE
153,US,B2,US 8167710 B2,102-912-962-857-946,2012-05-01,2012,US 200913127496 A,2009-11-04,US 200913127496 A;;US 11149608 P;;US 2009/0063321 W,2008-11-05,Controlling and configuring responsible gaming data,"A wagering game system and its operations are described herein. In embodiments, the operations can include determining a player account that is logged in to a wagering game session and presenting a wagering game during the wagering game session. The operations can further include determining accounting transaction data that relates to an amount of money that the player account has spent on gambling during a time period. The operations can further include presenting the accounting transaction data during the wagering game session so that the accounting transaction data and the wagering game are both perceptible to the player account. The operations can also include indicating the amount of money that the player account has spent on gambling in the time period.",AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R;;WMS GAMING INC,AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-11-10),https://lens.org/102-912-962-857-946,Granted Patent,yes,13,8,5,5,0,G06Q30/00;;G07F17/32;;G07F17/3227;;G07F17/3237;;G06Q30/00;;G07F17/3237;;G07F17/3227;;G07F17/32,A63F9/24,463/25;;463/29,2,0,,,"""PCT Application No. PCT/US09/63321 International Preliminary Report on Patentability"", Oct. 5, 2010 , 9 pages.;;""PCT Application No. PCT/US09/63321 International Search Report"", Dec. 29, 2009 , 8 pages.",ACTIVE
154,TW,A,TW 202132340 A,058-657-602-931-349,2021-09-01,2021,TW 109138259 A,2020-11-03,US 201962930433 P;;US 202063024407 P,2019-11-04,Methods for treating leukemia,"The present invention relates to treatment methods for leukemia using bispecific antibody constructs that specifically bind to human CD33 and human CD3. In particular, the present invention relates to methods for treating myeloid leukemia, including relapsed/refractory myeloid leukemia, in a patient in need thereof comprising administering to the patient at least one initiation cycle and at least one maintenance cycle of an anti-CD33 x anti-CD3 bispecific antibody construct, wherein each initiation cycle and maintenance cycle comprises administering the bispecific antibody construct according to specific dosage regimens. Pharmaceutical compositions comprising the bispecific antibody constructs for use in the methods are also disclosed.",AMGEN INC,AGARWAL SURESH;;KHALDOYANIDI SOPHIA;;NAGORSEN DIRK;;UPRETI VIJAY VISHESH,,https://lens.org/058-657-602-931-349,Patent of Addition,no,0,0,4,4,0,C07K2317/31;;C07K2317/73;;C07K16/2803;;C07K16/2809;;A61P35/02;;A61K2039/545;;C07K2317/60;;C07K2317/622;;A61K39/3955;;A61K31/573;;A61P35/02;;A61K31/573;;A61K39/3955;;A61K2039/505;;A61K2039/545;;C07K16/2803;;C07K16/2809;;C07K2317/31;;C07K2317/622,C07K16/28;;A61K39/395;;A61P35/02;;C07K16/46,,0,0,,,,PENDING
155,WO,A1,WO 2010/017252 A1,118-559-849-613-823,2010-02-11,2010,US 2009/0052771 W,2009-08-04,US 8620508 P,2008-08-05,MOBILE-PHONE-BASED WAGERING GAME ACCOUNT TRANSACTIONS,"In some embodiments a method includes receiving, from a mobile phone, a request to transfer a first fund amount from a player account to a wagering game machine. The method can also include determining that the player account does not include the first fund amount; receiving a second fund amount from a secondary funding source, and augmenting the player account by the second fund amount, wherein the augmenting results in the player account including the first fund amount. The method can also include transferring the first fund amount from the player account to the wagering game machine; debiting the player account by the first fund amount.",WMS GAMING INC;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,,https://lens.org/118-559-849-613-823,Patent Application,yes,3,75,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,G06Q20/00;;A63F9/24,,0,0,,,,PENDING
156,US,A1,US 2020/0316050 A1,058-704-630-055-496,2020-10-08,2020,US 201816766834 A,2018-12-17,EP 17208131 A;;EP 2018085269 W,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE,The present invention relates to a topical composition comprising a compound pf formula (I) wherein R is a cycloalkyl group with the total number of carbon atoms in the cycloalkyl group in the range 4 to 6.,CONOPCO INC DBA UNILEVER,AGARWAL KHUSHBU;;GADGIL VIJAY RAMCHANDRA;;KUNJUPILLAI BALU;;MAJUMDAR AMITABHA,CONOPCO INC. D/B/A UNILEVER (2019-01-30),https://lens.org/058-704-630-055-496,Patent Application,yes,1,3,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K31/455;;A01N43/40,,2,0,,,"CAS RN 333430-06-1, CAS STN Registry Database [online] [Entered STN: 30 Apr 2001] (Year: 2001);;CAS RN 1788767-86-1, CAS STN Registry Database [online] [Entered STN: 25 Jun 2015] (Year: 2015)",DISCONTINUED
157,GB,A,GB 2495880 A,143-812-721-871-076,2013-04-24,2013,GB 201301971 A,2009-08-04,US 8620508 P,2008-08-05,Mobile-phone-based player account transactions method for wagering machine funding,"The method involves receiving, from a mobile phone 104, a request to transfer a fund amount from a player account to a wagering game machine 102 e.g. slot machine. A determination is made whether the player account does not include the fund amount in which case another fund amount is received from a secondary funding source and the player account is augmented by the latter fund amount. The former fund amount is transferred from the player account to the wagering game machine and the player account is debited by the former fund amount. The secondary funding source is a financial institution server 110 operated by a bank. The method enables players to easily and securely make funds available for wagering games by allowing players to use mobile telephones for transferring funds between financial institution accounts, casino accounts, and game session accounts. The method allows mobile phones to store funds for later use in wagering games and allows fund transfers before or after players are physically present at wagering game machines.",WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,,https://lens.org/143-812-721-871-076,Patent Application,no,1,0,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,G06Q20/10;;G06Q20/00;;G06Q20/32;;G06Q20/40,,0,0,,,,DISCONTINUED
158,US,A1,US 2020/0364052 A1,181-968-440-710-937,2020-11-19,2020,US 201916679412 A,2019-11-11,US 201916679412 A;;US 201916412968 A,2019-05-15,BRANCH PENALTY REDUCTION USING MEMORY CIRCUIT,"A memory circuit included in a computer system stores multiple program instructions in program code. In response to fetching a loop boundary instruction, a processor circuit may store, in a loop storage circuit, a set of program instructions included in a program loop associated with the loop boundary instruction. In executing at least one iteration of the program loop, the processor circuit may retrieve the set of program instructions from the loop storage circuit.",WESTERN DIGITAL TECH INC,CHINCHOLE VIJAY;;RASTOGI NAMAN;;AGARWAL SONAM;;LINNEN DANIEL J,WESTERN DIGITAL TECHNOLOGIES INC (2019-11-05),https://lens.org/181-968-440-710-937,Patent Application,yes,2,2,1,3,0,G06F9/381;;G06F9/3814;;G06F9/3804;;G06F9/30054;;G06F8/452;;G06F8/4441;;G06F9/3818;;G06F9/381;;G06F9/3814;;G06F9/325,G06F9/38,,0,0,,,,DISCONTINUED
159,EP,A1,EP 3727316 A1,087-288-398-666-058,2020-10-28,2020,EP 18825653 A,2018-12-17,EP 17208131 A;;EP 2018085269 W,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE,,UNILEVER NV;;UNILEVER PLC,AGARWAL KHUSHBU;;GADGIL VIJAY RAMCHANDRA;;KUNJUPILLAI BALU;;MAJUMDAR AMITABHA,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/087-288-398-666-058,Patent Application,yes,0,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K8/49;;A61Q17/00,,0,0,,,,ACTIVE
160,US,A1,US 2012/0190437 A1,100-092-358-486-225,2012-07-26,2012,US 201213437657 A,2012-04-02,US 201213437657 A;;US 201113127496 A;;US 2009/0063321 W;;US 11149608 P,2008-11-05,CONTROLLING AND CONFIGURING RESPONSIBLE GAMING DATA,"A wagering game system and its operations are described herein. In embodiments, the operations can include presenting wagering game content during a wagering game session via a wagering game machine, where the wagering game session is for a first player account. The operations can further include detecting an amount of money spent on gambling via the first player account during a time period. The operations can further include determining that a second player account, associated with the first player account, is configured to authorize presentation of an indication of the amount of money spent on gambling during the time period. The operations can further include presenting the indication of the amount of money spent during the time period in response to the determining that the second player account is configured to authorize presentation of the indication of the amount of money spent on gambling.",AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R;;WMS GAMING INC,AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-11-10),https://lens.org/100-092-358-486-225,Patent Application,no,0,5,5,5,0,G06Q30/00;;G07F17/32;;G07F17/3227;;G07F17/3237;;G06Q30/00;;G07F17/3237;;G07F17/3227;;G07F17/32,A63F13/02,463/25,0,0,,,,ACTIVE
161,US,B2,US 8430745 B2,059-234-878-603-17X,2013-04-30,2013,US 200913057301 A,2009-08-04,US 8620508 P;;US 2009/0052771 W;;US 200913057301 A,2008-08-05,Mobile-phone-based wagering game account transactions,"In some embodiments a method includes receiving, from a mobile phone, a request to transfer a first fund amount from a player account to a wagering game machine. The method can also include determining that the player account does not include the first fund amount; receiving a second fund amount from a secondary funding source, and augmenting the player account by the second fund amount, wherein the augmenting results in the player account including the first fund amount. The method can also include transferring the first fund amount from the player account to the wagering game machine; debiting the player account by the first fund amount.",AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C;;WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-10-01),https://lens.org/059-234-878-603-17X,Granted Patent,yes,8,75,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,G06Q20/00;;A63F9/24,463/25;;463/42,7,0,,,"""PCT Application No. PCT/US09/52771 International Preliminary Report on Patentability"", Dec. 16, 2010, 8 pages.;;""PCT Application No. PCT/US09/52771 International Search Report"", Sep. 28, 2009, 8 pages.;;""UK Application No. 1103433.7 Examination Report"", Mar. 5, 2012, 1 page.;;""UK Application No. 1103433.7 Examination Report"", Feb. 7, 2013, 4 pages.;;""UK Application No. 1103433.7 Examination Report"", Jan. 8, 2013, 2 pages.;;""UK Application No. 1103433.7 Examination Report"", Jan. 25, 2013, 5 pages.;;""UK Application No. 1301971.6 Examination Report"", Feb. 20, 2013, 7 pages.",ACTIVE
162,US,B2,US 9778863 B2,056-991-528-642-928,2017-10-03,2017,US 201514701158 A,2015-04-30,IN 4920CH2014 A,2014-09-30,System and method for folding partial blocks into multi-level cell memory blocks,"A solution for combining a portion of data from a block of single level cells to a block of multi-level cells. The solution includes identifying word lines with only valid data and word lines with non-valid data in a selected block of single level cells, copying data from word lines with valid data to a destination block of multi-level cells and copying data from word lines in the selected block of single level cells with non-valid data to a separate compaction block of single level cells. The system includes a first controller module configured to scan for word lines with only valid data and pass a bitmap identifying valid and invalid word lines to a second controller module. The second controller module is configured to perform on-chip combining of data from valid word lines, and copy data from invalid data word lines to a compaction block of single level cells.",SANDISK TECHNOLOGIES INC;;SANDISK TECHNOLOGIES LLC,AGARWAL DINESH;;SIVASANKARAN VIJAY;;SANKULE SOURABH;;JAIN VIMAL KUMAR,SANDISK TECHNOLOGIES LLC (2015-04-29),https://lens.org/056-991-528-642-928,Granted Patent,yes,9,5,2,2,0,G11C29/4401;;G11C2029/0409;;G06F11/1072;;G11C11/5621;;G11C29/52;;G06F3/0619;;G11C11/5621;;G06F3/065;;G06F3/0688;;G11C29/52;;G06F11/1072;;G11C29/4401;;G11C2029/0409,G06F3/06;;G06F11/10;;G11C11/56;;G11C29/04;;G11C29/44;;G11C29/52,,0,0,,,,ACTIVE
163,US,A1,US 2011/0263318 A1,151-431-556-181-223,2011-10-27,2011,US 200913057301 A,2009-08-04,US 8620508 P;;US 2009/0052771 W;;US 200913057301 A,2008-08-05,MOBILE-PHONE-BASED WAGERING GAME ACCOUNT TRANSACTIONS,"In some embodiments a method includes receiving, from a mobile phone, a request to transfer a first fund amount from a player account to a wagering game machine. The method can also include determining that the player account does not include the first fund amount; receiving a second fund amount from a secondary funding source, and augmenting the player account by the second fund amount, wherein the augmenting results in the player account including the first fund amount. The method can also include transferring the first fund amount from the player account to the wagering game machine; debiting the player account by the first fund amount.",AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-10-01),https://lens.org/151-431-556-181-223,Patent Application,yes,3,140,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,G06Q20/00;;A63F9/24,463/25;;463/42,0,0,,,,ACTIVE
164,EP,B1,EP 3727316 B1,049-850-046-642-834,2021-10-13,2021,EP 18825653 A,2018-12-17,EP 17208131 A;;EP 2018085269 W,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE,,UNILEVER GLOBAL IP LTD;;UNILEVER IP HOLDINGS B V,AGARWAL KHUSHBU;;GADGIL VIJAY RAMCHANDRA;;KUNJUPILLAI BALU;;MAJUMDAR AMITABHA,UNILEVER GLOBAL IP LIMITED (2022-02-23);;UNILEVER IP HOLDINGS B.V. (2022-02-23),https://lens.org/049-850-046-642-834,Granted Patent,yes,2,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K8/49;;A61Q17/00,,5,0,,,"SIKDER A K ET AL: ""QUATERNARY SALTS OF 3,3'-BIS-PYRIDINIUM MONOOXIMES: SYNTHESIS AND BIOLOGICAL ACTIVITY"", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 82, no. 3, 1 January 1993 (1993-01-01), pages 258-261, XP000909817, ISSN: 0022-3549, DOI: 10.1002/JPS.2600820308;;HIEN-QUANG DO ET AL: ""Photoinduced, Copper-Catalyzed Alkylation of Amides with Unactivated Secondary Alkyl Halides at Room Temperature"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 136, no. 5, 21 January 2014 (2014-01-21), pages 2162-2167, XP055477549, US ISSN: 0002-7863, DOI: 10.1021/ja4126609;;COTE L ET AL: ""Studies on nicotinamide derivatives"", JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 61, no. 4, 1 April 1951 (1951-04-01), pages 463-467, XP002560848, ISSN: 0021-9193;;DATABASE REGISTRY [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 11 February 2016 (2016-02-11), XP002781273, Database accession no. 1864682-46-1;;DATABASE REGISTRY [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 30 April 2001 (2001-04-30), XP002781274, Database accession no. 333430-06-1",ACTIVE
165,GB,A,GB 2475643 A,068-496-875-506-16X,2011-05-25,2011,GB 201103433 A,2009-08-04,US 2009/0052771 W;;US 8620508 P,2008-08-05,Mobile-phone-based wagering game account transactions,"In some embodiments a method includes receiving, from a mobile phone, a request to transfer a first fund amount from a player account to a wagering game machine. The method can also include determining that the player account does not include the first fluid amount; receiving a second fluid amount from a secondary funding source, and augmenting the player account by the second fund amount, wherein the augmenting results in the player account including the first fiund amount. The method can also include transferring the first fund amount from the player account to the wagering game machine; debiting the player account by the first fund amount.",WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,,https://lens.org/068-496-875-506-16X,Patent Application,no,3,1,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,A63F9/24;;G06Q20/00;;G07F17/32,,0,0,,,,DISCONTINUED
166,CN,A,CN 111683649 A,118-881-874-364-49X,2020-09-18,2020,CN 201880081650 A,2018-12-17,EP 17208131 A;;EP 2018085269 W,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE,The present invention relates to a topical composition comprising a compound of formula (I) wherein R is a cycloalkyl group with the total number of carbon atoms in the cycloalkyl group in the range 4to 6.,UNILEVER NV,AGARWAL KHUSHBU;;GADGIL VIJAY RAMCHANDRA;;KUNJUPILLAI BALU;;MAJUMDAR AMITABHA,,https://lens.org/118-881-874-364-49X,Patent Application,no,6,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K8/49;;A61Q17/00,,2,0,,,"LUCILLE等: ""STUDIES ON NICOTINAMIDE DERIVATIVES"", 《JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY》;;LUCILLE等: ""STUDIES ON NICOTINAMIDE DERIVATIVES""",PENDING
167,US,A1,US 2016/0092128 A1,130-786-138-820-943,2016-03-31,2016,US 201514700814 A,2015-04-30,IN 4929CH2014 A,2014-09-30,MOVING AND COMMITTING VALID DATA ON A SET-BY-SET BASIS,"A storage module may be configured to organize data to be moved from an initial storage location to a destination storage location into sets, and to determine whether to commit the data to the destination storage location on a set-by-set basis. Error correction and/or a post write and read process may be performed on the sets that are copied to the destination storage location to determine whether to commit each of the copied sets.",SANDISK TECHNOLOGIES INC,JAIN VIMAL KUMAR;;AGARWAL DINESH;;SIVASANKARAN VIJAY;;AMARJIT KUMAR,SANDISK TECHNOLOGIES LLC (2015-03-06),https://lens.org/130-786-138-820-943,Patent Application,yes,7,11,2,2,0,G06F11/10;;G06F11/1048;;G06F3/0619;;G06F3/0647;;G06F3/0688;;G06F3/0619;;G06F3/0647;;G06F3/0688;;G06F11/10;;G06F11/1048,G06F3/06,,0,0,,,,ACTIVE
168,MX,A,MX 2020006280 A,134-638-496-669-201,2021-11-12,2021,MX 2020006280 A,2018-12-17,EP 17208131 A;;EP 2018085269 W,2017-12-18,A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE.,The present invention relates to a topical composition comprising a compound of formula (I) wherein R is a cycloalkyl group with the total number of carbon atoms in the cycloalkyl group in the range 4 to 6.,UNILEVER IP HOLDINGS B V,KUNJUPILLAI BALU;;MAJUMDAR AMITABHA;;AGARWAL KHUSHBU;;GADGIL VIJAY RAMCHANDRA,,https://lens.org/134-638-496-669-201,Patent Application,no,0,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61K8/49;;A61Q17/00,,0,0,,,,PENDING
169,US,B2,US 8821267 B2,134-635-516-273-13X,2014-09-02,2014,US 201213437657 A,2012-04-02,US 201213437657 A;;US 201113127496 A;;US 2009/0063321 W;;US 11149608 P,2008-11-05,Controlling and configuring responsible gaming data,"A wagering game system and its operations are described herein. In embodiments, the operations can include presenting wagering game content during a wagering game session via a wagering game machine, where the wagering game session is for a first player account. The operations can further include detecting an amount of money spent on gambling via the first player account during a time period. The operations can further include determining that a second player account, associated with the first player account, is configured to authorize presentation of an indication of the amount of money spent on gambling during the time period. The operations can further include presenting the indication of the amount of money spent during the time period in response to the determining that the second player account is configured to authorize presentation of the indication of the amount of money spent on gambling.",AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R;;WMS GAMING INC,AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-11-10),https://lens.org/134-635-516-273-13X,Granted Patent,yes,99,0,5,5,0,G06Q30/00;;G07F17/32;;G07F17/3227;;G07F17/3237;;G06Q30/00;;G07F17/3237;;G07F17/3227;;G07F17/32,G07F17/32,463/29;;463/16;;463/20;;463/25,38,0,,,"U.S. Appl. No. 12/991,391 Office Action, Mar. 12, 2012, 29 pages.;;U.S. Appl. No. 13/858,467, filed Apr. 8, 2013, Gagner, Mark B., et al.;;U.S. Appl. No. 13/858,467 Office Action, Dec. 30, 2013, 6 Pages.;;""Amendment in the Nature of a Substitute H.R. 3125, Offered by Mr. Goodlatte of Virginia"", Tech Law Journal www.techlawjournal.com Date obtained from the Internet Dec. 20, 2005 Apr. 5, 2000, 3 pages.;;""AT&T Corp. v. Coeur D'Alene Tribe, 45 F. Supp. 2d 995 (D. Idaho 1998)"", 1998 , 14 pages.;;""Bill HR 3125 IH The Internet Gambling Prohibition Art Oct. 21, 1999"", 17 pages.;;""Casino Systems Solutions"", IGT International Game Technolgoy Mar. 19, 1997, 20 pages.;;Examination Report, Sep. 17, 2009, 3 pages.;;""H.R. 3125, 106th Congress, 2d Session"", Internet Prohibition Act of 2000 http://thomas.loc.gov Date obtained from the Internet: Nov. 23, 2005 Oct. 21, 1999, 9 pages.;;""High-Tech Gambling Debuts at Turning Stone"", Syracuse Post Standard Feb. 27, 1995, 1 page.;;Pct Application No. PCT/US09/43055 International Preliminary Report on Patentability, Jun. 21, 2010, 14 pages.;;PCT Application No. PCT/US09/43055 International Search Report, Jun. 22, 2009, 10 pages.;;PCT Application No. PCT/US09/63321 International Search Report on Patentability, Oct. 5, 2010, 9 pages.;;PCT Application No. PCT/US09/63321 International Search Report, Dec. 22, 2009, 8 pages.;;PCT Application No. PCT/US2007/084316 International Preliminary Report on Patentability, Jan. 13, 2009, 8 pages.;;PCT Application No. PCT/US2007/084316 International Search Report and Written Opinion, May 23, 2008, 10 pages.;;""S. 692, 106th Congress, 1st Session"", Internet Gambling Prohibition Act of 1999, 8 pages.;;Singapore Application 0800336-0 IPO of Singapore Written Opinion, Feb. 25, 2009 , 7 pages.;;U.S. Appl. No. 11/483,558 Office Action, Jun. 24, 2009, 9 pages.;;U.S. Appl. No. 12/513,486 Office Action, Feb. 23, 2012, 36 pages.;;Banks, Michael A., ""America Online: A Graphics-Based Success"", Link-Up Jan./Feb. 1992, pp. 12, 14 and 15.;;Conti, Carl, ""Letter to Bruce T. Samboy"", Jun. 27, 1994, 2 pages.;;Corbisiero, Jr., Richard F., ""Letter to Niels C. Holch"", Jul. 14, 1994, 1 page.;;Gatley, Susan, ""Turning Stone Inter-Office Memorandum to Bong Woo"", re Instant Keno Issues Oct. 17, 1994 , 3 pages.;;Green, Marian, ""Cashing in"", Indian Gaming Business Fall 2006, 21-23.;;Grochowski, John, ""The Cashless Puzzle"", Slot Manager Jan./Feb. 2008, 5 pages.;;Holch, Niels C., ""Letter to Hon. Richard F. Corbisiero, Jr."", Jul. 12, 1994, 1 page.;;Minder, Jacqueline L., ""Letter to Ron Mach"", Jun. 20, 1994, 1 page.;;Monteau, Harold , ""Letter to Richard M. Milanovich"", National Indiam Gaming Commission Jun. 6, 1995, 2 pages.;;Monteau, Harold A., ""Semiannual Regulatory Agenda"", National Gaming Indian Commission Obtained from the Internet: Feb. 26, 2007, 1 page.;;Quick Track Gaming, Inc., , ""QuickTrack"", , 44 pages.;;Samboy, Bruce T., ""Letter to Carl Conti"", Jun. 13, 1994, 2 pages.;;Samboy, Bruce T., ""Letter to Carl Conti"", Jul. 1, 1994, 2 pages.;;Samboy, Bruce T., ""Letter to Hon. Richard F. Corbisiero, Jr."", Jun. 1, 1994 , 7 pages.;;Samboy, Bruce T., ""Letter to Hon. Richard F. Corbisiero, Jr."", Jun. 14, 1994, 8 pages.;;Smith, Katherine A., ""Letter to Hon. James R. Hurley"", Jun. 15, 1994, 4 pages.;;Washburn, Kevin K., ""Win Sports Betting"", Mar. 13, 2001, 3 pages.;;Yerak, Becky , ""At Cashless Slots: You've got mail, and a jackpot No more coins to insert, but you can get messages"", USA Today Nov. 13, 2000, 4 pages.",ACTIVE
170,BR,A2,BR 112020010720 A2,112-399-718-467-418,2020-11-10,2020,BR 112020010720 A,2018-12-17,EP 2018085269 W;;EP 17208131 A,2017-12-18,"composição tópica, método de desinfecção de superfícies, uso da composição e uso de composto",a presente invenção refere-se a uma composição tópica que compreende um composto da fórmula i: em que r é um grupo cicloalquila com número total de átomos de carbono no grupo cicloalquila na faixa de 4 a 6.,UNILEVER NV,AMITABHA MAJUMDAR;;BALU KUNJUPILLAI;;KHUSHBU AGARWAL;;VIJAY RAMCHANDRA GADGIL,UNILEVER IP HOLDINGS B.V. (PB) (2021-07-20),https://lens.org/112-399-718-467-418,Patent Application,no,0,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61Q17/00;;A61K8/49,,0,0,,,,ACTIVE
171,WO,A1,WO 2010/054027 A1,018-718-818-893-631,2010-05-14,2010,US 2009/0063321 W,2009-11-04,US 11149608 P,2008-11-05,CONTROLLING AND CONFIGURING RESPONSIBLE GAMING DATA,"A wagering game system and its operations are described herein. In embodiments, the operations can include determining a player account that is logged in to a wagering game session and presenting a wagering game during the wagering game session. The operations can further include determining accounting transaction data that relates to an amount of money that the player account has spent on gambling during a time period. The operations can further include presenting the accounting transaction data during the wagering game session so that the accounting transaction data and the wagering game are both perceptible to the player account. The operations can also include indicating the amount of money that the player account has spent on gambling in the time period.",WMS GAMING INC;;AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R,AGARWAL VIJAY K;;BURKE MARY M;;MASKALERIS ELIAS R,,https://lens.org/018-718-818-893-631,Patent Application,yes,3,1,5,5,0,G06Q30/00;;G07F17/32;;G07F17/3227;;G07F17/3237;;G06Q30/00;;G07F17/3237;;G07F17/3227;;G07F17/32,A63F9/24,,0,0,,,,PENDING
172,BR,B1,BR 112020010720 B1,150-572-847-512-048,2023-11-14,2023,BR 112020010720 A,2018-12-17,EP 2018085269 W;;EP 17208131 A,2017-12-18,"Composição tópica, método não terapêutico de desinfecção de superfícies, usos da composição e de um composto",a presente invenção refere-se a uma composição tópica que compreende um composto da fórmula i: em que r é um grupo cicloalquila com número total de átomos de carbono no grupo cicloalquila na faixa de 4 a 6.,UNILEVER IP HOLDINGS B V;;UNILEVER NV,MAJUMDAR AMITABHA;;KUNJUPILLAI BALU;;AGARWAL KHUSHBU;;VIJAY RAMCHANDRA GADGIL,UNILEVER IP HOLDINGS B.V. (PB) (2021-07-20),https://lens.org/150-572-847-512-048,Granted Patent,no,0,0,8,8,0,A61K8/4926;;A61Q17/005;;A01N43/40;;A61K31/455,A61Q17/00;;A61K8/49,,0,0,,,,ACTIVE
173,US,A1,US 2013/0210517 A1,198-687-972-386-919,2013-08-15,2013,US 201313851796 A,2013-03-27,US 201313851796 A;;US 201113057301 A;;US 2009/0052771 W;;US 8620508 P,2008-08-05,MOBILE-PHONE-BASED WAGERING GAME ACCOUNT TRANSACTIONS,"In some embodiments a method includes receiving, from a mobile phone, a request to transfer a first fund amount from a player account to a wagering game machine. The method can also include determining that the player account does not include the first fund amount; receiving a second fund amount from a secondary funding source, and augmenting the player account by the second fund amount, wherein the augmenting results in the player account including the first fund amount. The method can also include transferring the first fund amount from the player account to the wagering game machine; debiting the player account by the first fund amount.",WMS GAMING INC;;WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;PACE MARK C,SG GAMING INC (2015-06-29);;WMS GAMING INC (2008-10-01),https://lens.org/198-687-972-386-919,Patent Application,yes,2,8,8,8,0,G07F17/32;;G06Q20/10;;G06Q20/3255;;G06Q20/40;;G06Q20/403;;A63F9/24;;G07F17/32;;G07F17/3225;;G07F17/323,G06Q20/00;;G07F17/32,463/25;;463/42,0,0,,,,DISCONTINUED
174,KR,A,KR 20230066556 A,018-760-504-006-285,2023-05-16,2023,KR 20237007696 A,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,암 치료를 위한 향상된 음향역동 요법을 위한 초음파 어레이,"환자 인터페이스를 통해 음향 음파 조사 구동 패턴을 활용하여 초음파역학 요법에서 소노센서타이저를 활성화시키기 위한 초음파 트랜스듀서 요소 어레이가 개시된다. 비상관 음향장 생성은 저강도 평면 음파의 제어된 전달을 통하여 위상, 주파수, 및/또는 진폭을 변화시킨다. 방법은 제1 신호 및 제2 신호를 생성하여 위상, 주파수, 및 진폭을 가진 음향 음파 조사 구동 패턴을 각각 생성하는 단계 및 적어도 하나의 상대적 위상차, 주파수 차이, 또는 진폭 차이를 생성하여 제3 비상관 음향 음파 조사 패턴을 생성하여 소노센서타이저를 활성화시키는 단계를 포함한다. 보정 및 보완 요법 절차는 초음파역학 요법에 대한 세포의 세포 감염성을 향상시킨다.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/018-760-504-006-285,Patent Application,no,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61N7/02;;A61B18/00;;A61N7/00,,0,0,,,,PENDING
175,US,B1,US 7606867 B1,045-574-652-997-631,2009-10-20,2009,US 47146506 A,2006-06-19,US 47146506 A;;US 69271505 P,2005-06-21,Ordered application message delivery using multiple processors in a network element,"A data processing apparatus comprises a plurality of processors and message processing logic operable for establishing one of the processors as a master processor and all other processors as slave processors; receiving an application message from a particular message source among a plurality of message sources coupled to one or more network interfaces and the processors, wherein the application message comprises one or more data frames, packets and segments; granting exclusive control of the particular message source to a selected one of the slave processors; assigning an ordered sequence number to the application message; granting exclusive control, for a particular message destination among a plurality of message destinations coupled to the network interfaces and the processors, to the selected one of the slave processors; and providing the application message to the particular message destination.",CISCO TECH INC,SINGHAL PRAVIN;;TRAN LUU;;KOTHAMBAWALA JUZER;;AGARWAL ANOOP;;RAGHAVAN VIJAY,CISCO TECHNOLOGY INC (2006-06-14),https://lens.org/045-574-652-997-631,Granted Patent,yes,25,82,16,24,0,G06F2221/2141;;H04L41/026;;H04L41/06;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5096;;H04L43/0811;;H04L45/00;;H04L45/56;;H04L45/563;;H04L63/0245;;H04L63/0428;;H04L63/08;;H04L63/102;;H04L63/12;;H04L67/34;;H04L69/22;;G06F8/656;;H04L67/02;;H04L41/0894;;G06F2221/2141;;H04L41/026;;H04L41/06;;H04L41/0893;;H04L41/12;;H04L41/22;;H04L41/5003;;H04L41/5009;;H04L41/5012;;H04L41/5096;;H04L43/0811;;H04L45/00;;H04L45/56;;H04L45/563;;H04L63/0245;;H04L63/0428;;H04L63/08;;H04L63/102;;H04L63/12;;H04L67/34;;H04L69/22;;G06F8/656;;H04L9/40;;H04L67/02,G06F15/16;;G06F15/173;;G06F15/76;;H04L45/60,709/209;;709/238;;712/31,5,1,011-393-779-853-516,10.1109/90.836474,"International Searching Authority, ""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration,"" PCT/US2006/024375, dated Oct. 17, 2006, 10 pages.;;Current Claims, PCT/US2006/024375, 6 pages.;;Decasper, Dan et al., ""Router Plugins: A Software Architecture for Next-Generation Routers,"" IEEE ACM Transactions on Networking, vol. 9, No. 1, Feb. 2000, XP011038838, 14 pages.;;International Searching Authority, ""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration"", International application No. PCT/US05/46149, dated Jul. 20, 2007, 9 pages.;;Claims, International application No. PCT/US05/46149, 10 pages.",ACTIVE
176,WO,A2,WO 2022/032283 A2,064-731-568-540-992,2022-02-10,2022,US 2021/0071101 W,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/064-731-568-540-992,Patent Application,yes,0,4,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61N7/02,,0,0,,,,PENDING
177,US,B2,US 8090731 B2,103-492-137-427-207,2012-01-03,2012,US 18076008 A,2008-07-28,US 18076008 A;;US 98354307 P,2007-10-29,Document fidelity with binary XML storage,"Techniques are provided for ensuring lexical fidelity when an XML document is stored in a binary format. Operations, on the XML data, that would cause the loss of lexical fidelity between the original XML document and the binary-encoded version of the XML document are not performed. Such operations include the removal of unnecessary whitespace characters, certain data type conversions, CRLF normalization, the “collapsing” of two-tag empty elements into a single tag empty element, and the replacing of entity references or numeric character references with another value. An XML schema, to which the XML document conforms, may indicate that the XML document is to be stored in a lexical fidelity mode. Additionally, or alternatively, the database statement that (when executed) causes the XML document to be stored in a binary format may so indicate.",STHANIKAM BALASUBRAMANYAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN;;IDICULA SAM;;MEDI VIJAY;;ORACLE INT CORP,STHANIKAM BALASUBRAMANYAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN;;IDICULA SAM;;MEDI VIJAY,ORACLE INTERNATIONAL CORPORATION (2008-07-09),https://lens.org/103-492-137-427-207,Granted Patent,yes,24,30,3,3,0,G06F16/80;;G06F16/80;;G06F16/258;;G06F16/258,G06F17/30,707/756;;707/802;;715/234,6,1,026-253-682-177-785,10.1016/b978-012722442-8/50094-x,"Sivasankaran Chandrasekar et al., ""Oracle Binary XML Format"", Draft RFC Mar. 21, 2007, pp. 1-40.;;Ravi Murthy & Sandeepan Banerjee, ""XML Schemas in Oracle XML DB"", Proceedings of the 29th VLDB Conference, Berlin, Germany, 2003, pp. 1-10.;;""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration"" received from International application No. PCT/US2008/071492 mailed Nov. 26, 2008 (15 pages).;;""Efficient XML Interchange Measurements"" XP-002503310, Working Draft Jul. 25, 2007 (142 pages).;;Giradot, M. et al., ""Millau: an encoding format for efficient representation and exchange of XML over the Web"" XP-001005949, 2000 (20 pages).;;""XML Parsing"" XP-002503367 Oct. 11, 2008 (4 pages).",ACTIVE
178,WO,A2,WO 2015/082176 A2,199-032-020-152-743,2015-06-11,2015,EP 2014074331 W,2014-11-12,EP 13195777 A,2013-12-05,A DEVICE AND METHOD FOR MOVING PLURALITY OF ARTICLES,"Disclosed is a device for moving plurality of articles simultaneously, comprising: (i)a movable pair of superimposable plates, a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough to penetrate a respective article and releasably engage therewith; and (ii)a mechanism for releasing or ejecting said articles. Disclosed also is a method for moving plurality of articles simultaneously comprising the steps of: (i) positioning a movable pair of superimposable plates on an array of moulds each filled with castable non-solid material where said pair comprises a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough; (ii) causing each said pin to enter the non-solid material inside a mould; (iii) cooling said non-solid material to form a solid article in each mould releasably engaged with its pins; (iv) moving said articles simultaneously from a first position to a second position; and, (v) releasing or ejecting said articles.",UNILEVER NV;;UNILEVER PLC;;CONOPCO INC DBA UNILEVER,AGARWAL DEEPAK;;ANAND ARPAN;;KANNIMBELE SANDEEP;;KUMAR ARUN;;MENON VIJAY,,https://lens.org/199-032-020-152-743,Patent Application,yes,0,0,5,5,0,B29C39/36;;C11D13/16;;C11D13/16,B65G47/74,,0,0,,,,PENDING
179,US,A1,US 2023/0330443 A1,060-504-242-046-630,2023-10-19,2023,US 202318215525 A,2023-06-28,US 202318215525 A;;US 202318040610 A;;US 2021/0071101 W;;US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,ALPHEUS MEDICAL INC (2023-08-21),https://lens.org/060-504-242-046-630,Patent Application,yes,4,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61N7/02,,0,0,,,,PENDING
180,US,A1,US 2014/0379086 A1,188-996-298-560-933,2014-12-25,2014,US 201214345559 A,2012-09-20,US 201214345559 A;;US 201161536744 P;;US 2012/0056297 W,2011-09-20,Expandable Inter-Vertebral Cage and Method of Installing Same,An inter-vertebral cage for use in repairing a damaged inter-vertebral disc includes a plurality of cage sections and a hinge element that connects adjacent ones of the cage sections together for relative movement. The hinge elements automatically urge the cage sections to move from an extended orientation to an installed orientation.,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,THE UNIVERSITY OF TOLEDO (2014-05-21),https://lens.org/188-996-298-560-933,Patent Application,yes,79,37,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61F2/44;;A61B1/018;;A61F2/46,623/17.16;;600/104,0,0,,,,ACTIVE
181,CN,A,CN 106132656 A,024-311-036-556-190,2016-11-16,2016,CN 201480066371 A,2014-11-12,EP 13195777 A;;EP 2014074331 W,2013-12-05,A device and method for moving plurality of articles,"Disclosed is a device for moving plurality of articles simultaneously, comprising: (i)a movable pair of superimposable plates, a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough to penetrate a respective article and releasably engage therewith; and (ii)a mechanism for releasing or ejecting said articles. Disclosed also is a method for moving plurality of articles simultaneously comprising the steps of: (i) positioning a movable pair of superimposable plates on an array of moulds each filled with castable non-solid material where said pair comprises a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough; (ii) causing each said pin to enter the non-solid material inside a mould; (iii) cooling said non-solid material to form a solid article in each mould releasably engaged with its pins; (iv) moving said articles simultaneously from a first position to a second position; and, (v) releasing or ejecting said articles.",UNILEVER NV,AGARWAL DEEPAK;;ANAND ARPAN;;KANNIMBELE SANDEEP;;KUMAR ARUN;;MENON VIJAY,,https://lens.org/024-311-036-556-190,Patent Application,no,4,0,5,5,0,B29C39/36;;C11D13/16;;C11D13/16,B29C39/36;;C11D13/16,,0,0,,,,INACTIVE
182,US,B2,US 9561115 B2,059-174-449-419-081,2017-02-07,2017,US 201214345559 A,2012-09-20,US 201214345559 A;;US 201161536744 P;;US 2012/0056297 W,2011-09-20,Expandable inter-vertebral cage and method of installing same,An inter-vertebral cage for use in repairing a damaged inter-vertebral disc includes a plurality of cage sections and a hinge element that connects adjacent ones of the cage sections together for relative movement. The hinge elements automatically urge the cage sections to move from an extended orientation to an installed orientation.,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,THE UNIVERSITY OF TOLEDO (2014-05-21),https://lens.org/059-174-449-419-081,Granted Patent,yes,91,40,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61F2/44;;A61B1/018;;A61F2/28;;A61F2/30;;A61F2/46,,2,0,,,"European Extended Search Report, Application No. EP 12834152.6, dated Apr. 1, 2015.;;Japanese Office Action, Application No. JP 2014-531958, dated May 23, 2016.",ACTIVE
183,WO,A1,WO 2009/058448 A1,094-879-773-240-787,2009-05-07,2009,US 2008/0071492 W,2008-07-29,US 98354307 P;;US 18076008 A,2007-10-29,DOCUMENT FIDELITY WITH BINARY XML STORAGE,"Techniques are provided for ensuring lexical fidelity when an XML document is stored in a binary format. Operations, on the XML data, that would cause the loss of lexical fidelity between the original XML document and the binary-encoded version of the XML document are not performed. Such operations include the removal of unnecessary whitespace characters, certain data type conversions, CRLF normalization, the ""collapsing"" of two-tag empty elements into a single tag empty element, and the replacing of entity references or numeric character references with another value. An XML schema, to which the XML document conforms, may indicate that the XML document is to be stored in a lexical fidelity mode. Additionally, or alternatively, the database statement that (when executed) causes the XML document to be stored in a binary format may so indicate.",ORACLE INT CORP;;STHANIKAM BALASUBRAMANYAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN;;IDICULA SAM;;MEDI VIJAY,STHANIKAM BALASUBRAMANYAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN;;IDICULA SAM;;MEDI VIJAY,,https://lens.org/094-879-773-240-787,Patent Application,yes,2,0,3,3,0,G06F16/80;;G06F16/80;;G06F16/258;;G06F16/258,G06F17/30,,3,1,080-765-068-618-998,10.1016/s1389-1286(00)00051-7,"GIRARDOT M ET AL: ""MILLAU: AN ENCODING FORMAT FOR EFFICIENT REPRESENTATION AND EXCHANGE OF XML OVER THE WEB"", COMPUTER NETWORKS AND ISDN SYSTEMS, NORTH HOLLAND PUBLISHING. AMSTERDAM, NL, vol. 33, no. 1-06, 1 June 2000 (2000-06-01), pages 747 - 765, XP001005949, ISSN: 0169-7552;;ANONYMOUS: ""DB2 VERSION 9 fro Linux, UNIX , and Windows: Leveraging XML Support - XML Parsing"", IBM DB2 INFORMATION CENTRE HOME, 27 October 2006 (2006-10-27), pages 1 - 4, XP002503367, Retrieved from the Internet <URL:http://publib.boulder.ibm.com/infocenter/db2luw/v9/index.jsp?topic=/com.ibm.db2.udb.apdv.embed.doc/doc/c0023533.htm> [retrieved on 20081111];;ANONYMOUS: ""Efficient XML Interchange Measurements"", W3C, 25 July 2007 (2007-07-25), pages 1 - 141, XP002503310, Retrieved from the Internet <URL:http://www.w3.org/TR/2007/WD-exi-measurements-20070725/> [retrieved on 20081111]",PENDING
184,US,B2,US 7992081 B2,161-360-174-889-346,2011-08-02,2011,US 40750806 A,2006-04-19,US 40750806 A,2006-04-19,Streaming validation of XML documents,"A method and apparatus for streaming validation of XML documents is provided. A particular event of a series of events is received. The series of events is generated as an XML document is parsed by a parser, and the received particular event indicates that the parser has encountered a particular part of the XML document. The particular part of the XML document indicated by the particular event is then received. A current validation state for the XML document is determined. The current validation state, which is one of a plurality of validation states for the XML document, indicates a validation type associated with the particular part of the XML document. Based on at least the current validation state, the particular part of the XML document is validated against an XML schema that defines the structure of the XML document.",ORACLE INT CORP,MEDI VIJAY;;AGARWAL NIPUN;;MURTHY RAVI;;SEDLAR ERIC;;RABINOV ARKADY,ORACLE INTERNATIONAL CORPORATION (2006-04-17),https://lens.org/161-360-174-889-346,Granted Patent,yes,30,4,2,2,0,G06F40/149;;G06F40/221;;G06F40/226;;G06F40/143;;G06F40/221;;G06F40/149;;G06F40/226;;G06F40/143,G06F40/143,715/237,7,6,046-430-902-868-423;;134-047-773-192-540;;109-706-459-102-156;;175-365-472-788-587;;089-513-628-343-627;;086-033-760-705-419,10.1145/1111627.1111631;;10.1145/543621.543622;;10.1145/1017074.1017096;;10.1571/pr6-30-05cc;;10.1145/1185448.1185606;;10.1145/1042046.1042050,"Murata et al., Taxonomy of XML Schema Languages Using Formal Language Theory, Nov. 2005, ACM Transactions on Internet Technology, vol. 5, No. 4, pp. 660-704.;;Segoufin et al., Validating Streaming XML Documents, Jun. 3-6, 2002, ACM PODS 2002, pp. 53-64.;;Chitic et al., On Validation of XML Streams Using Finite State Machines, Jun. 17-18, 2004, Seventh International Workshop on the Web and Databases (WebDB 2004), pp. 85-90.;;""A Practice Guide for Building Enterprise XML Applications with Oracle Application Server 10g"" Oracle (2005) pp. 1-15.;;""XML Schema Part 0: Primer Second Edition"" W3C (2004) pp. 1-81.;;Zhang, et al., ""TDX: A High Performance Table-driven XML Parser"", In proceedings of the 44th annual (ACM) Southeast Regional Conference, Mar. 2006, ACM, 6 pages.;;Balmin et al., ""Incremental Validation of XML Documents"", ACM Trans. Database System 24, Dec. 2004, 42 pages.",ACTIVE
185,WO,A3,WO 2013/043850 A3,180-747-650-325-820,2013-05-16,2013,US 2012/0056297 W,2012-09-20,US 201161536744 P,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,An inter-vertebral cage for use in repairing a damaged inter- vertebral disc includes a plurality of cage sections and a hinge element that connects adjacent ones of the cage sections together for relative movement. The hinge elements automatically urge the cage sections to move from an extended orientation to an installed orientation.,UNIV TOLEDO;;ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/180-747-650-325-820,Search Report,yes,8,0,11,11,0,A61F2/447;;A61F2/4611;;A61F2002/2835;;A61F2002/30092;;A61F2002/30471;;A61F2002/30545;;A61F2002/30556;;A61F2002/30604;;A61F2002/30607;;A61F2002/30609;;A61F2002/30616;;A61F2002/30878;;A61F2002/4415;;A61F2310/00017;;A61F2310/00023;;A61F2310/00976;;A61F2/4465;;A61F2002/30004;;A61F2002/3054;;A61F2002/30462;;A61F2002/30433;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/2835;;A61F2002/30092;;A61F2002/30471;;A61F2002/30545;;A61F2002/30556;;A61F2002/30604;;A61F2002/30607;;A61F2002/30609;;A61F2002/30616;;A61F2002/30878;;A61F2002/4415;;A61F2310/00017;;A61F2310/00023;;A61F2310/00976;;A61F2002/3054;;A61F2002/30004;;A61F2002/30433;;A61F2002/30462;;A61F2002/30593;;A61F2002/30624;;A61F2/4465;;A61B1/018,A61F2/44,,0,0,,,,PENDING
186,AR,A1,AR 098606 A1,189-253-509-626-891,2016-06-01,2016,AR P140104503 A,2014-12-04,EP 13195777 A,2013-12-05,UN DISPOSITIVO Y UN MÉTODO PARA DESPLAZAR UNA PLURALIDAD DE ARTÍCULOS,"Se describe un dispositivo para desplazar una pluralidad de artículos en simultáneo, que comprende: (i) un par de placas móviles y superponibles, donde una primera placa comprende una pluralidad de vástagos que se proyectan hacia afuera, desde una de sus superficies principales, y una segunda placa provista de unos orificios que serán atravesados por dichos vástagos, a fin de penetrar en un respectivo artículo y unirse al mismo, de modo tal que pueda separase de él y (ii) un mecanismo para soltar o eyectar dichos artículos. También se describe un método para desplazar una pluralidad de artículos en simultáneo, que comprende los siguientes pasos: (i) colocar un par móvil de placas superponibles sobre una serie de moldes, cada uno de los cuales se llena con un material apto para colada y no sólido, donde dicho par comprende una primera placa que comprende una pluralidad de vástagos que se proyectan hacia, afuera desde una superficie principal de la misma, y una segunda placa, que comprende orificios para que dichos vástagos los atraviesen; (ii) hacer que cada uno de los mencionados vástagos ingrese en el material no sólido dentro de un molde; (iii) enfriar dicho material no sólido, para formar un artículo sólido en cada molde, unido a sus vástagos de modo tal que pueda separarse de ellos; (iv) desplazar los citados artículos en simultáneo, desde una primera posición hacia una segunda posición y (v) soltar o eyectar dichos artículos.",UNILEVER NV,SANDEEP KANNIMBELE;;ARUN KUMAR;;VIJAY MENON;;DEEPAK AGARWAL;;ARPAN ANAND,,https://lens.org/189-253-509-626-891,Patent Application,no,0,0,5,5,0,B29C39/36;;C11D13/16;;C11D13/16,B65G47/74,,0,0,,,,PENDING
187,EP,A2,EP 2758008 A2,185-019-368-982-487,2014-07-30,2014,EP 12834152 A,2012-09-20,US 201161536744 P;;US 2012/0056297 W,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE,,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/185-019-368-982-487,Patent Application,yes,0,0,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61B1/018;;A61F2/28;;A61F2/30;;A61F2/44;;A61F2/46,,0,0,,,,ACTIVE
188,EP,A2,EP 4192404 A2,043-715-988-985-099,2023-06-14,2023,EP 21853426 A,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,,ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/043-715-988-985-099,Patent Application,yes,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61F7/02;;A61K41/00,,0,0,,,,PENDING
189,US,A1,US 2023/0338754 A1,020-512-069-061-923,2023-10-26,2023,US 202318215515 A,2023-06-28,US 202318215515 A;;US 202118040610 A;;US 2021/0071101 W;;US 202063062937 P;;US 202063062926 P;;US 202063062915 P;;US 202063062895 P;;US 202063062879 P,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,ALPHEUS MEDICAL INC (2023-08-21),https://lens.org/020-512-069-061-923,Patent Application,yes,1,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61K41/00;;A61N7/00;;B06B1/06,,0,0,,,,PENDING
190,WO,A3,WO 2022/032283 A3,052-642-884-422-71X,2022-04-07,2022,US 2021/0071101 W,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/052-642-884-422-71X,Search Report,yes,3,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61K41/00;;A61F7/02,,0,0,,,,PENDING
191,US,A1,US 2009/0112902 A1,071-042-654-934-904,2009-04-30,2009,US 18076008 A,2008-07-28,US 18076008 A;;US 98354307 P,2007-10-29,DOCUMENT FIDELITY WITH BINARY XML STORAGE,"Techniques are provided for ensuring lexical fidelity when an XML document is stored in a binary format. Operations, on the XML data, that would cause the loss of lexical fidelity between the original XML document and the binary-encoded version of the XML document are not performed. Such operations include the removal of unnecessary whitespace characters, certain data type conversions, CRLF normalization, the “collapsing” of two-tag empty elements into a single tag empty element, and the replacing of entity references or numeric character references with another value. An XML schema, to which the XML document conforms, may indicate that the XML document is to be stored in a lexical fidelity mode. Additionally, or alternatively, the database statement that (when executed) causes the XML document to be stored in a binary format may so indicate.",ORACLE INT CORP,STHANIKAM BALASUBRAMANYAM;;CHANDRASEKAR SIVASANKARAN;;AGARWAL NIPUN;;IDICULA SAM;;MEDI VIJAY,ORACLE INTERNATIONAL CORPORATION (2008-07-09),https://lens.org/071-042-654-934-904,Patent Application,yes,14,29,3,3,0,G06F16/80;;G06F16/80;;G06F16/258;;G06F16/258,G06F17/30,707/101;;X707E17127,0,0,,,,ACTIVE
192,US,B2,US 10651953 B2,140-136-225-557-109,2020-05-12,2020,US 201816176928 A,2018-10-31,US 201816176928 A;;US 201762580604 P,2017-11-02,Low gain listen,"A wireless communication device includes an antenna to receive a signal, a low noise amplifier, and circuitry that determines the power level of the signal. The circuitry also determines whether the signal includes a packet, and causes the low noise amplifier to amplify the signal when the signal includes a packet and the power level of the signal is below a threshold. The circuitry also causes the low noise amplifier to be bypassed when the signal does not include a packet, or the power level of the signal is above the predetermined threshold and the signal includes a packet.",AVAGO TECH INT SALES PTE LID,FORBES MARCELLUS;;SUNDARARAJAN VIJAY;;BEHZAD ARYA;;BHUKANIA BIJOY;;AGARWAL RISHABH,AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-11-15),https://lens.org/140-136-225-557-109,Granted Patent,yes,3,0,2,2,0,H04W52/286;;H04B17/318;;H04B1/1027;;H04B17/102;;H04B17/13;;H04B1/18;;H03F2200/294;;H03F3/189;;H04B17/102;;H04B17/13;;H04B1/18;;H03F2200/294;;H04B17/336;;H03F3/189;;H04B17/391;;H04W52/286;;H04B17/318;;H04B1/1027,H04B17/10;;H03F3/189;;H04B1/10;;H04B1/18;;H04B17/13;;H04B17/318;;H04B17/336;;H04B17/391;;H04W52/28,,0,0,,,,ACTIVE
193,US,A1,US 2024/0024649 A1,193-966-984-290-033,2024-01-25,2024,US 202118040610 A,2021-08-04,US 202118040610 A;;US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,ALPHEUS MEDICAL INC (2023-08-21),https://lens.org/193-966-984-290-033,Patent Application,yes,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61N7/00;;A61M37/00;;B06B1/02;;B06B1/06,,0,0,,,,PENDING
194,WO,A2,WO 2013/043850 A2,017-794-318-936-357,2013-03-28,2013,US 2012/0056297 W,2012-09-20,US 201161536744 P,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,An inter-vertebral cage for use in repairing a damaged inter- vertebral disc includes a plurality of cage sections and a hinge element that connects adjacent ones of the cage sections together for relative movement. The hinge elements automatically urge the cage sections to move from an extended orientation to an installed orientation.,UNIV TOLEDO;;ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/017-794-318-936-357,Patent Application,yes,1,100,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61F2/44,,1,0,,,See also references of EP 2758008A4,PENDING
195,EP,B1,EP 2758008 B1,076-941-595-549-600,2019-09-11,2019,EP 12834152 A,2012-09-20,US 201161536744 P;;US 2012/0056297 W,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE,,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/076-941-595-549-600,Granted Patent,yes,11,0,11,11,0,A61F2/447;;A61F2/4611;;A61F2002/2835;;A61F2002/30092;;A61F2002/30471;;A61F2002/30545;;A61F2002/30556;;A61F2002/30604;;A61F2002/30607;;A61F2002/30609;;A61F2002/30616;;A61F2002/30878;;A61F2002/4415;;A61F2310/00017;;A61F2310/00023;;A61F2310/00976;;A61F2/4465;;A61F2002/30004;;A61F2002/3054;;A61F2002/30462;;A61F2002/30433;;A61F2002/30624;;A61F2002/30593;;A61F2/447;;A61F2/4611;;A61F2002/2835;;A61F2002/30092;;A61F2002/30471;;A61F2002/30545;;A61F2002/30556;;A61F2002/30604;;A61F2002/30607;;A61F2002/30609;;A61F2002/30616;;A61F2002/30878;;A61F2002/4415;;A61F2310/00017;;A61F2310/00023;;A61F2310/00976;;A61F2002/3054;;A61F2002/30004;;A61F2002/30433;;A61F2002/30462;;A61F2002/30593;;A61F2002/30624;;A61F2/4465;;A61B1/018,A61B1/018;;A61F2/28;;A61F2/30;;A61F2/44;;A61F2/46,,0,0,,,,ACTIVE
196,AU,A1,AU 2021/321597 A1,061-925-952-939-814,2023-03-09,2023,AU 2021/321597 A,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,Ultrasound arrays for enhanced sonodynamic therapy for treating cancer,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/061-925-952-939-814,Patent Application,no,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61F7/02;;A61K41/00,,0,0,,,,PENDING
197,EP,A4,EP 2758008 A4,125-447-091-294-896,2015-04-29,2015,EP 12834152 A,2012-09-20,US 201161536744 P;;US 2012/0056297 W,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/125-447-091-294-896,Search Report,no,3,0,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61F2/44,,1,0,,,See also references of WO 2013043850A2,ACTIVE
198,US,A1,US 2023/0330442 A1,171-969-408-197-16X,2023-10-19,2023,US 202318215497 A,2023-06-28,US 202318215497 A;;US 202318040610 A;;US 2021/0071101 W;;US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P,2020-08-07,INCOHERENT FIELD SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,ALPHEUS MEDICAL INC (2023-08-21),https://lens.org/171-969-408-197-16X,Patent Application,yes,17,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61K41/00;;A61N7/00;;B06B1/02;;B06B1/06,,1,1,103-181-752-347-761,33106054;;10.1080/02656736.2020.1828628,"J. Chen, S. LeBlang, A. Hananel, R. Aginsky, J. Perez, M. Gofeld, Y. Shir & J. F. Aubry (2020) An incoherent HIFU transducer for treatment of the medial branch nerve: Numerical study and in vivo validation, International Journal of Hyperthermia, 37:1, 1219-1228, DOI: 10.1080/02656736.2020.1828628 (Year: 2020)",PENDING
199,CN,A,CN 116209470 A,085-390-900-113-714,2023-06-02,2023,CN 202180067543 A,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,Ultrasound array for enhanced sonodynamic therapy for treatment of cancer,"The array of ultrasound transducer elements uses an acoustic acoustic transmission drive mode through the patient interface to activate the sonosensitizer in sonodynamic therapy. Varying phases, frequencies and/or amplitudes are generated by controlled delivery of incoherent sound fields of low intensity planar acoustic waves. The method includes generating a first signal and a second signal to generate respective acoustic transmission drive modes having a phase, frequency, and amplitude, and generating at least one relative phase, frequency, or amplitude difference to generate a third incoherent acoustic transmission mode to activate the sonosensitizer. Calibration and supplemental therapy processes are disclosed for improving the cellular susceptibility of cells to sonodynamic therapy.",ALPHES THERAPEUTICS INC,AGARWAL VIJAY;;ELLISON BRIAN;;LING JING;;BALLARD JAMES;;MILLER GARRET,,https://lens.org/085-390-900-113-714,Patent Application,no,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61K41/00,,0,0,,,,PENDING
200,WO,A3,WO 2015/082176 A3,162-141-423-110-249,2016-06-09,2016,EP 2014074331 W,2014-11-12,EP 13195777 A,2013-12-05,A DEVICE AND METHOD FOR MOVING PLURALITY OF ARTICLES,"Disclosed is a device for moving plurality of articles simultaneously, comprising: (i)a movable pair of superimposable plates, a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough to penetrate a respective article and releasably engage therewith; and (ii)a mechanism for releasing or ejecting said articles. Disclosed also is a method for moving plurality of articles simultaneously comprising the steps of: (i) positioning a movable pair of superimposable plates on an array of moulds each filled with castable non-solid material where said pair comprises a first plate comprising plurality of pins projecting outwardly from a major surface thereof and a second plate comprising holes for said pins to pass therethrough; (ii) causing each said pin to enter the non-solid material inside a mould; (iii) cooling said non-solid material to form a solid article in each mould releasably engaged with its pins; (iv) moving said articles simultaneously from a first position to a second position; and, (v) releasing or ejecting said articles.",UNILEVER NV;;UNILEVER PLC;;CONOPCO INC DBA UNILEVER,AGARWAL DEEPAK;;ANAND ARPAN;;KANNIMBELE SANDEEP;;KUMAR ARUN;;MENON VIJAY,,https://lens.org/162-141-423-110-249,Search Report,yes,2,0,5,5,0,B29C39/36;;C11D13/16;;C11D13/16,B65G47/74;;C11D13/14;;C11D13/16,,0,0,,,,PENDING
201,US,A1,US 2019/0132063 A1,079-223-429-627-215,2019-05-02,2019,US 201816176928 A,2018-10-31,US 201816176928 A;;US 201762580604 P,2017-11-02,LOW GAIN LISTEN,"A wireless communication device includes an antenna to receive a signal, a low noise amplifier, and circuitry that determines the power level of the signal. The circuitry also determines whether the signal includes a packet, and causes the low noise amplifier to amplify the signal when the signal includes a packet and the power level of the signal is below a threshold. The circuitry also causes the low noise amplifier to be bypassed when the signal does not include a packet, or the power level of the signal is above the predetermined threshold and the signal includes a packet.",AVAGO TECH INT SALES PTE LID,FORBES MARCELLUS;;SUNDARARAJAN VIJAY;;BEHZAD ARYA;;BHUKANIA BIJOY;;AGARWAL RISHABH,AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-11-15),https://lens.org/079-223-429-627-215,Patent Application,yes,3,3,2,2,0,H04W52/286;;H04B17/318;;H04B1/1027;;H04B17/102;;H04B17/13;;H04B1/18;;H03F2200/294;;H03F3/189;;H04B17/102;;H04B17/13;;H04B1/18;;H03F2200/294;;H04B17/336;;H03F3/189;;H04B17/391;;H04W52/286;;H04B17/318;;H04B1/1027,H04B17/10;;H03F3/189;;H04B1/18;;H04B17/13;;H04B17/336;;H04B17/391,,0,0,,,,ACTIVE
202,KR,A,KR 20140080501 A,178-318-139-735-534,2014-06-30,2014,KR 20147010410 A,2012-09-20,US 201161536744 P;;US 2012/0056297 W,2011-09-20,EXPANDABLE INTER-VERTEBRAL CAGE AND METHOD OF INSTALLING SAME,,UNIV TOLEDO,ELAHINIA MOHAMMAD;;AGARWAL ANAND;;GOEL VIJAY;;ANDERSON WALTER;;CHAPMAN CORY,,https://lens.org/178-318-139-735-534,Patent Application,no,4,1,11,11,0,A61F2/4465;;A61F2/4465;;A61B1/018;;A61F2/447;;A61F2/447;;A61F2/4611;;A61F2/4611;;A61F2002/2835;;A61F2002/2835;;A61F2002/30004;;A61F2002/30004;;A61F2002/30092;;A61F2002/30092;;A61F2002/30433;;A61F2002/30433;;A61F2002/30462;;A61F2002/30462;;A61F2002/30471;;A61F2002/30471;;A61F2002/3054;;A61F2002/3054;;A61F2002/30545;;A61F2002/30545;;A61F2002/30556;;A61F2002/30556;;A61F2002/30593;;A61F2002/30593;;A61F2002/30604;;A61F2002/30604;;A61F2002/30607;;A61F2002/30607;;A61F2002/30609;;A61F2002/30609;;A61F2002/30616;;A61F2002/30616;;A61F2002/30624;;A61F2002/30624;;A61F2002/30878;;A61F2002/30878;;A61F2002/4415;;A61F2002/4415;;A61F2310/00017;;A61F2310/00017;;A61F2310/00023;;A61F2310/00023;;A61F2310/00976;;A61F2310/00976,A61F2/44;;A61B17/70;;A61B17/94;;A61L27/04,,0,0,,,,ACTIVE
203,US,A1,US 2007/0250766 A1,196-737-615-366-223,2007-10-25,2007,US 40750806 A,2006-04-19,US 40750806 A,2006-04-19,Streaming validation of XML documents,"A method and apparatus for streaming validation of XML documents is provided. A particular event of a series of events is received. The series of events is generated as an XML document is parsed by a parser, and the received particular event indicates that the parser has encountered a particular part of the XML document. The particular part of the XML document indicated by the particular event is then received. A current validation state for the XML document is determined. The current validation state, which is one of a plurality of validation states for the XML document, indicates a validation type associated with the particular part of the XML document. Based on at least the current validation state, the particular part of the XML document is validated against an XML schema that defines the structure of the XML document.",MEDI VIJAY;;AGARWAL NIPUN;;MURTHY RAVI;;SEDLAR ERIC;;RABINOV ARKADY,MEDI VIJAY;;AGARWAL NIPUN;;MURTHY RAVI;;SEDLAR ERIC;;RABINOV ARKADY,ORACLE INTERNATIONAL CORPORATION (2006-04-17),https://lens.org/196-737-615-366-223,Patent Application,yes,28,59,2,2,0,G06F40/149;;G06F40/221;;G06F40/226;;G06F40/143;;G06F40/221;;G06F40/149;;G06F40/226;;G06F40/143,G06F15/00;;G06F40/143,715/513,0,0,,,,ACTIVE
204,CA,A1,CA 3185803 A1,075-041-606-196-469,2022-02-10,2022,CA 3185803 A,2021-08-04,US 202063062879 P;;US 202063062895 P;;US 202063062915 P;;US 202063062926 P;;US 202063062937 P;;US 2021/0071101 W,2020-08-07,ULTRASOUND ARRAYS FOR ENHANCED SONODYNAMIC THERAPY FOR TREATING CANCER,"Ultrasound transducer element arrays using acoustic ensonification drive patterns via a patient interface for sonosensitizer activation in sonodynamic therapy. Incoherent acoustic field generation varying phase, frequencies, and/or amplitude via controlled delivery of low intensity planar acoustic waves. Method includes generating a first and a second signal to generate respective acoustic ensonification drive patterns with phase, frequency, and amplitude and generating at least one relative phase, frequency or amplitude difference to generate a third incoherent acoustic ensonification pattern to activate a sonosensitizer. Calibration and complementary therapy procedures to improve cell susceptibility of cells to sonodynamic therapy are disclosed.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;ELIASON BRADEN;;LING JEREMY;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/075-041-606-196-469,Patent Application,no,0,0,13,13,0,A61N7/02;;A61B2018/00011;;A61N2007/0078;;A61N2007/0095;;A61B2018/00023;;B06B1/0637;;A61N7/02;;A61B2018/00011;;A61N2007/0095;;A61B2018/00023;;A61N2007/0078;;A61N7/02;;A61N2007/0078;;A61N2007/0091;;A61N2007/0095;;A61B2018/00011;;A61B2018/00023;;A61K41/0033;;A61N7/00;;A61N2007/0078;;B06B1/0215;;B06B1/0625;;B06B2201/76;;A61N7/02;;A61N2007/0021;;A61N2007/0073;;A61N2007/0043;;B06B1/0629;;B06B1/0633;;A61M37/0092;;A61N2007/0086;;B06B2201/55,A61F7/02;;A61K41/00,,0,0,,,,PENDING
205,US,A1,US 2019/0295089 A1,005-182-544-806-662,2019-09-26,2019,US 201815979297 A,2018-05-14,US 201815979297 A;;US 201862647467 P,2018-03-23,TRANSACTION FRAUD DETECTION BASED ON ENTITY LINKING,"Methods, systems, and computer program products are provided for transaction fraud detection based on entity linking. Identifying data is collected associated with at least one transaction in a set of fraudulent transactions. A second set of transactions is searched for first linked transactions that include at least some of the identifying data. For each of the first linked transactions, the second set of transactions is recursively searched for additional linked transactions based at least in part on additional identifying data included in each of the first linked transactions. A fraud island is designated to include the at least one transaction, the first linked transactions, and the additional linked transactions. Whether a subsequent transaction is fraudulent is determined based on the fraud island and a transaction fraud risk model.",MICROSOFT TECHNOLOGY LICENSING LLC,JIA YUTING;;NANDURI JAYARAM NM;;NARULA VIJAY;;LI QIANG;;AGARWAL SHREYA,MICROSOFT TECHNOLOGY LICENSING LLC (2018-05-10),https://lens.org/005-182-544-806-662,Patent Application,yes,3,7,1,1,0,G06Q20/4016;;G06Q20/4016;;G06N3/02;;G06N5/04;;G06N20/00;;G06Q20/10,G06Q20/40;;G06N3/02;;G06N5/04;;G06Q20/10,,0,0,,,,DISCONTINUED
206,AU,B2,AU 2016/204525 B2,072-114-159-533-923,2017-07-13,2017,AU 2016/204525 A,2016-06-30,AU 2016/204525 A;;AU 2013/215158 A;;US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Injectable, Biodegradable Bone Cements and Methods of Making and Using Same Abstract Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/072-114-159-533-923,Granted Patent,no,1,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,1,1,047-429-543-031-258,21479638;;10.1007/s10856-011-4288-5,"Touny, A.H et al., ""Hydrolysis of monetite/chitosan composites in a-MEM and SBF solutions"", J Mater Sci: Mater Med, (20110409), doi:doi:10.1007/s10856-011-4288-5, PAGE 1101 - 1109, 1101-1109 1-4,7,17-18",ACTIVE
207,AU,A1,AU 2016/204525 A1,110-779-552-129-057,2016-07-14,2016,AU 2016/204525 A,2016-06-30,AU 2016/204525 A;;AU 2013/215158 A;;US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Injectable, Biodegradable Bone Cements and Methods of Making and Using Same Abstract Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/110-779-552-129-057,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
208,JP,A,JP 2018038823 A,155-625-812-594-475,2018-03-15,2018,JP 2017185831 A,2017-09-27,US 201261593094 P;;US 201261697059 P,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING THE SAME","PROBLEM TO BE SOLVED: To provide bone cement compositions that are easily made, possess improved strength, mechanical properties and bioactivity, and can be used also to fill a tooth defect.SOLUTION: A bone cement composition contains magnesium phosphate containing newberyite, a biocompatible polymer, and silica; and is in the form of an injectable paste, putty, or hardened mass. The bone cement composition further contains calcium phosphate such as monetite, where the biocompatible polymer is chitosan and the magnesium phosphate further contains bobierrite, and additionally contains Sr.SELECTED DRAWING: Figure 1",UNIV TOLEDO,SARIT B BHADURI;;ZHOU HUAN;;ANAND K AGARWAL;;VIJAY K GOEL,,https://lens.org/155-625-812-594-475,Patent Application,no,5,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L27/12;;A61K6/838;;A61K6/898;;A61L24/00;;A61L24/02;;A61L24/08;;A61L27/02;;A61L27/20;;A61L27/50,,0,0,,,,PENDING
209,US,B2,US 7348435 B2,199-213-353-421-393,2008-03-25,2008,US 19572805 A,2005-08-03,IN 2035DE2004 A,2004-10-18,Process for producing cyanopiperidine,The present invention relates to an improved and single step process for producing cyanopiperidine by dehydrating respective piperidine carboxamide employing a suitable dehydrating agent.,JUBILANT ORGANOSYS LTD,KAUSHIK VIJAY KUMAR;;CHAURASIA NANHE LAL;;VERMA PRADEEP KUMAR;;AGARWAL ASHUTOSH,JUBILANT ORGANOSYS LIMITED (2005-07-16),https://lens.org/199-213-353-421-393,Granted Patent,yes,0,3,2,2,0,C07D211/62;;C07D211/62,C07D211/56,546/246,1,1,029-150-141-619-859,10.1021/jm0309349;;14640559,"Orjales et al., J. Med. Chem. Nov. 1, 2003, 46, 5512-5532.",INACTIVE
210,EP,A3,EP 1728513 A3,034-000-956-381-033,2007-10-31,2007,EP 06252644 A,2006-05-19,IN 608CH2005 A;;US 71878905 P,2005-05-20,Stable desloratadine compositions,"The present invention relates to stable pharmaceutical compositions of desloratadine comprising desloratadine in combination with a desloratadine-stabilizing amount of at least one amino acid.
",REDDYS LAB INC DR,AGARWAL SUDEEP KUMAR;;ALAGARSAMY ALAGUMURUGAN;;NASARE VIJAY DINANATHJI;;MOHAN MAILATUR SIVARAMAN,,https://lens.org/034-000-956-381-033,Search Report,yes,6,0,3,4,0,A61K45/06;;A61K31/185;;A61K31/198;;A61K31/445;;A61K31/4545,A61K31/4545;;A61K31/185;;A61K31/198;;A61K31/445;;A61K45/06,,0,0,,,,DISCONTINUED
211,US,A1,US 2016/0199532 A1,067-763-496-146-86X,2016-07-14,2016,US 201615079129 A,2016-03-24,US 201615079129 A;;US 201414375927 A;;US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, Biodegradable Bone Cements and Methods of Making and Using Same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/067-763-496-146-86X,Patent Application,yes,6,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898;;A61L24/08,,1,1,030-064-463-299-936,10.1016/j.biomaterials.2011.04.010;;21529931,"âAn injectable calcium phosphate cement for the local delivery of paclitaxel to bone,â Lopez-Heredia, M., et al., Biomaterials 32: 5411 - 5416 (available online 6 May 2011).",ACTIVE
212,US,B2,US 10052402 B2,075-310-033-796-792,2018-08-21,2018,US 201615078391 A,2016-03-23,US 201615078391 A;;US 201414375927 A;;US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/075-310-033-796-792,Granted Patent,yes,11,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61K6/00;;A61K6/06;;A61K6/838;;A61K6/898;;A61L24/02;;A61L24/08;;A61L27/32;;C23C30/00,,17,8,030-769-470-569-850;;069-409-900-179-200;;035-965-481-743-746;;039-728-693-835-008;;014-083-988-968-980;;029-672-946-486-000;;008-200-392-173-530;;090-037-908-880-284,10.6028/jres.115.021;;pmc2966325;;21037803;;21658480;;10.1016/j.actbio.2011.05.022;;10.1002/9780470291351.ch6;;21856456;;10.1016/j.actbio.2011.08.005;;10.1016/s0142-9612(02)00153-9;;12194519;;11456064;;10.1016/s0142-9612(00)00413-0;;20972610;;10.1007/s10856-010-4168-4;;10.1016/j.msec.2007.10.058,"“In Vivo Characteristics of Premixed Calcium Phosphate Cements When Implanted in Subcutaneous Tissues and Periodontal Bone Defects,” Sugawara, A., et al., Journal of Research of the National Institute of Standards and Technology 115(4): 277-290 (2010).;;Klammert, U., et al., ACTA Biomaterialia 7: 3469-3475 (available online May 25, 2011).;;Klammert, U., Acta Biomaterialia 6: 1529-1535 (available online Nov. 1, 2009).;;Australian Patent Examination Report No. 1, Application No. AU 2013215158 dated Nov. 25, 2015, [7-53682/D2012-10].;;Chinese 1st Office Action, Application No. CN 201380013370.2 dated Feb. 26, 2016, [55-53682/D2012-10].;;Desai et al., “A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair”, Advances in Bioceramics and Biocomposites II, 2007, pp. 61-69.;;European Search Report, Application No. EP 13742896.7 dated Sep. 7, 2015, [57-53682/D2012-10].;;European Search Report, Application No. EP 13742896.7 dated Jan. 21, 2016, [57-53682/D2012-10].;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024040 filed Jan. 31, 2013, dated Apr. 4, 2013, [53-53682/D2012-10].;;Tamimi et al., “Dicalcium Phosphate Cements: Brushite and Monetite”, Acta Biomaterialia, 2012, vol. 8, pp. 474-487.;;Touny et al., “Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions”, The Journal of Materials Science: Materials in Medicine, 2011, vol. 22, pp. 1101-1109.;;Wang et al., “Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements”, Biomaterials, 2002, vol. 23, pp. 4167-4176.;;Wang et al., “Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements”, Biomaterials, 2011, vol. 22, pp. 2247-2255.;;Australian Examination Report No. 1, Application No. AU 2016204525, dated Feb. 9, 2017.;;Borhan et al. “Evaluation of collodial silica suspension as efficient additive for improving physiochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement”, Journal of Material Science: Material Medicine, 2010, vol. 21, pp. 3171-3181.;;Jalota et al. “Using a synthetic body fluid (SBF) solution of 27 mM HCO3—to make bone subsitutes more osteointegrative,” Materials Science and Engineering C, 2008, pp. 129-140.;;Japanese Notification of Reasons for Rejection, Application No. JP 2014-555693, dated Oct. 26, 2016.",ACTIVE
213,CN,A,CN 107296977 A,125-139-934-951-758,2017-10-27,2017,CN 201710472178 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;CN 201380013370 A,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/125-139-934-951-758,Patent Application,no,7,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/08;;A61B17/88;;A61K6/838;;A61K6/898;;A61L24/00;;A61L24/02;;A61L27/32,,3,3,047-429-543-031-258;;054-667-435-613-266;;041-111-388-725-744,21479638;;10.1007/s10856-011-4288-5;;10.1016/j.jnoncrysol.2006.02.111;;30011620;;10.1016/j.msec.2009.11.007,"AHMED H.TOUNY ET AL.: ""Hydrolysis of monetite/chitosan composites in a-MEM and SBF solutions"", 《JOURNAL OF MATERIALS SCIENCE: MATERIAL MEDICINE》;;C.C.SILVA ET AL.: ""Microwave preparation, structure and electrical properties of calcium-sodium-phosphate biosystem"", 《JOURNAL OF NON-CRYSTALLINE SOLIDS》;;SAMAR J. KALITA ET AL.: ""Nanocrystalline hydroxyapatite bioceramic using microwave radiation: Synthesis"", 《MATERIALS SCIENCE AND ENGINEERING C》",ACTIVE
214,WO,A3,WO 2010/060082 A3,151-556-482-449-993,2010-08-05,2010,US 2009/0065733 W,2009-11-24,US 11754508 P,2008-11-24,"SYSTEMS. METHODS, AND COMPUTER READABLE MEDIA FOR PROVIDING TOLL-FREE SERVICE IN A TELECOMMUNICATIONS NETWORK","Methods, systems, and computer program products for providing toll- free service in a telecommunications network are disclosed. According to one aspect, the subject matter described herein includes a method for providing toll- free service in a telecommunications network. The method includes, at a signaling node that includes at least one processor: receiving a first signaling message that includes a toll-free called party number, where the first signaling message is one of a non-TCAP call setup message, a mobility management query, a number portability (NP) query, and an E.164 number (ENUM) query; determining a directory number associated with the toll-free called party number; and sending the first signaling message or a second signaling message, the sent message including at least one of the directory number and routing information associated with the directory number.",TEKELEC US;;MARATHE ROHINI VIJAY;;AGARWAL DEVESH;;RAO RANGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,MARATHE ROHINI VIJAY;;AGARWAL DEVESH;;RAO RANGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,,https://lens.org/151-556-482-449-993,Search Report,yes,3,0,4,4,0,H04M3/42306;;H04M15/00;;H04M15/08;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M2215/62;;H04Q3/0025;;H04Q3/005;;H04M3/42306;;H04Q3/005;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M15/00;;H04M2215/62;;H04M15/08;;H04Q3/0025,H04W4/24;;H04W40/02;;H04W80/04;;H04W80/10,,0,0,,,,PENDING
215,EP,A1,EP 2809364 A1,167-107-952-875-821,2014-12-10,2014,EP 13742896 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME",,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/167-107-952-875-821,Patent Application,yes,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
216,CA,C,CA 2863381 C,023-236-723-130-42X,2021-11-16,2021,CA 2863381 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/023-236-723-130-42X,Granted Patent,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/08;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
217,WO,A2,WO 2010/060082 A2,184-000-369-147-647,2010-05-27,2010,US 2009/0065733 W,2009-11-24,US 11754508 P,2008-11-24,"SYSTEMS. METHODS, AND COMPUTER READABLE MEDIA FOR PROVIDING TOLL-FREE SERVICE IN A TELECOMMUNICATIONS NETWORK","Methods, systems, and computer program products for providing toll- free service in a telecommunications network are disclosed. According to one aspect, the subject matter described herein includes a method for providing toll- free service in a telecommunications network. The method includes, at a signaling node that includes at least one processor: receiving a first signaling message that includes a toll-free called party number, where the first signaling message is one of a non-TCAP call setup message, a mobility management query, a number portability (NP) query, and an E.164 number (ENUM) query; determining a directory number associated with the toll-free called party number; and sending the first signaling message or a second signaling message, the sent message including at least one of the directory number and routing information associated with the directory number.",TEKELEC US;;MARATHE ROHINI VIJAY;;AGARWAL DEVESH;;RAO RANGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,MARATHE ROHINI VIJAY;;AGARWAL DEVESH;;RAO RANGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,,https://lens.org/184-000-369-147-647,Patent Application,yes,0,3,4,4,0,H04M3/42306;;H04M15/00;;H04M15/08;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M2215/62;;H04Q3/0025;;H04Q3/005;;H04M3/42306;;H04Q3/005;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M15/00;;H04M2215/62;;H04M15/08;;H04Q3/0025,H04W40/02;;H04W4/24;;H04W80/04;;H04W80/10,,0,0,,,,PENDING
218,US,B2,US 10052403 B2,039-003-579-255-925,2018-08-21,2018,US 201615079129 A,2016-03-24,US 201615079129 A;;US 201414375927 A;;US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/039-003-579-255-925,Granted Patent,yes,14,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61K6/00;;A61K6/06;;A61K6/838;;A61K6/898;;A61L24/02;;A61L24/08;;A61L27/32;;C23C30/00,,17,8,030-064-463-299-936;;069-409-900-179-200;;035-965-481-743-746;;039-728-693-835-008;;014-083-988-968-980;;029-672-946-486-000;;008-200-392-173-530;;090-037-908-880-284,10.1016/j.biomaterials.2011.04.010;;21529931;;21658480;;10.1016/j.actbio.2011.05.022;;10.1002/9780470291351.ch6;;21856456;;10.1016/j.actbio.2011.08.005;;10.1016/s0142-9612(02)00153-9;;12194519;;11456064;;10.1016/s0142-9612(00)00413-0;;20972610;;10.1007/s10856-010-4168-4;;10.1016/j.msec.2007.10.058,"“An injectable calcium phosphate cement for the local delivery of paclitaxel to bone,” Lopez-Heredia, M., et al., Biomaterials 32: 5411-5416 (available online May 6, 2011).;;Klammert, U., et al., Acta Biomaterialia 7: 3469-3475 (available online May 25, 2011). (Year: 2011).;;Klammert, U., Acta Biomaterialia 6: 1529-1535 (available online Nov. 1, 2009). (Year: 2009).;;Australian Patent Examination Report No. 1, Application No. AU 2013215158 dated Nov. 25, 2015.;;Chinese 1st Office Action, Application No. CN 201380013370.2 dated Feb. 26, 2016.;;Desai et al., “A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair”, Advances in Bioceramics and Biocomposites II, 2007, pp. 61-69.;;European Search Report, Application No. EP 13742896.7 dated Sep. 7, 2015.;;European Search Report, Application No. EP 13742896.7 dated Jan. 21, 2016.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024040 filed Jan. 31, 2013, dated Apr. 4, 2013.;;Tamimi et al., “Dicalcium Phosphate Cements: Brushite and Monetite”, Acta Biomaterialia, 2012, vol. 8, pp. 474-487.;;Touny et al., “Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions”, The Journal of Materials Science: Materials in Medicine, 2011, vol. 22, pp. 1101-1109.;;Wang et al., “Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements”, Biomaterials, 2002, vol. 23, pp. 4167-4176.;;Wang et al., “Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements”, Biomaterials, 2011, vol. 22, pp. 2247-2255.;;Borhan et al., “Evaluation of colloidal silica suspension as efficient additive for improving physiochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement”, Journal of Material Science: Materials in Medicine, 2010, vol. 21, pp. 3171-3181.;;Jalota et al., “Using a synthetic body fluid (SBF) solution of 27 mM HCO3—to make bone substitutes more osteointegrative”, Materials Science and Engineering C, vol. 28, 2008, pp. 129-140.;;Japanese Notification of Reasons for Rejection, Application No. JP 2014-555693, dated Oct. 25, 2016.;;Australian Examination Report No. 1, Application No. AU2016204525, dated Feb. 9, 2017.",ACTIVE
219,AU,B2,AU 2017/232233 B2,153-727-174-430-189,2019-05-02,2019,AU 2017/232233 A,2017-09-25,AU 2017/232233 A;;AU 2016/204525 A;;AU 2013/215158 A;;US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/153-727-174-430-189,Granted Patent,no,1,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,3,3,057-431-756-854-819;;001-443-948-802-649;;069-409-900-179-200,10.1016/j.actbio.2009.10.021;;19837194;;21324383;;10.1016/j.actbio.2011.02.007;;21658480;;10.1016/j.actbio.2011.05.022,"KLAMMERT, U et al.,’Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement’, Acta Biomaterialia, 6, 2010, Pages1529–1535, doi:10.1016/j.actbio.2009.10.021.;;TAMIMI, F. et al.,’ Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions’, Acta Biomaterialia, 7, 2011, Pages 2678–2685, doi:10.1016/j.actbio.2011.02.007.;;KLAMMERT, U et al., ‘In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model’, Acta Biomaterialia, 7, 2011, Pages 3469–3475, doi:10.1016/j.actbio.2011.05.022",ACTIVE
220,US,A1,US 2015/0005392 A1,147-982-140-550-167,2015-01-01,2015,US 201314375927 A,2013-01-31,US 201314375927 A;;US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"Injectable, Biodegradable Bone Cements and Methods of Making and Using Same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/147-982-140-550-167,Patent Application,yes,11,6,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61K6/838;;A61K6/898;;C23C30/00,514/769;;623/23.62;;606/94;;433/228.1;;106/691;;427/2.26,22,10,069-409-900-179-200;;035-965-481-743-746;;039-728-693-835-008;;014-083-988-968-980;;029-672-946-486-000;;008-200-392-173-530;;090-037-908-880-284;;133-808-222-567-147;;001-443-948-802-649;;069-409-900-179-200,21658480;;10.1016/j.actbio.2011.05.022;;10.1002/9780470291351.ch6;;21856456;;10.1016/j.actbio.2011.08.005;;10.1016/s0142-9612(02)00153-9;;12194519;;11456064;;10.1016/s0142-9612(00)00413-0;;20972610;;10.1007/s10856-010-4168-4;;10.1016/j.msec.2007.10.058;;10.1016/0022-0248(81)90472-3;;21324383;;10.1016/j.actbio.2011.02.007;;21658480;;10.1016/j.actbio.2011.05.022,"“The Physical Properties of Magnesium Oxide,” available from http://livestrong.com/article/500557-the-physical-properties-ofmagnesium-oxide/, as accessed Feb. 24, 2017.;;Klammert, U., et al., Acta Biomaterialia 7: 3469-3475 (available online May 25, 2011).;;Klammert, U., Acta Biomaterialia 6: 1529-1535 (available online Nov. 1, 2009).;;Desai et al., “A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair”, Advances in Bioceramics and Biocomposites II, 2007, pp. 61-69.;;Tamimi et al., “Dicalcium Phosphate Cements: Brushite and Monetite”, Acta Biomaterialia, 2012, vol. 8, pp. 474-487.;;Touny et al., “Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions”, The Journal of Materials Science: Materials in Medicine, 2011, vol. 22, pp. 1101-1109.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024040 filed Jan. 31, 2013, dated Apr. 4, 2013.;;Wang et al., “Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements”, Biomaterials, 2002, vol. 23, pp. 4167-4176.;;Wang et al., “Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements”, Biomaterials, 2011, vol. 22, pp. 2247-2255.;;Australian Patent Examination Report No. 1, Application No. AU 2013215158 dated Nov. 25, 2015.;;Chinese 1st Office Action, Application No. CN 201380013370.2 dated Feb. 26, 2016.;;European Search Report, Application No. EP 13742896.7 dated Sep. 7, 2015.;;European Search Report, Application No. EP 13742896.7 dated Jan. 21, 2016.;;Australian Examination Report No. 1, Application No. AU 2016204525, dated Feb. 9, 2017.;;Borhan et al. “Evaluation of collodial silica suspension as efficient additive for improving physiochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement”, Journal of Material Science: Material Medicine, 2010, vol. 21, pp. 3171-3181.;;Jalota et al. “Using a synthetic body fluid (SBF) solution of 27 mM HCO3— to make bone subsitutes more osteointegrative,” Materials Science and Engineering C, 2008, pp. 129-140.;;Japanese Notifications of Reasons for Rejections, Application No. JP 2014-555693, dated Oct. 26, 2016.;;Boistelle et al., “Morphology, Habit and Growth of Newberyite Crystals (MgHPO4 3H2O)”, Journal of Crystal Growth, 1981, vol. 54, pp. 275-295.;;Tamimi et al., “Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions”, Acta Biomaterialia, 2011, vol. 7, pp. 2678-2685.;;“The Physical Properties of Magnesium Oxide,” available from http://livestrong.com/article/500557-the-physical-properties-of magnesium-oxide/, as accessed 24 February 2017.;;Klammert, U., et al., Acta Biomaterialia 7: 3469 – 3475 (available online 25 May 2011).;;Klammert, U., Acta Biomaterialia 6: 1529 – 1535 (available online 1 November 2009).",ACTIVE
221,CN,A,CN 104837512 A,089-707-828-563-021,2015-08-12,2015,CN 201380013370 A,2013-01-31,US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/089-707-828-563-021,Patent Application,no,5,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,2,0,,,"TOUNY等: ""Hydrolysis of monetite/chitosan composites in a-MEM and SBF solutions"", 《J MATER SCI: MATER MED》, 9 April 2011 (2011-04-09), pages 1101 - 1109, XP019910216, DOI: doi:10.1007/s10856-011-4288-5;;WANG XH等: ""Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements"", 《BIOMATERIALS》, 15 August 2001 (2001-08-15), pages 2247 - 2255, XP004247498, DOI: doi:10.1016/S0142-9612(00)00413-0",ACTIVE
222,US,A1,US 2018/0369445 A1,197-547-466-744-639,2018-12-27,2018,US 201816117070 A,2018-08-30,US 201816117070 A;;US 201414375927 A;;US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, Biodegradable Bone Cements And Methods Of Making And Using Same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/197-547-466-744-639,Patent Application,yes,2,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61C5/62;;A61K6/00;;A61K6/06;;A61K6/838;;A61K6/898;;A61L24/02;;A61L24/08;;A61L27/32;;C08L5/08;;C23C30/00,,0,0,,,,DISCONTINUED
223,CA,A1,CA 2547274 A1,097-623-153-037-884,2006-11-20,2006,CA 2547274 A,2006-05-19,IN 608CH2005 A;;US 71878905 P,2005-05-20,STABLE DESLORATADINE COMPOSITIONS,The present invention relates to stable pharmaceutical compositions of desloratadine comprising desloratadine in combination with a desloratadine-stabilizing amount of at least one amino acid.,REDDYS LAB LTD DR;;REDDYS LAB INC DR,NASARE VIJAY DINANATHJI;;ALAGARSAMY ALAGUMURUGAN;;AGARWAL SUDEEP KUMAR;;MOHAN MAILATUR SIVARAMAN,,https://lens.org/097-623-153-037-884,Patent Application,no,0,0,3,4,0,A61K45/06;;A61K31/185;;A61K31/198;;A61K31/445;;A61K31/4545,A61K31/4545,,0,0,,,,DISCONTINUED
224,CA,A1,CA 2863381 A1,142-169-339-581-514,2013-08-08,2013,CA 2863381 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/142-169-339-581-514,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/08;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
225,US,A1,US 2007/0004671 A1,039-263-187-659-665,2007-01-04,2007,US 41920906 A,2006-05-19,US 41920906 A;;IN 608CH2005 A;;US 71878905 P,2005-05-20,STABLE DESLORATADINE COMPOSITIONS,The present invention relates to stable pharmaceutical compositions of desloratadine comprising desloratadine in combination with a desloratadine-stabilizing amount of at least one amino acid.,AGARWAL SUDEEP K;;ALAGARSAMY ALAGUMURUGAN;;NASARE VIJAY D;;MOHAN MAILATUR S,AGARWAL SUDEEP K;;ALAGARSAMY ALAGUMURUGAN;;NASARE VIJAY D;;MOHAN MAILATUR S,DR. REDDY'S LABORATORIES INC (2006-08-03);;DR. REDDY'S LABORATORIES LIMITED (2006-08-03),https://lens.org/039-263-187-659-665,Patent Application,yes,8,2,1,4,0,A61K31/198;;A61K31/198;;A61K31/473;;A61K31/473;;A61K31/7012;;A61K31/7012,A61K31/473;;A61K31/198;;A61K31/7012,514/53;;514/290;;514/565,0,0,,,,DISCONTINUED
226,MX,B,MX 351724 B,060-188-340-402-385,2017-10-26,2017,MX 2014009213 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME.","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,HUAN ZHOU;;SARIT B BHADURI;;ANAND K AGARWAL;;VIJAY K GOEL,,https://lens.org/060-188-340-402-385,Granted Patent,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
227,US,A1,US 2018/0271423 A1,085-529-061-281-330,2018-09-27,2018,US 201615764627 A,2016-10-06,US 201615764627 A;;US 201562238316 P;;US 2016/0055706 W,2015-10-07,"A BIOSENSOR DEVICE TO DETECT TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The SAM layer may include an anti-fouling agent. The transducer component includes an electrode (or set of electrodes that includes a working electrode) and microprocessor configured to screen noise and to pick up a detectable signal, such as impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;LIN BOREN,THE UNIVERSITY OF TOLEDO (2018-05-25),https://lens.org/085-529-061-281-330,Patent Application,yes,0,8,2,2,0,A61B5/14546;;A61B5/14546;;A61B5/0537;;A61B5/0537;;A61B5/1477;;A61B5/1477;;A61B5/24;;A61B5/24;;A61B5/7435;;A61B5/7435;;A61B2562/0295;;A61B2562/0295;;A61B2562/046;;A61B2562/046,A61B5/145;;A61B5/00;;A61B5/053;;A61B5/1477,,0,0,,,,DISCONTINUED
228,AU,B2,AU 2013/215158 B2,177-845-512-103-956,2016-06-16,2016,AU 2013/215158 A,2013-01-31,US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/177-845-512-103-956,Granted Patent,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,3,3,039-728-693-835-008;;029-672-946-486-000;;047-429-543-031-258,21856456;;10.1016/j.actbio.2011.08.005;;11456064;;10.1016/s0142-9612(00)00413-0;;21479638;;10.1007/s10856-011-4288-5,"TAMIMI, F. et al., 'Dicalcium phosphate cements: Brushite and monetite', Acta Biomaterialia, 8, 2012, Pages 474-487.;;WANG, X. et al, 'Structural characterization of phosphorylated chitosan and their applications as elective additives of calcium phosphate cements', Biomaterials 22, 2001, Pages 2247-2255;;TOUNY, A.H. et al., 'Hydrolysis of monetite/chitosan composites in a-MEM and SBF solutions', J Mater Sci: Mater Med, 2011, 22, Pages 1101-1109, DOI 10.1007/s10856-011-4288-5.",ACTIVE
229,EP,A2,EP 1618457 A2,016-102-668-283-417,2006-01-25,2006,EP 04760286 A,2004-04-19,US 2004/0012126 W;;US 42379403 A,2003-04-25,HIERARCHICAL SERVICE MANAGEMENT SYSTEM,,IPOLICY NETWORKS INC,PAREKH PANKAJ;;GUPTA SANDEEP;;MAMTANI VIJAY;;JAIN ATUL;;AGARWAL SANJAY KUMAR,,https://lens.org/016-102-668-283-417,Patent Application,yes,0,0,7,7,0,G06Q30/02;;G06Q30/02,G06F15/16;;G06F/;;G06F7/00;;G06F21/00;;G06F21/60;;G06F21/62;;G06Q30/02,,0,0,,,,DISCONTINUED
230,WO,A2,WO 2004/097556 A2,058-592-257-877-809,2004-11-11,2004,US 2004/0012126 W,2004-04-19,US 42379403 A,2003-04-25,HIERARCHICAL SERVICE MANAGEMENT SYSTEM,"The present invention provides a system, method and computer program product for managing customers in a hierarchical manner. The customer hierarchy comprises a root service provider (RSP), tiered service providers (TSPs) and end customers. The present invention enables the governing of the customers by a large service provider by providing an ability to make smaller service providers as customers and managing their resources. The smaller service provider, in turn, can have its own customers. The smaller service provider governs these customers without interference from the service providers above it in the hierarchy. The customers are governed by policies. A policy is a set of rules laid down by the service provider to control the customers. The present invention also enables the service provider to implement different policies on different customers and change the policy for a customer without affecting other customers.",IPOLICY NETWORKS INC,PAREKH PANKAJ;;GUPTA SANDEEP;;MAMTANI VIJAY;;JAIN ATUL;;AGARWAL SANJAY KUMAR,,https://lens.org/058-592-257-877-809,Patent Application,yes,0,0,7,7,0,G06Q30/02;;G06Q30/02,G06F/;;G06F7/00;;G06F21/00;;G06F21/60;;G06F21/62;;G06Q30/02,,0,0,,,,PENDING
231,WO,A1,WO 2013/116457 A1,075-011-235-824-683,2013-08-08,2013,US 2013/0024040 W,2013-01-31,US 201261593094 P;;US 201261697059 P,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO;;BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/075-011-235-824-683,Patent Application,yes,2,8,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,3,1,047-429-543-031-258,21479638;;10.1007/s10856-011-4288-5,"TOUNY ET AL.: ""Hydrolysis of Monetite/Chitosan Composites in a-MEM and SBF Solutions"", J. MATER SCI: MATER MED, vol. 22, no. 5, 2011, pages 1101 - 1109, XP019910216;;DESAI ET AL.: ""A Self-Setting, Monetite (CaHP04) Cement for Skeletal Repair"", ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES II, 2007, pages 61 - 69, XP055160664;;See also references of EP 2809364A4",PENDING
232,MX,A,MX 2014009213 A,060-509-426-527-79X,2015-06-05,2015,MX 2014009213 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME.","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,ZHOU HUAN;;BHADURI SARIT B;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/060-509-426-527-79X,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
233,AU,A1,AU 2013/215158 A1,089-900-404-904-827,2014-08-28,2014,AU 2013/215158 A,2013-01-31,US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/089-900-404-904-827,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
234,KR,A,KR 20140129058 A,099-073-488-938-464,2014-11-06,2014,KR 20147023748 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME",,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/099-073-488-938-464,Patent Application,no,2,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/02;;A61J1/00;;A61K6/838;;A61K6/898;;A61L24/04;;A61L24/10,,3,3,069-409-900-179-200;;047-429-543-031-258;;039-728-693-835-008,21658480;;10.1016/j.actbio.2011.05.022;;21479638;;10.1007/s10856-011-4288-5;;21856456;;10.1016/j.actbio.2011.08.005,"Klammert, U,. et al., “In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model”, Acta Biomaterialia 7, pp.3469-3475 (2011)*;;Ahmed H. Touny., et al., “Hydrolysis of monetite/chitosan composites in a-MEM and SBF solutions”, J Mater Sci: Mater Med 22, pp.1101-1109 (2011)*;;Faleh Tamimi et al., “Dicalcium phosphate cements: Brushite and monetite”, Acta Biomaterialia 8, pp.474-487(2012)*",ACTIVE
235,US,B2,US 8600007 B2,172-789-117-016-056,2013-12-03,2013,US 62499609 A,2009-11-24,US 62499609 A;;US 11754508 P,2008-11-24,"Systems, methods, and computer readable media for providing toll-free service in a telecommunications network","Methods, systems, and computer program products for providing toll-free service in a telecommunications network are disclosed. According to one aspect, the subject matter described herein includes a method for providing toll-free service in a telecommunications network. The method includes, at a signaling node that includes at least one processor: receiving a first signaling message that includes a toll-free called party number, where the first signaling message is one of a non-TCAP call setup message, a mobility management query, a number portability (NP) query, and an E.164 number (ENUM) query; determining a directory number associated with the toll-free called party number; and sending the first signaling message or a second signaling message, the sent message including at least one of the directory number and routing information associated with the directory number.",VIJAY MARATHE ROHINI;;AGARWAL DEVESH;;RAO RAGHAVENDRA GOPALA;;MARSICO PETER JOSEPH;;TEKELEC GLOBAL INC,VIJAY MARATHE ROHINI;;AGARWAL DEVESH;;RAO RAGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,TEKELEC GLOBAL INC (2010-01-04),https://lens.org/172-789-117-016-056,Granted Patent,yes,50,1,4,4,0,H04M3/42306;;H04M15/00;;H04M15/08;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M2215/62;;H04Q3/0025;;H04Q3/005;;H04M3/42306;;H04Q3/005;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M15/00;;H04M2215/62;;H04M15/08;;H04Q3/0025,H04M15/12;;G06Q30/00;;H04L12/66;;H04Q3/00,379/36;;370/218;;370/328;;370/352;;370/390;;379/88.13;;379/93.12;;379/201.02;;379/211.01;;379/221.14;;705/14.4;;707/999.202;;714/38.1,27,0,,,"""How Vanity Toll Free Numbers Work,"" http://www.mytollfree800number.com/vanity-numbers-800-toll-free-service.cfm, (copyright 2009) (downloaded from the Internet on Dec. 29, 2009).;;Norris, ""Toll Free Number and Advanced Routing,"" http://ezinearticles.com/?Toll-Free-Numbers-and-Advanced-Routing&id=699330, (article submitted on Aug. 22, 2007) (downloaded from the Internet on Dec. 29, 2009).;;""Toll-Free Strategy,"" http://www.tollfreestrategy.com/Vanity-toll-free-Numbers-Service.cfm, (downloaded from the Internet on Dec. 29, 2009).;;Notice of Allowance and Fee(s) Due for U.S. Appl. No. 11/085,620 (Sep. 17, 2010).;;European Search Report for European Patent No. 1867115 (Sep. 3, 2010).;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for International Application No. PCT/US2009/065733 (Jun. 15, 2010).;;Official Action for U.S. Appl. No. 11/085,620 (Apr. 15, 2010).;;Official Action for Chinese Patent Application No. 200680017480.6 (Mar. 18, 2010).;;Final Official Action for U.S. Appl. No. 11/085,620 (Jun. 19, 2009).;;Interview Summary for U.S. Appl. No. 11/085,620 (Apr. 30, 2009).;;Official Action for U.S. Appl. No. 11/085,620 (Dec. 19, 2008).;;Notification of European Publication Number and Information on the Application of Article 67(3) EPC for European Application No. 06 739 166.4 (Nov. 21, 2007).;;""Digital Cellular Telecommunications System (Phase 2+); Universal Mobile Telecommunications System (UMTS); Network Architecture,"" 3GPP TS 23.002 version 7.1.0 Release 7, ETSI TS 123 002 (Mar. 2006).;;""INAP Feature Module,"" Cisco MGC Software Release 9.5(2), pp. 1-16 (Dec. 3, 2003).;;""Tekelec Introduces TekWare(TM) IN and TekWare Mediation,"" Tekelec, p. 1 (May 28, 2003).;;""Tekelec Announces Advanced Signaling Architecture-TekWare,"" Tekelec, pp. 1-3 (Jun. 4, 2002).;;""Integrated Services Digital Network (ISDN); Signalling System No. 7 (SS7); ISDN User Part (ISUP) Version 4 for the International Interface; Part 1: Basic Services,"" European Telecommunications Standards Institute, ETSI EN 300 356-1, V4.2.1, pp. 1-44 (May 2001).;;Crowe, ""Cellular Network Perspectives,"" Wireless Review, pp. 1-4 (Mar. 2001).;;Gurbani et al., ""Accessing IN services from SIP networks,"" Internet-Draft, pp. 1-20 (Feb. 2001).;;""Integrated Services Digital Network (ISDN); Signalling System No. 7; Signalling Connection Control Part (SCCP) (connectionless and connection-oriented) to Support International Interconnection; Part 1: Protocol Specification,"" European Telecommunications Standards Institute, ETSI EN 300 009-1, V1.4.2, pp. 1-18 (Nov. 1999).;;Haerens, ""Intelligent Network Application Part (INAP) Support of the SIP/SDP Architecture,"" SIP Working Group, Internet Draft, pp. 1-12 (Oct. 1999).;;Liao et al., ""SS7-TCAP/IP Interworking,"" Internet Engineering Task Force, pp. 1-14 (Mar. 1999).;;Aitken, ""Signalling Relay Intelligence,"" Logica Aldiscon, pp. 1-11 (1999).;;""Eagle STP Platform,"" Tekelec, Publication 908-0126-01, Rev. A, pp. 1-4 (Copyright 1997).;;Supplemental Notice of of Allowability for U.S. Appl. No. 12/913,735 (Jan. 11, 2013).;;Notice of Allowance and Fee(s) Due for U.S. Appl. No. 12/913,735 (Nov. 16, 2012).;;Notice of Allowance and Fee(s) Due for U.S. Appl. No. 12/913,735 (Apr. 23, 2013).",ACTIVE
236,US,A1,US 2006/0084808 A1,028-300-634-191-269,2006-04-20,2006,US 19572805 A,2005-08-03,IN 2035DE2004 A,2004-10-18,Process for producing cyanopiperidine,The present invention relates to an improved and single step process for producing cyanopiperidine by dehydrating respective piperidine carboxamide employing a suitable dehydrating agent.,JUBILANT ORGANOSYS LTD,KAUSHIK VIJAY K;;CHAURASIA NANHE L;;VERMA PRADEEP K;;AGARWAL ASHUTOSH,JUBILANT ORGANOSYS LIMITED (2005-07-16),https://lens.org/028-300-634-191-269,Patent Application,yes,0,6,2,2,0,C07D211/62;;C07D211/62,C07D211/56,546/215,0,0,,,,INACTIVE
237,US,A1,US 2016/0199533 A1,059-462-913-169-087,2016-07-14,2016,US 201615078391 A,2016-03-23,US 201615078391 A;;US 201414375927 A;;US 2013/0024040 W;;US 201261593094 P;;US 201261697059 P,2012-01-31,"Injectable, Biodegradable Bone Cements and Methods of Making and Using Same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/059-462-913-169-087,Patent Application,yes,4,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61C5/06;;A61K6/00;;A61K6/06;;A61K6/838;;A61K6/898;;A61L24/02,,3,2,030-769-470-569-850;;069-409-900-179-200,10.6028/jres.115.021;;pmc2966325;;21037803;;21658480;;10.1016/j.actbio.2011.05.022,"âIn Vivo Characteristics of Premixed Calcium Phosphate Cements When Implanted in Subcutaneous Tissues and Periodontal Bone Defects,â Sugawara, A., et al., Journal of Research of the National Institute of Standards and Technology 115(4): 277 - 290 (2010).;;Klammert, U., et al., ACTA Biomaterialia 7: 3469 - 3475 (available online 25 May 2011).;;Klammert, U., Acta Biomaterialia 6: 1529 - 1535 (available online 1 November 2009).",ACTIVE
238,EP,A4,EP 2809364 A4,151-057-494-103-870,2016-01-27,2016,EP 13742896 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME",,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/151-057-494-103-870,Search Report,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,6,5,047-429-543-031-258;;029-672-946-486-000;;039-728-693-835-008;;035-965-481-743-746;;014-083-988-968-980,21479638;;10.1007/s10856-011-4288-5;;11456064;;10.1016/s0142-9612(00)00413-0;;21856456;;10.1016/j.actbio.2011.08.005;;10.1002/9780470291351.ch6;;10.1016/s0142-9612(02)00153-9;;12194519,"AHMED H TOUNY ET AL: ""Hydrolysis of monetite/chitosan composites in Î+--MEM and SBF solutions"", JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, KLUWER ACADEMIC PUBLISHERS, BO, vol. 22, no. 5, 9 April 2011 (2011-04-09), pages 1101 - 1109, XP019910216, ISSN: 1573-4838, DOI: 10.1007/S10856-011-4288-5;;WANG X ET AL: ""Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 22, no. 16, 15 August 2001 (2001-08-15), pages 2247 - 2255, XP004247498, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(00)00413-0;;FALEH TAMIMI ET AL: ""Dicalcium phosphate cements: Brushite and monetite"", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 8, no. 2, 6 August 2011 (2011-08-06), pages 474 - 487, XP028123808, ISSN: 1742-7061, [retrieved on 20110812], DOI: 10.1016/J.ACTBIO.2011.08.005;;""Advances in Bioceramics and Biocomposites II, Ceramic Engineering and Science Proceedings, Volume 27, Issue 6"", 1 January 2007, JOHN WILEY & SONS, INC., Hoboken, NJ, USA, ISBN: 978-0-47-008056-6, article TARANG R. DESAI ET AL: ""A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair"", pages: 61 - 69, XP055160664, DOI: 10.1002/9780470291351.ch6;;WANG X ET AL: ""Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 23, no. 21, 1 November 2002 (2002-11-01), pages 4167 - 4176, XP004373428, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(02)00153-9;;See also references of WO 2013116457A1",ACTIVE
239,AU,A1,AU 2017/232233 A1,003-800-971-307-983,2017-10-12,2017,AU 2017/232233 A,2017-09-25,AU 2017/232233 A;;AU 2016/204525 A;;AU 2013/215158 A;;US 201261697059 P;;US 201261593094 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/003-800-971-307-983,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,ACTIVE
240,US,A1,US 2017/0140010 A1,010-516-466-848-194,2017-05-18,2017,US 201514942187 A,2015-11-16,US 201514942187 A,2015-11-16,Automatically Determining a Recommended Set of Actions from Operational Data,"Methods, systems, and computer program products for determining a recommended set of actions from operational data are provided herein. A computer-implemented method includes associating multiple action templates with a set of operational data corresponding to a query; selecting a first action template from the multiple action templates; identifying one or more attributes associated with the first action template; forming a first step of a resolution action in response to the query by populating the first action template with at least one of the attributes; repeating, based on the first step of the resolution action and the set of operational data, said selecting, said identifying, and said forming for at least a second action template to form a second step of the resolution action; and outputting the resolution action, wherein the resolution action comprises a fixed sequence of at least the first step and the second step.",IBM,AGARWAL SHIVALI;;AGGARWAL VISHALAKSH;;DASGUPTA GAARGI B;;EKAMBARAM VIJAY;;SRIDHARA GIRIPRASAD,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-11-10),https://lens.org/010-516-466-848-194,Patent Application,yes,0,2,2,2,0,G06F2203/04803;;G06F3/0484;;H04L41/5074;;H04L41/147;;G06Q10/0633;;G06F3/0484;;G06F16/248;;G06F16/2455;;H04L41/147;;G06Q10/0633;;G06F2203/04803;;H04L41/5074,G06F17/30;;G06F3/0484,,0,0,,,,INACTIVE
241,US,B1,US 11604735 B1,058-557-703-272-890,2023-03-14,2023,US 202117541028 A,2021-12-02,US 202117541028 A,2021-12-02,Host memory buffer (HMB) random cache access,"Aspects of a storage device are provided that allow a controller to leverage cache to minimize occurrence of HMB address overlaps between different HMB requests. The storage device may include a cache and a controller coupled to the cache. The controller may store in the cache, in response to a HMB read request, first data from a HMB at a first HMB address. The controller may also store in the cache, in response to an HMB write request, second data from the HMB at a second HMB address. The controller may refrain from processing subsequent HMB requests in response to an overlap of the first HMB address with an address range including the second HMB address, and the controller may resume processing the subsequent HMB requests after the first data is stored. As a result, turnaround time delays for HMB requests may be reduced and performance may be improved.",WESTERN DIGITAL TECH INC,SEGEV AMIR;;AGARWAL DINESH KUMAR;;SIVASANKARAN VIJAY;;EISENSTEIN NAVA;;JOURNO JONATHAN,WESTERN DIGITAL TECHNOLOGIES INC (2021-12-08),https://lens.org/058-557-703-272-890,Granted Patent,yes,2,2,1,1,0,G06F2212/214;;G06F2212/311;;G06F2212/466;;G06F2212/313;;G06F2212/284;;G06F2212/7201;;G06F12/1408;;G06F2212/402;;G06F2212/7203;;G06F12/0857;;G06F12/0871;;G06F12/0891;;G06F12/0888,G06F12/0888;;G06F12/0891,,0,0,,,,ACTIVE
242,WO,A1,WO 2017/062591 A1,153-724-732-721-041,2017-04-13,2017,US 2016/0055706 W,2016-10-06,US 201562238316 P,2015-10-07,"A BIOSENSOR DEVICE TO DETECT TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The SAM layer may include an anti-fouling agent. The transducer component includes an electrode (or set of electrodes that includes a working electrode) and microprocessor configured to screen noise and to pick up a detectable signal, such as impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;LIN BOREN,,https://lens.org/153-724-732-721-041,Patent Application,yes,5,3,2,2,0,A61B5/14546;;A61B5/14546;;A61B5/0537;;A61B5/0537;;A61B5/1477;;A61B5/1477;;A61B5/24;;A61B5/24;;A61B5/7435;;A61B5/7435;;A61B2562/0295;;A61B2562/0295;;A61B2562/046;;A61B2562/046,A61B5/1473;;A61B5/00;;A61B5/145,,1,1,032-775-163-648-78X,10.1021/ie503897h,"FEYZIZARNAGH ET AL.: ""Protein Sensing with Aptamer Immobilized on an Antifouling Binary Self-Assembled Monolayer"", INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, vol. 54, no. 16, 27 February 2015 (2015-02-27), pages 4072 - 7, XP055380186",PENDING
243,US,B2,US 10342893 B2,175-053-468-419-823,2019-07-09,2019,US 201314375927 A,2013-01-31,US 201314375927 A;;US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,THE UNIVERSITY OF TOLEDO (2014-08-15),https://lens.org/175-053-468-419-823,Granted Patent,yes,17,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61B17/88;;A61C5/62;;A61K6/00;;A61K6/06;;A61K6/838;;A61K6/898;;A61L24/02;;A61L24/08;;A61L27/32;;C23C30/00,,23,11,069-409-900-179-200;;035-965-481-743-746;;039-728-693-835-008;;014-083-988-968-980;;029-672-946-486-000;;008-200-392-173-530;;090-037-908-880-284;;133-808-222-567-147;;001-443-948-802-649;;057-431-756-854-819;;069-409-900-179-200,21658480;;10.1016/j.actbio.2011.05.022;;10.1002/9780470291351.ch6;;21856456;;10.1016/j.actbio.2011.08.005;;10.1016/s0142-9612(02)00153-9;;12194519;;11456064;;10.1016/s0142-9612(00)00413-0;;20972610;;10.1007/s10856-010-4168-4;;10.1016/j.msec.2007.10.058;;10.1016/0022-0248(81)90472-3;;21324383;;10.1016/j.actbio.2011.02.007;;10.1016/j.actbio.2009.10.021;;19837194;;21658480;;10.1016/j.actbio.2011.05.022,"“The Physical Properties of Magnesium Oxide,” available from http://livestrong.com/article/500557-the-physical-properties-ofmagnesium-oxide/, as accessed Feb. 24, 2017.;;Klammert, U., et al., Acta Biomaterialia 7: 3469-3475 (available online May 25, 2011).;;Klammert, U., Acta Biomaterialia 6: 1529-1535 (available online Nov. 1, 2009).;;Desai et al., “A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair”, Advances in Bioceramics and Biocomposites II, 2007, pp. 61-69.;;Tamimi et al., “Dicalcium Phosphate Cements: Brushite and Monetite”, Acta Biomaterialia, 2012, vol. 8, pp. 474-487.;;Touny et al., “Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions”, The Journal of Materials Science: Materials in Medicine, 2011, vol. 22, pp. 1101-1109.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024040 filed Jan. 31, 2013, dated Apr. 4, 2013.;;Wang et al., “Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements”, Biomaterials, 2002, vol. 23, pp. 4167-4176.;;Wang et al., “Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements”, Biomaterials, 2011, vol. 22, pp. 2247-2255.;;Australian Patent Examination Report No. 1, Application No. AU 2013215158 dated Nov. 25, 2015.;;Chinese 1st Office Action, Application No. CN 201380013370.2 dated Feb. 26, 2016.;;European Search Report, Application No. EP 13742896.7 dated Sep. 7, 2015.;;European Search Report, Application No. EP 13742896.7 dated Jan. 21, 2016.;;Australian Examination Report No. 1, Application No. AU 2016204525, dated Feb. 9, 2017.;;Borhan et al. “Evaluation of collodial silica suspension as efficient additive for improving physiochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement”, Journal of Material Science: Material Medicine, 2010, vol. 21, pp. 3171-3181.;;Jalota et al. “Using a synthetic body fluid (SBF) solution of 27 mM HCO3— to make bone subsitutes more osteointegrative,” Materials Science and Engineering C, 2008, pp. 129-140.;;Japanese Notifications of Reasons for Rejections, Application No. JP 2014-555693, dated Oct. 26, 2016.;;Boistelle et al., “Morphology, Habit and Growth of Newberyite Crystals (MgHPO4 3H2O)”, Journal of Crystal Growth, 1981, vol. 54, pp. 275-295.;;Tamimi et al., “Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions”, Acta Biomaterialia, 2011, vol. 7, pp. 2678-2685.;;Australian Examination Report No. 1, Application No. AU 2017232233, dated Aug. 9, 2018.;;Klammert et al., “Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement”, Acta Biomaterialia, 2010, vol. 6, pp. 1529-1535.;;Klammert et al., “In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model”, Acta Biomaterialia, 2011, vol. 7, pp. 3469-3475.;;Japanese Notification of Reasons for Rejection, Application No. JP2017-185831, dated Jul. 24, 2018.",ACTIVE
244,US,B2,US 10534788 B2,037-243-327-534-637,2020-01-14,2020,US 201514942187 A,2015-11-16,US 201514942187 A,2015-11-16,Automatically determining a recommended set of actions from operational data,"Methods, systems, and computer program products for determining a recommended set of actions from operational data are provided herein. A computer-implemented method includes associating multiple action templates with a set of operational data corresponding to a query; selecting a first action template from the multiple action templates; identifying one or more attributes associated with the first action template; forming a first step of a resolution action in response to the query by populating the first action template with at least one of the attributes; repeating, based on the first step of the resolution action and the set of operational data, said selecting, said identifying, and said forming for at least a second action template to form a second step of the resolution action; and outputting the resolution action, wherein the resolution action comprises a fixed sequence of at least the first step and the second step.",IBM,AGARWAL SHIVALI;;AGGARWAL VISHALAKSH;;DASGUPTA GAARGI B;;EKAMBARAM VIJAY;;SRIDHARA GIRIPRASAD,INTERNATIONAL BUSINESS MACHINES CORPORATION (2015-11-10),https://lens.org/037-243-327-534-637,Granted Patent,yes,5,3,2,2,0,G06F2203/04803;;G06F3/0484;;H04L41/5074;;H04L41/147;;G06Q10/0633;;G06F3/0484;;G06F16/248;;G06F16/2455;;H04L41/147;;G06Q10/0633;;G06F2203/04803;;H04L41/5074,G06F16/00;;G06F3/0484;;G06F16/2455;;G06F16/248,,11,5,039-562-928-994-453;;019-617-387-312-148;;120-695-214-222-114;;136-644-003-961-591;;006-077-013-780-477,10.1002/asi.21231;;10.1145/2063576.2063848;;10.1145/219717.219748;;10.3115/1608858.1608859;;10.1007/978-3-662-45391-9_39,"Jiang et al., CRCTOL: A semantic-based domain ontology learning system, Journal of the American Society for Information Science and Technology 61(1):150-168 ⋅ Jan. 2010.;;Potharaju et al., Juggling the Jigsaw: Towards Automated Problem Inference from Network Trouble Tickets, 10th USENIX Symposium on Networked Systems Design and Implementation (NSDI '13).;;Ausum Systems, https://www.ausum.net/about/what.cfm, 2012.;;Wikipedia, Never-Ending Language Learning (NELL), https://en.wikipedia.org/w/index.php?title=Never-Ending_Language_Learning&oldid=664595378, May 29, 2015.;;R. Potharaju, N. Jain, and C. Nita-Rotaru, “Juggling the jigsaw: Towards automated problem inference from network trouble tickets,” in Presented as part of the 10th USENIX Symposium on Networked Systems Design and Implementation (NSDI 13), 2013, pp. 127-141.;;D. Majumdar, R. Catherine, S. Ikbal, and K. Visweswariah, “Privacy protected knowledge management in services with emphasis on quality data,” in Proceedings of the 20th ACM International Conference on Information and Knowledge Management, ser. CIKM '11, 2011, pp. 1889-1894.;;G. A. Miller, “Wordnet: A lexical database for English,” Communications of the ACM vol. 38, No. 11: 39-41., vol. 38, No. 11, 1995.;;Word2vec, https://code.google.com/p/word2vec/.;;M.-C. de Marneffe and C. D. Manning, “The stanford typed dependencies representation,” in Coling 2008: Proceedings of the Workshop on Cross-Framework and Cross-Domain Parser Evaluation, ser. CrossParser '08, 2008, pp. 1-8.;;R. Agrawal and R. Srikant, “Fast algorithms for mining association rules in large databases,” in Proceedings of the 20th International Conference on Very Large Data Bases, ser. VLDB '94, 1994, pp. 487-499.;;Dasgupta et al., “Towards auto-remediation in services delivery: Context-based classification of noisy and unstructured tickets,” in Service-Oriented Computing—12th International Conference, ICSOC 2014, Paris, France, Nov. 3-6, 2014. Proceedings, 2014, pp. 478-485.",INACTIVE
245,EP,B1,EP 2809364 B1,013-541-098-488-095,2017-11-01,2017,EP 13742896 A,2013-01-31,US 201261593094 P;;US 201261697059 P;;US 2013/0024040 W,2012-01-31,"INJECTABLE, BIODEGRADABLE BONE CEMENTS AND METHODS OF MAKING AND USING SAME",,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K,,https://lens.org/013-541-098-488-095,Granted Patent,yes,2,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,7,0,,,"AHMED H TOUNY ET AL: ""Hydrolysis of monetite/chitosan composites in Î+--MEM and SBF solutions"", JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, KLUWER ACADEMIC PUBLISHERS, BO, vol. 22, no. 5, 9 April 2011 (2011-04-09), pages 1101-1109, XP019910216, ISSN: 1573-4838, DOI: 10.1007/S10856-011-4288-5;;WANG X ET AL: ""Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 22, no. 16, 15 August 2001 (2001-08-15), pages 2247-2255, XP004247498, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(00)00413-0;;FALEH TAMIMI ET AL: ""Dicalcium phosphate cements: Brushite and monetite"", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 8, no. 2, 6 August 2011 (2011-08-06), pages 474-487, XP028123808, ISSN: 1742-7061, DOI: 10.1016/J.ACTBIO.2011.08.005 [retrieved on 2011-08-12];;Tarang R. Desai ET AL: ""A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair"" In: ""Advances in Bioceramics and Biocomposites II, Ceramic Engineering and Science Proceedings, Volume 27, Issue 6"", 1 January 2007 (2007-01-01), John Wiley & Sons, Inc., Hoboken, NJ, USA, XP055160664, ISBN: 978-0-47-008056-6 pages 61-69, DOI: 10.1002/9780470291351.ch6, * the whole document *;;WANG X ET AL: ""Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 23, no. 21, 1 November 2002 (2002-11-01), pages 4167-4176, XP004373428, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(02)00153-9;;TOUNY ET AL.: 'Hydrolysis of Monetite/Chitosan Composites in a-MEM and SBF Solutions' J. MATER SCI: MATER MED vol. 22, no. 5, 2011, pages 1101 - 1109, XP019910216;;DESAI ET AL.: 'A Self-Setting, Monetite (CaHP04) Cement for Skeletal Repair' ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES II 2007, pages 61 - 69, XP055160664",ACTIVE
246,EP,A4,EP 1618457 A4,036-773-705-304-073,2007-02-07,2007,EP 04760286 A,2004-04-19,US 2004/0012126 W;;US 42379403 A,2003-04-25,HIERARCHICAL SERVICE MANAGEMENT SYSTEM,,IPOLICY NETWORKS INC,PAREKH PANKAJ;;GUPTA SANDEEP;;MAMTANI VIJAY;;JAIN ATUL;;AGARWAL SANJAY KUMAR,,https://lens.org/036-773-705-304-073,Search Report,no,0,0,7,7,0,G06Q30/02;;G06Q30/02,G06F15/16;;G06F/;;G06F7/00;;G06F21/00;;G06F21/60;;G06F21/62;;G06Q30/02,,1,0,,,No Search,DISCONTINUED
247,US,B2,US 10064972 B2,051-732-429-061-476,2018-09-04,2018,US 14375927,2013-01-31,,,"Injectable, biodegradable bone cements and methods of making and using same","Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.",The University of Toledo,Sarit B. Bhaduri;;Huan Zhou;;Anand K. Agarwal;;Vijay K. Goel,,https://lens.org/051-732-429-061-476,Granted Patent,yes,9,0,1,1,0,A61L24/0063;;A61B17/8805;;A61C5/062;;A61K6/0082;;A61K6/0643;;A61K6/097;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0042;;A61L24/0084;;A61L24/02;;A61L24/08;;A61L27/32;;C23C30/005;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12,A61L24/00;;A61L24/08;;A61C5/06;;A61K6/00;;A61K6/06;;A61K6/097;;A61L24/02;;A61L27/32;;A61B17/88;;C23C30/00,,19,0,,,"“The Physical Properties of Magnesium Oxide,” available from http://livestrong.com/article/500557-the-physical-properties-ofmagnesium-oxide/, as accessed Feb. 24, 2017.;;Klammert, U., et al., Acta Biomaterialia 7: 3469-3475 (available online May 25, 2011).;;Klammert, U., Acta Biomaterialia 6: 1529-1535 (available online Nov. 1, 2009).;;Desai et al., “A Self-Setting, Monetite (CaHPO4) Cement for Skeletal Repair”, Advances in Bioceramics and Biocomposites II, 2007, pp. 61-69.;;Tamimi et al., “Dicalcium Phosphate Cements: Brushite and Monetite”, Acta Biomaterialia, 2012, vol. 8, pp. 474-487.;;Touny et al., “Hydrolysis of monetite/chitosan composites in α-MEM and SBF solutions”, The Journal of Materials Science: Materials in Medicine, 2011, vol. 22, pp. 1101-1109.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2013/024040 filed Jan. 31, 2013, dated Apr. 4, 2013.;;Wang et al., “Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements”, Biomaterials, 2002, vol. 23, pp. 4167-4176.;;Wang et al., “Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements”, Biomaterials, 2011, vol. 22, pp. 2247-2255.;;Australian Patent Examination Report No. 1, Application No. AU 2013215158 dated Nov. 25, 2015.;;Chinese 1st Office Action, Application No. CN 201380013370.2 dated Feb. 26, 2016.;;European Search Report, Application No. EP 13742896.7 dated Sep. 7, 2015.;;European Search Report, Application No. EP 13742896.7 dated Jan. 21, 2016.;;Australian Examination Report No. 1, Application No. AU 2016204525, dated Feb. 9, 2017.;;Borhan et al. “Evaluation of collodial silica suspension as efficient additive for improving physiochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement”, Journal of Material Science: Material Medicine, 2010, vol. 21, pp. 3171-3181.;;Jalota et al. “Using a synthetic body fluid (SBF) solution of 27 mM HCO3— to make bone subsitutes more osteointegrative,” Materials Science and Engineering C, 2008, pp. 129-140.;;Japanese Notifications of Reasons for Rejections, Application No. JP 2014-555693, dated Oct. 26, 2016.;;Boistelle et al., “Morphology, Habit and Growth of Newberyite Crystals (MgHPO4 3H2O)”, Journal of Crystal Growth, 1981, vol. 54, pp. 275-295.;;Tamimi et al., “Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions”, Acta Biomaterialia, 2011, vol. 7, pp. 2678-2685.",UNKNOWN
248,EP,A2,EP 1728513 A2,122-143-385-191-356,2006-12-06,2006,EP 06252644 A,2006-05-19,IN 608CH2005 A;;US 71878905 P,2005-05-20,Stable desloratadine compositions,"The present invention relates to stable pharmaceutical compositions of desloratadine comprising desloratadine in combination with a desloratadine-stabilizing amount of at least one amino acid.
",REDDYS LAB INC DR,AGARWAL SUDEEP KUMAR;;ALAGARSAMY ALAGUMURUGAN;;NASARE VIJAY DINANATHJI;;MOHAN MAILATUR SIVARAMAN,,https://lens.org/122-143-385-191-356,Patent Application,yes,0,7,3,4,0,A61K45/06;;A61K31/185;;A61K31/198;;A61K31/445;;A61K31/4545,A61K31/4545;;A61K31/185;;A61K31/198;;A61K31/445;;A61K45/06,,0,0,,,,DISCONTINUED
249,JP,A,JP 2020022773 A,177-233-876-843-86X,2020-02-13,2020,JP 2019185865 A,2019-10-09,JP 2017185831 A;;US 201261593094 P;;US 201261697059 P,2012-01-31,"BIODEGRADABLE BONE CEMENT FOR INJECTION, AND METHOD FOR MANUFACTURING AND USING THE SAME","To provide a composition of a bone cement of alkali earth phosphate easily manufactured and having improved strength, mechanical properties and bioactivities, a method for manufacturing the same, and a method for using the same.SOLUTION: A bone cement composition contains a powder containing a base source of calcium, magnesium, or strontium, a solidified solution containing HPOand a buffer, and a biocompatible polymer taken into the solidification solution. The powder and the solidification solution are mixed to produce a bone cement paste, which produces a dried powder by (a) solidification to a cured film, or (b) irradiation of an electromagnetic radiation, and then the dried powder is mixed with a second solidification solution, and generates radiation auxiliary bone cement which is solidified to a cured mass.SELECTED DRAWING: Figure 1",UNIV TOLEDO,SARIT B BHADURI;;ZHOU HUAN;;ANAND K AGARWAL;;VIJAY K GOEL,,https://lens.org/177-233-876-843-86X,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/08;;A61K6/838;;A61K6/898;;A61L24/00;;A61L24/02;;A61L24/10;;A61L27/12;;A61L27/14;;A61L27/20;;A61L27/22;;A61L27/44;;A61L27/50;;A61L27/54,,0,0,,,,ACTIVE
250,WO,A3,WO 2004/097556 A3,078-213-587-005-993,2006-07-20,2006,US 2004/0012126 W,2004-04-19,US 42379403 A,2003-04-25,HIERARCHICAL SERVICE MANAGEMENT SYSTEM,"The present invention provides a system, method and computer program product for managing customers in a hierarchical manner. The customer hierarchy comprises a root service provider (RSP), tiered service providers (TSPs) and end customers. The present invention enables the governing of the customers by a large service provider by providing an ability to make smaller service providers as customers and managing their resources. The smaller service provider, in turn, can have its own customers. The smaller service provider governs these customers without interference from the service providers above it in the hierarchy. The customers are governed by policies. A policy is a set of rules laid down by the service provider to control the customers. The present invention also enables the service provider to implement different policies on different customers and change the policy for a customer without affecting other customers.",IPOLICY NETWORKS INC,PAREKH PANKAJ;;GUPTA SANDEEP;;MAMTANI VIJAY;;JAIN ATUL;;AGARWAL SANJAY KUMAR,,https://lens.org/078-213-587-005-993,Search Report,yes,4,0,7,7,0,G06Q30/02;;G06Q30/02,G06F15/16;;G06F/;;G06F7/00;;G06F21/00;;G06F21/60;;G06F21/62;;G06Q30/02,,0,0,,,,PENDING
251,US,A1,US 2010/0158201 A1,097-632-110-684-55X,2010-06-24,2010,US 62499609 A,2009-11-24,US 62499609 A;;US 11754508 P,2008-11-24,"SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR PROVIDING TOLL-FREE SERVICE IN A TELECOMMUNICATIONS NETWORK","Methods, systems, and computer program products for providing toll-free service in a telecommunications network are disclosed. According to one aspect, the subject matter described herein includes a method for providing toll-free service in a telecommunications network. The method includes, at a signaling node that includes at least one processor: receiving a first signaling message that includes a toll-free called party number, where the first signaling message is one of a non-TCAP call setup message, a mobility management query, a number portability (NP) query, and an E.164 number (ENUM) query; determining a directory number associated with the toll-free called party number; and sending the first signaling message or a second signaling message, the sent message including at least one of the directory number and routing information associated with the directory number.",VIJAY MARATHE ROHINI;;AGARWAL DEVESH;;RAO RAGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,VIJAY MARATHE ROHINI;;AGARWAL DEVESH;;RAO RAGHAVENDRA GOPALA;;MARSICO PETER JOSEPH,TEKELEC GLOBAL INC (2010-01-04),https://lens.org/097-632-110-684-55X,Patent Application,yes,44,54,4,4,0,H04M3/42306;;H04M15/00;;H04M15/08;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M2215/62;;H04Q3/0025;;H04Q3/005;;H04M3/42306;;H04Q3/005;;H04M15/63;;H04M15/8292;;H04M2207/12;;H04M15/00;;H04M2215/62;;H04M15/08;;H04Q3/0025,H04M15/12,379/36,0,0,,,,ACTIVE
252,BR,A8,BR 112014018834 A8,047-933-149-168-232,2017-07-11,2017,BR 112014018834 A,2013-01-31,US 2013/0024040 W;;US 201261697059 P;;US 201261593094 P,2012-01-31,"COMPOSIÇÃO DE CIMENTO ÓSSEO, MÉTODO PARA FAZER UM CIMENTO ÓSSEO, ENTREGAR UMA DROGA A UM SUJEITO QUE NECESSITA DA MESMA, AUMENTAR A BIOCOMPATIBILIDADE DE IMPLANTES DE TITÂNIO, AUMENTAR A FORÇA DE UM CIMENTO DE SULFATO DE CÁLCIO DESIDRATADO, TRATAR UM LOCAL ANATÔMICO VISADO COM UMA COMPOSIÇÃO BIODEGRADÁVEL, TRATAR UM SUJEITO, EMPREENDER UM TRATAMENTO ORTOPÉDICO OU DENTÁRIO, AUMENTAR, SUBSTITUIR, OU TRATAR VÉRTEBRAS ENFRAQUECIDAS OU DANIFICADAS, PREENCHER UM DEFEITO EM UM DENTE, PREPARAR UM DEFEITO NO OSSO CRÂNIO-MAXILO-FACIAL, KIT PARA PREPARAR UMA PASTA DE CIMENTO ÓSSEO INJETÁVEL, SERINGA E OSSO NÃO HUMANO","COMPOSIÇÃO DE CIMENTO ÓSSEO, MÉTODO PARA FAZER UM CIMENTO ÓSSEO, ENTREGAR UMA DROGA A UM SUJEITO QUE NECESSITA DA MESMA, AUMENTAR A BIOCOMPATIBILIDADE DE IMPLANTES DE TITÂNIO, AUMENTAR A FORÇA DE UM CIMENTO DE SULFATO DE CÁLCIO DESIDRATADO, PREENCHER UM DEFEITO EM UM DENTE, REPARAR UM DEFEITO NO OSSO CRÂNIO-MAXILOFACIAL, KIT PARA PREPARAR UMA PASTA DE CIMENTO ÓSSEO INJETÁVEL, SERINGA E OSSO NÃO HUMANO. Composições, métodos para fazer e métodos para usar cimentos ósseos de fosfatos alcalino terrosos são divulgados.",UNIV TOLEDO,SARIT B BHADURI;;HUAN ZHOU;;ANAND K AGARWAL;;VIJAY K GOEL,,https://lens.org/047-933-149-168-232,Patent Application,no,0,0,34,34,0,A61B17/8825;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L24/0084;;A61L27/32;;A61L2400/06;;A61L2420/04;;A61L2430/02;;A61L2430/12;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61L24/0084;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0042;;A61L24/02;;A61L24/0063;;A61L24/08;;A61L24/0015;;A61L24/0021;;A61L24/0036;;A61L2400/06;;A61L2430/02;;A61L27/32;;A61L2420/04;;A61L2430/12;;A61K6/74;;A61K6/864;;A61K6/898;;A61L24/0084;;A61B17/8805;;C23C30/005;;A61C5/62;;C08L5/08,A61L24/00;;A61K6/838;;A61K6/898,,0,0,,,,DISCONTINUED
253,US,A1,US 2004/0215630 A1,069-338-086-053-674,2004-10-28,2004,US 42379403 A,2003-04-25,US 42379403 A,2003-04-25,Hierarchical service management system,"
   The present invention provides a system, method and computer program product for managing customers in a hierarchical manner. The customer hierarchy comprises a root service provider (RSP), tiered service providers (TSPs) and end customers. The present invention enables the governing of the customers by a large service provider by providing an ability to make smaller service providers as customers and managing their resources. The smaller service provider, in turn, can have its own customers. The smaller service provider governs these customers without interference from the service providers above it in the hierarchy. The customers are governed by policies. A policy is a set of rules laid down by the service provider to control the customers. The present invention also enables the service provider to implement different policies on different customers and change the policy for a customer without affecting other customers. 
",IPOLICY NETWORKS INC,PAREKH PANKAJ;;GUPTA SANDEEP;;MAMTANI VIJAY;;JAIN ATUL;;AGARWAL SANJAY KUMAR,IPOLICY NETWORKS INC (2003-04-20),https://lens.org/069-338-086-053-674,Patent Application,yes,9,21,7,7,0,G06Q30/02;;G06Q30/02,G06F/;;G06F7/00;;G06F21/00;;G06F21/60;;G06F21/62;;G06Q30/02,7071,0,0,,,,DISCONTINUED
254,US,A1,US 2023/0262641 A1,025-091-366-240-847,2023-08-17,2023,US 202217670376 A,2022-02-11,US 202217670376 A,2022-02-11,Event Triggered Network Migration of Subscribers,"A method includes receiving, by an equipment identity register application in the target mobile network, an International Mobile Equipment Identity (IMEI) of a user equipment (UE) associated with the subscriber and a Subscriber Identity Module (SIM) identifier (ID) identifying an inactive SIM card inserted into the UE or an inactive electronic SIM (eSIM) profile installed at the UE, determining that the UE is attempting to attach to the target mobile network for a first time based on the IMEI and the SIM ID, adding an event to an event queue of the target mobile network, and processing the event by accessing subscriber data stored at the source mobile network to validate that the IMEI of the UE is indicated in the subscriber data stored at the source mobile network, wherein the subscriber data includes a subscriber account indicated by the IMEI of the UE.",T MOBILE INNOVATIONS LLC,AGARWAL MUKESH;;DREILING RYAN P;;UEHLING PHILIP WARREN;;YELMAT VIJAY BHANU REDDY,T-MOBILE INNOVATIONS LLC (2022-02-10),https://lens.org/025-091-366-240-847,Patent Application,yes,6,0,3,3,0,H04W8/18;;H04W8/205;;H04W4/50;;H04M15/49;;H04M15/887;;H04W8/265;;H04W60/04,H04W60/04;;H04M15/00;;H04W4/50;;H04W8/26,,0,0,,,,ACTIVE
255,US,A1,US 2016/0307210 A1,173-949-068-197-271,2016-10-20,2016,US 201514690321 A,2015-04-17,US 201514690321 A,2015-04-17,Recommending User Actions Based on Collective Intelligence for a Multi-Tenant Data Analysis System,"A multi-tenant system stores data for customers. The multi-tenant system presents user interfaces allowing users associated with the customers to perform analysis of data stored for the customer. The multi-tenant system determines recommendations for subsequent user actions that can be performed by a user in a context. The context includes a report being analyzed, a type of visualization of the report, one or more interactions performed by the user with the report, and so on. The multi-tenant system presents one or more widgets based on the recommendations that allow the user to perform the recommended action. The multi-tenant system may determine a recommendation based on past interactions of a subset of users of the multi-tenant system, for example, users associated with a type of industry, users having a particular role in an organization, or a level of experience of the user with analysis of data.",GOODDATA CORP,AGARWAL GAURAV VIJAY;;VLCEK JAN;;CHRISTIE-BLICK WINSTON;;STENCL MICHAEL;;MATULA MARTIN,GOODDATA CORPORATION (2015-04-17),https://lens.org/173-949-068-197-271,Patent Application,yes,0,42,3,3,0,G06Q30/0201;;G06Q30/0201;;G06F3/0484;;G06F16/24578;;G06F16/24578;;G06Q10/06316;;G06Q10/06316,G06Q30/02;;G06F3/0484;;G06F17/30,,0,0,,,,ACTIVE
256,EP,A1,EP 4107779 A1,072-882-769-916-106,2022-12-28,2022,EP 20848821 A,2020-12-29,US 202016792560 A;;US 2020/0067322 W,2020-02-17,MULTI-CHIP STACKED DEVICES,,XILINX INC,KANDALA ANIL KUMAR;;KOGANTI VIJAY KUMAR;;YACHARENI SANTOSH;;AGARWAL SUNDEEP RAM GOPAL,,https://lens.org/072-882-769-916-106,Patent Application,yes,0,0,6,6,0,H01L25/0657;;H01L2225/06541;;H01L2225/06544;;H03K19/177;;H01L25/50;;H01L2224/08145;;H01L25/0657;;H01L24/07;;H01L2225/06544;;H01L2225/06527;;H01L2225/06524;;H01L2224/08123;;H01L2224/08145;;H01L23/481;;H01L25/0657,H01L25/065,,0,0,,,,PENDING
257,US,A1,US 2019/0114695 A1,180-541-246-027-609,2019-04-18,2019,US 201715786667 A,2017-10-18,US 201715786667 A,2017-10-18,CONSUMER SAMPLING WEBPAGE LINKED WITH DIGITAL WALLET,"A system and method for enabling a consumer to virtually sample and purchase a product while shopping on-line are provided. In accordance with embodiments of the present invention, a system and method provide an improved and streamlined holistic on-line shopping experience which includes providing a sampling webpage linked to a consumer's digital wallet to allow for sampling for a product and purchase thereof.",MASTERCARD INTERNATIONAL INC,CHANDORKAR PRIYANKA;;PANDEY PRIYANKA;;MATKAR ANKITA AGARWAL;;WALIA ANKIT;;GOYAL VIJAY KUMAR,MASTERCARD INTERNATIONAL INCORPORATED (2017-10-13),https://lens.org/180-541-246-027-609,Patent Application,yes,5,1,2,2,0,G06Q30/0641;;G06Q30/0641;;G06Q20/204;;G06Q20/204;;G06Q20/322;;G06Q20/322;;G06Q20/36;;G06Q20/36;;G06Q20/367;;G06Q20/367;;G06Q30/0643;;G06Q30/0643,G06Q30/06;;G06Q20/36;;G06T19/00,,0,0,,,,ACTIVE
258,US,B2,US 10796359 B2,141-861-498-183-286,2020-10-06,2020,US 201715786667 A,2017-10-18,US 201715786667 A,2017-10-18,Consumer sampling webpage linked with digital wallet,"A system and method for enabling a consumer to virtually sample and purchase a product while shopping on-line are provided. In accordance with embodiments of the present invention, a system and method provide an improved and streamlined holistic on-line shopping experience which includes providing a sampling webpage linked to a consumer's digital wallet to allow for sampling for a product and purchase thereof.",MASTERCARD INTERNATIONAL INC,CHANDORKAR PRIYANKA;;PANDEY PRIYANKA;;MATKAR ANKITA AGARWAL;;WALIA ANKIT;;GOYAL VIJAY KUMAR,MASTERCARD INTERNATIONAL INCORPORATED (2017-10-13),https://lens.org/141-861-498-183-286,Granted Patent,yes,5,0,2,2,0,G06Q30/0641;;G06Q30/0641;;G06Q20/204;;G06Q20/204;;G06Q20/322;;G06Q20/322;;G06Q20/36;;G06Q20/36;;G06Q20/367;;G06Q20/367;;G06Q30/0643;;G06Q30/0643,G06Q30/00;;G06Q20/20;;G06Q20/32;;G06Q20/36;;G06Q30/06,,1,0,,,"Jennifer, L. S. (2016). 5 digital retail trends that will be big in 2017. CIO, , n/a. Retrieved from https://dialog.proquest.com/professional/docview/1851043547?accountid=131444.",ACTIVE
259,WO,A1,WO 2021/183861 A1,186-854-735-323-885,2021-09-16,2021,US 2021/0022073 W,2021-03-12,US 202062988489 P,2020-03-12,METHOD FOR TREATMENT AND PROPHYLAXIS OF CRS IN PATIENTS COMPRISING A COMBINATION OF BISPECIFC ANTIBODIES BINDING TO CDS X CANCER CELL AND TNFALPHA OR IL-6 INHIBITOR,"The present invention relates to medical combination products comprising (i) at least one antibody construct comprising at least one domain which binds to a target antigen expressed on the surface of a cell and at least one other domain which binds to CD3 as well as (ii) at least one molecule that is inhibitor / antagonist of TNF/ TNFR reducing TNF/TNFR signaling and/or an inhibitor / antagonist of IL6/IL6R that reduces IL6/IL6R signaling, wherein a first dose of said inhibitor / antagonist is administered before administration of a first dose of said antibody construct. Furthermore, the invention provides therapeutic and preventive methods and medical uses of said combination products, as well as a kit comprising said at least one antibody construct and at least one antagonist / inhibitor of TNF or IL6 or its cognate receptor, wherein the interaction of said antagonist / inhibitor of TNF or an inhibitor / antagonist of IL6 with its cognate receptor reduces, mitigates, prevents, or treats cytokine release syndrome.",AMGEN INC,KHALDOYANIDI SOPHIA;;NAGORSEN DIRK;;ARVEDSON TARA;;AGARWAL SURESH;;UPRETI VIJAY;;YEA STEVEN,,https://lens.org/186-854-735-323-885,Patent Application,yes,141,1,4,4,1295,A61K2039/507;;C07K16/241;;C07K16/2809;;C07K16/2803;;C07K2317/31;;C07K2319/30;;A61P35/02;;A61K39/39558;;C07K16/30;;C07K16/248;;C07K2317/622;;C07K16/2863;;A61K31/573;;C07K16/3069;;C07K2317/30;;A61K45/06;;C07K14/7151;;C07K14/7155;;A61P35/00;;A61K38/1793;;A61K39/3955;;A61K45/06,C07K16/24;;A61K31/573;;A61K39/395;;A61P35/02;;C07K14/715;;C07K16/28;;C07K16/30,,67,49,049-928-468-792-434;;103-209-762-841-861;;039-823-493-863-720;;049-496-587-620-962;;006-817-615-112-362;;121-058-557-078-913;;049-928-468-792-434;;026-523-334-676-622;;175-994-733-981-759;;057-746-919-975-823;;049-927-605-642-877;;045-500-830-356-334;;105-713-717-461-195;;024-995-475-936-443;;020-026-345-586-213;;023-676-781-371-861;;053-739-294-997-262;;034-194-558-494-591;;034-331-211-704-877;;020-855-322-534-259;;085-277-440-303-853;;092-023-577-402-127;;083-771-782-040-353;;030-607-398-087-475;;055-933-943-437-663;;039-508-259-975-855;;021-641-900-032-887;;006-574-964-805-278;;162-646-650-680-173;;005-648-278-768-326;;016-219-576-017-946;;033-688-911-017-272;;028-287-909-016-889;;049-134-753-209-354;;049-134-753-209-354;;002-264-966-090-625;;027-865-728-112-439;;071-327-269-597-517;;042-064-861-703-426;;141-031-108-222-217;;043-968-156-521-588;;043-764-182-700-219;;022-385-630-807-414;;048-275-064-395-510;;059-212-558-154-670;;005-405-010-898-254;;039-141-300-950-038;;115-435-737-255-802;;010-670-795-970-321,31484792;;10.1126/scitranslmed.aax8861;;10.1007/s11912-019-0753-y;;30666425;;10.1089/scd.1.1995.4.433;;8581381;;10.3389/fonc.2014.00063;;pmc3978294;;24744989;;30880998;;10.2147/tcrm.s150524;;pmc6400118;;17493863;;10.1016/j.cytogfr.2007.04.002;;31484792;;10.1126/scitranslmed.aax8861;;10.1073/pnas.96.25.14523;;pmc24469;;10588738;;pmc19171;;9465086;;10.1073/pnas.95.4.1735;;2449118;;8756376;;10.1002/(sici)1097-0142(19960815)78:4<809::aid-cncr18>3.0.co;2-z;;10.1007/978-3-642-01147-4;;10.1017/cbo9780511596773;;10.1038/342877a0;;2687698;;25291284;;10.1016/0167-5699(83)90123-8;;10.1126/science.3929380;;3929380;;9057057;;10.3233/hab-1996-7302;;7602141;;10.1016/0022-1759(95)00018-6;;10.1038/352624a0;;1907718;;1748994;;10.1016/0022-2836(91)90498-u;;10.1038/ng0594-13;;8075633;;1404388;;10.1016/0022-2836(92)90223-7;;10.1021/bi00109a004;;1932005;;pmc392030;;10.1073/pnas.81.21.6851;;6436822;;10.1038/314452a0;;3920533;;7779254;;10.1016/0167-5699(95)80166-9;;pmc394555;;7556106;;10.1002/j.1460-2075.1995.tb00142.x;;10.1038/321522a0;;3713831;;10.1016/0959-440x(92)90091-k;;10.1073/pnas.80.23.7308;;6316357;;pmc390044;;10.1038/ng0297-146;;9020839;;pmc2212477;;10.1084/jem.188.3.483;;9687526;;10.1016/s1367-5931(00)00206-4;;11479122;;10.1016/0022-2836(87)90412-8;;3681981;;10.1016/0022-2836(87)90412-8;;3681981;;10.1073/pnas.85.16.5879;;3045807;;pmc281868;;7821762;;10.1096/fasebj.9.1.7821762;;1731188;;10.1016/0161-5890(92)90152-n;;11160301;;10.4049/jimmunol.166.4.2420;;10.4049/jimmunol.158.8.3965;;9103467;;pmc41463;;7624362;;10.1073/pnas.92.15.7021;;10.1007/s002620050431;;9435872;;10.1182/blood.v95.6.2098;;10706880;;10512714;;10.1006/jmbi.1999.3156;;10.1016/j.tibtech.2004.03.006;;10.1016/s0167-7799(04)00080-0;;15109810;;8114766;;10.1016/0161-5890(94)90001-9;;0007018830;;7018830;;10.1016/0003-2697(81)90168-8;;6175244;;2439875;;10.1016/0076-6879(87)38030-9,"LI JI ET AL: ""CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity"", SCIENCE TRANSLATIONAL MEDICINE, vol. 11, no. 508, 4 September 2019 (2019-09-04), US, pages eaax8861, XP055786539, ISSN: 1946-6234, Retrieved from the Internet <URL:https://stm.sciencemag.org/content/scitransmed/11/508/eaax8861.full.pdf> DOI: 10.1126/scitranslmed.aax8861;;ALDOSS IBRAHIM ET AL: ""Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment"", CURRENT ONCOLOGY REPORTS, CURRENT SCIENCE, GB, vol. 21, no. 1, 21 January 2019 (2019-01-21), XP037137674, ISSN: 1523-3790, [retrieved on 20190121], DOI: 10.1007/S11912-019-0753-Y;;GAST DE G C ET AL: ""CLINICAL EXPERIENCE WITH CD3 x CD19 BISPECIFIC ANTIBODIES IN PATIENTS WITH B CELL MALIGNANCIES"", JOURNAL OF HEMATOTHERAPY, NEW YORK, NY, US, vol. 4, no. 5, 1 January 1995 (1995-01-01), pages 433 - 437, XP009055817;;LINDSEY M. HOFFMAN ET AL: ""Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTEÂ Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications"", FRONTIERS IN ONCOLOGY, vol. 4, 31 March 2014 (2014-03-31), XP055548630, DOI: 10.3389/fonc.2014.00063;;KLINGER ET AL., IMMUNOL REVIEWS, 2016;;SHIMABUKURO-VORNHAGEN ET AL., J. IMMUNOTHER CANCER, vol. 6, 2018, pages 56;;RIEGLER ET AL., THERAPEUTICS AND CLINICAL RISK MANAGEMENT, vol. 15, 2019, pages 323 - 335;;BORREGA ET AL., HEMASPHERE, vol. 3, no. 2, 2019, pages e 19;;I.A. CLARK, CYTOKINE & GROWTH FACTOR REVIEWS, vol. 18, 2007, pages 335 - 343;;LI ET AL., SCI TRANSL MED, vol. 11, 2019, pages eaax8861;;COLIGANKRUISBEEKMARGULIESSHEVACHSTROBER: ""Current Protocols in Immunology"", 2002, WILEY-INTERSCIENCE;;HUBERT ET AL., PNAS, vol. 96, 1999, pages 14523 - 14528;;REITER ET AL., PROC. NAT. ACAD. SCI., vol. 95, 1998, pages 1735 - 1740;;ISRAELI ET AL., CANCER RES, vol. 53, 1993;;HOROSZEWICZ ET AL., ANTICANCER RES, vol. 7, 1987, pages 927 - 35;;O'KEEFE ET AL., BIOCHEM. BIOPHYS. ACTA, vol. 1443, no. 1, 1998, pages 13 - 127;;MURPHY ET AL., CANCER, vol. 78, 1996, pages 809 - 818;;REICHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329;;KONTERMANNDIIBEL: ""Antibody Engineering"", 2010, SPRINGER;;LITTLE: ""Recombinant Antibodies for Immunotherapy"", 2009, CAMBRIDGE UNIVERSITY PRESS;;CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877 - 546;;KOEHLER ET AL., NATURE, vol. 256, 1975, pages 495;;KOZBOR ET AL., IMMUNOLOGY TODAY, vol. 4, 1983, pages 7279;;MORRISON, SCIENCE, vol. 229, 1985, pages 1202 - 1207;;SCHIER, HUMAN ANTIBODIES HYBRIDOMAS, vol. 7, 1996, pages 97 - 105;;MALMBORG, J. IMMUNOL. METHODS, vol. 183, 1995, pages 7 - 13;;CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628;;MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597;;GREEN ET AL., NATURE GENETICS, vol. 7, 1994, pages 13 - 21;;TOMLINSON ET AL., J. MOL. BIOL., vol. 227, 1992, pages 776 - 798;;LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837;;MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 6855;;MORRISON ET AL., PROC. NATL. ACAD. SCL U.S.A., vol. 81, 1985, pages 6851;;TAKEDA ET AL., NATURE, vol. 314, 1985, pages 452;;COOK, G.P. ET AL., IMMUNOL. TODAY, vol. 16, no. 5, 1995, pages 237 - 242;;TOMLINSON ET AL., EMBO J, vol. 14, no. 14, 1995, pages 4628 - 4638;;JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525;;PRESTA, CURR. OP. STRUCT. BIOL., vol. 2, 1992, pages 593 - 596;;OI ET AL., BIOTECHNIQUES, vol. 4, 1986, pages 214;;TENG ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 80, 1983, pages 7308 - 7312;;OLSSON ET AL., METH. ENZYMOL., vol. 92, 1982, pages 3 - 16;;MENDEZ ET AL., NATURE GENETICS, vol. 15, 1997, pages 146 - 156;;GREENJAKOBOVITS, J. EXP. MED., vol. 188, 1998, pages 483 - 495;;MORRISON KLWEISS GA, CURR OPIN CHEM BIOL, vol. 5, no. 3, June 2001 (2001-06-01), pages 302 - 7;;CHOTHIA ET AL., J. MOL. BIOL, vol. 196, 1987, pages 901 - 917;;MACCALLUM ET AL., J. MOL. BIOL, vol. 263, 1996, pages 800;;""Antibody Engineering Lab Manual"", SPRINGER-VERLAG, article ""Protein Sequence and Structure Analysis of Antibody Variable Domains"";;CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901;;HUSTON ET AL., PROC. NATL. ACAD. SCI USA, vol. 85, 1988, pages 5879 - 5883;;RAAGWHITLOW, FASEB, vol. 9, no. 1, 1995, pages 73 - 80;;DALL'ACQUA ET AL., BIOCHEM., vol. 37, 1998, pages 9266 - 9273;;CHEADLE ET AL., MOL IMMUNOL, vol. 29, 1992, pages 21 - 30;;BRUHL, IMMUNOL., vol. 166, 2001, pages 2420 - 2426;;MACK, J. IMMUNOL., vol. 158, 1997, pages 3965 - 3970;;MACK, PNAS, vol. 92, 1995, pages 7021 - 7025;;KUFER, CANCER IMMUNOL. IMMUNOTHER., vol. 45, 1997, pages 193 - 197;;LOFFLER, BLOOD, vol. 95, no. 6, 2000, pages 2098 - 2103;;KIPRIYANOV, J. MOL. BIOL., vol. 293, 1999, pages 41 - 56;;KUFER P ET AL., TRENDS IN BIOTECHNOLOGY, vol. 22, no. 5, 2004, pages 238 - 244;;HOLLINGERPHILIPP ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 90, no. 14, July 1993 (1993-07-01), pages 6444 - 8;;PADLAN, MOLECULAR IMMUNOLOGY, vol. 31, no. 3, 1993, pages 169 - 217;;T. E. CREIGHTON: ""Proteins: Structure and Molecular Properties"", 1983, W. H. FREEMAN & CO., pages: 79 - 86;;APLINWRISTON, CRC CRIT. REV. BIOCHEM., 1981, pages 259 - 306;;HAKIMUDDIN ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 259, 1987, pages 52;;EDGE ET AL., ANAL. BIOCHEM., vol. 118, 1981, pages 131;;THOTAKURA ET AL., METH. ENZYMOL., vol. 138, 1987, pages 350;;DUSKIN ET AL., J. BIOL. CHEM., vol. 257, 1982, pages 3105",PENDING
260,WO,A1,WO 2021/167698 A1,184-309-352-013-437,2021-08-26,2021,US 2020/0067322 W,2020-12-29,US 202016792560 A,2020-02-17,MULTI-CHIP STACKED DEVICES,"Examples described herein generally relate to multi-chip devices having stacked chips. In an example, a multi-chip device includes a chip stack that includes chips. Neighboring chips are connected to each other. Plural chips of the chips collectively include columns of broken via pillars and bridges. Each of the plural chips has a broken via pillar in each column. The broken via pillar has first and second continuous via pillar portions aligned in a direction normal to a side of a semiconductor substrate of the respective chip. The first continuous via pillar portion is not connected within the broken via pillar to the second continuous via pillar portion. Each of the plural chips has one or more of the bridges. Each bridge connects, within the respective chip, the first continuous via pillar portion in a column and the second continuous via pillar portion in another column.",XILINX INC,KANDALA ANIL KUMAR;;KOGANTI VIJAY KUMAR;;YACHARENI SANTOSH;;AGARWAL SUNDEEP RAM GOPAL,,https://lens.org/184-309-352-013-437,Patent Application,yes,4,0,6,6,0,H01L25/0657;;H01L2225/06541;;H01L2225/06544;;H03K19/177;;H01L25/50;;H01L2224/08145;;H01L25/0657;;H01L24/07;;H01L2225/06544;;H01L2225/06527;;H01L2225/06524;;H01L2224/08123;;H01L2224/08145;;H01L23/481;;H01L25/0657,H01L25/065,,0,0,,,,PENDING
261,WO,A1,WO 2016/168036 A1,032-717-712-383-556,2016-10-20,2016,US 2016/0026296 W,2016-04-07,US 201514690321 A,2015-04-17,RECOMMENDING USER ACTIONS BASED ON COLLECTIVE INTELLIGENCE FOR A MULTI-TENANT DATA ANALYSIS SYSTEM,"A multi-tenant system stores data for customers. The multi-tenant system presents user interfaces allowing users associated with the customers to perform analysis of data stored for the customer. The multi-tenant system determines recommendations for subsequent user actions that can be performed by a user in a context. The context includes a report being analyzed, a type of visualization of the report, one or more interactions performed by the user with the report, and so on. The multi-tenant system presents one or more widgets based on the recommendations that allow the user to perform the recommended action. The multi-tenant system may determine a recommendation based on past interactions of a subset of users of the multi-tenant system, for example, users associated with a type of industry, users having a particular role in an organization, or a level of experience of the user with analysis of data.",GOODDATA CORP,AGARWAL GAURAV VIJAY;;VLCEK JAN;;CHRISTIE-BLICK WINSTON;;STENCL MICHAEL;;MATULA MARTIN,,https://lens.org/032-717-712-383-556,Patent Application,yes,1,0,3,3,0,G06Q30/0201;;G06Q30/0201;;G06F3/0484;;G06F16/24578;;G06F16/24578;;G06Q10/06316;;G06Q10/06316,G06Q30/02;;G06F17/30,,0,0,,,,PENDING
262,US,B1,US 11004833 B1,056-472-519-467-713,2021-05-11,2021,US 202016792560 A,2020-02-17,US 202016792560 A,2020-02-17,Multi-chip stacked devices,"Examples described herein generally relate to multi-chip devices having stacked chips. In an example, a multi-chip device includes a chip stack that includes chips. Neighboring chips are connected to each other. Plural chips of the chips collectively include columns of broken via pillars and bridges. Each of the plural chips has a broken via pillar in each column. The broken via pillar has first and second continuous via pillar portions aligned in a direction normal to a side of a semiconductor substrate of the respective chip. The first continuous via pillar portion is not connected within the broken via pillar to the second continuous via pillar portion. Each of the plural chips has one or more of the bridges. Each bridge connects, within the respective chip, the first continuous via pillar portion in a column and the second continuous via pillar portion in another column.",XILINX INC,KANDALA ANIL KUMAR;;KOGANTI VIJAY KUMAR;;YACHARENI SANTOSH;;AGARWAL SUNDEEP RAM GOPAL,XILINX INC (2020-02-17),https://lens.org/056-472-519-467-713,Granted Patent,yes,12,5,6,6,0,H01L25/0657;;H01L2225/06541;;H01L2225/06544;;H03K19/177;;H01L25/50;;H01L2224/08145;;H01L25/0657;;H01L24/07;;H01L2225/06544;;H01L2225/06527;;H01L2225/06524;;H01L2224/08123;;H01L2224/08145;;H01L23/481;;H01L25/0657,H01L25/065;;H01L23/48,,0,0,,,,ACTIVE
263,US,B2,US 8209361 B2,067-788-883-233-315,2012-06-26,2012,US 68972910 A,2010-01-19,US 68972910 A,2010-01-19,Techniques for efficient and scalable processing of complex sets of XML schemas,"Techniques are described herein for efficient and scalable processing of complex sets of XML schemas. The techniques described herein provide for reducing duplication of schema elements in volatile memory by building an XML schema in-memory model that stores repeating schema elements in in-memory data structures that are separate from in-memory data structures that store the parent schema elements which logically include or otherwise refer to the repeating schema elements. The techniques described herein also provide for faster generation of an in-memory model of an XML schema by pre-loading, in data structures on persistent storage, of schema elements from dependent XML schemas that are referenced and/or incorporated by the XML schema. The techniques described herein also provide for efficient processing of inter-dependent XML schemas by tracking all unresolved schema elements from dependent XML schemas and freeing the portions of volatile memory, which are used to process schema elements from the dependent XML schemas, as soon as the dependent schema elements being processed are stored in data structures on persistent storage.",IDICULA SAM;;TARACHANDANI ASHA;;CHANDRASEKAR SIVASANKARAN;;MEDI VIJAY;;TABAR ALI;;AGARWAL NIPUN;;ORACLE INT CORP,IDICULA SAM;;TARACHANDANI ASHA;;CHANDRASEKAR SIVASANKARAN;;MEDI VIJAY;;TABAR ALI;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2010-01-15),https://lens.org/067-788-883-233-315,Granted Patent,yes,19,12,2,2,0,G06F40/123;;G06F40/221;;G06F40/143;;G06F40/123;;G06F40/221;;G06F40/143,G06F17/30;;G06F40/143,707/803;;707/796;;707/801,2,1,106-809-566-107-553,10.14778/1687553.1687561,"Zhang et al., ""Binary XML Storage and Query Processing in Oracle 11g"", Proc. VLDB Endow. 2,2, Dated Aug. 2009, 12 pages.;;U.S. Appl. No. 12/689,196, filed Jan. 18, 2010, Office Action, mailed Dec. 21, 2011.",ACTIVE
264,WO,A1,WO 2023/154107 A1,052-536-694-831-038,2023-08-17,2023,US 2022/0052440 W,2022-12-09,US 202217670376 A,2022-02-11,EVENT TRIGGERED NETWORK MIGRATION OF SUBSCRIBERS,"A method includes receiving, by an equipment identity register application in the target mobile network, an International Mobile Equipment Identity (IMEI) of a user equipment (UE) associated with the subscriber and a Subscriber Identity Module (SIM) identifier (ID) identifying an inactive SIM card inserted into the UE or an inactive electronic SIM (eSIM) profile installed at the UE, determining that the UE is attempting to attach to the target mobile network for a first time based on the IMEI and the SIM ID, adding an event to an event queue of the target mobile network, and processing the event by accessing subscriber data stored at the source mobile network to validate that the IMEI of the UE is indicated in the subscriber data stored at the source mobile network, wherein the subscriber data includes a subscriber account indicated by the IMEI of the UE.",T MOBILE INNOVATIONS LLC,AGARWAL MUKESH;;DREILING RYAN P;;UEHLING PHILIP WARREN;;YELMAT VIJAY BHANU REDDY,,https://lens.org/052-536-694-831-038,Patent Application,yes,3,0,3,3,0,H04W8/18;;H04W8/205;;H04W4/50;;H04M15/49;;H04M15/887;;H04W8/265;;H04W60/04,H04W8/18;;H04W8/20,,0,0,,,,PENDING
265,KR,A,KR 20220138860 A,118-411-737-441-026,2022-10-13,2022,KR 20227030545 A,2020-12-29,US 202016792560 A;;US 2020/0067322 W,2020-02-17,멀티-칩 적층된 디바이스들,"본 명세서에서 설명된 예들은 일반적으로, 적층된 칩들을 가지는 멀티-칩 디바이스들에 관한 것이다. 예에서, 멀티-칩 디바이스는 칩들을 포함하는 칩 적층체를 포함한다. 이웃하는 칩들은 서로에 접속된다. 칩들 중의 복수의 칩들은 파단된 비아 필러들 및 브릿지들의 열들을 집합적으로 포함한다. 복수의 칩들의 각각은 각각의 열에서 파단된 비아 필러를 가진다. 파단된 비아 필러는 개개의 칩의 반도체 기판의 면에 수직인 방향으로 정렬된 제1 및 제2 연속적 비아 필러 부분들을 가진다. 제1 연속적 비아 필러 부분은 파단된 비아 필러 내에서 제2 연속적 비아 필러 부분에 접속되지 않는다. 복수의 칩들의 각각은 브릿지들 중의 하나 이상을 가진다. 각각의 브릿지는 개개의 칩 내에서, 열 내의 제1 연속적 비아 필러 부분 및 다른 열 내의 제2 연속적 비아 필러 부분을 접속한다.",XILINX INC,KANDALA ANIL KUMAR;;KOGANTI VIJAY KUMAR;;YACHARENI SANTOSH;;AGARWAL SUNDEEP RAM GOPAL,,https://lens.org/118-411-737-441-026,Patent Application,no,0,0,6,6,0,H01L25/0657;;H01L2225/06541;;H01L2225/06544;;H03K19/177;;H01L25/50;;H01L2224/08145;;H01L25/0657;;H01L24/07;;H01L2225/06544;;H01L2225/06527;;H01L2225/06524;;H01L2224/08123;;H01L2224/08145;;H01L23/481;;H01L25/0657,H01L25/065;;H01L23/00,,0,0,,,,PENDING
266,US,B2,US 11864148 B2,079-109-670-944-736,2024-01-02,2024,US 202217670376 A,2022-02-11,US 202217670376 A,2022-02-11,Event triggered network migration of subscribers,"A method includes receiving, by an equipment identity register application in the target mobile network, an International Mobile Equipment Identity (IMEI) of a user equipment (UE) associated with the subscriber and a Subscriber Identity Module (SIM) identifier (ID) identifying an inactive SIM card inserted into the UE or an inactive electronic SIM (eSIM) profile installed at the UE, determining that the UE is attempting to attach to the target mobile network for a first time based on the IMEI and the SIM ID, adding an event to an event queue of the target mobile network, and processing the event by accessing subscriber data stored at the source mobile network to validate that the IMEI of the UE is indicated in the subscriber data stored at the source mobile network, wherein the subscriber data includes a subscriber account indicated by the IMEI of the UE.",T MOBILE INNOVATIONS LLC;;T MOBILE INNOVATONS LLC,AGARWAL MUKESH;;DREILING RYAN P;;UEHLING PHILIP WARREN;;YELMAT VIJAY BHANU REDDY,T-MOBILE INNOVATIONS LLC (2022-02-10),https://lens.org/079-109-670-944-736,Granted Patent,yes,9,0,3,3,0,H04W8/18;;H04W8/205;;H04W4/50;;H04M15/49;;H04M15/887;;H04W8/265;;H04W60/04,H04W4/50;;H04M15/00;;H04W8/26;;H04W60/04,,1,0,,,"Foreign Communication From a Related Counterpart Application, International Search Report and Written Opinion dated May 8, 2023 International Application No. PCT/US22/052440.",ACTIVE
267,WO,A1,WO 2023/230246 A1,165-251-920-660-600,2023-11-30,2023,US 2023/0023558 W,2023-05-25,US 202263346192 P,2022-05-26,ULTRASOUND ARRAYS FOR ENHANCED TISSUE THERAPY,"Ultrasound transducer arrays are provided to for example, initiate and enhance therapeutic treatments with a normalized, randomized, and/or incoherent acoustic pressure field. Optimizing pressure uniformity (peak and average pressures) throughout the incoherent pressure field, and maximizing volume of that incoherent field may be achieved through controller filtering steps to assign unique element waveform phases for each element in the array. Ultrasound may be used alone, to activate a drug, pro drug, sonosensitizer, and/or microbubble additives, and can be combined with other energy (e.g., radiation, magnetism), for treatments including cancer, neurological disease, mood condition, sleep apnea, inflammation, and/or orthopedic diseases, and opening the blood brain barrier to improve access to the drugs and additives. Ultrasound transducer systems may used with a cooling system, an alignment device a monitoring system an authorization system (e.g., identification bar code, key) and/or a treatment planning system.",ALPHEUS MEDICAL INC,AGARWAL VIJAY;;LING JEREMY;;COOLIDGE TROY;;ELIASON BRADEN;;BALLARD JOHN;;MILLER GREGG,,https://lens.org/165-251-920-660-600,Patent Application,yes,5,0,1,1,0,A61N7/00;;B06B2201/76;;B06B1/0637;;A61N2007/0078;;A61N2007/0095;;A61N2007/0039;;A61N2007/0021;;A61N7/02,A61N7/00;;B06B1/06,,0,0,,,,PENDING
268,US,A1,US 2011/0179089 A1,068-374-096-749-79X,2011-07-21,2011,US 68972910 A,2010-01-19,US 68972910 A,2010-01-19,TECHNIQUES FOR EFFICIENT AND SCALABLE PROCESSING OF COMPLEX SETS OF XML SCHEMAS,"Techniques are described herein for efficient and scalable processing of complex sets of XML schemas. The techniques described herein provide for reducing duplication of schema elements in volatile memory by building an XML schema in-memory model that stores repeating schema elements in in-memory data structures that are separate from in-memory data structures that store the parent schema elements which logically include or otherwise refer to the repeating schema elements. The techniques described herein also provide for faster generation of an in-memory model of an XML schema by pre-loading, in data structures on persistent storage, of schema elements from dependent XML schemas that are referenced and/or incorporated by the XML schema. The techniques described herein also provide for efficient processing of inter-dependent XML schemas by tracking all unresolved schema elements from dependent XML schemas and freeing the portions of volatile memory, which are used to process schema elements from the dependent XML schemas, as soon as the dependent schema elements being processed are stored in data structures on persistent storage.",IDICULA SAM;;TARACHANDANI ASHA;;CHANDRASEKAR SIVASANKARAN;;MEDI VIJAY;;TABAR ALI;;AGARWAL NIPUN,IDICULA SAM;;TARACHANDANI ASHA;;CHANDRASEKAR SIVASANKARAN;;MEDI VIJAY;;TABAR ALI;;AGARWAL NIPUN,ORACLE INTERNATIONAL CORPORATION (2010-01-15),https://lens.org/068-374-096-749-79X,Patent Application,yes,11,24,2,2,0,G06F40/123;;G06F40/221;;G06F40/143;;G06F40/123;;G06F40/221;;G06F40/143,G06F17/30;;G06F40/143,707/803;;X707E17127;;X707E17052,0,0,,,,ACTIVE
269,US,A1,US 2011/0105619 A1,103-145-707-545-058,2011-05-05,2011,US 99788109 A,2009-06-15,US 99788109 A;;IN 1266MU2008 A;;US 13427508 P;;IB 2009005936 W,2008-06-16,AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF,"The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.",GLENMARK GENERICS LTD,SANGANABHATLA SHANKAR;;SONI VIJAY;;KHAN MUBEEN AHMED;;AGARWAL NANDLAL;;KAMBLE HEMANTH;;GORE SHARAD,,https://lens.org/103-145-707-545-058,Patent Application,yes,6,2,4,4,0,A61P25/24;;A61P25/34;;C07C225/16;;C07C225/16,A61K31/135;;A61P25/24;;A61P25/34;;C07C225/16,514/649;;564/345,0,0,,,,INACTIVE
270,BR,A2,BR 112016011515 A2,055-543-113-275-016,2020-10-13,2020,BR 112016011515 A,2014-11-21,US 2014/0066761 W;;US 201361907182 P,2013-11-21,método para produzir uma composição de cimento,"composições de cimento macroporoso, conversível e injetável e seus métodos para produção, solução gasosa, produto, implante ósseo e kit para produzir uma composição de cimento composições cimento macroporosas, métodos de produção das mesmas, e métodos de uso das mesmas, são descritos.",UNIV TOLEDO,ANAND K AGARWAL;;HUAN ZHOU;;SAMEH SALEH;;SARIT B BHADURI;;VIJAY K GOEL,,https://lens.org/055-543-113-275-016,Patent Application,no,0,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61C5/00,,0,0,,,,DISCONTINUED
271,US,A1,US 2020/0061235 A1,082-181-308-170-103,2020-02-27,2020,US 201916671582 A,2019-11-01,US 201916671582 A;;US 201615038218 A;;US 2014/0066761 W;;US 201361907182 P,2013-11-21,Macroporous Granules of Alkaline Earth Phosphates Using Cement Technology and Gas Evolving Porogen,"Macroporous cement compositions, methods of making the same, and methods of using the same, are described.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,THE UNIVERSITY OF TOLEDO (2016-05-26),https://lens.org/082-181-308-170-103,Patent Application,yes,0,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61L24/00;;A61L24/02;;A61L24/08;;A61L27/04;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;C04B28/34;;C04B38/02,,0,0,,,,DISCONTINUED
272,US,B2,US 8450376 B2,138-417-639-927-850,2013-05-28,2013,US 99788109 A,2009-06-15,US 99788109 A;;IN 1266MU2008 A;;US 13427508 P;;IB 2009005936 W,2008-06-16,Amorphous bupropion hydrobromide and preparation thereof,"The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.",SANGANABHATLA SHANKAR;;SONI VIJAY;;KHAN MUBEEN AHMED;;AGARWAL NANDLAL;;KAMBLE HEMANTH;;GORE SHARAD;;GLENMARK GENERICS LTD,SANGANABHATLA SHANKAR;;SONI VIJAY;;KHAN MUBEEN AHMED;;AGARWAL NANDLAL;;KAMBLE HEMANTH;;GORE SHARAD,,https://lens.org/138-417-639-927-850,Granted Patent,yes,8,0,4,4,0,A61P25/24;;A61P25/34;;C07C225/16;;C07C225/16,A61K31/12;;A61K31/137;;C07C225/16,514/649;;564/342;;564/343;;564/345,0,0,,,,INACTIVE
273,EP,A1,EP 1902365 A1,103-615-178-995-590,2008-03-26,2008,EP 06764165 A,2006-07-13,EP 2006064239 W;;US 18135205 A,2005-07-14,SYSTEM AND METHOD FOR DETECTING IMBALANCES IN DYNAMIC WORKLOAD SCHEDULING IN CLUSTERED ENVIRONMENTS,,IBM,AGARWAL MANOJ;;GUPTA MANISH;;MUMMERT LILY BARKOVIC;;GHOSAL SUGATA;;MANN VIJAY;;ANEROUSIS NIKOS,,https://lens.org/103-615-178-995-590,Patent Application,yes,0,0,7,7,0,G06F9/5083;;G06F9/5083,G06F9/50,,0,0,,,,DISCONTINUED
274,WO,A1,WO 2007/006811 A1,049-811-778-256-419,2007-01-18,2007,EP 2006064239 W,2006-07-13,US 18135205 A,2005-07-14,SYSTEM AND METHOD FOR DETECTING IMBALANCES IN DYNAMIC WORKLOAD SCHEDULING IN CLUSTERED ENVIRONMENTS,"Methods, systems and computer program products for detecting a workload imbalance in a dynamically scheduled cluster of computer servers are disclosed. One such method comprises the steps of monitoring a plurality of metrics at each of the computer servers, detecting change points in the plurality of metrics, generating alarm points based on the detected change points, correlating the alarm points and identifying, based on an outcome of the correlation, one or more of the computer servers causing a workload imbalance. Systems and computer program products for practicing the above method are also disclosed.",IBM;;IBM UK;;AGARWAL MANOJ;;GUPTA MANISH;;MUMMERT LILY BARKOVIC;;GHOSAL SUGATA;;MANN VIJAY;;ANEROUSIS NIKOS,AGARWAL MANOJ;;GUPTA MANISH;;MUMMERT LILY BARKOVIC;;GHOSAL SUGATA;;MANN VIJAY;;ANEROUSIS NIKOS,,https://lens.org/049-811-778-256-419,Patent Application,yes,4,2,7,7,0,G06F9/5083;;G06F9/5083,G06F9/50,,9,6,095-480-144-354-898;;002-659-354-353-881;;018-685-609-527-75X;;083-647-356-656-982;;044-751-714-109-280;;032-120-480-500-001,10.1109/inm.2001.918085;;10.1109/inm.2005.1440848;;10.1145/107971.107977;;10.1109/inm.2005.1440772;;16252814;;10.1109/tnn.2005.853411;;10.1109/icde.2000.839443,"APPLEBY K ET AL: ""Oceano-SLA Based Management of a Computing Utility"", IEEE/IFIP INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT PROCEEDINGS. INTEGRATED NETWORK MANAGEMENT. INTEGRATED MANAGEMENT STRATEGIES FOR THE NEW MILLENIUM, 14 May 2001 (2001-05-14), pages 855 - 868, XP002310934;;APPLEBY K ET AL: ""Using automatically derived load thresholds to manage compute resources on-demand"", INTEGRATED NETWORK MANAGEMENT, 2005. IM 2005. 2005 9TH IFIP/IEEE INTERNATIONAL SYMPOSIUM ON NICE, FRANCE 15-19 MAY 2005, PISCATAWAY, NJ, USA,IEEE, 15 May 2005 (2005-05-15), pages 747 - 760, XP010807111, ISBN: 0-7803-9087-3;;R. BERRY AND J. HELLERSTEIN: ""An approach to detecting changes in the factors affecting the performance of computer systems"", PROCEEDINGS OF THE 1991 ACM SIGMETRICS CONFERENCE ON MEASUREMENT AND MODELING OF COMPUTER SYSTEMS, 1991, San Diego, California, United States, pages 39 - 49, XP002408679, Retrieved from the Internet <URL:http://delivery.acm.org/10.1145/110000/107977/p39-berry.pdf?key1=107977&key2=5486214611&coll=GUIDE&dl=GUIDE&CFID=6723682&CFTOKEN=61499524>;;ANEROUSIS N ET AL: ""Health monitoring and control for application server environments"", INTEGRATED NETWORK MANAGEMENT, 2005. IM 2005. 2005 9TH IFIP/IEEE INTERNATIONAL SYMPOSIUM ON NICE, FRANCE 15-19 MAY 2005, PISCATAWAY, NJ, USA,IEEE, 15 May 2005 (2005-05-15), pages 75 - 88, XP010807145, ISBN: 0-7803-9087-3;;EMRE KICIMAN; ARMANDO FOX: ""IEEE transactions on Neural Networks: Special Issue on Adaptive Learning Systems in Communication Networks (invited paper"", 2005, SPRING, article ""Detecting Application-Level Failures in Component-based Internet Services"";;VASUNDHARA PUTTAGUNTA; KONSTANTINOS KALPAKIS: ""Adaptive Methods for Activity Monitoring of Streaming Data"", PROCEEDINGS OF THE 2002 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA'02, 24 June 2002 (2002-06-24), pages 197 - 203;;GURALNIK, V.; SRIVISTAVA, J., KNOWLEDGE DISCOVERY AND DATA MINING, 1999, pages 33 - 42;;GANTI, V.; GEHRKE, J.; RAMAKRISHNAN, R.: ""DEMON: Mining and monitoring evolving data"", ICDE, 2000, pages 439 - 448;;GRUSCHKE, B.: ""Integrated Event Management: Event Correlation using Dependency Graphs"", PROCEEDINGS OF 9TH IFIP/IEEE INTERNATIONAL WORKSHOP ON DISTRIBUTED SYSTEMS: OPERATIONS AND MANAGEMENT (DSOM 98, October 1998 (1998-10-01)",PENDING
275,CN,B,CN 101233491 B,087-342-117-833-230,2012-06-27,2012,CN 200680027592 A,2006-07-13,EP 2006064239 W;;US 18135205 A,2005-07-14,System and method for detecting imbalances in dynamic workload scheduling in clustered environments,"Methods, systems and computer program products for detecting a workload imbalance in a dynamically scheduled cluster of computer servers are disclosed. One such method comprises the steps of monitoring a plurality of metrics at each of the computer servers, detecting change points in the plurality of metrics, generating alarm points based on the detected change points, correlating the alarm points and identifying, based on an outcome of the correlation, one or more of the computer servers causing a workload imbalance. Systems and computer program products for practicing the above method are also disclosed.",IBM,BARKOVIC MUMMERT LILY;;SUGATA GHOSAL;;MANOJ AGARWAL;;MANISH GUPTA;;VIJAY MANN;;NIKOS ANEROUSIS,,https://lens.org/087-342-117-833-230,Granted Patent,no,0,0,7,7,0,G06F9/5083;;G06F9/5083,G06F9/50,,0,0,,,,INACTIVE
276,WO,A3,WO 2010/004386 A3,015-133-244-141-250,2010-11-04,2010,IB 2009005936 W,2009-06-15,IN 1266MU2008 A;;US 13427508 P,2008-06-16,AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF,"The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.",GLENMARK GENERICS LTD;;SHANKAR SANGANABHATLA;;VIJAY SONI;;MUBEEN AHMED KHAN;;NANDLAL AGARWAL;;HEMANTH KAMBLE;;SHARAD GORE,SHANKAR SANGANABHATLA;;VIJAY SONI;;MUBEEN AHMED KHAN;;NANDLAL AGARWAL;;HEMANTH KAMBLE;;SHARAD GORE,,https://lens.org/015-133-244-141-250,Search Report,yes,5,0,4,4,0,A61P25/24;;A61P25/34;;C07C225/16;;C07C225/16,C07C225/16;;A61K31/135;;C07C221/00,,0,0,,,,PENDING
277,CN,A,CN 101233491 A,042-254-943-302-367,2008-07-30,2008,CN 200680027592 A,2006-07-13,EP 2006064239 W;;US 18135205 A,2005-07-14,System and method for detecting imbalances in dynamic workload scheduling in clustered environments,,IBM,MANOJ AGARWAL;;MANISH GUPTA;;BARKOVIC MUMMERT LILY;;SUGATA GHOSAL;;VIJAY MANN;;NIKOS ANEROUSIS,,https://lens.org/042-254-943-302-367,Patent Application,no,0,5,7,7,0,G06F9/5083;;G06F9/5083,G06F9/50,,0,0,,,,INACTIVE
278,US,A1,US 2016/0279280 A1,122-433-082-843-797,2016-09-29,2016,US 201415038218 A,2014-11-21,US 201415038218 A;;US 201361907182 P;;US 2014/0066761 W,2013-11-21,Macroporous Granules of Alkaline Earth Phosphates Using Cement Technology and Gas Evolving Porogen,"Macroporous cement compositions, methods of making the same, and methods of using the same, are described.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,THE UNIVERSITY OF TOLEDO (2016-05-26),https://lens.org/122-433-082-843-797,Patent Application,yes,2,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61L24/00;;A61L24/02;;A61L24/08,,2,2,047-429-543-031-258;;053-661-883-551-528,21479638;;10.1007/s10856-011-4288-5;;10.1007/s10856-007-0139-9;;17277974,Touny et al. J Mater Sci Mater Med. 2011; 22: 1101-1109.;;Tamimi-Marino et al. J Mater Sci Mater Med. 2007; 18: 1195-1201.,DISCONTINUED
279,WO,A2,WO 2015/077531 A2,123-788-162-881-530,2015-05-28,2015,US 2014/0066761 W,2014-11-21,US 201361907182 P,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES USING CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,"Macroporous cement compositions, methods of making the same, and methods of using the same, are described.",UNIVERSTIY OF TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,,https://lens.org/123-788-162-881-530,Patent Application,yes,4,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,C04B9/04,,1,0,,,See also references of EP 3071140A4,PENDING
280,CN,A,CN 105828742 A,109-847-566-154-241,2016-08-03,2016,CN 201480069558 A,2014-11-21,US 201361907182 P;;US 2014/0066761 W,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES USING CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,"Macroporous cement compositions, methods of making the same, and methods of using the same, are described.",UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,,https://lens.org/109-847-566-154-241,Patent Application,no,10,2,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61C5/04,,0,0,,,,DISCONTINUED
281,WO,A3,WO 2015/077531 A3,169-715-855-283-033,2015-11-05,2015,US 2014/0066761 W,2014-11-21,US 201361907182 P,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES USING CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,"Macroporous cement compositions, methods of making the same, and methods of using the same, are described.",UNIVERSTIY OF TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,,https://lens.org/169-715-855-283-033,Search Report,yes,7,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61C5/04,,0,0,,,,PENDING
282,EP,B1,EP 3071140 B1,041-226-042-325-380,2021-01-06,2021,EP 14863173 A,2014-11-21,US 201361907182 P;;US 2014/0066761 W,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES OBTAINED WITH CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,,UNIV TOLEDO,GOEL VIJAY K;;SALEH SAMEH;;BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K,,https://lens.org/041-226-042-325-380,Granted Patent,yes,0,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61L27/04;;A61L24/00,,1,1,091-904-092-056-24X,10.1002/jab.770040303;;10146306,"LI: ""Effects of ions in aqueous media..."", JOURNAL OF APPLIED BIOMATERIALS, vol. 4, 1993, pages 221 - 229",ACTIVE
283,US,A1,US 2007/0016687 A1,039-726-572-262-814,2007-01-18,2007,US 18135205 A,2005-07-14,US 18135205 A,2005-07-14,System and method for detecting imbalances in dynamic workload scheduling in clustered environments,"Methods, systems and computer program products for detecting a workload imbalance in a dynamically scheduled cluster of computer servers are disclosed. One such method comprises the steps of monitoring a plurality of metrics at each of the computer servers, detecting change points in the plurality of metrics, generating alarm points based on the detected change points, correlating the alarm points and identifying, based on an outcome of the correlation, one or more of the computer servers causing a workload imbalance. Systems and computer program products for practicing the above method are also disclosed.",IBM,AGARWAL MANOJ K;;GHOSAL SUGATA;;GUPTA MANISH;;MANN VIJAY;;MUMMERT LILY;;ANEROUSIS NIKOLAOS,INTERNATIONAL BUSINESS MACHINES CORPORATION (2005-07-12),https://lens.org/039-726-572-262-814,Patent Application,yes,26,25,7,7,0,G06F9/5083;;G06F9/5083,G06F15/173,709/238,0,0,,,,DISCONTINUED
284,EP,A2,EP 3071140 A2,052-292-525-678-353,2016-09-28,2016,EP 14863173 A,2014-11-21,US 201361907182 P;;US 2014/0066761 W,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES USING CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,,https://lens.org/052-292-525-678-353,Patent Application,yes,0,1,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61C5/04,,0,0,,,,ACTIVE
285,EP,A4,EP 3071140 A4,196-297-213-518-443,2017-07-26,2017,EP 14863173 A,2014-11-21,US 201361907182 P;;US 2014/0066761 W,2013-11-21,MACROPOROUS GRANULES OF ALKALINE EARTH PHOSPHATES USING CEMENT TECHNOLOGY AND GAS EVOLVING POROGEN,,UNIV TOLEDO,BHADURI SARIT B;;ZHOU HUAN;;AGARWAL ANAND K;;GOEL VIJAY K;;SALEH SAMEH,,https://lens.org/196-297-213-518-443,Search Report,no,3,0,11,11,0,C04B28/34;;C04B38/02;;C04B2111/00836;;A61L27/047;;A61L27/12;;A61L27/20;;A61L27/54;;A61L27/56;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L24/0036;;A61K6/86;;A61K6/864;;A61P31/04;;A61L24/0015;;A61L24/02;;A61L24/08;;A61L27/12;;A61L27/54;;C04B28/34;;C04B2111/00836;;A61L27/047;;A61L27/20;;C04B38/02;;A61L27/56;;A61K6/86;;A61K6/864;;A61L24/0036;;A61L2430/02,A61L27/04;;A61L24/00,,2,0,,,"BOHNER M ET AL: ""Calcium Phosphate Emulsions"", SIXTH WORLD BIO- MATERIALS CONGRESS TRANSACTIONS (15-20/5 2000 - TRANSACTIONS OF THE SIXTH WORLD BIOMATERIALS CONGRESS : MAY 15 - 20, 2000, HILTON WAIKOLOA VILLAGE RESORT, KAMUELA (BIG ISLAND), HAWAII, U.S.A, SOCIETY FOR BIOMATERIALS, US, vol. 1, 1 January 2000 (2000-01-01), pages 20, XP008184854;;See also references of WO 2015077531A2",ACTIVE
286,WO,A2,WO 2010/004386 A2,194-724-711-535-191,2010-01-14,2010,IB 2009005936 W,2009-06-15,IN 1266MU2008 A;;US 13427508 P,2008-06-16,AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF,"The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.",GLENMARK GENERICS LTD;;SHANKAR SANGANABHATLA;;VIJAY SONI;;MUBEEN AHMED KHAN;;NANDLAL AGARWAL;;HEMANTH KAMBLE;;SHARAD GORE,SHANKAR SANGANABHATLA;;VIJAY SONI;;MUBEEN AHMED KHAN;;NANDLAL AGARWAL;;HEMANTH KAMBLE;;SHARAD GORE,,https://lens.org/194-724-711-535-191,Patent Application,yes,0,0,4,4,0,A61P25/24;;A61P25/34;;C07C225/16;;C07C225/16,C07C225/16;;A61K31/135;;C07C221/00,,0,0,,,,PENDING
287,EP,A1,EP 2983477 A1,067-315-693-518-82X,2016-02-17,2016,EP 14736036 A,2014-04-09,IN 1078DE2013 A;;IN 2014000224 W,2013-04-10,GIBBERELLIC ACID (GA3) FREE KAPPAPHYCUS ALVAREZII SAP AND ITS APPLICATION THEREOF,,COUNCIL SCIENT IND RES,GHOSH PUSHPITO KUMAR;;GHOSH ARUP;;MONDAL DIBYENDU;;PRASAD KAMALESH;;AGARWAL PRADEEP KUMAR;;AGARWAL PARINITA;;ZODAPE SUDHAKAR TUKARAMJI;;GOPALAKRISHNAN VIJAY ANAND KATTAERI,,https://lens.org/067-315-693-518-82X,Patent Application,yes,0,0,5,5,0,A01N65/00;;A01N65/03;;C05F11/10;;C05F11/00;;A01N65/03;;A01N65/00;;C05F11/10;;C05F11/00,A01N65/03;;C05F11/00,,0,0,,,,DISCONTINUED
288,WO,A1,WO 2014/167583 A1,118-333-708-011-907,2014-10-16,2014,IN 2014000224 W,2014-04-09,IN 1078DE2013 A,2013-04-10,GIBBERELLIC ACID (GA3) FREE KAPPAPHYCUS ALVAREZII SAP AND ITS APPLICATION THEREOF,"The present invention relates to a product Kappaphycus alvarezii seaweed sap free of Gibberellic acid (GA3) and its method of preparation. Kappaphycus alvarezii seaweed sap is a plant stimulant found to enhance yield and quality of a number of crops. Besides containing many macro- and micro- nutrients, there are many plant growth hormones present in Kappaphycus alvarezii sap. It has been observed that pristine Kappaphycus alvarezii sap and GA3 free sap enhanced grain yield but surprisingly selective removal of GA3 from the pristine sap had profound stimulating effect on total dry above ground biomass yield of maize over and above the pristine sap. Upon seed treatment with GA3 free sap, ?-amylase enzyme activity in the germinating seed of mung bean is found to be increased. The foliar spray of GA3 free sap on tomato plants upregulated disease responsive genes (PR-3 and PR-5) as compared to pristine sap.",COUNCIL SCIENT IND RES,GHOSH PUSHPITO KUMAR;;GHOSH ARUP;;MONDAL DIBYENDU;;PRASAD KAMALESH;;AGARWAL PRADEEP KUMAR;;AGARWAL PARINITA;;ZODAPE SUDHAKAR TUKARAMJI;;GOPALAKRISHNAN VIJAY ANAND KATTAERI,,https://lens.org/118-333-708-011-907,Patent Application,yes,4,5,5,5,0,A01N65/00;;A01N65/03;;C05F11/10;;C05F11/00;;A01N65/03;;A01N65/00;;C05F11/10;;C05F11/00,A01N65/03;;C05F11/00,,9,8,011-225-712-158-049;;013-268-654-334-579;;022-982-217-039-381;;011-225-712-158-049;;013-268-654-334-579;;011-225-712-158-049;;077-580-667-120-981;;069-658-664-429-198,10.1021/jf904500e;;20355716;;pmc1914132;;10.1104/pp.107.100370;;17616507;;10.1007/s10725-014-9967-z;;10.1021/jf904500e;;20355716;;pmc1914132;;10.1104/pp.107.100370;;17616507;;10.1021/jf904500e;;20355716;;10.1111/j.1399-3054.1962.tb08052.x;;11846609;;10.1006/meth.2001.1262,"KAMALESH PRASAD ET AL: ""Detection and Quantification of Some Plant Growth Regulators in a Seaweed-Based Foliar Spray Employing a Mass Spectrometric Technique sans Chromatographic Separation"", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 58, no. 8, 28 April 2010 (2010-04-28), pages 4594 - 4601, XP055140630, ISSN: 0021-8561, DOI: 10.1021/jf904500e;;D. WEISS ET AL: ""Mechanisms of Cross Talk between Gibberellin and Other Hormones"", PLANT PHYSIOLOGY, vol. 144, no. 3, July 2007 (2007-07-01), pages 1240 - 1246, XP055140632, ISSN: 0032-0889, DOI: 10.1104/pp.107.100370;;DIBYENDU MONDAL ET AL: ""Elimination of gibberellin from Kappaphycus alvarezii seaweed sap foliar spray enhances corn stover production without compromising the grain yield advantage"", PLANT GROWTH REGULATION, 19 August 2014 (2014-08-19), XP055140906, ISSN: 0167-6903, DOI: 10.1007/s10725-014-9967-z;;""Detection and quantification of some plant growth regulators in a seaweed-based foliar spray employing a mass spectrometric technique sans chromatographic separation"", JOURNAL OF AGRICULTURE AND FOOD CHEMISTRY, vol. 58, 2010, pages 4594 - 4601;;WEISS D; ORI N: ""Mechanisms of Cross Talk between Gibberellin and Other Hormones"", PLANT PHYSIOL, vol. 144, 2007, pages 1240 - 1246, XP055140632, DOI: doi:10.1104/pp.107.100370;;JOURNAL OF AGRICULTURE AND FOOD CHEMISTRY, vol. 58, 2010, pages 4594 - 4601;;JOURNAL OF AGRICULTURE AND FOOD CHEMISTRY, vol. 45, 1997, pages 774 - 776;;MURASHIGE T; SKOOG F: ""A revised medium for rapid growth and bioassays with tobacco tissue cultures"", PHYSIOL PLANT, vol. 15, 1962, pages 431 - 497;;LIVAK KJ; SCHMITTGEN TD: ""Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method"", METHODS, vol. 25, 2001, pages 402 - 408",PENDING
289,AU,A1,AU 2014/252137 A1,107-771-357-280-240,2015-11-19,2015,AU 2014/252137 A,2014-04-09,IN 1078DE2013 A;;IN 2014000224 W,2013-04-10,Gibberellic acid (GA3) free kappaphycus alvarezii sap and its application thereof,"The present invention relates to a product Kappaphycus alvarezii seaweed sap free of Gibberellic acid (GA3) and its method of preparation. Kappaphycus alvarezii seaweed sap is a plant stimulant found to enhance yield and quality of a number of crops. Besides containing many macro- and micro- nutrients, there are many plant growth hormones present in Kappaphycus alvarezii sap. It has been observed that pristine Kappaphycus alvarezii sap and GA3 free sap enhanced grain yield but surprisingly selective removal of GA3 from the pristine sap had profound stimulating effect on total dry above ground biomass yield of maize over and above the pristine sap. Upon seed treatment with GA3 free sap, ?-amylase enzyme activity in the germinating seed of mung bean is found to be increased. The foliar spray of GA3 free sap on tomato plants upregulated disease responsive genes (PR-3 and PR-5) as compared to pristine sap.",COUNCIL SCIENT IND RES,GHOSH PUSHPITO KUMAR;;GHOSH ARUP;;MONDAL DIBYENDU;;PRASAD KAMALESH;;AGARWAL PRADEEP KUMAR;;AGARWAL PARINITA;;ZODAPE SUDHAKAR TUKARAMJI;;GOPALAKRISHNAN VIJAY ANAND KATTAERI,,https://lens.org/107-771-357-280-240,Patent Application,no,0,0,5,5,0,A01N65/00;;A01N65/03;;C05F11/10;;C05F11/00;;A01N65/03;;A01N65/00;;C05F11/10;;C05F11/00,A01N65/03;;C05F11/00,,0,0,,,,DISCONTINUED
290,US,A1,US 2016/0060183 A1,098-845-028-431-452,2016-03-03,2016,US 201414783980 A,2014-04-09,IN 1078DE2013 A;;IN 2014000224 W,2013-04-10,GIBBERELLIC ACID (GA3) FREE KAPPAPHYCUS ALVAREZII SAP AND ITS APPLICATION THEREOF,"The present invention relates to a product Kappaphycus alvarezii seaweed sap free of Gibberellic acid (GA3) and its method of preparation. Kappaphycus alvarezii seaweed sap is a plant stimulant found to enhance yield and quality of a number of crops. Besides containing many macro- and micro-nutrients, there are many plant growth hormones present in Kappaphycus alvarezii sap. It has been observed that pristine Kappaphycus alvarezii sap and GA3 free sap enhanced grain yield but surprisingly selective removal of GA3 from the pristine sap had profound stimulating effect on total dry above ground biomass yield of maize over and above the pristine sap. Upon seed treatment with GA3 free sap, α-amylase enzyme activity in the germinating seed of mung bean is found to be increased. The foliar spray of GA3 free sap on tomato plants upregulated disease responsive genes (PR-3 and PR-5) as compared to pristine sap.",COUNCIL SCIENT IND RES,GHOSH PUSHPITO KUMAR;;GHOSH ARUP;;MONDAL DIBYENDU;;PRASAD KAMALESH;;AGARWAL PRADEEP KUMAR;;AGARWAL PARINITA;;ZODAPE SUDHAKAR TUKARAMJI;;GOPALAKRISHNAN VIJAY ANAND KATTAERI,COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (2015-11-16),https://lens.org/098-845-028-431-452,Patent Application,yes,0,2,5,5,0,A01N65/00;;A01N65/03;;C05F11/10;;C05F11/00;;A01N65/03;;A01N65/00;;C05F11/10;;C05F11/00,C05F11/00,,1,1,011-225-712-158-049,10.1021/jf904500e;;20355716,"Prasad et al. ""Detection and Quantification of Some Plant Growth Regulators in a Seaweed-Based Foliar Spray Employing a Mass Spectrometric Technique sans Chromatographic Separation"". J. Agric. Food Chem., 2010, 58 (8), pp 4594â4601",DISCONTINUED
291,CA,A1,CA 2909387 A1,094-881-487-386-374,2014-10-16,2014,CA 2909387 A,2014-04-09,IN 1078DE2013 A;;IN 2014000224 W,2013-04-10,GIBBERELLIC ACID (GA3) FREE KAPPAPHYCUS ALVAREZII SAP AND ITS APPLICATION THEREOF,"The present invention relates to a product Kappaphycus alvarezii seaweed sap free of Gibberellic acid (GA3) and its method of preparation. Kappaphycus alvarezii seaweed sap is a plant stimulant found to enhance yield and quality of a number of crops. Besides containing many macro- and micro- nutrients, there are many plant growth hormones present in Kappaphycus alvarezii sap. It has been observed that pristine Kappaphycus alvarezii sap and GA3 free sap enhanced grain yield but surprisingly selective removal of GA3 from the pristine sap had profound stimulating effect on total dry above ground biomass yield of maize over and above the pristine sap. Upon seed treatment with GA3 free sap, ?-amylase enzyme activity in the germinating seed of mung bean is found to be increased. The foliar spray of GA3 free sap on tomato plants upregulated disease responsive genes (PR-3 and PR-5) as compared to pristine sap.",COUNCIL SCIENT IND RES,GHOSH PUSHPITO KUMAR;;GHOSH ARUP;;MONDAL DIBYENDU;;PRASAD KAMALESH;;AGARWAL PRADEEP KUMAR;;AGARWAL PARINITA;;ZODAPE SUDHAKAR TUKARAMJI;;GOPALAKRISHNAN VIJAY ANAND KATTAERI,,https://lens.org/094-881-487-386-374,Patent Application,no,0,0,5,5,0,A01N65/00;;A01N65/03;;C05F11/10;;C05F11/00;;A01N65/03;;A01N65/00;;C05F11/10;;C05F11/00,A01N65/03;;C05F11/00,,0,0,,,,DISCONTINUED
292,US,A1,US 2017/0354372 A1,108-598-797-322-301,2017-12-14,2017,US 201715668036 A,2017-08-03,US 201715668036 A;;US 201313829898 A;;US 201213449755 A;;US 201213657854 A;;US 201213415698 A;;US 201161450423 P,2011-03-08,"SMART MATERIALS, DRY TEXTILE SENSORS, AND ELECTRONICS INTEGRATION IN CLOTHING, BED SHEETS, AND PILLOW CASES FOR NEUROLOGICAL, CARDIAC AND/OR PULMONARY MONITORING","Sensors mounted on a textile include at least one of electrically conductive textile electrodes; single or multiple optically coupled infrared and red emitter and photodiode or photo transistor; and thin film or Resistive Temperature Detector (RTD). Textile electrodes, electrical connections, and electrical functionalization use at least one of nanoparticles, nanostructures, and mesostructures. Conductive thread, for electrical connections, may include a fiber core made from conductive materials such as but not limited to metals, alloys, and graphine structures, and a sheath of insulating materials such as but not limited to nylon, polyester, and cotton.",NANOWEAR INC,VARADAN VIJAY K;;RAI PRATYUSH;;KUMAR PRASHANTH SHYAM;;MATHUR GYANESH N;;AGARWAL M P,NANOWEAR INC (2018-12-21),https://lens.org/108-598-797-322-301,Patent Application,yes,3,50,4,8,0,A61B2562/0215;;A61B5/6804;;A61B5/25;;A61B5/282;;A61B5/6804;;A61B2562/0215;;A61B5/25;;A61B5/282,A61B5/00;;A61B5/0408,,0,0,,,,ACTIVE
293,US,B1,US 10349994 B1,174-431-164-390-733,2019-07-16,2019,US 201514674502 A,2015-03-31,US 201514674502 A;;US 201461972864 P,2014-03-31,Bone graft material mixing and delivery device,Described herein are bone graft material (BGM) delivery devices having a tray configured to provide a mixing and/or holding area for BGM to substantially prevent BGM from inadvertently being delivered to an unacceptable surgical site.,UNIV TOLEDO,ELGAFY HOSSEIN;;AGARWAL ANAND K;;GOEL VIJAY K;;MOMENI SHAHRAKI NARJES;;KELKAR AMEY V,THE UNIVERSITY OF TOLEDO (2015-04-19),https://lens.org/174-431-164-390-733,Granted Patent,yes,5,2,1,1,0,A61B17/7061;;A61B17/7061;;A61F2/4601;;A61F2/4601,A61B17/88;;A61F2/46,,0,0,,,,INACTIVE
294,EP,A2,EP 2967801 A2,033-506-091-787-65X,2016-01-20,2016,EP 14773377 A,2014-03-13,US 201361783100 P;;US 2014/0026099 W,2013-03-14,INJECTABLE BIODEGRADABLE BONE MATRIX FOR MULTIPLE MYELOMA LESION AUGMENTATION AND OSTEOPOROSIS,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/033-506-091-787-65X,Patent Application,yes,0,1,7,7,3,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61F2/00;;A01N59/26;;A61K33/42;;A61K38/08;;A61L24/10;;A61L27/42;;A61P19/10,,0,0,,,,ACTIVE
295,EP,A4,EP 2967801 A4,043-584-556-858-478,2017-04-12,2017,EP 14773377 A,2014-03-13,US 201361783100 P;;US 2014/0026099 W,2013-03-14,INJECTABLE BIODEGRADABLE BONE MATRIX FOR MULTIPLE MYELOMA LESION AUGMENTATION AND OSTEOPOROSIS,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/043-584-556-858-478,Search Report,no,3,0,7,7,0,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61F2/00;;A01N59/26;;A61K33/42;;A61K38/08;;A61L24/10;;A61L27/42;;A61P19/10,,4,3,089-044-067-170-367;;151-393-867-111-965;;009-724-729-640-979,22709649;;10.1016/j.addr.2012.05.017;;10.1002/masy.200900171;;20093139;;10.1016/j.ijbiomac.2010.01.006,"KAZUHIRO AOKI ET AL: ""Peptide-based delivery to bone"", ADVANCED DRUG DELIVERY REVIEWS, vol. 64, no. 12, 1 September 2012 (2012-09-01), AMSTERDAM, NL, pages 1220 - 1238, XP055307966, ISSN: 0169-409X, DOI: 10.1016/j.addr.2012.05.017;;CHARLOTTE A.E. HAUSER ET AL: ""Designer Self-Assembling Peptide Materials for Diverse Applications"", MACROMOLECULAR SYMPOSIA., vol. 295, no. 1, 1 September 2010 (2010-09-01), DE, pages 30 - 48, XP055284383, ISSN: 1022-1360, DOI: 10.1002/masy.200900171;;SAHITHI K ET AL: ""Polymeric composites containing carbon nanotubes for bone tissue engineering"", INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, ELSEVIER BV, NL, vol. 46, no. 3, 1 April 2010 (2010-04-01), pages 281 - 283, XP026937518, ISSN: 0141-8130, [retrieved on 20100303], DOI: 10.1016/J.IJBIOMAC.2010.01.006;;See also references of WO 2014160232A2",ACTIVE
296,WO,A2,WO 2014/160232 A2,194-952-659-614-494,2014-10-02,2014,US 2014/0026099 W,2014-03-13,US 201361783100 P,2013-03-14,INJECTABLE BIODEGRADABLE BONE MATRIX FOR MULTIPLE MYELOMA LESION AUGMENTATION AND OSTEOPOROSIS,"Bone filler compositions, methods of making and using the same, and methods of treating osteoporosis and cancer-induced bone defects, are described.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/194-952-659-614-494,Patent Application,yes,1,2,7,7,3,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61K35/32;;A61K38/08,,0,0,,,,PENDING
297,US,A1,US 2016/0030631 A1,177-674-779-012-718,2016-02-04,2016,US 201414774500 A,2014-03-13,US 201414774500 A;;US 201361783100 P;;US 2014/0026099 W,2013-03-14,Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis,"Bone filler compositions, methods of making and using the same, and methods of treating osteoporosis and cancer-induced bone defects, are described.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,THE UNIVERSITY OF TOLEDO (2015-09-21),https://lens.org/177-674-779-012-718,Patent Application,yes,3,6,7,7,3,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61L27/12;;A61K9/00;;A61K31/05;;A61K33/42;;A61K35/32;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/00;;A61L24/02;;A61L24/08;;A61L24/10;;A61L27/26;;A61L27/38;;A61L27/54;;C12N5/077,,2,1,089-044-067-170-367,22709649;;10.1016/j.addr.2012.05.017,"Zein, J Tissue Sci Eng 2011, 2:5, 3 pages;;Aoki et al., Peptide-based delivery to bone, Adv. Drug Del. Rev. 64 (2012) 1220-1238",DISCONTINUED
298,CA,A1,CA 2614860 A1,034-338-409-567-355,2007-01-18,2007,CA 2614860 A,2006-07-13,US 18135205 A;;EP 2006064239 W,2005-07-14,SYSTEM AND METHOD FOR DETECTING IMBALANCES IN DYNAMIC WORKLOAD SCHEDULING IN CLUSTERED ENVIRONMENTS,"Methods, systems and computer program products for detecting a workload imbalance in a dynamically scheduled cluster of computer servers are disclosed. One such method comprises the steps of monitoring a plurality of metrics at each of the computer servers, detecting change points in the plurality of metrics, generating alarm points based on the detected change points, correlating the alarm points and identifying, based on an outcome of the correlation, one or more of the computer servers causing a workload imbalance. Systems and computer program products for practicing the above method are also disclosed.",IBM,GHOSAL SUGATA;;ANEROUSIS NIKOS;;MANN VIJAY;;MUMMERT LILY B;;AGARWAL MANOJ K;;GUPTA MANISH,,https://lens.org/034-338-409-567-355,Patent Application,no,0,0,7,7,0,G06F9/5083;;G06F9/5083,G06F9/50,,0,0,,,,DISCONTINUED
299,US,A1,US 2013/0211208 A1,163-287-701-568-814,2013-08-15,2013,US 201213657854 A,2012-10-22,US 201213657854 A;;US 201213415698 A;;US 201161450423 P,2011-03-08,"SMART MATERIALS, DRY TEXTILE SENSORS, AND ELECTRONICS INTEGRATION IN CLOTHING, BED SHEETS, AND PILLOW CASES FOR NEUROLOGICAL, CARDIAC AND/OR PULMONARY MONITORING","Sensors mounted on a textile include at least one of electrically conductive textile electrodes; single or multiple optically coupled infrared and red emitter and photodiode or photo transistor; and thin film or Resistive Temperature Detector (RTD). Textile electrodes, electrical connections, and electrical functionalization use at least one of nanoparticles, nanostructures, and mesostructures. Conductive thread, for electrical connections, may include a fiber core made from conductive materials such as but not limited to metals, alloys, and graphine structures, and a sheath of insulating materials such as but not limited to nylon, polyester, and cotton.",VARADAN VIJAY K;;RAI PRATYUSH;;KUMAR PRASHANTH SHYAM;;MATHUR GYANESH N;;AGARWAL M P,VARADAN VIJAY K;;RAI PRATYUSH;;KUMAR PRASHANTH SHYAM;;MATHUR GYANESH N;;AGARWAL M P,NANOWEAR INC (2014-05-21),https://lens.org/163-287-701-568-814,Patent Application,yes,4,86,1,8,0,A61B5/6831;;A61B5/02125;;A61B5/14552;;A61B2562/046;;A61B2562/12;;A61B2562/125;;A61B2562/227;;A61B5/6804;;A61B5/02055;;A61B5/015;;A61B5/0002;;A61B5/25;;A61B5/291;;A61B5/6804;;A61B5/0075;;A61B5/02055;;A61B5/015;;A61B5/0002;;A61B5/14552;;A61B5/02125;;A61B2562/046;;A61B2562/125;;A61B2562/227;;A61B5/6831;;A61B2562/12;;A61B5/296;;A61B5/398;;A61B5/25;;A61B5/291,A61B5/00;;A61B5/01;;A61B5/0205;;A61B5/296,600/301;;600/300,0,0,,,,DISCONTINUED
300,CN,A,CN 105263438 A,079-294-310-866-76X,2016-01-20,2016,CN 201480027123 A,2014-03-13,US 2014/0026099 W;;US 201361783100 P,2013-03-14,Injectable biodegradable bone matrix for multiple myeloma lesion augmentation and osteoporosis,"Bone filler compositions, methods of making and using the same, and methods of treating osteoporosis and cancer-induced bone defects, are described.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/079-294-310-866-76X,Patent Application,no,3,7,7,7,0,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61F2/00;;A01N59/26;;A61K33/42;;A61K38/08;;A61P19/10,,5,2,151-393-867-111-965;;076-861-619-896-624,10.1002/masy.200900171;;10.4061/2011/674287;;pmc3138058;;21776341,"CHARLOTTE A.E. HAUSER ET AL: ""Designer Self-Assembling Peptide Materials for Diverse Applications"", 《MACROMOL. SYMP》;;UEON SANG SHIN ET AL: ""Carbon Nanotubes in Nanocomposites and Hybrids with Hydroxyapatite for Bone Replacements"", 《JOURNAL OF TISSUE ENGINEERING》;;唐海: ""《椎体成形术及椎体后凸成形术》"", 31 December 2012;;余家会等: ""《纳米生物医药》"", 31 December 2011;;KEAN-KHOON CHEW等: ""Reinforcement of calcium phosphate cement with multi-walled carbon nanotubes and bovine serum albumin for injectable bone substitute applications"", 《JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS》",DISCONTINUED
301,US,A1,US 2023/0146593 A1,097-262-480-361-63X,2023-05-11,2023,US 202117910698 A,2021-03-12,US 202117910698 A;;US 202062988489 P;;US 2021/0022073 W,2020-03-12,METHOD FOR TREATMENT AND PROPHYLAXIS OF CRS IN PATIENTS COMPRISING A COMBINATION OF BISPECIFIC ANTIBODIES BINDING TO CDS X CANCER CELL AND TNF ALPHA OR IL-6 INHIBITOR,"The present invention relates to medical combination products comprising (i) at least one antibody construct comprising at least one domain which binds to a target antigen expressed on the surface of a cell and at least one other domain which binds to CD3 as well as (ii) at least one molecule that is inhibitor/antagonist of TNF/TNFR reducing TNF/TNFR signaling and/or an inhibitor/antagonist of IL6/IL6R that reduces IL6/IL6R signaling, wherein a first dose of said inhibitor/antagonist is administered before administration of a first dose of said antibody construct. Furthermore, the invention provides therapeutic and preventive methods and medical uses of said combination products, as well as a kit comprising said at least one antibody construct and at least one antagonist/inhibitor of TNF or IL6 or its cognate receptor, wherein the interaction of said antagonist/inhibitor of TNF or an inhibitor/antagonist of IL6 with its cognate receptor reduces, mitigates, prevents, or treats cytokine release syndrome.",AMGEN INC,KHALDOYANIDI SOPHIA K;;NAGORSEN DIRK;;ARVEDSON TARA;;AGARWAL SURESH;;UPRETI VIJAY VISHESH;;YEA STEVEN,AMGEN INC (2022-09-27),https://lens.org/097-262-480-361-63X,Patent Application,yes,0,0,4,4,1295,A61K2039/507;;C07K16/241;;C07K16/2809;;C07K16/2803;;C07K2317/31;;C07K2319/30;;A61P35/02;;A61K39/39558;;C07K16/30;;C07K16/248;;C07K2317/622;;C07K16/2863;;A61K31/573;;C07K16/3069;;C07K2317/30;;A61K45/06;;C07K14/7151;;C07K14/7155;;A61P35/00;;A61K38/1793;;A61K39/3955;;A61K45/06,A61K39/395;;A61K38/17;;A61K45/06;;A61P35/00,,0,0,,,,PENDING
302,WO,A3,WO 2014/160232 A3,001-508-939-093-099,2014-11-27,2014,US 2014/0026099 W,2014-03-13,US 201361783100 P,2013-03-14,INJECTABLE BIODEGRADABLE BONE MATRIX FOR MULTIPLE MYELOMA LESION AUGMENTATION AND OSTEOPOROSIS,"Bone filler compositions, methods of making and using the same, and methods of treating osteoporosis and cancer-induced bone defects, are described.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/001-508-939-093-099,Search Report,yes,2,0,7,7,3,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61F2/00;;A01N59/26;;A61K33/42;;A61K38/08;;A61P19/10,,2,2,151-393-867-111-965;;009-724-729-640-979,10.1002/masy.200900171;;20093139;;10.1016/j.ijbiomac.2010.01.006,"HAUSER ET AL.: ""Designer Self-Assembling Peptide Materials for Diverse Applications."", MACROMOLECULAR SYMPOSIA, vol. 295, no. 1, 2010, pages 30 - 48, XP055284383;;SAHITHI ET AL.: ""Polymeric composites containing carbon nanotubes for bone tissue engineering"", INT J BIOL MACROMOL., vol. 46, no. 3, 2010, pages 281 - 283, XP026937518",PENDING
303,EP,A1,EP 4118113 A1,174-343-374-748-051,2023-01-18,2023,EP 21716043 A,2021-03-12,US 202062988489 P;;US 2021/0022073 W,2020-03-12,METHOD FOR TREATMENT AND PROPHYLAXIS OF CRS IN PATIENTS COMPRISING A COMBINATION OF BISPECIFC ANTIBODIES BINDING TO CDS X CANCER CELL AND TNFALPHA OR IL-6 INHIBITOR,,AMGEN INC,KHALDOYANIDI SOPHIA K;;NAGORSEN DIRK;;ARVEDSON TARA;;AGARWAL SURESH;;UPRETI VIJAY VISHESH;;YEA STEVEN,,https://lens.org/174-343-374-748-051,Patent Application,yes,0,0,4,4,0,A61K2039/507;;C07K16/241;;C07K16/2809;;C07K16/2803;;C07K2317/31;;C07K2319/30;;A61P35/02;;A61K39/39558;;C07K16/30;;C07K16/248;;C07K2317/622;;C07K16/2863;;A61K31/573;;C07K16/3069;;C07K2317/30;;A61K45/06;;C07K14/7151;;C07K14/7155;;A61P35/00;;A61K38/1793;;A61K39/3955;;A61K45/06,C07K16/24;;A61K31/573;;A61K39/395;;A61P35/02;;C07K14/715;;C07K16/28;;C07K16/30,,0,0,,,,PENDING
304,EP,B1,EP 2967801 B1,111-320-533-227-29X,2020-07-08,2020,EP 14773377 A,2014-03-13,US 201361783100 P;;US 2014/0026099 W,2013-03-14,INJECTABLE BIODEGRADABLE BONE MATRIX FOR MULTIPLE MYELOMA LESION AUGMENTATION AND OSTEOPOROSIS,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;BHADURI SARIT B;;LIN BOREN,,https://lens.org/111-320-533-227-29X,Granted Patent,yes,5,0,7,7,0,A61K35/32;;A61K38/12;;A61K38/1793;;A61L2400/12;;A61L27/227;;A61L24/0063;;A61L2400/06;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61L27/425;;A61L2300/252;;A61L2300/432;;A61L2300/62;;A61L24/10;;A61L27/12;;A61K31/05;;A61K38/05;;A61K38/08;;A61L2430/02;;A61P19/10;;A61L27/3821;;A61L27/54;;A61L24/0015;;A61L24/02;;A61L24/108;;A61K35/32;;A61L2400/12;;A61K38/12;;A61L27/227;;A61L2400/06;;A61K38/1793;;A61L24/0063;;A61L27/425;;A61L2300/252;;A61L2300/62;;A61L2300/432;;A61L24/10;;A61L27/12;;A61K9/0024;;A61K31/05;;A61K33/42;;A61K35/545;;A61K38/05;;A61K38/08;;A61K45/06;;A61L24/0005;;A61L24/08;;A61L27/26;;A61L27/3847;;A61L27/3895;;A61L2430/02;;C12N5/0654;;C12N2506/03,A61L24/00;;A61K31/05;;A61K35/32;;A61K38/05;;A61K38/08;;A61K38/12;;A61K38/17;;A61L24/02;;A61L24/10,,5,0,,,"KAZUHIRO AOKI ET AL: ""Peptide-based delivery to bone"", ADVANCED DRUG DELIVERY REVIEWS, vol. 64, no. 12, 1 September 2012 (2012-09-01), pages 1220-1238, XP055307966, AMSTERDAM, NL ISSN: 0169-409X, DOI: 10.1016/j.addr.2012.05.017;;CHARLOTTE A.E. HAUSER ET AL: ""Designer Self-Assembling Peptide Materials for Diverse Applications"", MACROMOLECULAR SYMPOSIA., vol. 295, no. 1, 1 September 2010 (2010-09-01), pages 30-48, XP055284383, DE ISSN: 1022-1360, DOI: 10.1002/masy.200900171;;SAHITHI K ET AL: ""Polymeric composites containing carbon nanotubes for bone tissue engineering"", INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, ELSEVIER BV, NL, vol. 46, no. 3, 1 April 2010 (2010-04-01), pages 281-283, XP026937518, ISSN: 0141-8130, DOI: 10.1016/J.IJBIOMAC.2010.01.006 [retrieved on 2010-03-03];;HAUSER ET AL.: 'Designer Self-Assembling Peptide Materials for Diverse Applications.' MACROMOLECULAR SYMPOSIA vol. 295, no. 1, 2010, pages 30 - 48, XP055284383;;SAHITHI ET AL.: 'Polymeric composites containing carbon nanotubes for bone tissue engineering' INT J BIOL MACROMOL. vol. 46, no. 3, 2010, pages 281 - 283, XP026937518",ACTIVE
305,TW,A,TW 202200615 A,152-175-222-698-309,2022-01-01,2022,TW 110109009 A,2021-03-12,US 202062988489 P,2020-03-12,Method for treatment and prophylaxis of CRS in patients,"The present invention relates to medical combination products comprising (i) at least one antibody construct comprising at least one domain which binds to a target antigen expressed on the surface of a cell and at least one other domain which binds to CD3 as well as (ii) at least one molecule that is an antagonist of / an inhibitor of signaling, which is based on an interaction of TNF with its cognate receptor (TNFR), wherein the antagonisation or the inhibition of TNF or its cognate receptor prevents, reduces, or blocks TNF/TNFR-mediated signaling. Furthermore, the invention provides therapeutic and preventive methods and medical uses of said combination products, as well as a kit comprising said at least one antibody construct and at least one antagonist / inhibitor of TNF or its cognate receptor, wherein the interaction of said antagonist / inhibitor of TNF with its cognate receptor reduces, mitigates, prevents, or treats cytokine release syndrome.",AMGEN INC,KHALDOYANIDI SOPHIA K;;NAGORSEN DIRK;;ARVEDSON TARA;;AGARWAL SURESH;;UPRETI VIJAY VISHESH;;YEA STEVEN,,https://lens.org/152-175-222-698-309,Patent of Addition,no,0,0,4,4,0,A61K2039/507;;C07K16/241;;C07K16/2809;;C07K16/2803;;C07K2317/31;;C07K2319/30;;A61P35/02;;A61K39/39558;;C07K16/30;;C07K16/248;;C07K2317/622;;C07K16/2863;;A61K31/573;;C07K16/3069;;C07K2317/30;;A61K45/06;;C07K14/7151;;C07K14/7155;;A61P35/00;;A61K38/1793;;A61K39/3955;;A61K45/06,C07K16/24;;A61K39/395;;A61P35/00;;C07K14/715;;C07K16/28,,0,0,,,,PENDING
306,US,A1,US 2010/0094870 A1,124-138-328-516-843,2010-04-15,2010,US 24843008 A,2008-10-09,US 24843008 A,2008-10-09,METHOD FOR MASSIVELY PARALLEL MULTI-CORE TEXT INDEXING,"There is provided, in a parallel pipelined structure on a multi-core device, a method for parallel pipelined multi-core indexing. The method includes generating one or more single document indexes respectively corresponding to one or more single documents of a given data stream. The method further includes generating one or more multi-document interval-based hash tables from the one or more single document indexes. The method also includes generating a global hash table formed from merging one or more of the multi-document interval-based hash tables, the global hash table representing a collective index for all of the single documents for which the one or more single document indexes were generated.",NARANG ANKUR;;AGARWAL VIKAS;;GARG VIJAY KUMAR;;JOSEPH DOUGLAS JAMES;;KEDIA MONU;;MICHAEL MAGAD M,NARANG ANKUR;;AGARWAL VIKAS;;GARG VIJAY KUMAR;;JOSEPH DOUGLAS JAMES;;KEDIA MONU;;MICHAEL MAGAD M,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-29),https://lens.org/124-138-328-516-843,Patent Application,yes,8,18,2,2,0,G06F16/93;;G06F16/93,G06F17/30;;G06F9/00,707/736;;712/28;;X707E17002;;X712E09001,0,0,,,,INACTIVE
307,IN,B,IN 191622 B,017-763-861-462-200,2003-12-06,2003,IN 215DE2000 A,2000-03-09,IN 215DE2000 A,2000-03-09,A process for the production of biologically active phenolic compound (+) catechin from taxus wallichiana tissue cultures,,COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUMAR;;BENERJEE SUCHITRA;;AGARWAL SHIPRA;;KULSHIRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR,,https://lens.org/017-763-861-462-200,Granted Patent,no,0,0,1,1,0,,A61K31/15;;C07D311/62,,0,0,,,,EXPIRED
308,US,B2,US 10121157 B2,168-255-764-396-728,2018-11-06,2018,US 201514690321 A,2015-04-17,US 201514690321 A,2015-04-17,Recommending user actions based on collective intelligence for a multi-tenant data analysis system,"A multi-tenant system stores data for customers. The multi-tenant system presents user interfaces allowing users associated with the customers to perform analysis of data stored for the customer. The multi-tenant system determines recommendations for subsequent user actions that can be performed by a user in a context. The context includes a report being analyzed, a type of visualization of the report, one or more interactions performed by the user with the report, and so on. The multi-tenant system presents one or more widgets based on the recommendations that allow the user to perform the recommended action. The multi-tenant system may determine a recommendation based on past interactions of a subset of users of the multi-tenant system, for example, users associated with a type of industry, users having a particular role in an organization, or a level of experience of the user with analysis of data.",GOODDATA CORP,AGARWAL GAURAV VIJAY;;VLCEK JAN;;CHRISTIE-BLICK WINSTON;;{HACEK OVER (S)}TENCL MICHAEL;;MATULA MARTIN,GOODDATA CORPORATION (2015-04-17),https://lens.org/168-255-764-396-728,Granted Patent,yes,1,3,3,3,0,G06Q30/0201;;G06Q30/0201;;G06F3/0484;;G06F16/24578;;G06F16/24578;;G06Q10/06316;;G06Q10/06316,G06Q10/00;;G06F3/0484;;G06F17/30;;G06Q10/06;;G06Q30/02,,1,0,,,"PCT International Search Report and Written Opinion, PCT Application No. PCT/US2016/26296, dated Sep. 26, 2016, ten pages.",ACTIVE
309,US,B2,US 8229916 B2,105-211-043-501-348,2012-07-24,2012,US 24843008 A,2008-10-09,US 24843008 A,2008-10-09,Method for massively parallel multi-core text indexing,"There is provided, in a parallel pipelined structure on a multi-core device, a method for parallel pipelined multi-core indexing. The method includes generating one or more single document indexes respectively corresponding to one or more single documents of a given data stream. The method further includes generating one or more multi-document interval-based hash tables from the one or more single document indexes. The method also includes generating a global hash table formed from merging one or more of the multi-document interval-based hash tables, the global hash table representing a collective index for all of the single documents for which the one or more single document indexes were generated.",NARANG ANKUR;;AGARWAL VIKAS;;GARG VIJAY KUMAR;;JOSEPH DOUGLAS JAMES;;KEDIA MONU;;MICHAEL MAGED M;;IBM,NARANG ANKUR;;AGARWAL VIKAS;;GARG VIJAY KUMAR;;JOSEPH DOUGLAS JAMES;;KEDIA MONU;;MICHAEL MAGED M,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-09-29),https://lens.org/105-211-043-501-348,Granted Patent,yes,8,4,2,2,0,G06F16/93;;G06F16/93,G06F17/30,707/711,1,0,,,"lnderjit S. Dhillon, Efficient Clustering of Very Large Document Collections, 2001, userweb.cs.utexas.edu.",INACTIVE
310,WO,A1,WO 2014/164654 A1,197-894-680-498-383,2014-10-09,2014,US 2014/0023126 W,2014-03-11,US 201361775939 P,2013-03-11,"A BIOSENSOR DEVICE TO TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The transducer component includes the electrode and microprocessor configured to screen noise and to pick up impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,,https://lens.org/197-894-680-498-383,Patent Application,yes,7,7,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N33/50,,1,0,,,See also references of EP 2972333A4,PENDING
311,EP,B1,EP 2972333 B1,115-595-267-671-854,2018-09-19,2018,EP 14779197 A,2014-03-11,US 201361775939 P;;US 2014/0023126 W,2013-03-11,"A BIOSENSOR DEVICE TO TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME",,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,THE UNIVERSITY OF TOLEDO (2018-05-23),https://lens.org/115-595-267-671-854,Granted Patent,yes,0,2,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N33/50,,1,1,135-222-185-215-795,10.1016/s0927-7765(99)00148-4;;10915944,"NATALIE WISNIEWSKI ET AL: ""Methods for reducing biosensor membrane biofouling"", COLLOIDS AND SURFACES. B, BIOINTERFACES, vol. 18, no. 3-4, 1 October 2000 (2000-10-01), NL, pages 197 - 219, XP055415442, ISSN: 0927-7765, DOI: 10.1016/S0927-7765(99)00148-4",ACTIVE
312,US,B2,US 10849540 B2,043-037-717-870-847,2020-12-01,2020,US 201414774499 A,2014-03-11,US 201414774499 A;;US 201361775939 P;;US 2014/0023126 W,2013-03-11,"Biosensor device to target analytes in situ, in vivo, and/or in real time, and methods of making and using the same","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The transducer component includes the electrode and microprocessor configured to screen noise and to pick up impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,THE UNIVERSITY OF TOLEDO (2015-09-18),https://lens.org/043-037-717-870-847,Granted Patent,yes,115,0,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,A61B5/00;;A61B5/145;;A61B5/1473;;G01N27/327;;G01N33/543;;G01N33/569,,9,4,015-444-964-677-844;;077-968-202-518-675;;020-529-262-073-177;;135-222-185-215-795,10.3390/s120811013;;23112644;;pmc3472872;;10.1016/j.electacta.2008.01.037;;pmc3376556;;10.3390/s120303449;;22737018;;10.1016/s0927-7765(99)00148-4;;10915944,"Carrara et al., “Fully Integrated Biochip Platforms for Advanced Healthcare”, Sensors, 2012, vol. 12, pp. 11013-11060.;;Geng et al., “Self-assembled monolayers-based immunosensor for detection of Escherichia coli using electrochemical impedance spectroscopy”, Electrochimica Acta 53, 2008, pp. 4663-4668.;;Wang et al., “New Trends in Impedimetric Biosensors for the Detection of Foodbome Pathogenic Bacteria”, Sensors, 2012, vol. 12, pp. 3449-3471.;;Wisniewski et al., “Methods for reducing biosensor membrane biofouling”, Colloids and Surfaces B: Biointerfaces, 2000, vol. 18, pp. 197-219.;;Zheng, “The development of an aptamer-based surface plasmon resonance (SPR) sensor of the real-time detection of glycated protein”, The University of Toledo, Theses and Dissertation, 2012, pp. 1-206.;;European Examination Report, Application No. EP14779197.4 dated Oct. 20, 2017.;;Second Chinese Office Action, Application No. 201480026380.4, dated Jun. 13, 2017.;;PCT International Search Report and the Written Opinion, Application No. PCT/US2014/023126 filed Mar. 11, 2014, dated Jul. 9, 2014.;;Intellectual Property India, Examination report under sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003, Application No. 6073/CHENP/2015, dated Mar. 3, 2020.",ACTIVE
313,CN,A,CN 105190310 A,037-931-141-925-84X,2015-12-23,2015,CN 201480026380 A,2014-03-11,US 2014/0023126 W;;US 201361775939 P,2013-03-11,"A biosensor device to target analytes in situ, in vivo, and/or in real time, and methods of making and using the same","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The transducer component includes the electrode and microprocessor configured to screen noise and to pick up impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,,https://lens.org/037-931-141-925-84X,Patent Application,no,9,6,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N33/50,,0,0,,,,INACTIVE
314,EP,A4,EP 2972333 A4,164-190-321-926-734,2016-11-09,2016,EP 14779197 A,2014-03-11,US 201361775939 P;;US 2014/0023126 W,2013-03-11,"A BIOSENSOR DEVICE TO TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME",,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,THE UNIVERSITY OF TOLEDO (2018-05-23),https://lens.org/164-190-321-926-734,Search Report,no,0,0,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N33/50,,5,3,077-968-202-518-675;;020-529-262-073-177;;015-444-964-677-844,10.1016/j.electacta.2008.01.037;;pmc3376556;;10.3390/s120303449;;22737018;;10.3390/s120811013;;23112644;;pmc3472872,"RUI ZHENG: ""The development of an aptamer-based surface plasmon resonance (SPR) sensor for the real-time detection of glycated protein"", 1 December 2012 (2012-12-01), XP055304905, Retrieved from the Internet <URL:http://utdr.utoledo.edu/cgi/viewcontent.cgi?article=1517&context=theses-dissertations> [retrieved on 20160922];;GENG ET AL: ""Self-assembled monolayers-based immunosensor for detection of Escherichia coli using electrochemical impedance spectroscopy"", ELECTROCHIMICA ACTA, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 53, no. 14, 20 January 2008 (2008-01-20), pages 4663 - 4668, XP022561480, ISSN: 0013-4686;;YIXIAN WANG ET AL: ""New Trends in Impedimetric Biosensors for the Detection of Foodborne Pathogenic Bacteria"", SENSORS, vol. 12, no. 12, 12 March 2012 (2012-03-12), pages 3449 - 3471, XP055184383, DOI: 10.3390/s120303449;;SANDRO CARRARA ET AL: ""Fully Integrated Biochip Platforms for Advanced Healthcare"", SENSORS, vol. 12, no. 12, 8 August 2012 (2012-08-08), pages 11013 - 11060, XP055305525, DOI: 10.3390/s120811013;;See also references of WO 2014164654A1",ACTIVE
315,EP,A1,EP 2972333 A1,134-362-641-789-433,2016-01-20,2016,EP 14779197 A,2014-03-11,US 201361775939 P;;US 2014/0023126 W,2013-03-11,"A BIOSENSOR DEVICE TO TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME",,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,THE UNIVERSITY OF TOLEDO (2018-05-23),https://lens.org/134-362-641-789-433,Patent Application,yes,0,0,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N33/50,,0,0,,,,ACTIVE
316,US,A1,US 2016/0022185 A1,196-353-431-185-273,2016-01-28,2016,US 201414774499 A,2014-03-11,US 201414774499 A;;US 201361775939 P;;US 2014/0023126 W,2013-03-11,"A Biosensor Device to Target Analytes in Situ, in Vivo, and/or in Real Time, and Methods of Making and Using the Same","A biosensor device for the real-time detection of a target analyte includes a receptor component operatively connected to a transducer component which is adapted to interpret and transmit a detectable signal. The receptor component includes a sensing element capable of detecting and binding to at least one target analyte, and a self-assembled monolayer (SAM) layer. The SAM layer is positioned between and in contact with the sensing element and an electrode such that the sensing element, in the presence of the target analyte, causes a detectable signal capable of being transmitted to the electrode. The transducer component includes the electrode and microprocessor configured to screen noise and to pick up impedance change at a very low frequency range.",UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;KIM DONG-SHIK;;YOON DO-YOUNG;;LIN BOREN;;FEYZIZARNAGH HAMID,THE UNIVERSITY OF TOLEDO (2015-09-18),https://lens.org/196-353-431-185-273,Patent Application,yes,28,43,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,A61B5/1473;;A61B5/00;;A61B5/145;;G01N27/327,,0,0,,,,ACTIVE
317,WO,A1,WO 2021/072200 A1,130-464-865-351-512,2021-04-15,2021,US 2020/0054995 W,2020-10-09,US 201962914474 P,2019-10-12,WAFER HEATER WITH BACKSIDE AND INTEGRATED BEVEL PURGE,"Substrate supports comprising a plurality of bonded plates forming a single component support body and methods of forming the substrate supports are described. The single component support body has an outer peripheral edge, a top surface and a bottom surface. A pocket is formed in the top surface and has a bottom surface, a depth and an outer peripheral edge. A purge ring is spaced a distance from the outer peripheral edge and comprises at least one opening in the top surface in fluid communication with a purge gas line within the body thickness.",APPLIED MATERIALS INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,,https://lens.org/130-464-865-351-512,Patent Application,yes,5,0,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,H01L21/687;;C23C16/455;;C23C16/458;;H01L21/67;;H01L21/683;;H05B3/00;;H05B3/20,,0,0,,,,PENDING
318,TW,A,TW 202117918 A,192-401-470-025-924,2021-05-01,2021,TW 109135118 A,2020-10-12,US 201962914474 P,2019-10-12,Wafer heater with backside and integrated bevel purge,"Substrate supports comprising a plurality of bonded plates forming a single component support body and methods of forming the substrate supports are described. The single component support body has an outer peripheral edge, a top surface and a bottom surface. A pocket is formed in the top surface and has a bottom surface, a depth and an outer peripheral edge. A purge ring is spaced a distance from the outer peripheral edge and comprises at least one opening in the top surface in fluid communication with a purge gas line within the body thickness.",APPLIED MATERIALS INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,,https://lens.org/192-401-470-025-924,Patent of Addition,no,0,0,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,H01L21/683;;B08B5/00;;H01L23/34,,0,0,,,,PENDING
319,GB,A,GB 2360516 A,105-741-283-560-134,2001-09-26,2001,GB 0007057 A,2000-03-24,GB 0007057 A;;JP 2000088563 A;;US 53576700 A,2000-03-24,Preparation of (+)Catechin,"A process for the production of a biologically active (+) catechin from <I>Taxus wallichiana</I> tissue cultures, comprising the steps of (a) inoculating the explants <I>Taxus wallichiana</I> on a culture medium supplemented with combinations of auxins and cytokinins, (b) incubating the cultures under continuous light or dark conditions for 4-6 weeks for callus initiation followed by subculturing at 4-6 weeks intervals, ( c) extracting the fresh pulverized calli with polar solvents at room temperature; (d) evaporating the solvent to obtain a residue; and (e) treating the residue with a chlorinated solvent and isolating (+) catechin compound by filtration.",COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUNAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR;;KUMAR SUSHIL,,https://lens.org/105-741-283-560-134,Patent Application,no,0,0,5,5,0,C07D311/60;;C07D311/60,C07D311/60;;C12P17/06;;C12N1/00;;C12N5/02;;C12R1/91,C2C CVA;;C2C CWE;;C2C C1673;;C2C C20Y;;C2C C213;;C2C C220;;C2C C25Y;;C2C C253;;C2C C30Y;;C2C C306;;C2C C36Y;;C2C C365;;C2C C43X;;C2C C643;;C2C C662;;C2C C672;;C2C C774;;C6Y Y420,0,0,,,,EXPIRED
320,WO,A3,WO 2008/097490 A3,114-618-899-856-462,2008-10-16,2008,US 2008/0001416 W,2008-01-31,US 70181107 A,2007-02-02,A METHOD AND AN APPARATUS TO DISAMBIGUATE REQUESTS,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",NUANCE COMMUNICATIONS INC;;AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,,https://lens.org/114-618-899-856-462,Search Report,yes,4,0,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,G06F7/00,,0,0,,,,PENDING
321,US,A1,US 2021/0111059 A1,128-788-771-623-870,2021-04-15,2021,US 202017066974 A,2020-10-09,US 202017066974 A;;US 201962914474 P,2019-10-12,Wafer Heater With Backside And Integrated Bevel Purge,"Substrate supports comprising a plurality of bonded plates forming a single component support body and methods of forming the substrate supports are described. The single component support body has an outer peripheral edge, a top surface and a bottom surface. A pocket is formed in the top surface and has a bottom surface, a depth and an outer peripheral edge. A purge ring is spaced a distance from the outer peripheral edge and comprises at least one opening in the top surface in fluid communication with a purge gas line within the body thickness.",APPLIED MATERIALS INC;;APPLIES MAT INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,APPLIED MATERIALS INC (2020-10-14),https://lens.org/128-788-771-623-870,Patent Application,yes,3,2,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,H01L21/683;;C23C16/455;;C23C16/458;;H01L21/67,,0,0,,,,DISCONTINUED
322,US,A1,US 2023/0113057 A1,178-756-361-921-354,2023-04-13,2023,US 202218080421 A,2022-12-13,US 202218080421 A;;US 202017066974 A;;US 201962914474 P,2019-10-12,Wafer Heater With Backside And Integrated Bevel Purge,"Substrate supports comprising a plurality of bonded plates forming a single component support body and methods of forming the substrate supports are described. The single component support body has an outer peripheral edge, a top surface and a bottom surface. A pocket is formed in the top surface and has a bottom surface, a depth and an outer peripheral edge. A purge ring is spaced a distance from the outer peripheral edge and comprises at least one opening in the top surface in fluid communication with a purge gas line within the body thickness.",APPLIED MATERIALS INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,APPLIED MATERIALS INC (2020-10-14),https://lens.org/178-756-361-921-354,Patent Application,yes,3,0,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,C23C16/458;;H01L21/683;;H01L21/67,,0,0,,,,ACTIVE
323,GB,B,GB 2360516 B,177-992-112-427-759,2004-07-14,2004,GB 0007057 A,2000-03-24,GB 0007057 A;;JP 2000088563 A;;US 53576700 A,2000-03-24,A process for the production of a biologically active phenolic compound (+) catechin,,COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUNAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR;;KUMAR SUSHIL,,https://lens.org/177-992-112-427-759,Granted Patent,no,0,0,5,5,0,C07D311/60;;C07D311/60,C07D311/60;;C12P17/06;;C12N1/00;;C12N5/02;;C12R1/91,C2C CVA;;C2C CWE;;C2C C1673;;C2C C20Y;;C2C C213;;C2C C220;;C2C C25Y;;C2C C253;;C2C C30Y;;C2C C306;;C2C C36Y;;C2C C365;;C2C C43X;;C2C C643;;C2C C662;;C2C C672;;C2C C774;;C6Y Y420,0,0,,,,EXPIRED
324,US,A1,US 2008/0187121 A1,014-137-153-281-102,2008-08-07,2008,US 70181107 A,2007-02-02,US 70181107 A;;US 69989907 A,2007-01-29,Method and an apparatus to disambiguate requests,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,NUANCE COMMUNICATIONS INC (2007-05-07),https://lens.org/014-137-153-281-102,Patent Application,yes,14,22,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,H04M3/42,379/218.01,0,0,,,,ACTIVE
325,US,B2,US 11769684 B2,182-707-096-346-830,2023-09-26,2023,US 202218080421 A,2022-12-13,US 202218080421 A;;US 202017066974 A;;US 201962914474 P,2019-10-12,Wafer heater with backside and integrated bevel purge,"Substrate supports comprising a plurality of bonded plates forming a single component support body and methods of forming the substrate supports are described. The single component support body has an outer peripheral edge, a top surface and a bottom surface. A pocket is formed in the top surface and has a bottom surface, a depth and an outer peripheral edge. A purge ring is spaced a distance from the outer peripheral edge and comprises at least one opening in the top surface in fluid communication with a purge gas line within the body thickness.",APPLIED MATERIALS INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,APPLIED MATERIALS INC (2020-10-14),https://lens.org/182-707-096-346-830,Granted Patent,yes,16,0,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,H01T23/00;;C23C16/455;;C23C16/458;;H01L21/67;;H01L21/683,,2,1,002-190-474-226-400,10.1108/978-1-78756-721-420191004,"PCT International Search Report and Written Opinion in PCT/US2020/054995 dated Jan. 28, 2021, 14 pages.;;Machine Translation of JP2016189425, 37 pages.",ACTIVE
326,US,B2,US 9131050 B2,006-717-618-311-043,2015-09-08,2015,US 201213456144 A,2012-04-25,US 201213456144 A;;US 70181107 A;;US 69989907 A,2007-01-29,Method and an apparatus to disambiguate requests,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR;;NUANCE COMMUNICATIONS INC,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,MICROSOFT TECHNOLOGY LICENSING LLC (2023-09-20),https://lens.org/006-717-618-311-043,Granted Patent,yes,20,0,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,H04M3/42;;H04M3/493,,0,0,,,,ACTIVE
327,KR,A,KR 20220079650 A,088-084-369-777-092,2022-06-13,2022,KR 20227015679 A,2020-10-09,US 201962914474 P;;US 2020/0054995 W,2019-10-12,통합된 베벨 퍼지 기능 및 후면을 갖는 웨이퍼 가열기,"단일 컴포넌트 지지 바디를 형성하는 복수의 본딩된 플레이트들을 포함하는 기판 지지부들 및 기판 지지부들을 형성하는 방법들이 설명된다. 단일 컴포넌트 지지 바디는 외측 주변 에지, 최상부 표면 및 최하부 표면을 갖는다. 포켓은 최상부 표면에 형성되고, 최하부 표면, 깊이 및 외측 주변 에지를 갖는다. 퍼지 링은 외측 주변 에지로부터 일정 거리만큼 이격되며, 바디 두께 내에서 퍼지 가스 라인과 유체 연통하는, 최상부 표면 내의 적어도 하나의 개구를 포함한다.",APPLIED MATERIALS INC,ULAVI TEJAS;;PARKHE VIJAY D;;NAGARAJA NAVEEN KUMAR;;BALUJA SANJEEV;;KUMAR SURAJIT;;KASHYAP DHRITIMAN SUBHA;;AGARWAL ASHUTOSH,,https://lens.org/088-084-369-777-092,Patent Application,no,0,0,7,7,0,H01L21/67103;;H01L21/68735;;H01L21/6831;;H01L21/67109;;H01L21/67248;;C23C16/4586;;C23C16/45521;;C23C16/4585;;C23C16/52;;C23C16/46;;H01L21/68735;;C23C16/4586;;H01L21/67103;;H01L21/67109;;H01L21/67248;;H01L21/6833;;H01L21/6833;;H01L21/67103;;C23C16/45544;;C23C16/4585;;C23C16/4586;;H01L21/67248,H01L21/687;;C23C16/458;;H01L21/67;;H01L21/683,,0,0,,,,DISCONTINUED
328,US,B2,US 8175248 B2,121-578-706-034-80X,2012-05-08,2012,US 70181107 A,2007-02-02,US 70181107 A;;US 69989907 A,2007-01-29,Method and an apparatus to disambiguate requests,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR;;NUANCE COMMUNICATIONS INC,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,NUANCE COMMUNICATIONS INC (2007-05-07),https://lens.org/121-578-706-034-80X,Granted Patent,yes,14,5,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,H04M3/42,379/218.01;;379/218.02,1,0,,,"PCT Search Report and Written Opinion, PCT/US08/01416, mailed on Aug. 1, 2008, 10 pages.",ACTIVE
329,WO,A2,WO 2008/097490 A2,189-364-695-619-768,2008-08-14,2008,US 2008/0001416 W,2008-01-31,US 70181107 A,2007-02-02,A METHOD AND AN APPARATUS TO DISAMBIGUATE REQUESTS,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",NUANCE COMMUNICATIONS INC;;AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,,https://lens.org/189-364-695-619-768,Patent Application,yes,0,0,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,H04M3/42,,0,0,,,,PENDING
330,US,A1,US 2012/0209594 A1,000-593-248-770-727,2012-08-16,2012,US 201213456144 A,2012-04-25,US 201213456144 A;;US 70181107 A;;US 69989907 A,2007-01-29,METHOD AND AN APPARATUS TO DISAMBIGUATE REQUESTS,"A method and an apparatus to disambiguate requests are presented. In one embodiment, the method includes receiving a request for information from a user. Then data is retrieved from a back-end database in response to the request. Based on a predetermined configuration of a disambiguation system and the data retrieved, the ambiguity within the request is dynamically resolved.",AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,AGARWAL RAJEEV;;ARDMAN DAVID;;MASTER MUNEEB;;MAURO DAVID ANDREW;;RAMAN VIJAY R;;ULUG AMY E;;VALLI ZULFIKAR,MICROSOFT TECHNOLOGY LICENSING LLC (2023-09-20),https://lens.org/000-593-248-770-727,Patent Application,yes,6,17,6,6,0,G06F16/33;;H04M3/4931;;H04M3/4931;;H04M2201/10;;H04M2201/10;;H04M2201/39;;H04M2201/39;;H04M2201/40;;H04M2201/40,G06F17/30;;G06F17/27,704/9;;707/722;;X707E17014;;X707E17044,0,0,,,,ACTIVE
331,US,B1,US 6620599 B1,170-237-081-539-139,2003-09-16,2003,US 53580600 A,2000-03-28,US 53580600 A,2000-03-28,Process for the production of a biologically active phenolic compound(+) catechin,"
    The invention provides a process for the production of a biologically active phenolic compound () catechin from Taxus wallichiana tissue cultures, said process comprising the steps of (a) inoculating the of explants on a culture medium supplemented with combinations of auxins and cytokinins, (b) incubating the cultures under continuous light or dark conditions for 4-6 weeks for callus initiation followed by subculturing at 4-6 weeks intervals, (c) extracting the fresh pulverized calli with polar solvents at room temperature; (d) evaporating the solvent to obtain a residue; and (e) treating the residue with a chlorinated solvent and isolating () catechin compound by filtration. 
",COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUMAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR;;KUMAR SUSHIL,COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (2000-04-17),https://lens.org/170-237-081-539-139,Granted Patent,yes,1,3,1,1,0,C12N5/0025;;C12N5/04;;C12P17/06;;C12P17/06;;C12N5/0025;;C12N5/04,C12N5/00;;C12N5/04;;C12P17/06,435/123;;435/119;;435/118;;435/117;;435/155,11,8,124-437-014-753-205;;042-222-971-281-173;;057-779-849-768-976;;082-320-331-986-028;;022-037-404-682-296;;118-769-693-026-66X;;092-981-933-230-472;;012-453-218-625-052,10.1016/0031-9422(93)85231-f;;10.1016/s0031-9422(98)00426-9;;10.1016/s0031-9422(00)90397-2;;10.1016/0031-9422(92)80267-i;;10.1007/bf00039697;;10.1016/0031-9422(81)83001-4;;10.1055/s-2006-957424;;9581525;;10.1016/0031-9422(89)80191-8,"Chattopadhyay et al., Chattopadhyay, S.K., et al., Indian J. Chem., Sect B: Org. Chem. Incl. Med. chem. (1999), vol. 38B(2), pp. 246-247.*;;Banergee et al., Planta Medica (1996), 62(4), 333-335.*;;Sigma Plant Cell Culture Catalogue, 1991-92, pp. 7-11.*;;F. Trotin et al., ""Flavanol production of fagopyrum esculetum hairy and normal root cultures,"" Phytochemistry, vol. 32, No. 4, pps. 929-931, 1993.;;Kahn Ono et al., ""Catechin production in cultured poygonum hydropiper cells,"" Phytochemistry, vol. 49, No. 7, pps. 1935-1938, 1998.;;T. Bahorun et al., ""Comparative polyphenolic productions in crataegus monegyna callus cultures,"" Phytochemistry, vol. 3y7, No. 5, pps. 1273-1276, 1994.;;Y. Moumou et al., ""Catechin production by callus cultures of Fogopyrum esculentum"", Phytochemistry, vol. 31, No. 4, pps. 1239-1241, 1992.;;Mondher Jaziri et al., ""Taxus sp. Cell, tissue and organ cultures as alternative sources for taxoids production: a literature survey,"" Plant Cell, Tissue and Organ Culture 46:59-75, 1996.;;Eckhard Wollenweber et al., ""Occurrence and distribution of free flavonoid aglycones in plants,"" Phytochemistry, vol. 20, No. 5, pps. 869-932, 1981.;;S. Jha et al., ""Improved Taxol Yield in Cell Suspension Culture of Taxus wallichiana (Himalayan Yew),"" Plant Medica, vol. 64, pps. 270-272, 1998.;;Khoon-Huat Law et al., ""Production of(-) Epicatechin by Uncaria Elliptica Callus Cultures,"" Phytochemistry, vol. 28, No. 4, pps. 1099-1100, 1989.",EXPIRED
332,EP,A1,EP 0713591 A1,110-647-229-457-208,1996-05-29,1996,EP 95923818 A,1995-06-12,US 9507446 W;;US 25902794 A,1994-06-13,SYSTEM AND METHOD FOR GENERATING ELECTRICAL COMPONENT MODELS,,CADENCE DESIGN SYSTEMS INC,WOODRUFF KENNETH P;;AGARWAL ALOKKUMAR B;;DUNSKY NATAN;;VAN DYKE ERIC J;;MADHAVAN VIJAY C;;MCCANLIES ELIZABETH R,,https://lens.org/110-647-229-457-208,Patent Application,yes,0,0,7,7,0,G06F30/30;;G06F30/33;;G06F30/33;;G06F30/30;;G06F30/3308,G06F17/50,,0,0,,,,EXPIRED
333,EP,B1,EP 0713591 B1,171-002-204-306-352,2004-09-08,2004,EP 95923818 A,1995-06-12,US 9507446 W;;US 25902794 A,1994-06-13,SYSTEM AND METHOD FOR GENERATING ELECTRICAL COMPONENT MODELS,,CADENCE DESIGN SYSTEMS INC,WOODRUFF KENNETH P;;AGARWAL ALOKKUMAR B;;DUNSKY NATAN;;VAN DYKE ERIC J;;MADHAVAN VIJAY C;;MCCANLIES ELIZABETH R,,https://lens.org/171-002-204-306-352,Granted Patent,yes,1,0,7,7,0,G06F30/30;;G06F30/33;;G06F30/33;;G06F30/30;;G06F30/3308,G06F17/50,,2,0,,,"COMPUTER, vol. 23, no. 2, February 1990 LOS ALAMITOS CA US, pages 18-30, FOO ET AL 'databases and cell-selection algorithms for vlsi cell libraries';;IEEE EXPERT, vol. 6, no. 2, April 1991 LOS ALAMITOS CA US, pages 56-70, HEKMATPOUR ET AL 'hierarchical modeling of the vlsi design process'",EXPIRED
334,US,B2,US 9879341 B2,035-261-049-580-76X,2018-01-30,2018,US 201615188103 A,2016-06-21,IN 3110CH2015 A,2015-06-22,Method and apparatus for microwave assisted chalcogen radicals generation for 2-D materials,"Embodiments described herein provide a remote plasma system utilizing a microwave source. Additionally, generation and deposition techniques for 2D transition metal chalcogenides with large area uniformity utilizing microwave assisted generation of radicals is disclosed. Plasma may be generated remotely utilizing the microwave source. A processing platform configured to deposit 2D transition metal chalcogenides is also disclosed.",APPLIED MATERIALS INC,SINGH KAUSHAL K;;JADHAV DEEPAK;;AGARWAL ASHUTOSH;;GOEL ASHISH;;PARIHAR VIJAY;;PING ER-XUAN;;THAKUR RANDHIR P S,APPLIED MATERIALS INC (2016-06-24),https://lens.org/035-261-049-580-76X,Granted Patent,yes,8,2,2,2,0,H01L21/0262;;H01L21/02568;;H01L21/02381;;H01L21/02658;;H01L21/0217;;H01L21/02181;;H01L21/02568;;H01L21/02381;;H01L21/02658;;C23C16/45525;;C23C14/56;;C23C16/54;;H01L21/6719;;H01L21/67167;;H01L21/6723;;H01L21/0262,H01L21/67;;C23C14/56;;C23C16/455;;C23C16/54;;H01L21/02,,0,0,,,,ACTIVE
335,US,A,US 5510998 A,082-558-696-440-271,1996-04-23,1996,US 25902794 A,1994-06-13,US 25902794 A,1994-06-13,System and method for generating component models,"An electrical component model generator generates, stores, and retrieves component models in a component model library. Component models comprise property values. A property value quantifies a property. Properties are associated with a plurality of component models. The component model generator generates rules. A rule is a relationship between two or more properties. A rule applied to two or more properties associated with the component model define a property value for at least one of these properties. Properties that are not defined by rules or that have a value different from the value generated by a rule are quantified by an exception value that is input by a user. The component model generator stores the component models by storing the rules for all component models and the exception values for each component model. Generating and maintaining the component model library is facilitated by automatically applying the rules to the component model to generate some or most of the property values. A user does not need to manually input these values. As a result, user input time and data entry errors are reduced.",CADENCE DESIGN SYSTEMS INC,WOODRUFF KENNETH P;;AGARWAL ALOKKUMAR B;;DUNSKY NATAN;;VAN DYKE ERIC J;;MADHAVAN VIJAY C;;MCCANLIES ELIZABETH R,CADENCE DESIGN SYSTEMS INC (1994-10-27),https://lens.org/082-558-696-440-271,Granted Patent,yes,10,33,7,7,0,G06F30/30;;G06F30/33;;G06F30/33;;G06F30/30;;G06F30/3308,G06F17/50,364/489;;364/488,5,5,011-123-293-669-655;;012-709-302-326-713;;068-615-893-787-320;;017-032-515-783-950;;015-085-597-210-350,10.1109/2.44902;;10.1109/64.79710;;10.1109/dac.1985.1585970;;10.1109/t-c.1969.222727;;10.1109/jssc.1989.572628,"S. Foo et al., Databases and Cell Selection Algorithms for VLSI Cell Libraries , Computer, pp. 18 30, Feb. 23, 1990, No. 2. Los Alamitos, CA.;;A. Hekmatpour et al., Hierarchical Modeling of the VLSI Design Process , IEEE Expert, pp. 56 70, Apr. 6, 1991, No. 2. Los Alamitos, CA.;;Automatic Generation of Digital System Schematic Diagrams by Arya et al, IEEE 22nd Design Automation Conference, 1985, pp. 388 394.;;Methods Used in an Automatic Logic Design Generator (ALERT) by Friedman et al, IEEE Trans. on Computers, vol. C 18, No. 7, Jul. 1969, pp. 593 614.;;Cell Libraries and Assembly Tools for Analog/Digital CMOS and BiCMOS ApplicationSpecific Integrated Circuit Design by Smith et al, IEEE Solid State Circuits, Oct. 1989, pp. 1419 1432.",EXPIRED
336,US,A1,US 2016/0372351 A1,030-135-228-847-862,2016-12-22,2016,US 201615188103 A,2016-06-21,IN 3110CH2015 A,2015-06-22,METHOD AND APPARATUS FOR MICROWAVE ASSISTED CHALCOGEN RADICALS GENERATION FOR 2-D MATERIALS,"Embodiments described herein provide a remote plasma system utilizing a microwave source. Additionally, generation and deposition techniques for 2D transition metal chalcogenides with large area uniformity utilizing microwave assisted generation of radicals is disclosed. Plasma may be generated remotely utilizing the microwave source. A processing platform configured to deposit 2D transition metal chalcogenides is also disclosed.",APPLIED MATERIALS INC,SINGH KAUSHAL K;;JADHAV DEEPAK;;AGARWAL ASHUTOSH;;GOEL ASHISH;;PARIHAR VIJAY;;PING ER-XUAN;;THAKUR RANDHIR P S,APPLIED MATERIALS INC (2016-06-24),https://lens.org/030-135-228-847-862,Patent Application,yes,8,5,2,2,0,H01L21/0262;;H01L21/02568;;H01L21/02381;;H01L21/02658;;H01L21/0217;;H01L21/02181;;H01L21/02568;;H01L21/02381;;H01L21/02658;;C23C16/45525;;C23C14/56;;C23C16/54;;H01L21/6719;;H01L21/67167;;H01L21/6723;;H01L21/0262,H01L21/67;;C23C16/455;;H01L21/02;;H01L21/441;;H01L21/475;;H01L21/4757,,0,0,,,,ACTIVE
337,US,A1,US 2022/0197852 A1,024-748-333-367-638,2022-06-23,2022,US 202217692031 A,2022-03-10,US 202217692031 A,2022-03-10,Circuits And Methods For Coherent Writing To Host Systems,A circuit system includes slow running logic circuitry that generates write data and a write command for a write request. The circuit system also includes fast running logic circuitry that receives the write data and the write command from the slow running logic circuitry. The fast running logic circuitry stores the write data and the write command. A host system generates a write response in response to receiving the write command from the fast running logic circuitry. The host system sends the write response to the fast running logic circuitry. The fast running logic circuitry sends the write data to the host system in response to receiving the write response from the host system before providing the write response to the slow running logic circuitry.,INTEL CORP,NAIR MOHAN;;AGARWAL ISHWAR;;GUPTA ASHISH;;PUROHIT PEEYUSH;;GOVINDARAJ VIJAY POTHI RAJ;;PALIWAL NITISH;;BOYAPATI RAHUL;;JUAN MINJER,INTEL CORPORATION (2022-03-03),https://lens.org/024-748-333-367-638,Patent Application,yes,0,0,1,1,0,G06F15/17;;G06F15/17331;;G06F2212/621;;G06F9/5016,G06F15/173;;G06F9/50,,0,0,,,,PENDING
338,US,B2,US 9956008 B2,037-394-142-333-343,2018-05-01,2018,US 201414784855 A,2014-04-25,US 201414784855 A;;US 201361815992 P;;US 2014/0035464 W,2013-04-25,Stabilized spinal fixation device,A spinal fixation device includes a device body configured for implantation in a human body and a clamp that is formed from shape memory material and attached to the device body.,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D'ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,THE UNIVERSITY OF TOLEDO (2015-10-27),https://lens.org/037-394-142-333-343,Granted Patent,yes,17,2,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/70;;A61B17/00,,2,0,,,"CN Office Action, Application No. 201480030935.2, dated May 22, 2017.;;European Search Report, Application No. EP14788930, dated Aug. 17, 2016.",ACTIVE
339,WO,A1,WO 1995/034868 A1,054-602-417-229-343,1995-12-21,1995,US 9507446 W,1995-06-12,US 25902794 A,1994-06-13,SYSTEM AND METHOD FOR GENERATING COMPONENT MODELS,"An electrical component model generator generates, stores, and retrieves component models in a component model library. Component models comprise property values. A property value quantifies a property. Properties are associated with a plurality of component models. The component model generator generates rules. A rule is a relationship between two or more properties. A rule applied to two or more properties associated with the component model define a property value for at least one of these properties. Properties that are not defined by rules or that have a value different from the value generated by a rule are quantified by an exception value that is input by a user. The component model generator stores the component models by storing the rules for all component models and the exception values for each component model. Generating and maintaining the component model library is facilitated by automatically applying the rules to the component model to generate some or most of the property values. A user does not need to manually input these values. As a result, user input time and data entry errors are reduced.",CADENCE DESIGN SYSTEMS INC,WOODRUFF KENNETH P;;AGARWAL ALOKKUMAR B;;DUNSKY NATAN;;VAN DYKE ERIC J;;MADHAVAN VIJAY C;;MCCANLIES ELIZABETH R,,https://lens.org/054-602-417-229-343,Patent Application,yes,1,3,7,7,0,G06F30/30;;G06F30/33;;G06F30/33;;G06F30/30;;G06F30/3308,G06F17/50,,2,2,011-123-293-669-655;;012-709-302-326-713,10.1109/2.44902;;10.1109/64.79710,"FOO ET AL: ""databases and cell-selection algorithms for vlsi cell libraries"", COMPUTER, vol. 23, no. 2, LOS ALAMITOS CA US, pages 18 - 30;;HEKMATPOUR ET AL: ""hierarchical modeling of the vlsi design process"", IEEE EXPERT, vol. 6, no. 2, LOS ALAMITOS CA US, pages 56 - 70",PATENTED
340,AU,A,AU 1995/028250 A,001-111-890-095-839,1996-01-05,1996,AU 1995/028250 A,1995-06-12,US 25902794 A;;US 9507446 W,1994-06-13,System and method for generating component models,,CADENCE DESIGN SYSTEMS INC,WOODRUFF KENNETH P;;AGARWAL ALOKKUMAR B;;DUNSKY NATAN;;DYKE ERIC J VAN;;MADHAVAN VIJAY C;;MCCANLIES ELIZABETH R,,https://lens.org/001-111-890-095-839,Patent Application,no,0,0,7,7,0,G06F30/30;;G06F30/33;;G06F30/33;;G06F30/30;;G06F30/3308,G06F17/50,,0,0,,,,PENDING
341,TW,A,TW 202303801 A,142-720-965-401-770,2023-01-16,2023,TW 111107482 A,2022-03-02,US 202117214340 A,2021-03-26,Heater assembly with purge gap control and temperature unifomrity for batch processing chambers,"A heater assembly having a backside purge gap formed between a top plate and a heater of the heater assembly, the top plate having a top plate wall. The top plate wall having an upper portion, a middle portion and a lower portion, the middle portion forming an incline relative to the top portion.",APPLIED MATERIALS INC,KASHYAP DHRITIMAN SUBHA;;SHEREKAR AMIT RAJENDRA;;SHAH KARTIK;;AGARWAL ASHUTOSH;;HOFFMANN ERIC J;;BALUJA SANJEEV;;PARKHE VIJAY D,,https://lens.org/142-720-965-401-770,Patent of Addition,no,0,0,5,5,0,H01L21/68771;;H01L21/68764;;H01L21/68792;;H01L21/68735;;H01L21/6831;;H01L21/67103;;H01L21/67126;;H05B3/28;;H01L21/67103;;H01L21/67126;;H01L21/6831;;H01L21/68735;;H01L21/68764;;H01L21/68771;;H01L21/68792;;H05B1/0233;;H05B3/28;;H01L21/67103;;H05B1/0233,H01L21/67;;H01L21/687;;H05B1/02,,0,0,,,,PENDING
342,WO,A1,WO 2022/204482 A1,102-458-659-373-968,2022-09-29,2022,US 2022/0021891 W,2022-03-25,US 202117214340 A,2021-03-26,HEATER ASSEMBLY WITH PURGE GAP CONTROL AND TEMPERATURE UNIFORMITY FOR BATCH PROCESSING CHAMBERS,"A heater assembly having a backside purge gap formed between a top plate and a heater of the heater assembly, the top plate having a top plate wall. The top plate wall having an upper portion, a middle portion and a lower portion, the middle portion forming an incline relative to the top portion.",APPLIED MATERIALS INC,KASHYAP DHRITIMAN SUBHA;;SHEREKAR AMIT RAJENDRA;;SHAH KARTIK;;AGARWAL ASHUTOSH;;HOFFMANN ERIC J;;BALUJA SANJEEV;;PARKHE VIJAY D,,https://lens.org/102-458-659-373-968,Patent Application,yes,5,0,5,5,0,H01L21/68771;;H01L21/68764;;H01L21/68792;;H01L21/68735;;H01L21/6831;;H01L21/67103;;H01L21/67126;;H05B3/28;;H01L21/67103;;H01L21/67126;;H01L21/6831;;H01L21/68735;;H01L21/68764;;H01L21/68771;;H01L21/68792;;H05B1/0233;;H05B3/28;;H01L21/67103;;H05B1/0233,H01L21/67;;C23C16/458;;H01L21/687,,0,0,,,,PENDING
343,US,A1,US 2022/0312553 A1,037-493-604-105-075,2022-09-29,2022,US 202117214340 A,2021-03-26,US 202117214340 A,2021-03-26,HEATER ASSEMBLY WITH PURGE GAP CONTROL AND TEMPERATURE UNIFORMITY FOR BATCH PROCESSING CHAMBERS,"A heater assembly having a backside purge gap formed between a top plate and a heater of the heater assembly, the top plate having a top plate wall. The top plate wall having an upper portion, a middle portion and a lower portion, the middle portion forming an incline relative to the top portion.",APPLIED MATERIALS INC,KASHYAP DHRITIMAN SUBHA;;SHEREKAR AMIT RAJENDRA;;SHAH KARTIK;;AGARWAL ASHUTOSH;;HOFFMANN ERIC J;;BALUJA SANJEEV;;PARKHE VIJAY D,APPLIED MATERIALS INC (2021-04-02),https://lens.org/037-493-604-105-075,Patent Application,yes,4,0,5,5,0,H01L21/68771;;H01L21/68764;;H01L21/68792;;H01L21/68735;;H01L21/6831;;H01L21/67103;;H01L21/67126;;H05B3/28;;H01L21/67103;;H01L21/67126;;H01L21/6831;;H01L21/68735;;H01L21/68764;;H01L21/68771;;H01L21/68792;;H05B1/0233;;H05B3/28;;H01L21/67103;;H05B1/0233,H05B1/02,,0,0,,,,ACTIVE
344,US,B2,US 11818810 B2,068-873-150-339-086,2023-11-14,2023,US 202117214340 A,2021-03-26,US 202117214340 A,2021-03-26,Heater assembly with purge gap control and temperature uniformity for batch processing chambers,"A heater assembly having a backside purge gap formed between a top plate and a heater of the heater assembly, the top plate having a top plate wall. The top plate wall having an upper portion, a middle portion and a lower portion, the middle portion forming an incline relative to the top portion.",APPLIED MATERIALS INC,KASHYAP DHRITIMAN SUBHA;;SHEREKAR AMIT RAJENDRA;;SHAH KARTIK;;AGARWAL ASHUTOSH;;HOFFMANN ERIC J;;BALUJA SANJEEV;;PARKHE VIJAY D,APPLIED MATERIALS INC (2021-04-02),https://lens.org/068-873-150-339-086,Granted Patent,yes,11,0,5,5,0,H01L21/68771;;H01L21/68764;;H01L21/68792;;H01L21/68735;;H01L21/6831;;H01L21/67103;;H01L21/67126;;H05B3/28;;H01L21/67103;;H01L21/67126;;H01L21/6831;;H01L21/68735;;H01L21/68764;;H01L21/68771;;H01L21/68792;;H05B1/0233;;H05B3/28;;H01L21/67103;;H05B1/0233,H05B1/02;;H01L21/67,,1,0,,,"PCT International Search Report and Written Opinion in PCT/US2022/021891 dated Jul. 21, 2022, 10 pages.",ACTIVE
345,KR,A,KR 20230158618 A,116-317-884-038-102,2023-11-20,2023,KR 20237036536 A,2022-03-25,US 202117214340 A;;US 2022/0021891 W,2021-03-26,뱃치 프로세싱 챔버들을 위한 퍼지 갭 제어 및 온도 균일성을 갖는 히터 조립체,"히터(heater) 조립체는 히터 조립체의 최상부 플레이트(plate)와 히터 사이에 형성된 후면 퍼지 갭(purge gap)을 갖고, 최상부 플레이트는 최상부 플레이트 벽을 갖는다. 최상부 플레이트 벽은 상부 부분, 중간 부분 및 하부 부분을 가지며, 중간 부분은 최상부 부분에 대해 경사를 형성한다.",APPLIED MATERIALS INC,KASHYAP DHRITIMAN SUBHA;;SHEREKAR AMIT RAJENDRA;;SHAH KARTIK;;AGARWAL ASHUTOSH;;HOFFMANN ERIC J;;BALUJA SANJEEV;;PARKHE VIJAY D,,https://lens.org/116-317-884-038-102,Patent Application,no,0,0,5,5,0,H01L21/68771;;H01L21/68764;;H01L21/68792;;H01L21/68735;;H01L21/6831;;H01L21/67103;;H01L21/67126;;H05B3/28;;H01L21/67103;;H01L21/67126;;H01L21/6831;;H01L21/68735;;H01L21/68764;;H01L21/68771;;H01L21/68792;;H05B1/0233;;H05B3/28;;H01L21/67103;;H05B1/0233,H01L21/67;;H01L21/683;;H01L21/687;;H05B1/02;;H05B3/28,,0,0,,,,PENDING
346,EP,B1,EP 1575520 B1,070-179-838-992-325,2007-11-07,2007,EP 03811861 A,2003-09-03,IN 0300296 W;;IN 1187DE2002 A;;IN 271DE2003 A,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,,DEFENSE RES & DEV ORGANISATION,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/070-179-838-992-325,Granted Patent,yes,3,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,C12Q1/04;;A61K/;;A61K6/00;;G01N33/569,,1,0,,,"DATABASE CA DATABASE [Online] LIM P.L. ET AL: 'A one-step two-particle latex immunoassay for the detection of Salmonella typhi endotoxin.', XP002992592 Retrieved from STN-international. Database accession no. (114:137509) & JOURNAL OF IMMUNOLOGICAL METHODS. vol. 135, no. 1-2, 1990, pages 257 - 261",EXPIRED
347,AU,A1,AU 2003/256063 A1,198-881-163-244-645,2004-06-18,2004,AU 2003/256063 A,2003-09-03,IN 1187DE2002 A;;IN 271DE2003 A;;IN 0300296 W,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,,DEFENSE RES AND DEV ORGANISATI,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/198-881-163-244-645,Patent Application,no,0,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,0,0,,,,DISCONTINUED
348,WO,A9,WO 2014/176507 A9,109-659-491-459-586,2015-01-22,2015,US 2014/0035464 W,2014-04-25,US 201361815992 P,2013-04-25,STABILIZED SPINAL FIXATION DEVICE,A spinal fixation device includes a device body configured for implantation in a human body and a clamp that is formed from shape memory material and attached to the device body.,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,,https://lens.org/109-659-491-459-586,Search Report,yes,0,0,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/56;;A61B17/70;;A61B17/84,,0,0,,,,PENDING
349,US,A1,US 2016/0058478 A1,123-344-666-739-645,2016-03-03,2016,US 201414784855 A,2014-04-25,US 201414784855 A;;US 201361815992 P;;US 2014/0035464 W,2013-04-25,Stabilized Spinal Fixation Device,A spinal fixation device includes a device body configured for implantation in a human body and a clamp that is formed from shape memory material and attached to the device body.,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,THE UNIVERSITY OF TOLEDO (2015-10-27),https://lens.org/123-344-666-739-645,Patent Application,yes,11,23,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/70,,0,0,,,,ACTIVE
350,WO,A1,WO 2014/176507 A1,000-617-700-735-578,2014-10-30,2014,US 2014/0035464 W,2014-04-25,US 201361815992 P,2013-04-25,STABILIZED SPINAL FIXATION DEVICE,A spinal fixation device includes a device body configured for implantation in a human body and a clamp that is formed from shape memory material and attached to the device body.,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,,https://lens.org/000-617-700-735-578,Patent Application,yes,6,0,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/56;;A61B17/70;;A61B17/84,,1,0,,,See also references of EP 2988685A4,PENDING
351,US,A1,US 2006/0127960 A1,085-263-912-518-258,2006-06-15,2006,US 53653305 A,2005-11-29,IN 1187DE2002 A;;IN 271DE2003 A;;IN 0300296 W,2002-11-26,Process for preparation of an agglutination reagent for rapid detection of typhoid,"A process for the preparation of an agglutination reagent for rapid and early detection of typhoid, comprising the steps of: preparing Salmonella typhi specific antibody; preparing latex particles suspension; and coating said latex particles with the antibody.",DEFENSE RES & DEV ORGANISATION,RAI GANGA P;;AGARWAL GAURI S;;SHARMA SHRI K;;JAISWAL DEVENDRA K;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY K,DEFENCE RESEARCH & DEVELOPMENT ORGANISATION (2005-10-04),https://lens.org/085-263-912-518-258,Patent Application,yes,2,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,G01N33/554;;A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,435/7.32,0,0,,,,DISCONTINUED
352,EP,A1,EP 2988685 A1,194-401-023-165-741,2016-03-02,2016,EP 14788930 A,2014-04-25,US 201361815992 P;;US 2014/0035464 W,2013-04-25,STABILIZED SPINAL FIXATION DEVICE,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,,https://lens.org/194-401-023-165-741,Patent Application,yes,0,0,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/56;;A61B17/00;;A61B17/70;;A61B17/84,,0,0,,,,DISCONTINUED
353,EP,A4,EP 2988685 A4,049-456-844-283-383,2016-09-28,2016,EP 14788930 A,2014-04-25,US 201361815992 P;;US 2014/0035464 W,2013-04-25,STABILIZED SPINAL FIXATION DEVICE,,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,,https://lens.org/049-456-844-283-383,Search Report,no,5,0,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/56;;A61B17/00;;A61B17/70;;A61B17/84,,1,0,,,See also references of WO 2014176507A1,DISCONTINUED
354,WO,A3,WO 2004/047721 A3,083-308-181-824-537,2005-08-11,2005,IN 0300296 W,2003-09-03,IN 1187DE2002 A;;IN 271DE2003 A,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,"A process for the preparation of an agglutination for rapid and early detection of typhoid, comprising in the steps: (a) preparing Salmonella typhi specific antibody, (b) preparing latex particles suspensions, (c) coating said latex particles with the antibody.",DEFENSE RES & DEV ORGANISATION;;RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/083-308-181-824-537,Search Report,yes,3,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,1,1,067-712-429-384-104,10.1016/0022-1759(90)90279-5;;2273260,"DATABASE CA DATABASE [online] LIM P.L. ET AL: ""A one-step two-particle latex immunoassay for the detection of Salmonella typhi endotoxin."", XP002992592, accession no. STN-international. Database accession no. (114:137509)",PATENTED
355,EP,A2,EP 1575520 A2,160-331-852-549-393,2005-09-21,2005,EP 03811861 A,2003-09-03,IN 0300296 W;;IN 1187DE2002 A;;IN 271DE2003 A,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,,DEFENSE RES & DEV ORGANISATION,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/160-331-852-549-393,Patent Application,yes,0,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,1,0,,,See references of WO 2004047721A3,EXPIRED
356,EP,A3,EP 1575520 A3,159-974-092-330-420,2005-09-28,2005,EP 03811861 A,2003-09-03,IN 0300296 W;;IN 1187DE2002 A;;IN 271DE2003 A,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,,DEFENSE RES & DEV ORGANISATION,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/159-974-092-330-420,Search Report,yes,0,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,0,0,,,,EXPIRED
357,WO,A2,WO 2004/047721 A2,030-247-839-838-865,2004-06-10,2004,IN 0300296 W,2003-09-03,IN 1187DE2002 A;;IN 271DE2003 A,2002-11-26,A PROCESS FOR PREPARATION OF AN AGGLUTINATION REAGENT FOR RAPID DETECTION OF TYPHOID,"A process for the preparation of an agglutination for rapid and early detection of typhoid, comprising in the steps: (a) preparing Salmonella typhi specific antibody, (b) preparing latex particles suspensions, (c) coating said latex particles with the antibody.",DEFENSE RES & DEV ORGANISATION;;RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,RAI GANGA PRASAD;;AGARWAL GAURI SHANKAR;;SHARMA SHRI KRISHNA;;JAISWAL DEVENDRA KUMAR;;SHEKHAR KRISHANAMURTHY;;ARORA KAJAL;;CHAUDHARY VIJAY KUMAR,,https://lens.org/030-247-839-838-865,Patent Application,yes,0,5,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,0,0,,,,PATENTED
358,CN,C,CN 100519759 C,010-077-851-407-799,2009-07-29,2009,CN 03825732 A,2003-09-03,IN 1187DE2002 A,2002-11-26,A process for preparation of an agglutination reagent for rapid detection of typhoid,,DEFENSE RES & DEV ORGANISATION,PRASAD RAI GANGA;;SHANKAR AGARWAL GAURI;;KRISHNA SHARMA SHRI;;KUMAR JAISWAL DEVENDRA;;KRISHANAMURTHY SHEKHAR;;KAJAL ARORA;;KUMAR CHAUDHARY VIJAY,,https://lens.org/010-077-851-407-799,Granted Patent,no,0,0,2,10,0,Y02A50/30,C12Q1/04,,0,0,,,,EXPIRED
359,AU,A8,AU 2003/256063 A8,139-412-336-167-886,2004-06-18,2004,AU 2003/256063 A,2003-09-03,IN 1187DE2002 A;;IN 271DE2003 A;;IN 0300296 W,2002-11-26,A process for preparation of an agglutination reagent for rapid detection of typhoid,,DEFENSE RES AND DEV ORGANISATI,AGARWAL GAURI SHANKAR;;SHEKHAR KRISHANAMURTHY;;CHAUDHARY VIJAY KUMAR;;JAISWAL DEVENDRA KUMAR;;SHARMA SHRI KRISHNA;;RAI GANGA PRASAD;;ARORA KAJAL,,https://lens.org/139-412-336-167-886,Patent Application,no,0,0,8,10,0,C12Q1/04;;C12Q1/04;;G01N33/56916;;G01N33/56916;;Y02A50/30;;Y02A50/30,A61K/;;A61K6/00;;C12Q1/04;;G01N33/569,,0,0,,,,DISCONTINUED
360,CN,A,CN 105246420 A,130-302-629-509-494,2016-01-13,2016,CN 201480030935 A,2014-04-25,US 2014/0035464 W;;US 201361815992 P,2013-04-25,Stabilized spinal fixation device,A spinal fixation device includes a device body configured for implantation in a human body and a clamp that is formed from shape memory material and attached to the device body.,UNIV TOLEDO,AGARWAL ANAND K;;GOEL VIJAY K;;D ONOFRIO JOHN R;;DUBOIS NATHANIEL E;;PACK JARED R;;TAYLOR DAVID J,,https://lens.org/130-302-629-509-494,Patent Application,no,5,1,8,8,0,A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7032;;A61B17/7035;;A61B17/7056;;A61B2017/00867;;A61B17/7049,A61B17/56;;A61B17/70;;A61B17/84,,0,0,,,,INACTIVE
361,US,B2,US 10790180 B2,097-209-484-877-331,2020-09-29,2020,US 201916576645 A,2019-09-19,US 201916576645 A;;US 201314094601 A,2013-12-02,Electrostatic chuck with variable pixelated magnetic field,"Electrostatic chucks with variable pixelated magnetic field are described. For example, an electrostatic chuck (ESC) includes a ceramic plate having a front surface and a back surface, the front surface for supporting a wafer or substrate. A base is coupled to the back surface of the ceramic plate. A plurality of electromagnets is disposed in the base, the plurality of electromagnets configured to provide pixelated magnetic field tuning capability for the ESC.",APPLIED MATERIALS INC,HSU CHIH-HSUN;;GUNG TZA-JING;;SCHWARZ BENJAMIN;;RAUF SHAHID;;AGARWAL ANKUR;;PARKHE VIJAY D;;WILLWERTH MICHAEL D;;GUO ZHIQIANG,,https://lens.org/097-209-484-877-331,Granted Patent,yes,39,2,4,4,0,H01L21/6833;;H01L21/6833;;H01J37/3266;;H01J37/3266;;H01J37/32715;;H01J37/32715,H01L21/683;;H01J37/32,,0,0,,,,ACTIVE
362,US,A1,US 2020/0013661 A1,077-703-495-034-450,2020-01-09,2020,US 201916576645 A,2019-09-19,US 201916576645 A;;US 201314094601 A,2013-12-02,ELECTROSTATIC CHUCK WITH VARIABLE PIXELATED MAGNETIC FIELD,"Electrostatic chucks with variable pixelated magnetic field are described. For example, an electrostatic chuck (ESC) includes a ceramic plate having a front surface and a back surface, the front surface for supporting a wafer or substrate. A base is coupled to the back surface of the ceramic plate. A plurality of electromagnets is disposed in the base, the plurality of electromagnets configured to provide pixelated magnetic field tuning capability for the ESC.",APPLIED MATERIALS INC,HSU CHIH-HSUN;;GUNG TZA-JING;;SCHWARZ BENJAMIN;;RAUF SHAHID;;AGARWAL ANKUR;;PARKHE VIJAY D;;WILLWERTH MICHAEL D;;GUO ZHIQIANG,,https://lens.org/077-703-495-034-450,Patent Application,yes,0,0,4,4,0,H01L21/6833;;H01L21/6833;;H01J37/3266;;H01J37/3266;;H01J37/32715;;H01J37/32715,H01L21/683,,0,0,,,,ACTIVE
363,US,A1,US 2020/0073716 A1,050-376-245-676-607,2020-03-05,2020,US 201816166889 A,2018-10-22,IN 201811032727 A,2018-08-31,ARTIFICIAL INTELLIGENCE (AI) BASED RESOURCE IDENTIFICATION,"An Artificial Intelligence (AI) based resource identification system enables identifying available resources in response to receiving a request for resources. The request attributes are mapped to the attributes of the resources in a resource pool. Matching index scores are calculated and resources that match the request can be selected based on the matching index scores. If no resources are available suitable alternate resources with lower matching index scores are suggested so that a user has the choice to filter this alternate resources based on a threshold score. Particular suggestions to change one or more of the request attributes can be provided based on analysis of the mapping of the request and the resource attributes which enables the resource identification system to suggest changes to one or more of the skill attributes, level attributes, time attributes or location attributes of the request.",ACCENTURE GLOBAL SOLUTIONS LTD,KAUL RINKU;;SRIKANTH N R;;KARIAPPA SHOBA;;AGARWAL SANGITA;;SAHA NIREN;;SUNDARAMOORTHY BHARANIDHARAN;;MURUGAPPAN CHELLAPPAN;;SEETHARAM SREEDHAR P;;SRINIVAS VIJAY,ACCENTURE GLOBAL SOLUTIONS LIMITED (2018-09-17),https://lens.org/050-376-245-676-607,Patent Application,yes,12,5,2,2,0,G06F9/5005;;G06Q10/06311;;G06N5/025;;G06N3/006;;G06N20/00;;G06N5/022;;G06F16/367;;G06F9/5011;;G06F9/5055;;G06F2209/503;;G06F2209/5011;;G06F2209/5021;;G06F2209/5022;;G06F17/18;;G06F16/367;;G06F16/24578;;G06N7/01,G06F9/50;;G06F17/18;;G06N7/00,,0,0,,,,ACTIVE
364,US,A1,US 2015/0155193 A1,002-703-084-207-846,2015-06-04,2015,US 201314094601 A,2013-12-02,US 201314094601 A,2013-12-02,ELECTROSTATIC CHUCK WITH VARIABLE PIXELATED MAGNETIC FIELD,"Electrostatic chucks with variable pixelated magnetic field are described. For example, an electrostatic chuck (ESC) includes a ceramic plate having a front surface and a back surface, the front surface for supporting a wafer or substrate. A base is coupled to the back surface of the ceramic plate. A plurality of electromagnets is disposed in the base, the plurality of electromagnets configured to provide pixelated magnetic field tuning capability for the ESC.",HSU CHIH-HSUN;;GUNG TZA-JING;;SCHWARZ BENJAMIN;;RAUF SHAHID;;AGARWAL ANKUR;;PARKHE VIJAY D;;WILLWERTH MICHAEL D;;GUO ZHIQIANG,HSU CHIH-HSUN;;GUNG TZA-JING;;SCHWARZ BENJAMIN;;RAUF SHAHID;;AGARWAL ANKUR;;PARKHE VIJAY D;;WILLWERTH MICHAEL D;;GUO ZHIQIANG,APPLIED MATERIALS INC (2014-09-18),https://lens.org/002-703-084-207-846,Patent Application,yes,21,26,4,4,0,H01L21/6833;;H01L21/6833;;H01J37/3266;;H01J37/3266;;H01J37/32715;;H01J37/32715,H01L21/683;;H01L21/67,,1,0,,,"translation of KR 20090108420 A, accessed 2/23/17.",ACTIVE
365,US,B2,US 10901787 B2,129-669-137-162-469,2021-01-26,2021,US 201816166889 A,2018-10-22,IN 201811032727 A,2018-08-31,Artificial intelligence (AI) based resource identification,"An Artificial Intelligence (AI) based resource identification system enables identifying available resources in response to receiving a request for resources. The request attributes are mapped to the attributes of the resources in a resource pool. Matching index scores are calculated and resources that match the request can be selected based on the matching index scores. If no resources are available suitable alternate resources with lower matching index scores are suggested so that a user has the choice to filter this alternate resources based on a threshold score. Particular suggestions to change one or more of the request attributes can be provided based on analysis of the mapping of the request and the resource attributes which enables the resource identification system to suggest changes to one or more of the skill attributes, level attributes, time attributes or location attributes of the request.",ACCENTURE GLOBAL SOLUTIONS LTD,KAUL RINKU;;SRIKANTH N R;;KARIAPPA SHOBA;;AGARWAL SANGITA;;SAHA NIREN;;SUNDARAMOORTHY BHARANIDHARAN;;MURUGAPPAN CHELLAPPAN;;SEETHARAM SREEDHAR P;;SRINIVAS VIJAY,ACCENTURE GLOBAL SOLUTIONS LIMITED (2018-09-17),https://lens.org/129-669-137-162-469,Granted Patent,yes,16,0,2,2,0,G06F9/5005;;G06Q10/06311;;G06N5/025;;G06N3/006;;G06N20/00;;G06N5/022;;G06F16/367;;G06F9/5011;;G06F9/5055;;G06F2209/503;;G06F2209/5011;;G06F2209/5021;;G06F2209/5022;;G06F17/18;;G06F16/367;;G06F16/24578;;G06N7/01,G06F9/455;;G06F9/46;;G06F9/50;;G06F16/2457;;G06F16/36;;G06F17/18;;G06N7/00,,1,1,001-382-813-887-853,10.1145/3106426.3106503,"Audun Vennesland, Matcher Composition for Identification of Subsumption Relations in Ontology Matching, 2017, pp. 154-161. https://dl.acm.org/doi/pdf/10.1145/3106426.3106503 (Year: 2017).",ACTIVE
366,US,B2,US 10460968 B2,190-646-720-477-628,2019-10-29,2019,US 201314094601 A,2013-12-02,US 201314094601 A,2013-12-02,Electrostatic chuck with variable pixelated magnetic field,"Electrostatic chucks with variable pixelated magnetic field are described. For example, an electrostatic chuck (ESC) includes a ceramic plate having a front surface and a back surface, the front surface for supporting a wafer or substrate. A base is coupled to the back surface of the ceramic plate. A plurality of electromagnets is disposed in the base, the plurality of electromagnets configured to provide pixelated magnetic field tuning capability for the ESC.",APPLIED MATERIALS INC,HSU CHIH-HSUN;;GUNG TZA-JING;;SCHWARZ BENJAMIN;;RAUF SHAHID;;AGARWAL ANKUR;;PARKHE VIJAY D;;WILLWERTH MICHAEL D;;GUO ZHIQIANG,APPLIED MATERIALS INC (2014-09-18),https://lens.org/190-646-720-477-628,Granted Patent,yes,46,0,4,4,0,H01L21/6833;;H01L21/6833;;H01J37/3266;;H01J37/3266;;H01J37/32715;;H01J37/32715,H01L21/67;;H01J37/32;;H01L21/683,,2,0,,,"Translation of KR 20090108420 A, accessed Feb. 23, 2017.;;Parkhe, Vijay D. et al., “Electrostatic Chuck With Variable Pixelated Heating”, U.S. Appl. No. 14/085,026, filed Nov. 20, 2013 33 pgs.",ACTIVE
367,US,B2,US 10645046 B2,016-565-303-268-987,2020-05-05,2020,US 201414473536 A,2014-08-29,US 201414473536 A,2014-08-29,Systems and methods for temporarily postponing messages,"A method postpones an electronic message displayed for a user of a computing device. The user provides input to postpone the electronic message. Postponement options are displayed for the user. The user selects one of the options. Display of the message at the computing device is inhibited accordingly. One option enables a user to repeat the most recently selected postponement option. Another option postpones the message until the computing device is at a user-designated location. Another option inhibits display of the message at the computing device, but enables display of the message at another user-specified second computing device. Some postponement options are generated according to context of the electronic message, such as the content of the electronic message, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE LLC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/016-565-303-268-987,Granted Patent,yes,49,3,6,6,0,H04L51/214;;H04L51/214,G06F15/16;;H04L12/58,,0,0,,,,ACTIVE
368,US,A1,US 2021/0112026 A1,055-774-582-758-051,2021-04-15,2021,US 202017130108 A,2020-12-22,US 202017130108 A;;US 202016834918 A;;US 201414473536 A,2014-08-29,SYSTEMS AND METHODS FOR TEMPORARILY POSTPONING MESSAGES,"A system and method for postponing an electronic message displayed for a user of a computing device. Postponement options are displayed for the user. Display of the electronic message at the computing device is inhibited based on received user input. One option enables a user to repeat the most recently selected postponement option. Another option postpones the electronic message until the computing device is at a user-designated location. Some postponement options are generated according to context of the electronic message, such as the content of the electronic message, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE LLC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/055-774-582-758-051,Patent Application,yes,5,0,6,6,0,H04L51/214;;H04L51/214,H04L12/58,,0,0,,,,ACTIVE
369,US,A1,US 2016/0065524 A1,007-075-986-658-213,2016-03-03,2016,US 201414473536 A,2014-08-29,US 201414473536 A,2014-08-29,Systems and Methods for Temporarily Postponing Messages,"A method postpones an electronic message displayed for a user of a computing device. The user provides input to postpone the electronic message. Postponement options are displayed for the user. The user selects one of the options. Display of the message at the computing device is inhibited accordingly. One option enables a user to repeat the most recently selected postponement option. Another option postpones the message until the computing device is at a user-designated location. Another option inhibits display of the message at the computing device, but enables display of the message at another user-specified second computing device. Some postponement options are generated according to context of the electronic message, such as the content of the electronic message, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE INC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/007-075-986-658-213,Patent Application,yes,75,6,6,6,0,H04L51/214;;H04L51/214,H04L12/58,,0,0,,,,ACTIVE
370,US,B2,US 11546282 B2,136-255-204-714-694,2023-01-03,2023,US 202017130108 A,2020-12-22,US 202017130108 A;;US 202016834918 A;;US 201414473536 A,2014-08-29,Systems and methods for temporarily postponing messages,"A system and method for postponing an electronic message displayed for a user of a computing device. Postponement options are displayed for the user. Display of the electronic message at the computing device is inhibited based on received user input. One option enables a user to repeat the most recently selected postponement option. Another option postpones the electronic message until the computing device is at a user-designated location. Some postponement options are generated according to context of the electronic message, such as the content of the electronic message, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE LLC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/136-255-204-714-694,Granted Patent,yes,55,0,6,6,0,H04L51/214;;H04L51/214,G06F15/16;;H04L51/214,,0,0,,,,ACTIVE
371,US,A1,US 2020/0228482 A1,100-262-004-368-896,2020-07-16,2020,US 202016834918 A,2020-03-30,US 202016834918 A;;US 201414473536 A,2014-08-29,Systems and Methods for Temporarily Postponing Messages,"A method postpones a plurality of associated electronic messages displayed for a user of a computing device. Postponement options are displayed for the user. Display of the plurality of electronic messages at the computing device is inhibited based on received user input. One option enables a user to repeat the most recently selected postponement option. Another option postpones the plurality of electronic messages until the computing device is at a user-designated location. Some postponement options are generated according to context of the plurality of electronic messages, such as the content of one or more of the electronic messages in the plurality of electronic messages, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE LLC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/100-262-004-368-896,Patent Application,yes,0,0,6,6,0,H04L51/214;;H04L51/214,H04L12/58,,0,0,,,,ACTIVE
372,US,B2,US 10904187 B2,037-248-423-533-127,2021-01-26,2021,US 202016834918 A,2020-03-30,US 202016834918 A;;US 201414473536 A,2014-08-29,Systems and methods for temporarily postponing messages,"A method postpones a plurality of associated electronic messages displayed for a user of a computing device. Postponement options are displayed for the user. Display of the plurality of electronic messages at the computing device is inhibited based on received user input. One option enables a user to repeat the most recently selected postponement option. Another option postpones the plurality of electronic messages until the computing device is at a user-designated location. Some postponement options are generated according to context of the plurality of electronic messages, such as the content of one or more of the electronic messages in the plurality of electronic messages, the date or time when the user requested the postponement, or prior history of user-selected postponements. Some options are based on a sampling of postponement options selected by a plurality of users.",GOOGLE LLC,UMAPATHY VIJAY;;POLLOCK XANDER;;PROCH RYAN;;KOURIM TAYLOR;;SEGEL-BROWN LIAM ASHER;;FIORAVANTI RYAN JAMES;;LANDRY MICHAEL CHRISTOPHER JOSEPH;;AGARWAL SHALINI,GOOGLE LLC (2014-08-27),https://lens.org/037-248-423-533-127,Granted Patent,yes,50,2,6,6,0,H04L51/214;;H04L51/214,G06F15/16;;H04L12/58,,0,0,,,,ACTIVE
373,US,B1,US 6301266 B1,068-887-754-771-74X,2001-10-09,2001,US 24738699 A,1999-02-10,US 24738699 A,1999-02-10,Network manager and method thereof for a communication system,"A method of managing objects residing in a communication system includes the steps of reading (201), by a network manager for a plurality of objects represented by at least one agent and residing in a communication system, a mapping of bitmap types to object types and monitoring (203) at least one communication resource between the network manager and the at least one agent. After service interruption on one communication resource of the at least one communication resource, and upon detecting (207) a return to service of the one communication resource, the network manager reads at least one bitmap from the at least one agent, wherein the at least one bitmap represents information relating to at least one object of the plurality of objects, and interpreting (213) the at least one bitmap by utilizing the mapping of bitmap types to object types in order to determine a status of the at least one object of the plurality of objects.",MOTOROLA INC,PETERSON LARRY M;;AGARWAL VIJAY;;BALLEW ELIZA;;CRAMER KRISTIN;;DUBINSKY LANA;;HARPER JOHN D;;KARCH BRAD;;KREMSKE RANDALL G;;MATZ STEVEN A,MOTOROLA INC (1999-03-22),https://lens.org/068-887-754-771-74X,Granted Patent,yes,8,17,2,2,0,H04L41/0226;;H04L41/046;;H04L41/0226;;H04L41/046,H04L12/24,370/465;;370/254;;709/223,0,0,,,,EXPIRED
374,US,A1,US 2018/0004753 A1,088-916-612-930-827,2018-01-04,2018,US 201615199440 A,2016-06-30,US 201615199440 A,2016-06-30,REROUTING TO AN INTERMEDIATE LANDING PAGE,"A system and method for intermediate landing page rerouting are provided. In example embodiments, determine whether a webpage associated with a hyperlink has corresponding social network activities. Extract content from the webpage determined to have corresponding social network activities. In response to a selection of the hyperlink, reroute a web browser to an intermediate landing page. Cause presentation, at a user interface, of the extracted content and the corresponding social network activities.",LINKEDLN CORP,CHATTERJEE SHAUNAK;;VIJAY RAVI KIRAN HOLUR;;ROSALES ROMER E;;MAHMOUD MOHAMED GAMAL MOHAMED;;LI ZHENG;;TAO KWEI-YOU;;CHEN BEE-CHUNG;;AGARWAL DEEPAK,LINKEDIN CORPORATION (2016-07-12);;MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-18),https://lens.org/088-916-612-930-827,Patent Application,yes,3,4,2,2,0,G06Q50/01;;G06Q10/107;;H04L67/02;;G06F16/9574;;G06F16/955;;H04L67/535;;H04L67/02;;G06F16/9574;;G06F16/955;;G06Q50/01;;G06Q10/107;;H04L67/535,G06F3/0484;;G06F17/30;;H04L29/08,,0,0,,,,ACTIVE
375,US,B2,US 10726093 B2,165-810-380-428-592,2020-07-28,2020,US 201615199440 A,2016-06-30,US 201615199440 A,2016-06-30,Rerouting to an intermediate landing page,"A system and method for intermediate landing page rerouting are provided. In example embodiments, determine whether a webpage associated with a hyperlink has corresponding social network activities. Extract content from the webpage determined to have corresponding social network activities. In response to a selection of the hyperlink, reroute a web browser to an intermediate landing page. Cause presentation, at a user interface, of the extracted content and the corresponding social network activities.",MICROSOFT TECHNOLOGY LICENSING LLC,CHATTERJEE SHAUNAK;;VIJAY RAVI KIRAN HOLUR;;ROSALES ROMER E;;MAHMOUD MOHAMED GAMAL MOHAMED;;LI ZHENG;;TAO KWEI-YOU;;CHEN BEE-CHUNG;;AGARWAL DEEPAK,LINKEDIN CORPORATION (2016-07-12);;MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-18),https://lens.org/165-810-380-428-592,Granted Patent,yes,4,1,2,2,0,G06Q50/01;;G06Q10/107;;H04L67/02;;G06F16/9574;;G06F16/955;;H04L67/535;;H04L67/02;;G06F16/9574;;G06F16/955;;G06Q50/01;;G06Q10/107;;H04L67/535,G06F16/00;;G06F16/955;;G06F16/957;;G06Q10/10;;G06Q50/00;;H04L29/08,,0,0,,,,ACTIVE
376,CA,A1,CA 2298163 A1,079-684-706-199-047,2000-08-10,2000,CA 2298163 A,2000-02-07,US 24738699 A,1999-02-10,A NETWORK MANAGER AND METHOD THEREOF FOR A COMMUNICATION SYSTEM,"A method of managing objects residing in a communication system includes the steps of reading (201), by a network manager for a plurality of objects represented by at least one agent and residing in a communication system, a mapping of bitmap types to object types and monitoring (203) at least one communication resource between the network manager and the at least one agent. After service interruption on one communication resource of the at least one communication resource, and upon detecting (207) a return to service of the one communication resource, the network manager reads at least one bitmap from the at least one agent, wherein the at least one bitmap represents information relating to at least one object of the plurality of objects, and interpreting (213) the at least one bitmap by utilizing the mapping of bitmap types to object types in order to determine a status of the at least one object of the plurality of objects.",MOTOROLA INC,HARPER JOHN D;;AGARWAL VIJAY;;MATZ STEVEN A;;KARCH BRAD;;PETERSON LARRY M;;KREMSKE RANDALL G;;BALLEW ELIZA;;CRAMER KRISTIN;;DUBINSKY LANA S,,https://lens.org/079-684-706-199-047,Patent Application,no,0,0,2,2,0,H04L41/0226;;H04L41/046;;H04L41/0226;;H04L41/046,H04L12/24,,0,0,,,,DISCONTINUED
377,HK,A1,HK 1213325 A1,053-245-178-281-857,2016-06-30,2016,HK 16101319 A,2016-02-04,US 2014/0023126 W;;US 201361775939 P,2013-03-11,"A BIOSENSOR DEVICE TO TARGET ANALYTES IN SITU, IN VIVO, AND OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME",,UNIV TOLEDO,AGARWAL ANAND K AK;;GOEL VIJAY K VK;;KIM DONG-SHIK D-S;;YOON DO-YOUNG D-Y;;LIN BOREN B;;FEYZIZARNAGH HAMID H,,https://lens.org/053-245-178-281-857,Patent Application,no,0,0,9,9,0,G01N33/5438;;G01N33/56911;;G01N33/56938;;G01N33/5438;;G01N33/56938;;G01N33/56911;;Y02A50/30;;A61B5/14546;;A61B5/14735;;A61B5/4547;;A61B2503/40;;A61B2562/125;;G01N27/3272;;G01N27/3276,G01N/,,0,0,,,,DISCONTINUED
378,CA,A1,CA 2303550 A1,038-599-839-898-403,2001-09-30,2001,CA 2303550 A,2000-03-31,CA 2303550 A,2000-03-31,A PROCESS FOR THE PRODUCTION OF STABLE (+) CATECHIN PENTA ACETATE USEFUL AS A PRECURSOR FOR THE PRODUCTION OF (+) CATECHIN,"The invention relates to a process for the production of a stable compound (+) catechin penta acetate of formula (2) from T. wallichiana tissue cultures and production of compound (+) catechin of formula (1), said process comprising the steps of inoculation of explants on culture media supplemented with auxins and cytokinins, incubation of the cultures for callus initiation followed by subculturing at 4-6 weeks intervals, extraction of fresh pulverized calli with polar solvents, evaporating the polar solvent to give a residue, treating t:he residue with a chlorinated solvent to isolate (+) catechin by filtration or treating the residue with water and extracting with a chlorinated solvent and evaporating the solvent to semi-solid mass, subjecting the resultant mass to column chromatography over suitable adsorbents, eluting with organic solvent or mixtures of organic solvent to obtain(+)catechin penta acetate.",COUNCIL SCIENT IND RES,SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR;;KUKREJA ARUN KUMAR;;TRIPATHI VINAYAK;;BANERJEE SUCHITRA;;KUMAR SUSHIL;;CHATTOPADHYAY SUNIL KUMAR;;AGARWAL SHIPRA;;SASHIDHARA KONENI VENKATA;;KULSHRESTHA MANISH,,https://lens.org/038-599-839-898-403,Patent Application,no,0,1,1,1,0,C12N5/04;;C12P17/06,C12N5/04;;C12P17/06,,0,0,,,,DISCONTINUED
379,US,B1,US 6365757 B1,146-969-146-507-183,2002-04-02,2002,US 53576700 A,2000-03-28,US 53576700 A;;GB 0007057 A;;JP 2000088563 A,2000-03-24,Process for the production of a compound (+) catechin penta acetate useful as a precursor for the production of (+) catechin,"
    This invention relates to a process for the production of a compound () catechin penta acetate of formula I from Taxus wallichiana tissue cultures which comprises : (a) inoculation of explants on different media compositions supplemented with combinations of auxins (1-5 mg/l) and cytokinins (0.1-1.0 mg/l); (b) incubation of the cultures under continuous light or dark conditions for 4-6 weeks for callus cultures followed by subculturing at 4-6 weeks intervals; (c) harvesting of the calli at different growth phases ranging from 12-36 months; (d) extraction of fresh pulverized calli with polar solvents at room temperature; (e) evaporating the solvent to give a residue; and partitioning of the residue between water and chlorinated solvents and evaporating the solvent to a semisolid mass; (f) subjecting the resultant mass to column chromatography over suitable adsorbent and (g) eluting with organic solvent/mixtures of organic solvents to get () catechin penta acetate. 
",COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUMAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;SASHIDHARA KONENI VENKATA;;TRIPATHI VINAYAK;;KUKREJA ARUN KUMAR;;KUMAR SUSHIL;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR,COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (2000-07-20),https://lens.org/146-969-146-507-183,Granted Patent,yes,1,2,5,5,0,C07D311/60;;C07D311/60,C07D311/60;;C12P17/06;;C12N1/00;;C12N5/02;;C12R1/91,549/403,12,8,124-437-014-753-205;;042-222-971-281-173;;057-779-849-768-976;;082-320-331-986-028;;022-037-404-682-296;;118-769-693-026-66X;;092-981-933-230-472;;012-453-218-625-052,10.1016/0031-9422(93)85231-f;;10.1016/s0031-9422(98)00426-9;;10.1016/s0031-9422(00)90397-2;;10.1016/0031-9422(92)80267-i;;10.1007/bf00039697;;10.1016/0031-9422(81)83001-4;;10.1055/s-2006-957424;;9581525;;10.1016/0031-9422(89)80191-8,"Cahttopadhyay, et al., 1999, National Institute of Science Comm., 38B(2), 246-247.*;;Sigma Plant Cell Culture Catalogue, 1991-1992, pp. 7-11.;;S. Banerjee et al., ""Taxanes from in vitro cultures of the himalayan yew taxus wallachiana,"" Medical vol. 62, pp. 333-335, 1996.;;F. Trotin et al., ""Flavanol production of fagopyrum esculetum hairy and normal root cultures,"" Phytochemistry, vol. 32, No. 4, pp. 929-931, 1993.;;Kahn Ono et al., ""Catechin production in cultured poygonum hydropiper cells,"" Phytochemistry, vol. 49, No. 7, pp. 1935-1938, 1998.;;T. Bahorun et al., ""Comparative polyphenolic productions in crataegus monegyna callus cultures,"" Phytochemistry, vol. 3y7, No. 5, pp. 1273-1276, 1994.;;Y. Moumou et al., ""Catechin production by callus cultures of Fogopyrum esculentum"", Phytochemistry, vol. 31, No. 4, pp. 1239-1241, 1992.;;Mondher Jaziri et al., ""Taxus sp. Cell, tissue and organ cultures as alternative sources for taxoids production: a literature survey,"" Plant Cell, Tissue and Organ Culture 46:59-75, 1996.;;Eckhard Wollenweber et al., ""Occurrence and distribution of free flavonoid aglycones in plants,"" Phytochemistry, vol. 20, No. 5, pp. 869-932, 1981.;;S. Jha et al., ""Improved Taxol Yield in Cell Suspension Culture of Taxus wallichiana (Himalayan Yew),"" Plant Medica, vol. 64, pp. 270-272, 1998.;;Khoon-Huat law et al., ""Production of (-) Epicatechin by Uncaria Elliptica Callus Cultures,"" Phytochemistry, vol. 28, No. 4, pp. 1099-1100, 1989.;;Cahttopadhyay, et al., 1999, National Institute of Science Comm., 38B(2), 246-247.",EXPIRED
380,IT,A0,IT RM20000235 A0,103-656-597-223-676,2000-05-03,2000,IT RM20000235 A,2000-05-03,IT RM20000235 A,2000-05-03,PROCEDIMENTO PER LA PRODUZIONE DI PENTA ACETATO DI CATECHINA (+) STABILE UTILE COME PRECURSORE PER LA PRODUZIONE DI CATECHINA (+).,,CONCIL OF SCIENT AND IND RES,CHATTOPADHYAY SUNIL KUMAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;SASHIDHARA KONENI VENKATA;;TRIPATHI VINAYAK;;KUKREJA ARUN KUMAR;;KUMAR SUSHIL;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR,,https://lens.org/103-656-597-223-676,Patent Application,no,0,0,3,3,0,,C07D/;;C12N/,,0,0,,,,EXPIRED
381,IT,B1,IT 1317023 B1,077-736-097-728-511,2003-05-26,2003,IT RM20000235 A,2000-05-03,IT RM20000235 A,2000-05-03,"Production of catechin from Taxus wallichiana cultures involves inoculation and incubation of cultures, followed by extraction with polar solvent","Production of (+) catechin (I) from Taxus wallichiana tissue cultures involves inoculation of explants on a culture medium supplemented with a combination of auxins and cytokinins, incubation of the cultures and extraction of fresh pulverized calli with polar solvents at room temperature. Production of a biologically active phenolic compound (+) catechin (I) from Taxus wallichiana tissue cultures comprises: (a) inoculation of explants on a culture medium supplemented with combination of auxins and cytokinins; (b) incubating the cultures under continuous light or dark conditions for 4-6 weeks for callus initiation followed by subculturing at 4-6 weeks intervals; (c) extraction of fresh pulverized calli with polar solvents at room temperature; (d) evaporating the solvent to obtain a residue, and (e) treating the residue with a chlorinated solvent and isolation of (I) by filtration.",COUNCIL SCIENT IND RES,CHATTOPADHYAY SUNIL KUMAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;SASHIDHARA KONENI VENKATA;;TRIPATHI VINAYAK;;KUKREJA ARUN KUMAR;;KUMAR SUSHIL;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR,,https://lens.org/077-736-097-728-511,Granted Patent,no,0,0,3,3,0,,C07D/;;C12N/,,0,0,,,,EXPIRED
382,IT,A1,IT RM20000235 A1,079-260-251-846-236,2001-11-05,2001,IT RM20000235 A,2000-05-03,IT RM20000235 A,2000-05-03,PROCEDIMENTO PER LA PRODUZIONE DI PENTA ACETATO DI CATECHINA (+) STABILE UTILE COME PRECURSORE PER LA PRODUZIONE DI CATECHINA (+).,,CONCIL OF SCIENT AND IND RES,CHATTOPADHYAY SUNIL KUMAR;;BANERJEE SUCHITRA;;AGARWAL SHIPRA;;SASHIDHARA KONENI VENKATA;;TRIPATHI VINAYAK;;KUKREJA ARUN KUMAR;;KUMAR SUSHIL;;KULSHRESTHA MANISH;;SHARMA RAM PRAKASH;;MEHTA VIJAY KUMAR,,https://lens.org/079-260-251-846-236,Patent Application,no,0,0,3,3,0,,C07D/;;C12N/,,0,0,,,,EXPIRED
383,US,A1,US 2020/0396306 A1,123-968-395-862-419,2020-12-17,2020,US 201916528006 A,2019-07-31,US 201916528006 A;;US 201962860981 P,2019-06-13,APPARATUSES AND METHODS FOR A DISTRIBUTED MESSAGE SERVICE IN A VIRTUALIZED COMPUTING SYSTEM,"Examples of a distributed message service include a virtualized file system including a virtual disk configured to store messages for a message topic, and a broker logically allocated to the message topic. The broker is configured to cause a message directed to the message topic provided from a publisher to be stored at the virtual disk, and to route the message to a subscriber of the message topic that is registered with the broker. The distributed message service further includes an operating system configured to manage the virtualized file system and includes a message service configured to manage logical allocation of the broker and manage allocation of the virtual disk to the message topic.",NUTANIX INC,JALTADE AMOD VILAS;;JALTADE ADITYA VILAS;;KAMAT CHINMAY DINESH;;ALLURI GOWTHAM;;AGARWAL HARSHIT;;GUPTA KARAN;;SADAVARTE MAYUR VIJAY;;SHAH MONIL DEVANG;;RAMACHANDRAN PARTHA;;BOLLA RAMYA,NUTANIX INC (2019-08-05),https://lens.org/123-968-395-862-419,Patent Application,yes,0,8,1,1,0,G06F16/182;;G06F9/542;;G06F9/546;;H04L69/40;;G06F9/45558;;G06F2009/45579;;G06F2009/4557;;H04L67/562;;G06F2009/45579;;G06F9/5077;;G06F9/45558;;H04L67/562,H04L29/08;;G06F9/455;;G06F9/50,,0,0,,,,DISCONTINUED
384,WO,A3,WO 2009/032856 A3,143-097-664-733-637,2009-05-07,2009,US 2008/0075143 W,2008-09-03,US 89940107 A,2007-09-04,CUSTOMIZED TODAY MODULE,"A method and apparatus for customizing content presented to individual users or user segments is provided. There may be three components, a web portal and toolbar component, a modeling component, and a scoring component. The web portal and toolbar component presents content items and collects data. The web portal and toolbar component generates user event data based on the user actions. The user event data is forwarded to the modeling component. The modeling component generates content scoring functions based on user event data and attributes of content items. Content scoring functions may be unique to individual user segments. The content scoring functions based on content features generate probability a content item will be viewed. The scoring component decides which content items are placed in a portal. The scoring component uses the scoring functions generated by the modeling component to rank content items in real time.",YAHOO INC;;AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY;;RAMAKRISHNAN RAGHU;;ROY HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY;;RAMAKRISHNAN RAGHU;;ROY HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,,https://lens.org/143-097-664-733-637,Search Report,yes,6,0,6,6,0,G06Q30/02;;G06Q30/02,G06Q50/00,,0,0,,,,PENDING
385,WO,A2,WO 2009/032856 A2,141-495-772-002-293,2009-03-12,2009,US 2008/0075143 W,2008-09-03,US 89940107 A,2007-09-04,CUSTOMIZED TODAY MODULE,"A method and apparatus for customizing content presented to individual users or user segments is provided. There may be three components, a web portal and toolbar component, a modeling component, and a scoring component. The web portal and toolbar component presents content items and collects data. The web portal and toolbar component generates user event data based on the user actions. The user event data is forwarded to the modeling component. The modeling component generates content scoring functions based on user event data and attributes of content items. Content scoring functions may be unique to individual user segments. The content scoring functions based on content features generate probability a content item will be viewed. The scoring component decides which content items are placed in a portal. The scoring component uses the scoring functions generated by the modeling component to rank content items in real time.",YAHOO INC;;AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY;;RAMAKRISHNAN RAGHU;;ROY HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY;;RAMAKRISHNAN RAGHU;;ROY HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,,https://lens.org/141-495-772-002-293,Patent Application,yes,0,1,6,6,0,G06Q30/02;;G06Q30/02,G06Q50/00,,0,0,,,,PENDING
386,AU,A4,AU 2021/102701 A4,100-989-373-579-426,2021-11-04,2021,AU 2021/102701 A,2021-05-19,AU 2021/102701 A,2021-05-19,A SYSTEM FOR GENES EXPRESSION CLASSIFICATION AND A METHOD THEREOF,"A system for classification of gene expressions, comprises of:a dataset 102 comprising of microarray gene expression data, wherein the dataset 102 module comprises of a training data module 104 and a testing data module 106, wherein the training data module 104 takes input from the dataset 102 and forms a plurality of input nodes, wherein each node is assigned a weight for predicting the gene expressions, wherein the testing data module 106 evaluates accuracy of the training data module 104, and at least two deep learning modules 108, comprises of a sigmoid function for classifying the gene expressions in to a plurality of classes, wherein the sigmoid function is optimized to predict the presence of a cancer cell from the gene expressions using a binary value of 0 or 1, wherein the binary value represents the presence of the cancer cell. TRAINING DATAMODULE TESTING DATA MODULE LEARNING MODULE storing a plurality of input data containing microarray gene expressions using a dataset 102 comprising of microarray gene expression data, wherein dividing the dataset 102 module into a training data module 104 and a testing data module 106, wherein the training data module 104 takes 202 input from the dataset 102 and forms a plurality of input nodes, wherein each node is assigned a weight for predicting the gene expressions, wherein the testing data module 106 evaluates accuracy of the training data module 104 classifying the gene expressions using at least two deep learning modules 108, each connected to the training data module 104 and the testing data module 106, wherein the classification of the gene expression is performed using a sigmoid function in to a plurality of classes, wherein the sigmoid function is optimized to predict the presence of a cancer cell from the gene expressions using a 204 binary value of 0 or 1, wherein the binary value represents the presence of the cancer cell Sigmoid IOptimizaton Training aigFunction Accuracy Micro array gene ~ taD expression data Testing Fucin Optimizaton Dat- & Prediction -W Testing Accuracy",AGARWAL NEHA DR;;AKHEELA KHANUM MOHAMMADI DR;;ANUDEEP RAVILISETTY MR;;BHARDWAJ ANURAG MR;;GOSWAMI ANJALI DR;;KALITA KANDARPA MR;;KUMAR DUBEY KAMLESH DR;;KUMAR MOHIT MR;;NAIR RAJIT;;PORWAL ANSHUL MR;;RAJASEKARAN S DR;;SHARMA AMIT KUMAR;;TEWARI ANURAG MR;;VENUGOPAL VIJAY,KUMAR MOHIT;;VENUGOPAL VIJAY;;AKHEELA KHANUM MOHAMMADI;;PORWAL ANSHUL;;TEWARI ANURAG;;KUMAR DUBEY KAMLESH;;BHARDWAJ ANURAG;;GOSWAMI ANJALI;;KALITA KANDARPA;;AGARWAL NEHA;;SHARMA AMIT KUMAR;;ANUDEEP RAVILISETTY;;RAJASEKARAN S;;NAIR RAJIT,,https://lens.org/100-989-373-579-426,Limited Patent,no,0,0,1,1,0,G06N3/02;;G16H50/30;;G06F16/285;;C12Q1/6886;;C12Q2600/112;;G16B25/00;;C12Q1/6837;;G06F18/24147,G06N3/02;;C12Q1/6837;;C12Q1/6886;;G06F16/28;;G06K9/62;;G06N20/10;;G16B25/00;;G16H50/30,,0,0,,,,INACTIVE
387,US,A1,US 2013/0244761 A1,183-840-555-516-448,2013-09-19,2013,US 201313861750 A,2013-04-12,US 201313861750 A;;US 91816010 A;;US 2009/0035938 W;;US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,PRESENTING WAGERING GAME CONTENT IN MULTIPLE WINDOWS,"In some embodiments, a method including determining a first wagering game content and a second wagering game content, wherein the first wagering game content is related to a first wagering game, and wherein the second wagering game content is related to a second wagering game. The method can also include determining, based on priority rules, a first display priority for the first wagering game content, and a second display priority for the second wagering game content. The method can also include presenting, based on the first display priority, the first wagering game content. The method can also include presenting, based on the second display priority, the second wagering game content after the presenting of the first wagering game content, and detecting player inputs. The method can also include assigning priority values to the player inputs, and responding to the player inputs in an order related to the priority values.",WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-03-11),https://lens.org/183-840-555-516-448,Patent Application,yes,13,7,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,G07F17/32,463/25,0,0,,,,ACTIVE
388,US,B2,US 8430741 B2,039-765-105-324-168,2013-04-30,2013,US 91816009 A,2009-03-03,US 91816009 A;;US 5427008 P;;US 4691208 P;;US 3667108 P;;US 3367808 P;;US 2009/0035938 W,2008-03-04,Presenting wagering game content in multiple windows,"Described herein are processes and devices that present wagering game content in multiple windows. One of the devices described is a wagering game system. The wagering game system can receive wagering game content and control information from more than one content provider. The wagering game system can present the content from the various content providers in one or more windows, such as by presenting content from one provider in a main window while presenting content from a second provider in one or more auxiliary windows. The wagering game system can also determine priority information for content displayed in the windows and control the appearance and actions of the windows, or content displayed within the windows, based on the priority information.",AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J;;WMS GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2009-02-10),https://lens.org/039-765-105-324-168,Granted Patent,yes,55,11,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24;;A63F13/00;;G06F17/00;;G06F19/00,463/20;;463/16;;463/40;;463/41;;463/42;;463/43;;715/805,5,0,,,"""PCT Application No. PCT/US09/35938 International Preliminary Report on Patentability"", Mar. 11, 2010 , 13 pages.;;""PCT Application No. PCT/US09/35938 International Search Report"", Apr. 24, 2009 , 8 pages.;;""PCT Application No. PCT/US09/35939 International Preliminary Report on Patentability"", Mar. 29, 2010 , 12 pages.;;""PCT Application No. PCT/US09/35939 International Search Report"", May 4, 2009 , 10 pages.;;""U.S. Appl. No. 12/918,179 Office Action"", Jun. 29, 2012 , 11 pages.",ACTIVE
389,US,A1,US 2011/0028203 A1,131-328-876-510-38X,2011-02-03,2011,US 91816009 A,2009-03-03,US 91816009 A;;US 5427008 P;;US 4691208 P;;US 3667108 P;;US 3367808 P;;US 2009/0035938 W,2008-03-04,PRESENTING WAGERING GAME CONTENT IN MULTIPLE WINDOWS,"Described herein are processes and devices that present wagering game content in multiple windows. One of the devices described is a wagering game system. The wagering game system can receive wagering game content and control information from more than one content provider. The wagering game system can present the content from the various content providers in one or more windows, such as by presenting content from one provider in a main window while presenting content from a second provider in one or more auxiliary windows. The wagering game system can also determine priority information for content displayed in the windows and control the appearance and actions of the windows, or content displayed within the windows, based on the priority information.",AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2009-02-10),https://lens.org/131-328-876-510-38X,Patent Application,yes,52,78,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24,463/20;;463/43;;463/42,0,0,,,,ACTIVE
390,US,B2,US 9336649 B2,053-620-980-618-359,2016-05-10,2016,US 201313861750 A,2013-04-12,US 201313861750 A;;US 91816010 A;;US 2009/0035938 W;;US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,Present wagering game content in multiple windows,"In some embodiments, a method including determining a first wagering game content and a second wagering game content, wherein the first wagering game content is related to a first wagering game, and wherein the second wagering game content is related to a second wagering game. The method can also include determining, based on priority rules, a first display priority for the first wagering game content, and a second display priority for the second wagering game content. The method can also include presenting, based on the first display priority, the first wagering game content. The method can also include presenting, based on the second display priority, the second wagering game content after the presenting of the first wagering game content, and detecting player inputs. The method can also include assigning priority values to the player inputs, and responding to the player inputs in an order related to the priority values.",BALLY GAMING INC,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-03-11),https://lens.org/053-620-980-618-359,Granted Patent,yes,71,0,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24;;G07F17/32,,10,0,,,"""AU Application No. 2009221922 Examination Report"", Apr. 8, 2013 , 2 pages.;;""PCT Application No. PCT/US09/35938 International Preliminary Report on Patentability"", Mar. 11, 2010 , 13 pages.;;""PCT Application No. PCT/US09/35938 International Search Report"", Apr. 24, 2009 , 8 pages.;;""PCT Application No. PCT/US09/35939 International Preliminary Report on Patentability"", Mar. 29, 2010 , 12 pages.;;""PCT Application No. PCT/US09/35939 International Search Report"", May 4, 2009 , 10 pages.;;""U.S. Appl. No. 12/918,160 Office Action"", Apr. 23, 2012 , 16 pages.;;""U.S. Appl. No. 12/918,179 Final Office Action"", Mar. 15, 2013 , 14 pages.;;""U.S. Appl. No. 12/918,179 Office Action"", Jun. 29, 2012 , 11 pages.;;""U.S. Appl. No. 14/134,947 Office Action"", Jun. 26, 2015, 12 Pages.;;U.S. Appl. No. 14/134,947 Final Office Action, Jan. 11, 2016, 11 pages.",ACTIVE
391,AU,B2,AU 2009/221922 B2,120-704-305-461-980,2014-04-17,2014,AU 2009/221922 A,2009-03-03,US 3367808 P;;US 3667108 P;;US 5427008 P;;US 4691208 P;;US 2009/0035938 W,2008-03-04,Presenting wagering game content in multiple windows,"Described herein are processes and devices that present wagering game content in multiple windows. One of the devices described is a wagering game system. The wagering game system can receive wagering game content and control information from more than one content provider. The wagering game system can present the content from the various content providers in one or more windows, such as by presenting content from one provider in a main window while presenting content from a second provider in one or more auxiliary windows. The wagering game system can also determine priority information for content displayed in the windows and control the appearance and actions of the windows, or content displayed within the windows, based on the priority information.",BALLY GAMING INC,BUCHHOLZ DALE R;;PARRA JACQUELINE F;;DINOVO TIMOTHY F;;HALPRIN JAMES S;;GANGADHARAN MAGESH;;WARD MATTHEW J;;AGARWAL VIJAY K;;BURKE MARY M;;PACE MARK C;;PRYOR DAVID M;;GRABIEC JACEK A,"BALLY GAMING, INC. (2016-11-17)",https://lens.org/120-704-305-461-980,Granted Patent,no,1,0,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24,,0,0,,,,ACTIVE
392,WO,A2,WO 2009/111514 A2,100-311-700-992-586,2009-09-11,2009,US 2009/0035938 W,2009-03-03,US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,PRESENTING WAGERING GAME CONTENT IN MULTIPLE WINDOWS,"Described herein are processes and devices that present wagering game content in multiple windows. One of the devices described is a wagering game system. The wagering game system can receive wagering game content and control information from more than one content provider. The wagering game system can present the content from the various content providers in one or more windows, such as by presenting content from one provider in a main window while presenting content from a second provider in one or more auxiliary windows. The wagering game system can also determine priority information for content displayed in the windows and control the appearance and actions of the windows, or content displayed within the windows, based on the priority information.",WMS GAMING INC;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,,https://lens.org/100-311-700-992-586,Patent Application,yes,0,7,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F13/10,,0,0,,,,PENDING
393,AU,A1,AU 2009/221922 A1,117-076-490-093-928,2009-09-11,2009,AU 2009/221922 A,2009-03-03,US 3367808 P;;US 3667108 P;;US 5427008 P;;US 4691208 P;;US 2009/0035938 W,2008-03-04,Presenting wagering game content in multiple windows,,WMS GAMING INC,PACE MARK C;;GRABIEC JACEK A;;WARD MATTHEW J;;GANGADHARAN MAGESH;;PARRA JACQUELINE F;;HALPRIN JAMES S;;PRYOR DAVID M;;BUCHHOLZ DALE R;;AGARWAL VIJAY K;;DINOVO TIMOTHY F;;BURKE MARY M,"BALLY GAMING, INC. (2016-11-17)",https://lens.org/117-076-490-093-928,Patent Application,no,0,0,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24,,0,0,,,,ACTIVE
394,WO,A3,WO 2009/111514 A3,145-484-728-811-597,2010-01-07,2010,US 2009/0035938 W,2009-03-03,US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,PRESENTING WAGERING GAME CONTENT IN MULTIPLE WINDOWS,"Described herein are processes and devices that present wagering game content in multiple windows. One of the devices described is a wagering game system. The wagering game system can receive wagering game content and control information from more than one content provider. The wagering game system can present the content from the various content providers in one or more windows, such as by presenting content from one provider in a main window while presenting content from a second provider in one or more auxiliary windows. The wagering game system can also determine priority information for content displayed in the windows and control the appearance and actions of the windows, or content displayed within the windows, based on the priority information.",WMS GAMING INC;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,,https://lens.org/145-484-728-811-597,Search Report,yes,3,0,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24,,0,0,,,,PENDING
395,US,A1,US 2009/0063984 A1,040-441-303-040-603,2009-03-05,2009,US 89940107 A,2007-09-04,US 89940107 A,2007-09-04,Customized today module,"A method and apparatus for customizing content presented to individual users or user segments is provided. There may be three components, a web portal and toolbar component, a modeling component, and a scoring component. The web portal and toolbar component presents content items and collects data. The web portal and toolbar component generates user event data based on the user actions. The user event data is forwarded to the modeling component. The modeling component generates content scoring functions based on user event data and attributes of content items. Content scoring functions may be unique to individual user segments. The content scoring functions based on content features generate probability a content item will be viewed. The scoring component decides which content items are placed in a portal. The scoring component uses the scoring functions generated by the modeling component to rank content items in real time.",AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY HOWARD SCOTT;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY HOWARD SCOTT;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,YAHOO! INC (2016-05-31);;EXCALIBUR IP LLC (2016-05-31);;R2 SOLUTIONS LLC (2020-04-28),https://lens.org/040-441-303-040-603,Patent Application,yes,21,25,6,6,0,G06Q30/02;;G06Q30/02,G06F3/048,715/733,0,0,,,,ACTIVE
396,TW,A,TW 200925970 A,099-242-923-205-105,2009-06-16,2009,TW 97130769 A,2008-08-13,US 89940107 A,2007-09-04,Customized today module,"A method and apparatus for customizing content presented to individual users or user segments is provided. There may be three components, a web portal and toolbar component, a modeling component, and a scoring component. The web portal and toolbar component presents content items and collects data. The web portal and toolbar component generates user event data based on the user actions. The user event data is forwarded to the modeling component. The modeling component generates content scoring functions based on user event data and attributes of content items. Content scoring functions may be unique to individual user segments. The content scoring functions based on content features generate probability a content item will be viewed. The scoring component decides which content items are placed in a portal. The scoring component uses the scoring functions generated by the modeling component to rank content items in real time.",YAHOO INC,AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY SCOTT HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDER;;PHADKE AMIT;;SALISBURY MICHAEL,,https://lens.org/099-242-923-205-105,Patent of Addition,no,0,0,6,6,0,G06Q30/02;;G06Q30/02,G06F3/048,,0,0,,,,INACTIVE
397,TW,B,TW I412991 B,158-278-094-740-583,2013-10-21,2013,TW 97130769 A,2008-08-13,US 89940107 A,2007-09-04,Customized today module,,YAHOO INC,AGARWAL DEEPAK;;CHEN BEE CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY SCOTT HOWARD;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDER;;PHADKE AMIT;;SALISBURY MICHAEL,,https://lens.org/158-278-094-740-583,Granted Patent,no,4,0,6,6,0,G06Q30/02;;G06Q30/02,,,0,0,,,,INACTIVE
398,US,B2,US 8065619 B2,120-649-902-961-036,2011-11-22,2011,US 89940107 A,2007-09-04,US 89940107 A,2007-09-04,Customized today module,"A method and apparatus for customizing content presented to individual users or user segments is provided. There may be three components, a web portal and toolbar component, a modeling component, and a scoring component. The web portal and toolbar component presents content items and collects data. The web portal and toolbar component generates user event data based on the user actions. The user event data is forwarded to the modeling component. The modeling component generates content scoring functions based on user event data and attributes of content items. Content scoring functions may be unique to individual user segments. The content scoring functions based on content features generate probability a content item will be viewed. The scoring component decides which content items are placed in a portal. The scoring component uses the scoring functions generated by the modeling component to rank content items in real time.",AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY HOWARD SCOTT;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL;;YAHOO INC,AGARWAL DEEPAK;;CHEN BEE-CHUNG;;ELANGO PRADHEEP;;MOTGI NITIN;;NARAYANAN VIJAY K;;RAMAKRISHNAN RAGHU;;ROY HOWARD SCOTT;;SETH AMITABH;;SINGH VIK;;ZACHARIAH JOE;;ISRANI SHARAT;;THRALL JOHN;;VENKATARAMAN CHANDAR;;PHADKE AMIT;;SALISBURY MICHAEL,YAHOO! INC (2016-05-31);;EXCALIBUR IP LLC (2016-05-31);;R2 SOLUTIONS LLC (2020-04-28),https://lens.org/120-649-902-961-036,Granted Patent,yes,21,8,6,6,0,G06Q30/02;;G06Q30/02,G06F3/00,715/742;;715/744;;715/745,3,0,,,"""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration"" received in corresponding International application No. PCT/US2008/075143 dated Feb. 25, 2009 (11 pages).;;International Searching Authority, International Search Report for PCT application No. PCT/US2010/041960 with written Opinion dated Feb. 18, 2011, 9 pages.;;Current claims for PCT application No. PCT/US2010/041960, 4 pgs.",ACTIVE
399,WO,A3,WO 2009/111515 A3,073-390-484-913-396,2010-01-07,2010,US 2009/0035939 W,2009-03-03,US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,CONTROLLING WAGERING TRANSACTIONS FOR MULTI-PROVIDER GAME CONTENT,Described herein are processes and devices that control wagering transactions for multi-provider game content. One of the devices described is a wagering game system. The wagering game system can process a plurality of wagering games from multiple wagering game providers on a single wagering game machine during a single wagering game session. The system can communicate wagering transaction information for the plurality of wagering games between the wagering game machine and an account server. The wagering game system can synchronize a session funds balance on the wagering game machine with an account balance on the account server. The system can utilize different modes of synchronizing the account information for the multiple wagering games.,WMS GAMING INC;;ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,,https://lens.org/073-390-484-913-396,Search Report,yes,2,0,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24,,0,0,,,,PENDING
400,US,A1,US 2014/0106865 A1,048-922-914-895-510,2014-04-17,2014,US 201314134947 A,2013-12-19,US 201314134947 A;;US 91817910 A;;US 2009/0035939 W;;US 3367808 P;;US 3667108 P;;US 5427008 P;;US 4691208 P,2008-03-04,Funding concurrent wagering games,"Described herein are processes and devices that perform operations that, in some embodiments, include receiving a request for concurrent presentation of a first wagering game and a second wagering game via a display device of a wagering game machine. The first wagering game includes first content that originates from a first content source, and the second wagering game includes second content that originates from a second content source. The operations further include accessing funds associated with the first wagering game. The operations further include funding one or more wagers for the second wagering game using at least a portion of the accessed funds associated with the first wagering game.",WMS GAMING INC,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-05-22),https://lens.org/048-922-914-895-510,Patent Application,yes,1,5,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,G07F17/32,463/25,0,0,,,,ACTIVE
401,US,A1,US 2011/0009188 A1,116-301-957-771-959,2011-01-13,2011,US 91817909 A,2009-03-03,US 91817909 A;;US 367807 P;;US 3667108 P;;US 4691208 P;;US 5427008 P;;US 2009/0035939 W,2007-11-20,CONTROLLING WAGERING TRANSACTIONS FOR MULTI-PROVIDER GAME CONTENT,Described herein are processes and devices that control wagering transactions for multi-provider game content. One of the devices described is a wagering game system. The wagering game system can process a plurality of wagering games from multiple wagering game providers on a single wagering game machine during a single wagering game session. The system can communicate wagering transaction information for the plurality of wagering games between the wagering game machine and an account server. The wagering game system can synchronize a session funds balance on the wagering game machine with an account balance on the account server. The system can utilize different modes of synchronizing the account information for the multiple wagering games.,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,SG GAMING INC (2015-06-29);;WMS GAMING INC (2008-05-22),https://lens.org/116-301-957-771-959,Patent Application,yes,52,52,1,13,0,G07F17/32;;G07F17/323;;G07F17/3262;;G07F17/3262;;G07F17/323;;G07F17/32,A63F9/24,463/25;;463/43,0,0,,,,DISCONTINUED
402,WO,A2,WO 2009/111515 A2,029-137-042-952-852,2009-09-11,2009,US 2009/0035939 W,2009-03-03,US 3367808 P;;US 3667108 P;;US 4691208 P;;US 5427008 P,2008-03-04,CONTROLLING WAGERING TRANSACTIONS FOR MULTI-PROVIDER GAME CONTENT,Described herein are processes and devices that control wagering transactions for multi-provider game content. One of the devices described is a wagering game system. The wagering game system can process a plurality of wagering games from multiple wagering game providers on a single wagering game machine during a single wagering game session. The system can communicate wagering transaction information for the plurality of wagering games between the wagering game machine and an account server. The wagering game system can synchronize a session funds balance on the wagering game machine with an account balance on the account server. The system can utilize different modes of synchronizing the account information for the multiple wagering games.,WMS GAMING INC;;ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,,https://lens.org/029-137-042-952-852,Patent Application,yes,0,10,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F13/10,,0,0,,,,PENDING
403,US,B2,US 9443385 B2,025-923-290-755-906,2016-09-13,2016,US 201314134947 A,2013-12-19,US 201314134947 A;;US 91817910 A;;US 2009/0035939 W;;US 3367808 P;;US 3667108 P;;US 5427008 P;;US 4691208 P,2008-03-04,Funding concurrent wagering games,"“Described herein are processes and devices that perform operations that, in some embodiments, include receiving a request for concurrent presentation of a first wagering game and a second wagering game via a display device of a wagering game machine. The first wagering game includes first content that originates from a first content source, and the second wagering game includes second content that originates from a second content source. The operations further include accessing funds associated with the first wagering game. The operations further include funding one or more wagers for the second wagering game using at least a portion of the accessed funds associated with the first wagering game.”",WMS GAMING INC;;BALLY GAMING INC,ADIRAJU SRINIVYASA M;;AGARWAL VIJAY K;;BUCHHOLZ DALE R;;BURKE MARY M;;DINOVO TIMOTHY F;;GANGADHARAN MAGESH;;GRABIEC JACEK A;;HALPRIN JAMES S;;PACE MARK C;;PARRA JACQUELINE F;;PRYOR DAVID M;;WARD MATTHEW J,LNW GAMING INC (2015-06-29);;WMS GAMING INC (2008-05-22),https://lens.org/025-923-290-755-906,Granted Patent,yes,72,24,12,13,0,G07F17/3211;;G07F17/3244;;G07F17/3286;;G07F17/3211;;G07F17/3286;;G07F17/3244,A63F9/24;;A63F13/00;;G06F17/00;;G06F19/00;;G07F17/32,,11,0,,,"U.S. Appl. No. 13/861,750, filed Apr. 12, 2013, Agarwal, Vijay K., et al.;;""AU Application No. 2009221922 Examination Report"", Apr. 8, 2013 , 2 pages.;;""PCT Application No. PCT/US09/35938 International Preliminary Report on Patentability"", Mar. 11, 2010 , 13 pages.;;""PCT Application No. PCT/US09/35938 International Search Report"", Apr. 24, 2009 , 8 pages.;;""PCT Application No. PCT/US09/35939 International Preliminary Report on Patentability"", Mar. 29, 2010 , 12 pages.;;""PCT Application No. PCT/US09/35939 International Search Report"", May 4, 2009 , 10 pages.;;""U.S. Appl. No. 12/918,160 Office Action"", Apr. 23, 2012 , 16 pages.;;""U.S. Appl. No. 12/918,179 Final Office Action"", Mar. 15, 2013 , 14 pages.;;""U.S. Appl. No. 12/918,179 Office Action"", Jun. 29, 2012 , 11 pages.;;""U.S. Appl. No. 13/861,750 Office Action"", May 18, 2015, 12 Pages.;;""U.S. Appl. No. 13/861,750 Office Action"", Sep. 15, 2015, 8 Pages.",ACTIVE
404,WO,A1,WO 2019/002407 A1,113-438-022-570-893,2019-01-03,2019,EP 2018067322 W,2018-06-27,IN 201721022621 A,2017-06-28,PROCESS FOR THE PREPARATION OF TIPIRACIL HYDROCHLORIDE,The present invention relates to a process for preparation of tipiracil of formula (I) or salt thereof.,AMNEAL PHARMACEUTICALS COMPANY GMBH,MAHETA ABHAY SUBODHBHAI;;KANERIA ANKUR AMRUTLAL;;BHESANIYA KAPIL DHANJIBHAI;;SAVALIYA BHAVESH LALJIBHAI;;KOILPILLAI JOSEPH PRABAHAR;;AGARWAL VIRENDRA KUMAR;;CHAVAN RAHUL BABURAO;;ARABIANI MOHSIN RAZAKBHAI;;HEDAPARA KALPESH RATILAL;;KATARIYA LALIT KESHAV;;PATEL VIJAY PREMAJIBHAI;;THUMMAR MAHESH KURAJIBHAI;;BHALODIYA RAHUL HARSUKHLAL,,https://lens.org/113-438-022-570-893,Patent Application,yes,15,0,1,1,0,A61P35/00;;C07D403/06;;C07B2200/13,C07D403/06;;A61K31/513;;A61P35/00,,4,3,009-214-187-079-899;;015-413-740-118-320;;018-277-602-507-235,10.1023/a:1016241927429;;7494814;;16247953;;10.1081/ncn-200059790;;10.1081/scc-120002693,"BYRN ET AL.: ""Pharmaceutical Solids: A strategic Approach to Regulatory Considerations"", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1 January 1995 (1995-01-01), US, pages 945 - 954, XP055399407, ISSN: 0724-8741, DOI: 10.1023/A:1016241927429;;WILLIAM K HUBBARD: ""International Conference on Harmonisation; Guidance on Impurities: Residual Solvents (Q3C Impurities)"", FEDERAL REGISTER, VOL. 62, NO. 247, 24 December 1997 (1997-12-24), U.S., pages 67377 - 67388, XP055505999, Retrieved from the Internet <URL:https://www.gpo.gov/fdsys/pkg/FR-1997-12-24/pdf/97-33639.pdf> [retrieved on 20180911];;NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, vol. 24, no. 5-7, 2005, pages 367 - 373;;SYNTHETIC COMMUNICATIONS, vol. 32, no. 6, 2002, pages 851 - 855",PENDING
405,US,P,US PP010935 P,052-739-192-386-675,1999-06-01,1999,US 85576897 V,1997-04-22,US 85576897 V,1997-04-22,Mint plant Mentha arvensis 'Himalaya',"A new and distinct hybrid plant named `Himalaya` (Mentha arvensis) characterized by its higher yield of oil which is rich in menthol, improved regeneration potential, vigorous growth, deep green broad thick leaves, pinkish white flowers and tolerance to rust such as alternaria leaf blight, corynespora leaf spot and powdery mildew.",COUNCIL SCIENT IND RES,KUMAR SUSHIL;;TYAGI BALI RAM;;BAHL JANAK RAJ;;SINGH HARI;;SINGH VIKRAM;;UJAGIR RAM;;KHANUJA SUMAN PREET SINGH;;SHASANY AJIT KUMAR;;SHUKLA RAM SAJIVAN;;SATTAR ABDUL;;SINGH DWIJENDRA;;HASEEB AKHTAR;;SINGH VIJAY PAL;;RAM PALTOO;;SINGH KAMBOD;;SINGH SAUDAN;;SINGH SURENDRA PRATAP;;PATRA NIRMAL KUMAR;;ALAM MANSOOR;;NAQVI ARIF ALI;;RAM MUNI;;AGARWAL KRISHAN KUMAR;;SINGH KAILASH,,https://lens.org/052-739-192-386-675,Plant Patent,yes,0,2,1,1,0,A01H6/504;;A01H6/504,A01H5/02,PLT 259,0,0,,,,PENDING
